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Abstract 
This thesis explores the role of small RNAs as regulators of early vertebrate 
development using the frog species Xenopus laevis and Xenopus tropicalis as 
experimental systems. Firstly, I investigate spatial control of Nodal signalling, which is 
critical for organisation of the vertebrate body plan during gastrulation, by uncovering 
the functional relevance and mechanism of spatial regulation of the Nodal coreceptor 
Cripto-1 in the early X. laevis embryo. Xenopus Cripto-1 (XCR1) mRNA is ubiquitous 
in the early embryo, but the protein is absent in the prospective endoderm, from which 
Nodal signalling originates. Cripto-1 is a stem cell marker and upregulated in many 
cancers and Nodal signalling is reactivated in melanomas and prostate cancer. Therefore 
understanding how control of Nodal signalling and XCR1 regulation is achieved may 
have implications for its misregulation in cancer. I show that spatial regulation of XCR1 
is critical for the location, timing and magnitude of Nodal signalling in the early 
Xenopus embryo. Spatial regulation occurs at the level of translational repression, is 
dependent on the 3’ UTR and the microRNA-processing enzyme Dicer and is abolished 
by mutating four nucleotides in the minimal regulatory region of the 3’ UTR. I show 
that XCR1 is negatively regulated by xla-miR-427 in a 3’ UTR-independent 
mechanism, adding to recent research in Xenopus and zebrafish showing microRNA 
control of Nodal signalling at the ligand, receptor and antagonist level.  
Whilst studying Xenopus Cripto-1, it became clear that relatively little was known 
about microRNAs in early vertebrate development. To fill this void, I performed 
genome-wide sequencing of all small RNAs expressed in the early X. tropicalis embryo 
at three stages of development. This revealed dynamic and localised expression of 
hundreds of microRNAs in the early embryo and the presence of Piwi-interacting RNA 
sequences. Extensive validation of the small RNA-seq dataset is presented, and novel 
microRNAs and a novel class of intronic small RNAs are uncovered within the 95 % of 
the early vertebrate embryo small RNAome that was previously uncharacterised.  
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RNAi- RNA interference 
R-Smad- receptor-regulated Smad 
SARA- Smad anchor for receptor activation 
SDS- sodium dodecyl sulfate 
SINE- short interspersed nuclear element 
siRNA- small interfering RNA 
SSC- saline sodium citrate 
SSPE- sodium chloride sodium phosphate- EDTA  
TAE- Tris-acetate-EDTA 
Taq- Thermus aquaticus 
TBE- Tris-borate-EDTA 
TCF3- transcription factor 3 
TDGF1- teratocarcinoma-derived growth factor 1 
tdrd7- tudor domain containing protein 7 
TE- Tris-EDTA 
TEMED- tetramethylethylenediamine 
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TGF-β- transforming growth factor-β 
TNF-α -tumour necrosis factor-α 
TTP- tristetrapolin 
U6- spliceosomal small RNA U6  
uPA- urokinase plasminogen activator 
3’ UTR- 3’ untranslated region 
VEGF- vascular endothelial growth factor 
XCR1- Xenopus Cripto-1 
Xnr- Xenopus Nodal-related 
ZEB1- zinc finger E-box binding homeobox 1 
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Chapter 1. Introduction 
The initial aim of this thesis was to understand the mechanism of spatial regulation of 
Xenopus Cripto-1 (XCR1), a coreceptor for the TGF-β superfamily member, Nodal. 
This led to further investigation of potential regulators of XCR1 that can modulate gene 
expression via the 3’ UTR including microRNAs and RNA-binding proteins. In this 
chapter I will introduce the Xenopus embryo as a model for understanding signalling 
events that control early vertebrate development and explore the roles that regulators 
such as ligands of the TGF-β superfamily, Cripto co-receptors, small RNAs and RNA-
binding proteins play to regulate gene expression in early development.  
1.1 Spatial regulation of transcription and protein localisation 
specify and pattern the germ layers of the early Xenopus 
embryo 
During gastrulation, the embryo changes from a ball of cells to a structure containing 
three layers by morphogenetic cell movements. The three ‘germ layers’ are the 
endoderm, mesoderm and ectoderm. The innermost layer is the endoderm, which 
becomes the epithelial lining of the gut and lungs and organs such as the liver and 
pancreas. Mesodermal derivatives form from the middle layer and include the 
notochord, blood, somites, head mesoderm, the heart, blood vessels and limbs. The skin 
and nervous system form from the outermost layer, the ectoderm (Moody, 1987). Germ 
layer formation and patterning in Xenopus requires signalling events along two 
embryonic axes: the animal-vegetal axis and the dorsal-ventral axis (Figure 1.1).  
The animal-vegetal axis is determined by the structure of the egg, which consists of a 
pigmented animal hemisphere and a yolky vegetal hemisphere. In contrast, the dorsal-
ventral axis is established at fertilisation. The point of sperm entry on the egg defines 
the future location of the dorsal lip of the blastopore directly opposite the point of sperm 
entry (Gerhart et al., 1989), and is where the prospective mesoderm and endoderm will 
start to involute during gastrulation. Transcription from the newly formed zygotic 
genome does not begin until the mid-blastula transition (embryonic stage 9) and 
maternal mRNAs and proteins are expressed up until this point (Newport and 
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Kirschner, 1982a, b). Transcriptional activation at the mid-blastula transition in 
Xenopus and zebrafish correlates with the acquisition of the activatory trimethylated 
H3K4 histone mark (Akkers et al., 2009; Vastenhouw et al., 2010). Maternal mRNAs 
are cleared at the mid-blastula transition by miR-427 in Xenopus and in zebrafish, by 
the corresponding homologue, miR-430 (Lund et al., 2009; Giraldez et al., 2006).  
Sperm entry also initiates rotation of the vegetal cortex (a layer of actin filaments) 
away from the sperm entry point and towards the future dorsal region by 30°(Schroeder 
and Gard, 1992). Cortical rotation requires microtubule polymerisation and is blocked 
by UV light or microtubule polymerisation inhibitors (Elinson and Rowning, 1988; 
Scharf and Gerhart, 1983). Cortical rotation leads to the accumulation of the 
transcriptional cofactor β-catenin in the future dorsal region of the embryo (Rowning et 
al., 1997). Nuclear β-catenin interacts with the transcription factor Tcf3 to regulate 
target gene expression (Moon and Kimelman, 1998). mRNA of the transcription factor 
VegT is vegetally localised in the oocyte, leading to vegetal expression of maternal 
VegT protein, which induces expression of Xenopus Nodal-related TGF-β ligands 
(Xnrs)(Zhang and King, 1996). The overlapping zone of dorsal β-catenin and vegetal 
VegT expression forms the Nieuwkoop centre, which initiates expression of Xnr5 and 
Xnr6 when zygotic transcription begins (Takahashi et al., 2000). Expression of Xnr1, 2, 
and 4 is also enriched dorsally (Agius et al., 2000). This is assumed to create a gradient 
from high Nodal ligand levels in the vegetal dorsal region to low Nodal ligand levels on 
the opposing ventral side of the embryo. 
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Figure 1.1 Germ layer specification and patterning requires spatial control of 
TGF-β  superfamily signalling across the animal-vegetal and dorsal-ventral 
embryonic axes in the early Xenopus embryo 
Schematic lateral view of a stage 10 Xenopus embryo showing the prospective 
endoderm, mesoderm and ectoderm. Vegetal Xnr signalling is shown in blue, and the 
gradient indicates the dorsal-ventral concentration gradient of Xnrs established by the 
Nieuwkoop centre. Xnrs are also expressed in mesoderm. The Nieuwkoop centre 
induces the Spemann organiser, which secretes the BMP antagonists chordin, noggin 
and follistatin (shown in green). These inhibitors are diffusible and act over a long 
range to establish a gradient of BMP ligand activity that is higher on the ventral side 
than the dorsal side (orange gradient). High ventral BMP activity in the prospective 
ectoderm specifies an epidermal cell fate, whereas low BMP activity on the dorsal side 
specifies neural tissue (shown by grey arrows).  
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Nodal ligands are required for patterning mesoderm and are transduced to the nucleus 
by phosphorylated Smad2 (Figure 1.2 and section 1.1.2 for a detailed discussion of the 
pathway). If Nodal ligands are bound by an artificial extracellular inhibitor, Cerberus-
short (Piccolo et al., 1999), mesoderm specification is blocked and endodermal markers 
are downregulated (Engleka et al., 2001; Piccolo et al., 1999). An activity gradient of 
Nodal ligands that is high on the dorsal side and lower on the ventral side is thought to 
lead to a variety of endodermal cell fates along the dorsal-ventral axis in the prospective 
endoderm (Figure 1.1), although it is not known whether a linear dose-response 
relationship is obeyed as reported for the TGF-β ligand Activin (Gurdon et al., 1994). 
Activation of the transcription factor sox17α by vegetal VegT is thought to prevent 
mesodermal gene expression in the prospective endoderm in response to Nodal signals 
(Engleka et al., 2001).  
The Nieuwkoop centre establishes the Spemann Organiser above the dorsal lip of the 
blastopore by secretion of a diffusible signal thought to be Wnt11 (Tao et al., 2005). 
When the Spemann Organiser is excised and grafted onto the opposing ventral side of 
another embryo, a secondary body axis forms, demonstrating the powerful inductive 
capacity of the region (Spemann and Mangold, 2001). The homeobox transcription 
factor goosecoid is expressed in the organiser region and ventral ectopic expression of 
goosecoid mRNA has the same effect as an organiser graft, suggesting that goosecoid 
plays a major role in controlling gene expression in the organiser (Cho et al., 1991).  
The organiser region secretes antagonists of the TGF-β superfamily ligands, BMPs 
(bone morphogenetic proteins). In Xenopus, BMP2, BMP4 and BMP7 pattern ectoderm 
and mesoderm and are expressed in ectoderm and mesoderm, with BMP4 expression 
higher on the ventral side (Hemmati-Brivanlou and Thomsen, 1995). The mechanism of 
BMP signal transduction to the nucleus is described in Figure 1.2. Secretion of the BMP 
inhibitors chordin, noggin and follistatin from the organiser in the dorsal marginal zone 
antagonises the ventralising activity of BMPs to establish a gradient of BMP ligand 
activity (not concentration) along the dorsal-ventral axis that is high on the ventral side 
and low on the dorsal side (Figure 1.1)(Piccolo et al., 1996; Zimmerman et al., 1996). 
This can be directly observed by immunostaining of phospho-Smad1, the intracellular 
transducer of BMP activity (Faure et al., 2000; Wu et al., 2011). Low BMP activity on 
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the dorsal side of the prospective ectoderm specifies neural tissue, whereas high BMP 
activity specifies epidermal tissue (Wilson and Hemmati-Brivanlou, 1995). A range of 
mesoderm types form along the dorso-ventral BMP gradient (Graff, 1997). Dorsal 
mesoderm derivatives form where BMP activity is low and include head mesoderm and 
notochord. Ventral mesoderm derivatives form where BMP activity is high and include 
muscle and kidney.  
The ventralising activity of BMPs is observed when a late blastula embryo is 
dissected along the dorsal-ventral axis. The dorsal half forms a complete, but smaller 
embryo, whereas the ventral half forms a ‘belly piece’ lacking any dorsal structures 
(Reversade and De Robertis, 2005; Spemann, 1938). The dorsally expressed BMP, 
ADMP, is thought to allow the dorsal half to recover a BMP activity gradient to 
correctly pattern the embryo (Reversade and De Robertis, 2005). The antagonism of 
BMP activity by the organiser is subject to a further layer of regulation by the opposing 
activities of the dorsalising organiser gene goosecoid, and the ventralising BMP target 
gene vent1, which downregulate each other by mutual transcriptional repression 
(Sander et al., 2007). 
In short, spatial control of transcription and protein localisation along the animal-
vegetal and dorsal-ventral axes are required for germ layer formation and patterning in 
the early Xenopus embryo. For example, maternal VegT mRNA localisation, dorsal 
localisation of β-catenin, dorsal Xnr transcription from the Nieuwkoop centre to 
establish the Nodal activity gradient and the Spemann organiser, and subsequent 
establishment of the BMP activity gradient are critical events requiring spatial 
regulation.  
1.1.1 Parallels with other vertebrates 
Spatial control of Nodal signalling along embryonic axes is required for germ layer 
formation in other vertebrate systems including zebrafish, chick and mouse (reviewed in 
(Wu and Hill, 2009; Zorn and Wells, 2009). In general, endoderm is derived from 
Nodal-producing cells leading to mesoderm induction in adjacent cells. In zebrafish, 
signalling events across the dorsal-ventral axis are similar to those in Xenopus, with a 
dorsal organiser region known as the shield establishing the dorsal-ventral BMP activity 
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gradient. The zebrafish Nodal ligands are squint and cyclops, and are produced in a 
marginal layer of cells closest to the yolk in the zebrafish epiblast. During gastrulation, 
marginal cells involute under the epiblast to form the germ layers.  
In contrast to Xenopus and zebrafish, there is one Nodal gene in chick and mouse. 
Again, Nodal signalling is critical for germ layer formation, but is spatially regulated 
across the anterior-posterior axis. Nodal activity is higher in the posterior epiblast cells 
due to antagonism by the inhibitors lefty and cerberus in the anterior cells (see Figure 
1.2). High Nodal activity initiates gastrulation by forming the primitive streak, which is 
where posterior epiblast cells involute to form the germ layers.  
1.1.2 TGF-β signal transduction in early Xenopus development 
As illustrated in Figure 1.2, there are traditionally two main branches of TGF-β 
signalling in Xenopus development, the BMP pathway, and the Activin-related 
pathway. Signalling by the BMP ligands BMP2, 4 and 7 through a Type I and Type II 
receptor complex (ALK3/ALK2 and BMPRII respectively) leads to phosphorylation 
and activation of Smad1 and Smad5 in Xenopus. The activated Smad complexes 
accumulate in the nucleus and bind DNA in association with transcription factors to 
activate BMP target genes. The phospho-Smad1 gradient reflects the dorsal-ventral 
BMP activity gradient, and is established at late stage 9 (Faure et al., 2000).  
Activin-related pathway ligands include Activin, the Xenopus Nodal ligands Xnr1, 2, 
3, 4, 5 and 6, Derriere and Vg-1. With the exception of Xnr3, a neural rather than a 
mesoderm inducer (Hansen et al., 1997), Activin-related pathway ligands induce 
phosphorylation of Smad2 and Smad3 via a Type I-Type II receptor complex (ALK4 
and ActRIIA/ActRIIB) and are crucial for mesoderm formation. ALK7 can also act as a 
Type I receptor for Nodal ligands (Reissmann et al., 2001). There is very little Smad3 in 
early Xenopus development (Howell et al., 2001), so phospho-Smad2 rather than 
phospho-Smad3 is the main readout of TGF-β signalling by activin-related ligands. 
Phospho-Smad2 expression begins at stage 9, after the mid-blastula transition and 
mirrors the Nodal activity gradient. Phospho-Smad2 is dorsally localised at stage 9, and 
found in the vegetal pole and not the animal pole at stage 10, with some phospho-
Smad2 in the marginal zone (Faure et al., 2000). A Smad2 isoform lacking the amino 
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acids encoded by exon3, Smad2Δexon3, is also responsive to activin-related ligands and 
mirrors the expression of full length Smad2 (Faure et al., 2000). 
 In addition to their role as potent mesoderm inducers (Section 1.1), asymmetrical 
expression of Nodal ligands controls left-right asymmetry later in development, for 
example in organogenesis. Strikingly, the direction of a snail shell coil can be reversed 
by altering the expression domain of Nodal, and loss of shell coiling is observed when 
Nodal is inhibited (Grande and Patel, 2009; Kuroda et al., 2009).   
Recent work indicates that the simple division of TGF-β signalling into the BMP 
pathway signalling via Smad1/5 (and Smad 8 in humans) and the Activin-related 
pathway signalling through Smad2/3 is not entirely accurate. Phosphorylation of Smad1 
and Smad5 in response to TGF-β stimulation (equivalent to Activin/Nodal stimulation 
in Xenopus) has been observed in multiple human cell lines and leads to the formation 
of novel Smad complexes, such as phosphorylated Smad1-Smad2 complexes instead of 
the traditional phospho-Smad2/3-Smad4 complex (Daly et al., 2008) (Liu et al., 2009). 
However, Smad1 and Smad5 phosphorylation in response to Activin-related ligands has 
not yet been demonstrated in Xenopus.  
Moreover, TGF-β ligands from both branches can heterodimerise and signal. In 
addition to endogenous BMP2-BMP7 heterodimer activation of BMP signalling in 
zebrafish (Little and Mullins, 2009), BMP4 can heterodimerise with the Activin-related 
ligand Derriere when overexpressed in Xenopus (Eimon and Harland, 2002). Nodal and 
BMP7 form dimers when immature ligands lacking cleavage sites are overexpressed in 
Xenopus, and coexpression of mature ectopic BMP7 and Nodal inhibits Smad2 and 
Smad1 phosphorylation, suggesting that BMP7-Nodal heterodimer formation could be 
responsible for the mutual antagonism of BMP and Nodal signalling (Yeo and 
Whitman, 2001). The Vg-1-related ligand, GDF1, can heterodimerise with Nodal in the 
mouse to form a more potent activator of the Nodal pathway than either GDF1 or Nodal 
homodimers (Tanaka et al., 2007). 
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Figure 1.2 Schematic of TGF-β  superfamily signal transduction in Xenopus 
Traditionally, there are two branches of TGF-β signalling in Xenopus: the BMP 
pathway (ligands are BMP2, 4, 7) and the Activin-related pathway (Xnrs, Derriere, Vg-
1 and Activin). TGF-β ligands induce complex formation between the Type II and Type 
I receptors, leading to phosphorylation and activation of the Type I receptor serine-
threonine kinase activity, which phosphorylates R-Smads. R-Smads form complexes 
with the co-Smad, Smad4 and accumulate in the nucleus where they bind DNA in 
association with cofactors to initiate gene regulation. Antagonism by extracellular 
inhibitors is indicated and the coreceptors XCR1, 2 and 3 are critical for signal 
transduction by Xnr ligands of the Activin-related pathway.
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However, there are some clear differences in regulation of the BMP and Activin-
related branches of TGF-β signalling in Xenopus (Figure 1.2). Firstly, signal 
transduction by Nodal ligands requires coreceptors of the EGF-CFC family (Yeo and 
Whitman, 2001), which are extracellular membrane-linked proteins that contain a 
conserved EGF-like domain and a CFC domain (see section 1.2). There are three EGF-
CFCs in Xenopus, XCR1, 2 and 3 (Dorey and Hill, 2006). Whereas Xnrs require EGF-
CFCs to signal, other ligands of the Activin-related pathway, such as Activin, do not. 
Moreover, EGF-CFCs are sensitive to antagonism by the diffusible inhibitor Lefty 
(Meno et al., 1999), which also binds Nodals directly to decrease ligand availability for 
receptor binding (Chen and Shen, 2004). In contrast, the extracellular inhibitor Cerberus 
inhibits both the BMP and Activin-related branches by direct binding to ligands to 
decrease ligand availability for receptor binding (Piccolo et al., 1999). Cerberus is 
expressed in the anterior endoderm, represses trunk and tail mesoderm formation and is 
important for head induction, as targeted overexpression of Cerberus leads to the 
formation of an extra head (Bouwmeester et al., 1996).  
Moreover, transcriptional responses specific to BMP or Activin-related ligand 
stimulation are achieved by the interaction of Smads with particular transcriptional 
cofactors. Smads cannot activate transcription from DNA alone and instead require a 
chromatin template (Ross et al., 2006). Smad2-Smad4 complexes are recruited to 
promoters by interaction with FoxH1 or Mix family transcription factors containing a 
Smad interaction motif (SIM) (Germain et al., 2000), or p53 (Cordenonsi et al., 2003), 
leading to transcription from Activin/Nodal target genes. For example, Xnr1 
transcription is activated by Smad2-Smad4 and FoxH1, leading to upregulation and 
maintenance of Nodal signalling (Osada et al., 2000). The transcription factor OAZ is 
thought to recruit Smad1-Smad4 complexes to DNA to activate transcription of the 
BMP target gene, Vent2, although the OAZ recognition motif is similar to a Smad-
binding element identified in Drosophila (Hata et al., 2000) (von Bubnoff et al., 2005).  
Recent work has uncovered microRNA regulation of Activin-related pathway 
signalling at multiple levels.  In zebrafish, the Nodal ligand squint and the inhibitor lefty 
are repressed by miR-430 (Choi et al., 2007). Similarly, lefty is a target of the miR-430 
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homologue in Xenopus, miR-427, which also targets the Nodal ligands Xnr5 and Xnr6 
(Rosa et al., 2009). The human homologue, miR-302 targets lefty (but not Nodal 
ligands), thereby enhancing Nodal signalling. At the receptor level, the Type II receptor 
ActRIIA is targeted by miR-15 and miR-16 to downregulate Nodal signalling and 
restrict the size of the organiser in Xenopus (Martello et al., 2007). miR-15 and miR-16 
expression is thought to be ventrally enriched, with the ActRIIA protein ventrally 
localised. Intriguingly, the signal thought to establish the ventral expression of miR-15 
and miR-16 is suggested to be inhibition of miR-15 and miR-16 expression by dorsal β-
catenin (established by cortical rotation, see section 1.1) (Martello et al., 2007). 
1.2 Role of the Nodal coreceptor, Cripto-1 
Cripto was first identified in humans in undifferentiated teratocarcinoma cells (hence 
Cripto is also known as teratocarcinoma-derived growth factor 1, TDGF1), and in 
Xenopus as a secreted ligand activator of FGF receptor signalling, FRL1 (for FGF 
receptor related ligand)(Ciccodicola et al., 1989; Kinoshita et al., 1995). EGF-CFCs 
were first identified as essential for Nodal signalling by genetic studies in zebrafish. 
Maternal-zygotic mutants for the zebrafish EGF-CFC, oep (one-eyed pinhead), do not 
respond to Nodal ligands and phenocopy mutants of the Nodal ligands cyclops and 
squint (Gritsman et al., 1999). EGF-CFCs are conserved in vertebrates and other family 
members include human Cripto, mouse Cripto and Cryptic and Xenopus Cripto-1, 2 and 
3 (XCR1, 2 and 3) (Dorey and Hill, 2006; Onuma et al., 2006a; Saloman et al., 2000). 
Figure 1.3 shows the conserved EGF-like and CFC domains in zebrafish, frog and 
human EGF-CFCs. EGF-CFCs also contain an N-terminal signal sequence, are linked 
to the cell membrane by a glycophosphatidyl inositol (GPI) tag and are modified by N-
glycosylation, including a fucosylation modification that is essential for Nodal 
signalling in mammalian cells (Schiffer et al., 2001). The evidence for the role of EGF-
CFCs as coreceptors for Nodal is the interaction of Cripto with ALK4 via the CFC 
domain in Xenopus, which is essential for Nodal binding the Type I-Type II receptor 
complex and Smad2 activation (Yeo and Whitman, 2001). Moreover, Cripto can bind 
Nodal directly in mammalian cells and Xnr1 in Xenopus and enhances Nodal signal 
transduction via ALK7 (Reissmann et al., 2001; Yan et al., 2002). Transgenic mice 
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lacking Cripto-1 are embryonically lethal because they are unable to gastrulate, 
illustrating the importance of Cripto-1 coreceptor activity (Ding et al., 1998). 
 
Figure 1.3 EGF-CFC family members are conserved in vertebrates 
Protein alignment of X. laevis, X. tropicalis, human and zebrafish EGF-CFCs coloured 
for percentage identity in Jalview and generated in Clustal W. Xenopus laevis Cripto-1, 
2 and 3 (XCR1, 2 and 3) and the proteins resulting from the XCR1 pseudoalleles, 
XCR1α and XCR1β are shown. The founding EGF-CFC family member is zebrafish 
one-eyed pinhead (oep). The conserved EGF-like domain and CFC domain are 
highlighted in red. The CFC domain is named after founding members of the protein 
family Cripto, FRL-1 (later renamed XCR1) and Cryptic.  
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In Xenopus, Cripto-1, 2 and 3 (XCR1, 2 and 3) are differentially expressed in early 
development. XCR1 and XCR3 mRNA is expressed maternally and zygotically until 
neurulation begins, whereas XCR2 is only expressed after gastrulation and persists to 
tadpole stage (Dorey and Hill, 2006; Onuma et al., 2006b). Whereas XCR2 is important 
for left-right patterning, XCR1 and 3 are essential for Nodal signalling in Xenopus 
(Dorey and Hill, 2006). The initial characterisation of XCR1 an FGF receptor ligand 
instead of a Nodal coreceptor could be explained by ERK induction due to the wound-
healing response when animal caps are cut and/or the neural phenotype of XCR1 
morphants (Christen and Slack, 1999) (Yabe et al., 2003). Moreover the EGF-like 
domain of Cripto-1 can activate MAP kinase in mammalian cells (Kannan et al., 1997). 
However, the critical role of XCR1 and XCR3 in Xenopus embryos is to act as 
coreceptors for Nodal ligands (Dorey and Hill, 2006).  
XCR3 is expressed ubiquitously in the embryo, but XCR1 protein expression is 
temporally and spatially regulated (Dorey and Hill, 2006). XCR1 mRNA levels are 
constant whilst XCR1 protein peaks at gastrulation. This post-transcriptional regulation 
has been shown to be due to the increased association of XCR1 mRNA with 
polyribosomes and elongation of the mRNA poly(A) tail after fertilisation, which 
promotes translation of XCR1 mRNA (Zhang et al., 2009). XCR1 mRNA is 
ubiquitously expressed at gastrulation (stage 10 of Xenopus development); however, 
XCR1 protein is only found in the animal cap and marginal zone. XCR3 is therefore the 
only Cripto expressed in the vegetal pole where Nodal ligands are synthesised (see 
section 1.1).  
XCR1 and XCR3 synergise with different Xnrs in early Xenopus development to 
cause downstream phosphorylation and activation of Smad2 (Dorey and Hill, 2006). 
XCR1 synergises with Xnr1, 2, 5 and 6, and XCR3 synergises with Xnr 1, 2, 4, 6 and 
Derriere. Since XCR3 alone is expressed in the vegetal pole at gastrulation, only XCR3-
dependent ligands are able to signal. In contrast, since Xnr5 synergises with XCR1 and 
not XCR3, Xnr5 signalling is potentiated in the marginal zone and not in the vegetal 
pole. In this way, spatial regulation of XCR1 expression controls the spatial activation 
of the Nodal pathway. The mechanism of spatial regulation of XCR1 has yet to be 
elucidated, but involves spatial control of translation in the gastrula-stage embryo and is 
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a major point of investigation in this thesis (see Chapter 3). One study has also 
suggested that XCR1 interacts with maternal Wnt11 and acts as a coreceptor for Wnt 
signalling (Tao et al., 2005), however this result has not been reproduced in any other 
systems and there is very little maternal XCR1 protein (Dorey and Hill, 2006). 
In cell culture, Cripto acts as a secreted growth factor (Brandt et al., 1994). It is 
thought that Cripto can act as a soluble ligand and a membrane-bound coreceptor by its 
release from the cell membrane. Both forms of Cripto can activate Nodal signalling, and 
a C-terminally truncated oep mRNA lacking the GPI-tag sequence can rescue the 
phenotype and Nodal signalling activity of oep mutants (Yan et al., 2002; Zhang et al., 
1998). In contrast to the activatory role of Cripto as a Nodal coreceptor in 
developmental systems, Cripto has been shown to bind TGF-β via the EGF-like domain 
to antagonise TGF-β signalling in multiple human cell lines and thereby inhibit the 
growth suppressive effects of TGF-β in mammary epithelial cells (Gray et al., 2006). 
 Cripto is also thought to regulate Nodal signalling at the level of ligand processing 
and trafficking. In cell culture, Cripto interacts with the pro-domain of the Nodal ligand 
precursor and with the convertases Furin and PACE4 at the cell surface to form a 
ligand-processing complex (Blanchet et al., 2008a). Cripto also promotes the 
internalisation of Nodal-receptor complexes to endosomes for signalling and Smad 
activation via interaction with SARA (Smad anchor for receptor activation), rather than 
lysosomal degradation (Blanchet et al., 2008a; Blanchet et al., 2008b).  
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1.3 Cripto-1 in cancer 
Cripto-1 is implicated in tumourigenesis due to its overexpression in many cancers 
including breast cancer, colorectal tumours, pancreatic cancer, gastric cancer and oral 
squamous cell carcinoma (Salomon et al., 1999) (Ciardiello et al., 1991) (Friess et al., 
1994) (Kuniyasu et al., 1991) (Yoon et al., 2011). Cell culture studies have shown that 
Cripto-1 expression promotes transformation, proliferation, anchorage-independent 
growth, cell migration, angiogenesis and inhibits differentiation of mammary cells 
(Ciccodicola et al., 1989) (Adamson et al., 2002). Transgenic mice overexpressing 
human Cripto-1 in the mammary gland develop hyperplasias and adenocarcinomas and 
show upregulation of EMT markers, demonstrating the in vivo role of Cripto-1 in 
tumourigenesis (Strizzi et al., 2004; Wechselberger et al., 2005) (Bianco et al., 2005). 
Therefore, understanding how Cripto-1 is regulated in Xenopus may have implications 
for the mechanism of Cripto-1 deregulation in cancer.  
 Cripto-1 protein in the plasma is a biomarker for breast and colon cancer detection, 
and antibodies targeting the CFC domain successfully inhibit tumour cell growth in 
xenograft models of testicular and colon cancer (Bianco et al., 2006) (Adkins et al., 
2003). Cripto-1 is also a marker for undifferentiated human embryonic stem cells 
(Brivanlou et al., 2003). Within a human embryonal carcinoma stem cell population 
(stem cells from teratocarcinomas), high Cripto-1 expression correlates with 
tumourigenesis and the expression of pluripotent embryonic stem cell marker genes 
such as Oct4 and Nanog (Watanabe et al., 2010). Similarly, melanomas secrete Nodal 
and Nodal is considered a biomarker for melanoma progression (Topczewska et al., 
2006). However, very little Cripto-1 expression was detected in melanomas (Strizzi et 
al., 2009). Instead, Nodal expression in melanomas appears to be dependent on Notch4 
(Hardy et al., 2010). Strikingly, transplantation of melanoma cells onto the zebrafish 
embryo induces secondary axis formation via upregulation of axial mesoderm through 
Nodal secretion (Topczewska et al., 2006). These observations provide evidence for the 
view that the reactivation of embryonic signalling pathways is important in 
tumourigenesis. 
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1.4 Overview of small RNA biogenesis and modes of action 
Whereas ligands of the TGF-β superfamily regulate gene expression by initiating 
specific transcriptional programs in early development, small RNAs regulate gene 
expression at the level of post-transcriptional regulation or epigenetic mechanisms. 
Based on biogenesis criteria, there are three main classes of small RNAs: siRNAs, 
microRNAs and piRNAs. Small RNA biogenesis requires proteins of the Argonaute 
(Ago) family (comprised of Ago and Piwi proteins), and the RNAseIII enzymes Drosha 
and Dicer (reviewed in (Kim et al., 2009)). 
1.4.1 siRNA biogenesis and mechanism of action  
Small interfering RNAs (siRNAs) are ~21-24 nt small RNAs that have antisense 
complementarity to target mRNA and silence gene expression by causing mRNA 
degradation. siRNAs were first identified in response to viral infection in plants and 
have since been sequenced in Drosophila, C. elegans, mouse oocytes and embryonic 
stem cells and most recently in X. tropicalis (Czech et al., 2008) (Hamilton and 
Baulcombe, 1999)  (Ambros et al., 2003b) (Armisen et al., 2009; Babiarz et al., 2008; 
Watanabe et al., 2008).  
Endogenous siRNAs are generated from long double-stranded RNA precursors that 
are transcribed from repetitive loci in the genome such as transposons or siRNA clusters 
(Figure 1.4). Double-stranded endo-siRNA precursors form from sense and antisense 
transcripts from the same or different loci, or from self-complementary transcripts that 
fold into hairpin structures. Double-stranded RNA can also be introduced 
experimentally by microinjection or transfection (exogenous dsRNA). Double stranded 
RNA from endogenous or exogenous sources is processed by Dicer into short 21-24 nt 
dsRNA duplexes. One strand of the siRNA duplex is then degraded and the other 
interacts with Ago2 (a member of the Ago subfamily with ‘slicer’ endonuclease 
activity) to guide interaction of Ago2 with the target mRNA to cause mRNA 
degradation (Figure 1.4). Interaction of endo-siRNAs with the RNA-binding protein 
R2D2 is necessary to restrict endo-siRNA loading to Ago2, rather than Ago1 in 
Drosophila (Okamura et al., 2011). In plants, yeast and C. elegans, an RNA-dependent 
RNA polymerase can synthesise double-stranded endo-siRNA precursors from a single-
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stranded RNA template to cause gene silencing by RNA-interference (RNAi). Both 
endo-siRNA and exogenous siRNA (exo-siRNA) dsRNA precursors can be synthesised 
by RNA-dependent RNA polymerase to amplify the RNAi effect in these systems.  
Experimental siRNA inhibition of gene expression or RNAi is effective in many 
organisms, but not in Xenopus or zebrafish. Morpholino oligonucleotides have been 
used as alternative tools to siRNAs for loss of function studies. A recent study showed 
that Ago proteins are saturated with siRNAs in the Xenopus embryo before the onset of 
zygotic Ago expression at the mid-blastula transition (Lund et al., 2011). Lack of Ago 
protein availability inhibits double-stranded siRNA processing by Dicer into single-
stranded small RNAs (see Figure 1.5). Overexpression of human Ago proteins renders 
the embryo competent for siRNA-mediated knockdown of gene expression (Lund et al., 
2011).  
In addition to post-transcriptional gene silencing by degradation of target transcripts, 
siRNAs can silence gene expression at the level of chromatin in plants, yeast, and 
animals. In plants, siRNAs bound to Ago4 can direct DNA methylation and acquisition 
of repressive H3K9 methylation at target repeat sequences in the genome. Often, 
siRNAs are often complementary to a repeat in the promoter of a silenced gene (Verdel 
et al., 2009). In yeast, a complex containing siRNA, Ago1 and Chp1 (which binds 
trimethylated H3K9) directly binds DNA to mediate siRNA-directed heterochromatin 
formation (Verdel et al., 2004).  
Exogenous siRNAs complementary to the promoter DNA can modify chromatin in 
mammalian cells, involving Ago1 or Ago2 recruitment to the promoter (Janowski et al., 
2006). Examples of exogenous siRNA-directed chromatin modification include 
repression of the EF1A locus in humans, requiring H3K27 methylation (Weinberg et 
al., 2006) and repression of the INK4/ARF locus (Gonzalez et al., 2006). On the other 
hand, exogenous 21 nt dsRNAs complementary to the promoters of E-cadherin, p21 and 
VEGF caused loss of repressive H3K9 methylation and Ago2-dependent activation of 
gene expression (Li et al., 2006). The mechanism for exogenous siRNA-mediated 
activation of gene expression is unknown, but was not effective for dsRNAs targeted to 
CpG-rich regions of the same promoters. One study has shown that transcription 
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overlapping the promoter is a feature of exogenous siRNA-directed chromatin 
modification of the INK4/ARF locus, suggesting that RNA:RNA interactions at the 
promoter may be critical, in contrast to previous studies where increased methylation of 
promoter DNA was observed (Gonzalez et al., 2008) (Morris et al., 2004).   
 
Figure 1.4 siRNA biogenesis pathway 
Endogenous siRNAs (endo-siRNAs) originate from transcription from siRNA loci in 
the genome, which may be transposons, other repetitive elements or siRNA clusters. 
Double-stranded RNA endo-siRNAs precursors can be derived from overlapping sense 
and antisense transcripts or hairpin structures. Exogenous dsRNA from viruses or 
experimentally introduced dsRNA and endo-siRNA precursors are processed by Dicer 
in the cytoplasm to single-stranded short interfering RNAs (siRNAs) which are bound 
by Argonaute-2 proteins (Ago2). Degradation of the complementary target mRNA by 
Ago2 slicer activity, or siRNA-mediated remodelling of chromatin for epigenetic 
silencing may then occur.  
Chapter 1. Introduction 
 34 
1.4.2 MicroRNA biogenesis and mechanism of action 
MicroRNAs are 22-23 nt small RNAs that are present in many species, ranging in 
complexity from single-celled algae to humans. Currently, there are 16,772 microRNAs 
listed in the miRbase registry (miRbase 17), of which 1424 are human microRNAs and 
208 are Xenopus miRNAs (Griffiths-Jones et al., 2006). MicroRNAs are well conserved 
in bilateran animals. For example, 54 % of Drosophila miRNAs have a human 
homologue (Ibanez-Ventoso et al., 2008). MicroRNAs generally bind the 3’UTR of 
target transcripts to negatively regulate gene expression post-transcription. MicroRNA 
loci are often found in clusters and cotranscribed; for example nearly 50 % of X. 
tropicalis microRNA genes are found in a microRNA cluster (Lee et al., 2002) (Tang 
and Maxwell, 2008). The oncogenic miR-17-92 cluster encodes a transcript containing 
six microRNAs and is conserved in vertebrates (Mendell, 2008). MicroRNA loci are 
generally found in introns, and this is true of Xenopus microRNAs (Kim et al., 2009; 
Tang and Maxwell, 2008)).  
MicroRNAs are transcribed as long primary-miRNA transcripts (pri-miRNA) by 
RNA polymerase II in the nucleus (Figure 1.5). pri-miRNA is co-transcriptionally 
processed into ~ 70 nt hairpin precursors by a microprocessor complex consisting of 
Drosha and DGCR8, an essential dsRNA-binding protein cofactor. Drosha and DGCR8 
recognise dsRNA:ssRNA junctions in pri-miRNA transcripts and cleave ssRNA from 
the dsRNA hairpin stem approximately 11 bp away from the dsRNA:ssRNA junction to 
form pre-miRNA (Han et al., 2006). Exportin5 then exports pre-miRNAs to the 
cytoplasm, where they interact with Dicer in the RNA-induced silencing complex 
(RISC). Dicer cleaves pre-miRNA at the opposite end of the hairpin to Drosha, 
removing the loop of the hairpin to form a miRNA:miRNA duplex (Macrae et al., 
2006). The least thermodynamically stable strand of the miRNA duplex is then 
degraded, known as the miRNA* or ‘passenger’ strand. The mature, single-stranded 
miRNA then associates with Ago proteins.  
Studies in C. elegans and Drosophila have shown that siRNA-like miRNA duplexes 
with perfect base-pairing are loaded onto Ago2, whereas miRNA duplexes with a 
central bulge from mismatched bases are loaded onto other members of the Ago family 
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(Ago1 in Drosophila) (Jannot et al., 2008) (Tomari et al., 2007). Ago2 contains 
endonuclease activity and can interact with other factors to cause exonucleolytic 
degradation of mRNA (Figure 1.6). However, this type of microRNA interaction with a 
target mRNA is rare in animals, and the human Ago proteins (Ago1-4) bind miRNAs 
without sorting by structure (Azuma-Mukai et al., 2008). GW182 proteins have recently 
emerged as critical regulators of microRNA interaction with target mRNAs. GW182 
proteins contain an N-terminal Ago-binding domain with GW repeats and a C-terminal 
silencing domain and are required for miRNA-mediated mRNA degradation and 
inhibition of mRNA translation (Eulalio et al., 2008). The role of Ago proteins is to 
recruit GW182, as artificially tethering GW182 to the 3’UTR in the absence of Ago is 
sufficient to repress translation and cause mRNA degradation (Eulalio et al., 2008). 
microRNA-mediated mRNA decay involves deadenylation of target mRNAs; for 
example miR-430 in zebrafish and its X. laevis homologue miR-427 mediate 
deadenylation of their respective maternal mRNA targets (Giraldez et al., 2006; Lund et 
al., 2009). Decapping follows removal of the poly(A) tail, which permits mRNA 
degradation by exonucleases in the 5’ to 3’ direction. GW182 interacts with poly(A)-
binding protein (PABP) via the silencing domain to recruit the deadenylase complex 
CCR4/NOT1, thereby promoting mRNA degradation (carbon catabolite repression 4, 
negative on TATA-less)(Behm-Ansmant et al., 2006; Huntzinger et al., 2010). PABP 
promotes initiation of translation by interaction with the eIF4G scaffold protein (Figure 
1.7), therefore GW182 interaction with PABP may disrupt the closed-loop 
conformation required for translation initiation. However, GW182 repression of 
translation does not require a poly(A) tail, so other interactions of GW182 may be 
important for translational repression (Eulalio et al., 2008). 
Earlier models of miRNA-mediated translational repression focussed on Ago proteins 
binding the 5’ methylguanosine cap to prevent eIF4E cap binding, which is required for 
initiation of translation (Figure 1.7) (Kiriakidou et al., 2007). This was supported by the 
observation that addition of recombinant eIF4E rescues miRNA-mediated repression of 
translation by let-7 in cell extracts (Mathonnet et al., 2007). However, later studies 
showed that functionally inactive Ago was still able to bind the cap (Eulalio et al., 
2008). Impaired recruitment of the 60S ribosomal subunit was also suggested to account 
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for microRNA inhibition of translation, particularly as a complex containing the 60S 
subunit, Dicer and Ago was detected, however the mechanism is still unclear 
(Chendrimada et al., 2007).  
Evidence from genome-wide proteomic studies and microarray analysis reveals that 
both mRNA stability and translation are affected in response to overexpression and 
knockdown of exogenous microRNAs (Baek et al., 2008; Selbach et al., 2008). Protein 
levels of hundreds of genes were modestly affected by manipulation of microRNA 
levels (generally less than 4-fold) (Selbach et al., 2008). While examples of 
translational repression without a decrease in mRNA levels were observed, in general, 
the strongest downregulation of protein levels following microRNA overexpression was 
accompanied by a decrease in mRNA levels (Baek et al., 2008; Selbach et al., 2008). 
Intriguingly, two measurements of protein and mRNA levels 24 hours apart showed that 
translation alone was inhibited first by microRNA overexpression and followed 24 
hours later by a decrease in mRNA levels (and consequently translation), suggesting 
that mRNA degradation is a consequence of miRNA-mediated translational repression 
(Selbach et al., 2008).  
Later studies measuring the effects of microRNAs on translation by sequencing 
mRNA associated with ribosomes (ribosome profiling) with parallel mRNA-seq 
transcriptome profiling showed that at least 84 % of decreased protein synthesis was 
due to lower mRNA levels (Guo et al., 2010). A study measuring mRNA association 
with polysomes (multiple ribosomes on one transcript) by sucrose gradient separation 
revealed that miR-124 target mRNA association with polysomes is decreased on miR-
124 overexpression in human cells, suggesting that microRNAs repress translation by 
inhibiting the initiation step (Hendrickson et al., 2009). Again, modest effects on gene 
regulation were observed: mRNA levels of miR-124 targets decreased by 35 % and 
protein levels by 12 % (Hendrickson et al., 2009). 
Genome-wide studies have also revealed that the major factor determining microRNA 
recognition of a target mRNA is the presence of an exact match to the microRNA seed 
sequence (nucleotides 2-7 of the miRNA) in the 3’ UTR of the mRNA (Baek et al., 
2008; Hafner et al., 2010; Selbach et al., 2008). However, the contribution of 
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microRNA:mRNA base-pairing outside the seed region to microRNA target recognition 
has been documented (Bartel, 2009; Shin et al., 2010). The presence of mismatches in 
base-pairing between an mRNA containing a perfect seed match and nucleotides 9-11 
of the miRNA correlates with repression of translation independent of mRNA level, 
suggesting that imperfect base pairing outside the seed region favours translational 
repression (Selbach et al., 2008). Ago proteins and microRNAs are known to bind 
coding regions as well as 3’UTRs; however, Ago binding sites in the coding region 
have minimal effects on mRNA stability in comparison to 3’UTR sites (Shin et al., 
2010).  
MicroRNA activation of TNF-α translation has been reported in quiescent cells and 
Xenopus oocytes and is dependent upon miR-369-3p-Ago binding to FXR1 (Fragile-X-
related protein 1) (Mortensen et al., 2011; Vasudevan et al., 2007). The miRNA-Ago-
FXR1 complex localises to polysomes for upregulation of translation in quiescent cells 
(Vasudevan et al., 2007). However, the TNF-α 3’ UTR is a well-characterised site for 
repressive gene regulation mediated by RNA-binding proteins (see section 1.6.1), which 
could be affected by overexpression of miR-369-3p. In summary, microRNA activation 
of gene expression is in contrast to the genome-wide trend of miRNA repression of 
gene expression observed in proliferating cells.  
Modulation of microRNA processing has emerged as a critical point of regulation to 
determine microRNA function. For example, Smads form a complex with the RNA 
helicase p68 to interact with Drosha to enhance processing of the TGF-β-responsive 
microRNA, miR-21 (Davis et al., 2008). A microRNA processing pathway that does not 
require Dicer has been identified in zebrafish and mice (Cheloufi et al., 2010a; 
Cifuentes et al., 2010). Instead, miR-451 is processed by the endonuclease activity of 
Ago2 which cleaves the miRNA* strand. The balance of Dicer or Ago2-mediated 
processing is determined by pre-miRNA structure. Dicer-dependent miRNAs can be 
converted into Ago-2 dependent miRNAs by shortening the pre-miRNA hairpin and 
removing internal bulges (Cifuentes et al., 2010). Whether this mechanism applies to a 
wider range of microRNAs has yet to be determined but it fits well with recent work 
that suggests limiting Ago protein restricts miRNA processing in Xenopus (Lund et al., 
2011).  
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Some studies have suggested that in addition to their role of post-transcriptional 
regulation, microRNAs may also repress transcription by directing chromatin 
remodelling to the promoter, based on the observation that exogenous siRNAs 
complementary to the promoter can silence gene expression by this mechanism (see 
section 1.4.1). For example, the requirement for antisense transcription overlapping the 
promoter for siRNA-mediated chromatin remodelling of the INK4/ARF locus prompted 
the investigation of microRNAs complementary to promoter-overlapping transcripts 
(Gonzalez et al., 2008). Overexpression of miR-17-5p and miR-20a was shown to result 
in chromatin remodelling of promoters containing overlapping transcripts in 
mammalian cells, although how generally applicable this mechanism is has yet to be 
explored (Gonzalez et al., 2008). Another example of miRNA-directed chromatin 
remodelling is that of human miR-320, which is transcribed from the promoter of 
POLR3D (a cell cycle gene) in the antisense orientation and mediates AGO1 binding 
and acquisition of trimethylated H3K27 to silence POLR3D expression (Kim et al., 
2008).  
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Figure 1.5 MicroRNA biogenesis pathway 
MicroRNA genes are transcribed by RNA polymerase II in the nucleus and the primary-
miRNA transcript is processed to a pre-miRNA hairpin by Drosha. The mature miRNA 
sequence is shown in red. Pre-miRNA is exported to the cytoplasm and is then ‘diced’ 
into a microRNA duplex by interaction with Dicer. The miRNA duplex is loaded onto 
Argonaute proteins and the miRNA* strand is degraded. Ago proteins  (Ago1-4) 
mediate the interaction of the mature miRNA with its target mRNA. The dsRNA-
binding proteins DGCR8 (DiGeorge syndrome critical region gene 8) and TRBP 
(transactivation-responsive RNA-binding protein) are cofactors for microRNA 
processing. 
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Figure 1.6 MicroRNA interactions with target mRNA 
Mature microRNAs bind the 3’UTR of target mRNA to silence gene expression by two 
mechanisms: translational repression, or mRNA degradation. Mature miRNAs (red) 
bound to Ago proteins interact with GW182 proteins, which are required for mRNA 
degradation and repression of translation. GW182 promotes mRNA degradation by 
interacting with poly(A)-binding protein (PABP) to recruit deadenylases (CCR4-Not1 
complex). GW182 proteins repress translation in a mechanism independent of the 
poly(A) tail or methylguanosine (mG) RNA cap binding (see Figure 1.7). Ago2 has 
slicer activity and can cause direct endonucleolytic cleavage of target mRNAs in some 
cases.  
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Figure 1.7 MicroRNA recruitment of GW182 to mRNA inhibits initiation of 
translation 
Schematic of the translation initiation complex. The methylguanosine cap (mG) is 
recognised by the eIF4E translation initiation factor (eukaryotic initiation factor 4E), 
which interacts with eIF3 to recruit the 40S ribosomal subunit. eIF4G acts as a 
scaffolding protein, and interacts with PABP to form a circular loop of mRNA in the 
translation initiation complex. The 40S subunit scans the mRNA for the AUG start 
codon, indicated by the red arrow. GW182 proteins could repress translation via 
disruption of the PABP-eIF4G interaction, given that GW182 proteins interact with 
PABP. GW182 also promotes removal of the poly(A) tail to destabilise formation of the 
translation initiation complex.   
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1.4.3 piRNA biogenesis and mechanism of action 
Piwi-interacting RNAs are 25-30 nt small RNAs that function via interaction with 
Piwi proteins in the Argonaute family and were initially discovered in Drosophila by 
small RNA sequencing (Aravin et al., 2003). Mutations in the Drosophila piwi gene (P-
element induced wimpy testis) lead to male sterility and a lack of germ cells in the 
ovary (Lin and Spradling, 1997), pointing to a role of piRNAs in germline development. 
piRNAs are complementary to intergenic repeats (such as transposons) and mediate 
silencing of transposons (see section 1.5.3). piRNAs have been sequenced in mice, 
zebrafish and X. tropicalis (Aravin et al., 2006; Armisen et al., 2009; Houwing et al., 
2007), and most recently in somatic tissues of the mouse and rhesus macaque (Yan et 
al., 2011).  
In contrast to microRNAs, piRNAs do not require Dicer for their biogenesis (Vagin et 
al., 2006) and are modified at the 3’ end by methylation of 2’ hydroxyl groups catalysed 
by homologues of the hen1 methyltransferase (Kamminga et al., 2010; Kirino and 
Mourelatos, 2007). There is evidence from zebrafish hen1 mutants to suggest that 
methylation of piRNAs is critical for their stability (Kamminga et al., 2010). The 
components needed for piRNA biogenesis are largely uncharacterised, however the 
putative mechanism is described in Figure 1.8. The Drosophila Piwi family proteins are 
PIWI, AUB (Aubergine) and AGO3. piRNAs are transcribed from both strands of 
repetitive intergenic loci, are processed to 25-30 nt small RNAs by an unknown factor 
and subsequently associate with Piwi family proteins. The antisense piRNAs guide the 
Piwi proteins (which contain slicer activity) to sense transposon transcripts to mediate 
their cleavage and degradation, and initiate a ‘ping-pong’ cycle of antisense piRNA 
amplification (Brennecke et al., 2007; Gunawardane et al., 2007). Cleavage of the sense 
transposon transcript generates a sense piRNA, which then interacts with AGO3 to 
cleave antisense transposon transcripts and generate more antisense piRNAs (Figure 
1.8). piRNA biogenesis varies between germline cells and somatic cells in Drosophila. 
Ping-pong amplification of piRNAs (see Figure 1.8) occurs in the germline to target a 
wide range of transposons transcripts for cleavage, whereas in somatic cells of the 
ovary, piRNA precursors are directly processed from the flamenco piRNA locus 
without an amplification step (Malone et al., 2009). 
Chapter 1. Introduction 
 43 
 
Figure 1.8 piRNA biogenesis requires processing and 'ping-pong' amplification 
Schematic of piRNA synthesis in Drosophila. piRNA precursors are transcribed from 
repetitive elements on both strands of the genome and are processed into 25-30 nt 
lengths. piRNAs interact with Piwi family proteins PIWI or AUB (Aubergine) and 
recruit transposons with a complementary sequence. Endonuclease activity of Piwi 
family proteins is thought to cleave the transposon transcript (shown by a purple 
arrowhead), generating the 5’ end of a new sense piRNA, which interacts with the Piwi 
protein AGO3 and in turn recruits an antisense transposon transcript. Subsequent 
cleavage of the antisense transposon transcript by AGO3 generates an antisense piRNA, 
which can bind PIWI/AUB to restart the cycle of piRNA amplification and transposon 
transcript cleavage.  
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1.5 Overview of small RNA function in early vertebrate development 
1.5.1 siRNA function in early development 
As discussed in section 1.4.1, exogenous and endogenous siRNAs can elicit RNAi 
knockdown of complementary transcripts in most organisms and direct heterochromatin 
formation to silence gene expression in plants, yeast and in certain circumstances, in 
mammalian cells. RNAi in plants and C. elegans is thought to be a viral defence 
mechanism: in response to viral DNA or RNA, complementary RNA is synthesised by 
an RNA-dependent RNA polymerase to form dsRNA duplexes which are then degraded 
(Ding and Voinnet, 2007; Wang et al., 2010a). However, the role of endogenous 
siRNAs in vertebrate animals with a complex immune system is not fully understood.   
Sequencing of small RNAs associated with AGO1 and AGO2 in Drosophila ovary 
and somatic tissues revealed that endo-siRNAs mapped to sites of overlapping 
transcription, hairpin transcripts, transposons and piRNA clusters and required Dicer-2 
for processing (Chung et al., 2008; Czech et al., 2008; Ghildiyal et al., 2008). Mutation 
of Ago-2 or Dicer-2 also increased levels of transposon transcripts, suggesting that 
endo-siRNAs may play a similar role in somatic cells similar to that of piRNAs in 
transposon silencing in the germ line (Chung et al., 2008). Moreover, segmentation of 
Ago-2 and Dicer-2 mutants is defective when external temperature differences are 
applied to half the embryo, suggesting that endo-siRNAs could modulate gene 
expression in response to environmental conditions (Lucchetta et al., 2009).  
Endo-siRNAs have recently been sequenced in X. tropicalis oocytes and somatic 
tissues, and in mouse ovaries and embryonic stem cells (Armisen et al., 2009; Babiarz 
et al., 2008; Watanabe et al., 2008). In these studies, mouse endo-siRNAs were shown 
to originate from overlapping transcription, hairpin transcripts and transposons, like 
Drosophila endo-siRNAs (Watanabe et al., 2008). An additional source of endo-
siRNAs from pseudogenes was also identified (Watanabe et al., 2008). Downregulation 
of Dicer and Ago2 in mouse ovaries caused an increase in retrotransposon transcripts 
and in protein coding mRNAs, showing that mammalian endo-siRNAs can negatively 
regulate gene expression and protect against transposons (Watanabe et al., 2008). Since 
embryonic stem cells are models of early embryonic development, it is possible that the 
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role of mouse endo-siRNAs is conserved in the embryonic development of other 
vertebrate species. 
1.5.2 MicroRNA function in early development 
As discussed in section 1.4.2, microRNAs can negatively regulate gene expression by 
promoting mRNA degradation and/or inhibiting translation. Overexpression of a single 
microRNA can (modestly) downregulate the expression of hundreds of proteins 
(Selbach et al., 2008). An example of a well-characterised microRNA with multiple 
roles in early vertebrate development is miR-430 in zebrafish. Ectopic expression of 
miR-430 can rescue defects in brain morphogenesis, somite boundary formation and 
trunk morphology defects in embryos lacking Dicer (Giraldez et al., 2005). miR-430 
also facilitates the onset of the zygotic transcriptional program at the mid-blastula 
transition in zebrafish by promoting the deadenylation and degradation of hundreds of 
maternal mRNAs (Giraldez et al., 2006). miR-430 processing requires Dicer, and so the 
onset of the maternal-zygotic transition is delayed in zebrafish mutants lacking Dicer 
(Giraldez et al., 2006). The Xenopus homologue of miR-430, miR-427 also regulates 
the stability of maternal mRNAs, although this has only been demonstrated for two 
targets, cyclin A1 and cyclin B2 (Lund et al., 2009).  
Zebrafish miR-430 also contributes to regulation of genes specifically expressed in 
the germline. For example, in somatic cells, miR-430 destabilises nanos1 mRNA, a 
gene required for germ cell development, whereas in germ cells, miR-430 activity is 
counteracted by RNA-binding proteins (see section 1.6), relieving miR-430-mediated 
repression of nanos1. Zebrafish miR-430 also regulates Nodal signalling by targeting 
the Nodal ligand squint and the inhibitor, lefty (Choi et al., 2007). Similarly, Xenopus 
miR-427 negatively regulates expression of Xnr5, Xnr6 and Lefty in Xenopus (Rosa et 
al., 2009). The Nodal pathway is also targeted at the receptor level by miR-15 and miR-
16 in Xenopus (see section 1.1.2).  
In addition to regulation of Nodal signalling, microRNAs have been implicated in 
regulation of multiple pathways in early development. Xenopus miR-449 and its human 
homologue target the Notch1 receptor and its ligand DLL1 (Delta-like 1) (Marcet et al., 
2011). This interaction is critical for downregulation of Notch signalling in cilia 
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development on epithelial cells in humans and the epidermis in Xenopus, where miR-
449 is first expressed in multi-ciliated progenitor cells at neurula stage (Marcet et al., 
2011). In humans, transcription of miR-449 is under cell-cycle control and mature miR-
449 inhibits cell proliferation (Bou Kheir et al., 2011; Yang et al., 2009). Loss of miR-
449 has been documented in gastric tumours, pointing to a role for miR-449 as a tumour 
suppressor (Bou Kheir et al., 2011).  
miR-214 in zebrafish controls muscle cell fate by modulation of Hedgehog signalling 
via direct targeting of su(fu) mRNA (Flynt et al., 2007). su(fu) negatively regulates Hh 
signalling by tethering the effector Gli (a transcription factor) to the cytoplasm, 
preventing transcriptional regulation of Hh target genes in the nucleus. miR-214 
targeting of su(fu) amplifies the effect of high or low Hedgehog signalling on muscle 
cell fate (Flynt et al., 2007). Moreover, by targeting mRNA of the transcriptional 
repressor hairy1, X. tropicalis miR-9 can promote neurogenesis in the X. tropicalis 
embryo via FGF and Wnt-mediated proliferation of neural progenitors (Bonev et al., 
2011).  
The examples of microRNA control of embryonic signalling discussed point to a role 
of microRNAs in controlling cell differentiation. This is underscored by the tissue-
specific expression of microRNAs observed in zebrafish and in Xenopus tropicalis, in 
particular in the nervous system (Walker and Harland, 2008; Wienholds et al., 2005). 
For example, Xenopus miR-124 is specifically expressed in the nervous system and 
restricts eye and forebrain neurogenesis via targeting the pro-neural transcription factor, 
NeuroD1, whilst also promoting cell proliferation (Liu et al., 2011). miR-9 and miR-
124 are critical regulators of neural fate; for example, their ectopic expression can 
convert human fibroblasts to neurons (Yoo et al., 2011). miR-1 and miR-133 are 
specifically expressed in somites and muscle tissue in X. tropicalis and mouse embryos 
(Chen et al., 2006; Walker and Harland, 2008). miR-1 and miR-133 are cotranscribed in 
mammalian cells and regulate skeletal muscle development, illustrating the 
conservation of miRNA expression and function in vertebrates (Chen et al., 2006). 
As mentioned above, in early Xenopus embryos and in human embryonic stem cells 
(a model of human embryonic development), miR-427 and its human homologue miR-
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302 promote mesodermal cell fate via regulation of Nodal signalling (Rosa et al., 2009). 
Downregulation of miR-427/miR-302 leads to the loss of mesendodermal marker 
expression in both systems, and overexpression of miR-302 upregulates neuroectoderm 
markers Pax6, Sox1 and pluripotency markers Oct4 and Nanog (Rosa et al., 2009). This 
supports the suggestion that the function of microRNAs in early vertebrate development 
is to promote differentiation and repress pluripotency. MicroRNA downregulation 
(notably by coding region targeting) of Nanog, Oct4, and Sox2 translation in mouse 
embryonic stem cells in response to retinoic acid-induced differentiation further 
supports this view (Tay et al., 2008). Moreover, microRNA expression profiles can 
distinguish the differentiation status of tumours and downregulation of global 
microRNA expression in tumours compared to normal tissues has been reported, 
suggesting that abrogation of microRNA-induced differentiation contributes to cancer 
(Lu et al., 2005). 
The wider role of microRNAs in early vertebrate development has been assessed by 
knockdown or mutation of individual microRNAs and the microRNA-processing 
enzyme, Dicer. Whereas mouse Dicer knockouts are lethal, zebrafish dicer mutants 
display modest morphology and brain development defects (Bernstein et al., 2003; 
Giraldez et al., 2005). Similarly, zebrafish ago2 mutants show delayed erythropoesis, 
whereas homozygous mouse Ago2 mutants die as neonates due to anaemia, in both 
cases due to loss of the Dicer-independent microRNA miR-451 (Cheloufi et al., 2010a; 
Cifuentes et al., 2010). Xenopus Dicer morphants display late-development phenotypes. 
Eye development is inhibited and neural crest derivatives such as melanocytes and 
craniofacial cartilage are reduced (Gessert et al., 2010). This suggests that mammalian 
development is more sensitive to defects in mature microRNA production than 
zebrafish or Xenopus development or there are multiple Dicer genes in Xenopus and 
zebrafish. Mouse microRNA knockouts have revealed microRNA regulation of cardiac 
development (miR-1 and miR-208), immune cell development (miR-155 and miR-223) 
and miRNA requirement in early development (miR-17-92 cluster) (Smibert and Lai, 
2008). Recently, mouse ES cells carrying deletions for 392 of the 476 mouse 
microRNA genes have been generated as a resource for miRNA knockout mouse 
generation, which should uncover the biological role of microRNAs in vertebrates 
(Prosser et al., 2011). 
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MicroRNAs have also emerged as critical regulators of epithelial to mesenchymal 
transition (EMT), a process crucial for morphogenesis and cell migration in 
development and metastatic spread of cancer, wherein cells undergo a change from 
epithelial to mesenchymal morphology (Chaffer and Weinberg, 2011). The zinc-finger 
transcription factors ZEB1and ZEB2 are critical activators of EMT and are 
transcriptional targets of TGF-β signalling (Comijn et al., 2001). ZEB1 and ZEB2 
repress the expression of epithelial genes including E-cadherin by interaction with 
transcriptional corepressors. The miR-200 family directly targets ZEB1 and ZEB2 to 
promote epithelial differentiation, however, ZEB1 and ZEB2 also repress the 
transcription of the miR-200 family miRNAs to create a feedback loop (Bracken et al., 
2008; Burk et al., 2008). 
 Overexpression of the miR-200 family members miR-200c, miR-203 and miR-183 in 
pancreas carcinoma cells leads to downregulation of stem-cell markers such as Bmi1, 
indicating that ZEB1/2 repression of the miR-200 family promotes acquisition of stem 
cell characteristics in cancer cells (Wellner et al., 2009). This agrees with previous work 
showing EMT-induced expression of stem cell markers and mammosphere formation (a 
trait of stem cells) in human mammary epithelial cells (Mani et al., 2008) and fits well 
with the idea that microRNAs repress pluripotency in cancer as well as in embryonic 
development.  
A possible mechanism for global microRNA downregulation and EMT promotion in 
cancer is the downregulation of Dicer by miR-103/107 in breast cancer (Martello et al., 
2010a). MicroRNA-mediated repression of Dicer is suggested to downregulate the 
processing of mature miR-200 family microRNAs, thereby relieving post-
transcriptional repression of ZEB1/2 to promote EMT. Metastatic breast cancer cells 
were found to have high miR-103/107 levels (Martello et al., 2010a). MicroRNA 
control of metastasis in breast cancer by miR-10b under the transcriptional control of 
the EMT activating transcription factor Twist has also been documented (Ma et al., 
2007).  
In summary, microRNAs control many aspects of early vertebrate development, 
including the clearance of maternal mRNAs at the maternal-zygotic transition, 
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modulation of embryonic signalling pathways such as Nodal signalling, promoting cell 
differentiation and controlling cell fate, (particularly in germ layer formation and neural 
differentiation) and regulating epithelial to mesenchymal transition. Aberrant regulation 
or reactivation of embryonic signalling in many of these processes is observed in 
cancer. 
1.5.3 piRNA function in early development 
Mutations in Piwi proteins cause defective germ cell production and the activation of 
transposons in Drosophila, zebrafish and mice (Carmell et al., 2007; Girard et al., 2006; 
Houwing et al., 2007; Kalmykova et al., 2005; Lin and Spradling, 1997). The evidence 
suggests that the role of piRNAs in germ cell maintenance is directly related to their 
role in genome defence against transposon integration: piRNA biogenesis pathway 
mutations lead to the accumulation of double strand breaks and the activation of the 
ATR/Chk2 DNA damage checkpoint in Drosophila (Klattenhoff et al., 2007). In 
addition to mediating degradation of transposon transcripts, mouse piRNAs are thought 
to direct CpG methylation of DNA to transcriptionally silence LINE and LTR 
retrotransposons (Kuramochi-Miyagawa et al., 2008). 
 In addition to transposon silencing, Drosophila piRNAs are implicated in telomere 
protection: mutation of aubergine disrupts telomere binding to the telomere protection 
complex (Khurana et al., 2010). piRNAs can target repetitive transcripts that are not 
derived from transposons. For example, the protein coding Stellate gene contains 
multiple tandem repeats and is repressed by piRNA interaction with AUB2, which 
cleaves Stellate mRNA (Nishida et al., 2007). Moreover, piRNA targeting of maternal 
nanos mRNA for cleavage via recruitment of CCR4 deadenylase in a manner 
reminiscent of zebrafish miR-430 has been reported in Drosophila (Rouget et al., 2010). 
piRNAs from two transposons (412 and roo) target 129 nt and 75 nt regions of the 
nanos 3’ UTR respectively and form a complex with AUB, an RNA-binding protein 
(Smaug) and the deadenylase CCR4 to mediate poly(A) tail removal and subsequent 
degradation of nanos mRNA, which is critical for head development (Rouget et al., 
2010).  
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The mechanism of piRNA interaction with chromatin is unclear. Drosophila Piwi 
family protein mutants (PIWI, AUB) and RNA-helicase spindle-E mutants (critical for 
piRNA synthesis) show loss of transposon silencing and heterochromatin including 
reduction in repressive epigenetic marks such as H3K9 methylation and decreased HP1 
localisation (Klenov et al., 2007; Pal-Bhadra et al., 2004). HP1 binds methylated lysines 
and mediates silencing by recruitment of other factors such as histone deacetlyases and 
histone methyltransfereases in a repressive complex. These results suggest that piRNA 
biogenesis promotes heterochromatin formation at transposons. On the other hand, 
recent work has shown that heterochromatin directs piRNA synthesis. Methylation of 
H3K9 by the histone methyl-transferase dSETDB1 is essential for transcription of 
piRNA clusters and in its absence transposons are activated, leading to loss of germ 
cells (Rangan et al., 2011). Moreover, HP1 recruitment is independent of AGO2 and 
PIWI expression, suggesting that heterochromatin formation is independent of siRNA 
or piRNA-guided recruitment of these proteins to DNA (Moshkovich and Lei, 2010).  
piRNAs were recently sequenced in the mouse pancreas and in tissues of the macaque 
reproductive system, suggesting that piRNAs may play a role outside of genome 
defence in the germline. Macaque piRNA expression domains overlapped with Piwi 
family mRNAs and expression of the mouse PIWI homologue in the pancreas was 
confirmed (Yan et al., 2011). The role of piRNAs outside of maintaining germline 
integrity could include silencing transcription from non-transposon repeats or 
maintenance of heterochromatin, although the best understood function of human and 
mouse piRNAs is in germline development (Girard et al., 2006). Similarly, Xenopus 
Piwi family proteins are expressed in testes and oocytes, and piRNAs are the most 
abundant class of small RNAs found in oocytes and mature eggs (Lau et al., 2009). 
Both Xenopus Piwi family proteins XIWI and XILI are found in oocytes but are not 
expressed in adult Xenopus tissues (Armisen et al., 2009), suggesting that piRNA 
biogenesis is not active in adult X. tropicalis animals. In summary, piRNAs are critical 
for maintaining genome integrity in the germline of animals, but may have other 
functions, particularly in somatic tissues, which have yet to be explored. 
In summary, small non-coding RNAs have emerged in the last decade as critical 
regulators of gene expression in early development. Recent research has also shown that 
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interplay between small RNAs and RNA-binding proteins in the 3’ UTR of their target 
genes is an important mechanism for modulation of gene expression in embryogenesis.  
1.6 Role of RNA-binding proteins in early vertebrate 
development  
1.6.1 Regulation of RNA stability  
As discussed in section 1.4.2, mRNA degradation can be mediated by deadenylase-
mediated removal of the poly(A) tail and removal of the 5’ methyl-guanosine cap. 
GW182 interacts with poly(A)-binding protein (PABP) to recruit a deadenylase 
complex (see Figure 1.6) via the silencing domain which is similar to the PABP-
interaction motif 2 (PAM2) of the PABP-interacting protein PAIP2 (Huntzinger et al., 
2010). The PAIP proteins regulate PABP activity: PAIP1 promotes translation, whereas 
PAIP2 inhibits translation by displacing PABP from the poly(A) tail. The PAM2 motif 
is present in various RNA-binding proteins that regulate mRNA stability or translation 
such as eukaryotic peptide chain release factor 3A (ERF3A) (Albrecht and Lengauer, 
2004).  
Deadenylation of the poly(A) tail has been extensively studied in Xenopus, where the 
RNA-binding protein EDEN (embryonic deadenylation element) binds the 3’ UTR of 
target oocyte mRNAs to clear them from fertilized embryos. The human homologue of 
EDEN is CUG-BP, which recruits the deadenylase PARN (poly(A)-specific 
ribonuclease) to initiate mRNA decay (Moraes et al., 2006). CUG-BP was initially 
identified for its propensity to bind CUG repeats but it also recognises AU-rich 
elements (AREs) in the 3’UTR. CUG-BP belongs to the elav family of RNA-binding 
proteins that are conserved in vertebrates and regulate mRNA stability and translation, 
named after the Drosophila mutant embryonic lethal abnormal visual system (Samson, 
2008).  
Whilst many elav proteins are neuronal, the human elav protein HuR is expressed 
ubiquitously, is nuclear and cytoplasmic and promotes stability of many mRNAs 
including MyoD, p21, VEGF and TNF-α amongst others (Barreau et al., 2005). HuR 
contains three RNA-binding domains and recognises a 17-20 bp U-rich motif, with 
Chapter 1. Introduction 
 52 
UAUUUAU as a core high-affinity motif (Lebedeva et al., 2011; Lopez de Silanes et 
al., 2004). Genome-wide studies of HuR binding revealed that as well as 3’ UTR 
recognition, HuR binds in introns of pre-mRNA, indicating a possible role in pre-
mRNA splicing consistent with previous results showing HuR association with the 
spliceosome (Chen et al., 2007; Lebedeva et al., 2011; Mukherjee et al., 2011). The 
number of HuR binding sites directly correlated with mRNA stability, and mRNAs with 
both intronic and 3’ UTR HuR binding were the most stable (Mukherjee et al., 2011). 
HuR knockdown upregulates processing of miR-7, an intronic miRNA residing in a 
gene containing intronic and exonic Hur binding sites (Lebedeva et al., 2011). In this 
study, many HuR and Ago binding sites were found to be within 10 nt of each other and 
microRNA seeds were generally proximate but not overlapping with Hur binding sites, 
suggesting that HuR competes with microRNAs for 3’ UTR binding (Lebedeva et al., 
2011; Mukherjee et al., 2011). 
Other ARE-binding proteins have a well-characterised role in promoting mRNA 
degradation. For example, tristetrapolin (TTP) targets the mRNA of HIF-1α, TNF-α 
and proteins involved in breast cancer invasion and metastasis including urokinase 
plasminogen activator (uPA) and matrix metalloproteinase-1 (MMP-1) for degradation 
(Al-Souhibani et al., 2010). TTP itself is downregulated whilst its targets are 
upregulated in the breast cancer cell line MDA-MB-231 compared to control breast cell 
lines, suggesting that TTP may play a role in breast cancer (Al-Souhibani et al., 2010).  
RNA-binding proteins can also modulate clearance of maternal mRNAs by miR-430 
in zebrafish. DAZL (deleted in azoospermia-like) is specifically expressed in primordial 
germ cells in zebrafish (which give rise to gametes) and promotes polyadenylation of 
target mRNAs to oppose the deadenylation activity of miR-430 (Takeda et al., 2009). In 
this way, DAZL promotes translation of the germ cell specific proteins nanos1 and 
tdrd7 (Takeda et al., 2009). Moreover, in Xenopus, DAZL interacts with PABP to 
promote translation initiation (Collier et al., 2005). DAZL is also essential for germ cell 
formation and differentiation of primordial germ cells into male or female gametes in 
the mouse (Gill et al., 2011). 
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 DND1 (dead end 1) is also expressed in primordial germ cells in zebrafish and 
humans and counteracts miR-430 activity in fish by preventing recognition of miR-430 
binding sites in the 3’ UTR by the miR-430:RISC complex (Kedde et al., 2007). DND1 
promotes RNA stability by recognition of U-rich regions close to miRNA binding sites 
via its RNA binding domain. Zebrafish DND1 targets include the germ cell specific 
genes nanos and tdrd7, whilst human target mRNAs include tumour suppressors LATS2 
and p27, which are negatively regulated by miR-372 and miR-221 respectively (Kedde 
et al., 2007). Essentially, DND1 binding prevents microRNA-RISC complexes binding 
microRNA target sequences in the 3’ UTR to alleviate microRNA-mediated gene 
repression. 
1.6.2 Translational control 
Several RNA-binding proteins regulate translation efficiency without affecting 
mRNA levels. As described in Figure 1.7, translation initiation involves recognition of 
the methyl-guanosine cap by the translation initiation factor eIF4E to form a closed loop 
complex with mRNA via eIF4E interaction with eIF4G and PABP bound to the poly(A) 
tail. RNA-binding proteins containing an eIF4E-binding motif can compete with eIF4G 
for eIF4E binding and inhibit initiation of translation by preventing formation of the 
closed loop complex. For example, Xenopus cyclin B1 is translationally repressed in 
oocytes via interaction of Maskin, which contains an eIF4E-binding motif, with CPEB 
(cytoplasmic polyadenylation element binding protein) in the 3’ UTR (de Moor et al., 
2005). Translation of Maskin itself is activated by poly(A) tail elongation, which 
promotes interaction of PABP with eIF4G (Meijer et al., 2007). Similarly, Drosophila 
oskar and nanos mRNAs are translationally repressed by Bruno (a homologue of 
Xenopus EDEN and elav family member), which recruits the eIF4E-binding protein 
Cup to inhibit translation (Richter and Sonenberg, 2005). In contrast, the affinity of 
mammalian eIF4E binding proteins (4E-BP) for eIF4E is decreased by mTOR-mediated 
phosphorylation to link control of protein synthesis to cellular nutritional status and 
growth (Richter and Sonenberg, 2005). The elav family proteins ElrA and ElrB also 
mediate translational repression of Vg1 mRNA in the X. laevis oocyte by binding to 
AREs in the Vg1 3’ UTR, however the mechanistic details are unclear. 
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Pumilio RNA-binding proteins also inhibit translation and are conserved from yeast 
to humans. Pumilio was first identified as a translational repressor of maternal 
hunchback mRNA in the posterior of the Drosophila embryo, but is now known to 
associate with many mRNAs via the 3’ UTR motif UGUANAUA in Drosophila and 
humans (Gerber et al., 2006; Morris et al., 2008). Pumilio is able to repress cap-
independent translation in Drosophila, but the mechanism of Pumilio translational 
inhibition remains unclear, although it is known to be dependent on residues in the 
RNA-binding domain (Wharton et al., 1998). Knockdown of a human Pumilio protein, 
Pum1 resulted in increased half-life for Pum1-associated mRNAs, in agreement with 
observations of Pumilio proteins in other species that Pumilio regulates RNA stability 
(Morris et al., 2008). Yeast Pumilio proteins promote mRNA deadenylation and 
degradation by interacting with components of the CCR4-Not deadenylase complex 
(Goldstrohm et al., 2006).  
Recent work has indicated that Pumilio proteins can interact with microRNA 
regulation. Human Pum1 and Pum2 target mRNAs are enriched in microRNA binding 
sites, and evidence for Pumilio binding altering mRNA structure to enhance microRNA 
binding has been demonstrated for miR-221 and miR-222 binding of the p27 3’UTR in 
mammalian systems (Galgano et al., 2008; Kedde et al., 2010). Interactions between 
microRNAs and RNA binding proteins such as Hur, DND1 and Pumilio in 3’ UTR-
mediated gene regulation are emerging as an important mechanism for combinatorial 
control of gene expression.  
In summary, early vertebrate development is orchestrated by the activation of 
transcriptional programs in response to extracellular ligands, modulation of signal 
transduction and control of gene expression by regulators including coreceptors such as 
XCR1, small RNAs including microRNAs, endo-siRNAs and piRNAs and RNA-
binding proteins.  
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1.7 Aims of the thesis 
• To explore the role of small RNAs as regulators in early vertebrate 
development. 
• To investigate the mechanism and functional relevance of spatial regulation of 
Xenopus Cripto-1, a coreceptor for the Nodal signalling pathway. 
• To characterise the small RNA profile of early vertebrate development by 
genome-wide sequencing of the small RNAome of the early X. tropicalis 
embryo. 
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Laboratory chemicals were purchased from Sigma-Aldrich, Roche or Fisher 
Scientific unless otherwise stated. Standard laboratory solutions including 10 x TAE, 10 
x TBE, 5 M sodium chloride, 0.5 M EDTA (pH 8), 1 M Tris-HCl (pH 7.8 or 8), 10 x 
PBS, 1 x PBS and autoclaved water were prepared by Cancer Research UK Cell 
Services.  
2.1 Molecular Biology 
A list of general molecular biology solutions and buffers is detailed in Section 2.1.3.  
2.1.1 Preparation of plasmid DNA 
2.1.1.1 Transformation of TG1 super-competent bacteria 
Plasmid DNA from the Developmental Signalling laboratory plasmid database or 
gifts from other laboratories was retransformed into competent TG1 bacteria. 50 µl 
aliquots of TG1s were thawed on ice and incubated with 100 ng of plasmid DNA for 10 
minutes, then subjected to a mild heat shock by incubation at 37 °C for 1 minute, 
followed by incubation on ice for 2 minutes. 200 µl of LB broth was added and shaking 
incubation at 37 °C for 20 minutes was carried out to allow for recovery of the TG1s 
and activation of the ampicillin resistance gene. Transformed bacteria were then plated 
onto pre-warmed LB-agar plates containing ampicillin at a concentration of 100 µg/ml 
to select for transformed bacteria. After overnight incubation at 37 °C, a single colony 
was picked using a sterile pipette tip and added to a flask containing 200 ml of LB broth 
supplemented with 100 µg/ml ampicillin and incubated shaking at 37 °C overnight to 
grow large-scale transformed bacterial culture from which to extract plasmid DNA.   
2.1.1.2 Maxi-prep plasmid DNA purification 
Plasmid DNA was extracted from large-scale bacterial cultures using the GenElute kit 
(Sigma) according to the manufacturer’s instructions. Briefly, bacterial cultures were 
centrifuged at 4000 rpm for 20 minutes to obtain a bacterial pellet, which was 
resuspended and bacteria were then lysed using sodium hydroxide and SDS lysis buffer 
to release plasmid DNA. Subsequent column purification was used to remove 
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contaminating cellular debris from the DNA that was bound to the silica column 
membrane, which was then washed with ethanol, eluted and precipitated using 
isopropanol. After ethanol washes, the DNA pellet was air-dried and resuspended in TE 
(see section 2.1.3).  
2.1.1.3 Estimation of nucleic acid concentration 
The concentration of purified plasmid DNA was estimated by quantification on a 
Nanodrop spectrophotometer. This calculates the DNA concentration, c, in ng/µl based 
on the absorbance, A, of 260 nm UV light passed through the nucleic acid sample using 
the Beer-Lambert law. At 260 nm, double-stranded DNA has an average extinction 
coefficient (ε) of 0.02 (ng/µl)-1cm-1, and the path length, b, in the Nanodrop is 10 mm. 
The Beer-Lambert law can be rearranged to calculate DNA concentration as follows: 
c = A 
      εb 
 
 
For example, an absorbance of 1 corresponds to a DNA concentration of 50 ng/µl.  
Absorbance ratios at different wavelengths can indicate the purity of the DNA sample. 
The A260/A280 ratio is 1.8 for pure DNA. For purified RNA, a sample with an 
absorbance of 1 at 260 nm corresponds to an RNA concentration of 40 ng/µl. The 
A260/A280 ratio for pure RNA is 2.0.   
2.1.2 Cloning 
2.1.2.1 PCR amplification and product purification 
The sequence of interest was amplified from template DNA by the polymerase chain 
reaction (PCR). PCR forward and reverse primers contained overhanging sites for 
restriction enzymes to allow cloning of the PCR product into a digested vector (see 
section 2.1.6 for a list of primers used in cloning). A typical PCR reaction and program 
are described below. Homemade Taq polyermase was prepared by Mike Howell. The 
PCR reaction was then subjected to agarose gel electrophoresis (1 % or 2 % agarose 
depending on expected product sizes) and visualised by ethidium bromide staining to 
confirm the sizes of the PCR products by comparison to standard DNA markers (NEB). 
The band was then excised from the gel and DNA was extracted from the gel slice using 
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the QIAquick Gel Extraction kit (Qiagen) using the microcentrifuge protocol according 
to the manufacturer’s instructions. Briefly, this involved melting and solubilising the gel 
slice, applying the solution to a column that bound the DNA, ethanol washing and DNA 
elution from the column by adding 30 µl water heated to 50 °C and centrifugation.  
PCR reaction (25 µ l) 
10 x PCR buffer 2.5 µl  
10 µM forward primer 0.5 µl  
10 µM reverse primer 0.5 µl  
DNA (100 ng/µl) 1 µl  
10 mM dNTPs 0.5 µl  
water 19 µl  
2.5 units Taq (homemade) 1 µl  
 
94 °C 2 minutes 
94 °C 30 seconds 
50 °C 30 seconds 
72 °C 30 seconds (or 1 minute/kB) 
72 °C 5 minutes 
4 °C ∞ 
2.1.2.2 Restriction digests  
The gel purified PCR product was then digested with the intended restriction enzymes 
(NEB), gel purified again and the DNA concentration was determined by Nanodrop 
quantification. The vector was prepared by restriction digest of 3 µg of DNA and 5’ 
phosphates were removed by incubation with alkaline phosphatase (Roche) prior to gel 
purification and DNA quantification. Where the selected restriction enzyme digest 
would be inhibited or blocked by Dam methylation (e.g. XbaI), the DNA was 
retransformed into the Dam negative bacterial strain JM110.  
x 30 cycles 
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Insert restriction digest 
30 µl gel purified DNA 
4 µl 10 x BSA 
4 µl NEB reaction buffer  
1 µl restriction enzyme A (20,000 units/ml) 
1 µl restriction enzyme B (20,000 units/ml) 
Incubate for 2 hours at 37 °C 
Vector restriction digest  
3 µg of vector DNA 
2 µl 10 x BSA 
2 µl NEB reaction buffer  
1 µl restriction enzyme A (20,000 units/ml) 
1 µl restriction enzyme B (20,000 units/ml) 
Up to 20 µl with water 
Incubation for 2 hours at 37 °C, followed by incubation with 1 µl (20 units/µl) of 
alkaline phosphatase (Roche) for 5 minutes at room temperature.  
2.1.2.3 Ligations and transformation  
The prepared insert and vector DNA were ligated using T4 DNA ligase (NEB). A 
vector-only control was included to assess the extent of vector re-ligation. Ligation 
reactions were incubated for 1 hour at room temperature and then transformed into TG1 
bacteria, plated onto LB-agar plates supplemented with the appropriate antibiotic and 
incubated at 37 °C overnight to allow colonies to grow.    
2.1.2.4 Screening colonies by restriction digest and confirmation of 
successful cloning by sequencing  
Colonies were picked using a sterile pipette tip and added to 3 ml of LB medium 
supplemented with the relevant antibiotic and incubated overnight at 37 °C in a shaking 
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incubator. Plasmid DNA was extracted from the small-scale bacterial cultures using the 
QIAprep Spin Mini-prep kit (Qiagen) according to the manufacturer’s instructions. 
Briefly, bacteria were lysed using an alkaline lysis buffer and lysates were neutralised 
and cleared of cellular debris by centrifugation. The solution containing a white 
flocculate was then applied to a silica column that binds DNA. The column was washed 
with ethanol and DNA was eluted by the addition of 50 µl water and centrifugation. The 
DNA samples were then screened for presence of the insert by restriction digest. 8 µl of 
mini-prep DNA (concentration approximately 40 ng/µl) was digested with the selected 
restriction enzymes and the reaction was subjected to electrophoresis on a 1 % agarose 
gel. At least one positive sample was retransformed and a single colony was picked and 
grown up in a large-scale bacterial culture. DNA was extracted as in Section 2.1.1.2, 
and sequenced as described below. The sequencing reaction was cleaned up to remove 
unincorporated dye-terminators using the Dyex 2.0 Spin Kit (Qiagen) and the DNA was 
dried using a vacuum centrifuge. Samples were then submitted to the Cancer Research 
UK Equipment Park for capillary sequencing.  
Sequencing reaction   
1 µl DNA (200 ng) 
1 µl primer (10 µM) 
8 µl (Applied Biosystems) Big Dye Terminator 
10 µl water  
Sequencing program   
96 °C 10 seconds 
50 °C 5 seconds 
60 °C 4 minutes 
60 °C 1 minute 
10 °C ∞ 
x 30 cycles 
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2.1.3  General molecular biology solutions and buffers 
500 x Ampicillin 
2.5 g Ampicillin (Sigma) 
50 ml water 
Ampicillin stocks were aliqoted and stored at -20°C and used at a final concentration 
of 100 µg/ml 
TE 
10 mM Tris-HCl pH 7.5 
1 mM EDTA 
Autoclaved and stored at room temperature. 
10 x PCR buffer 
500 mM KCl 
100 mM Tris-HCl pH 8.3 
15 mM MgCl2 
Aliquoted and stored at -20 °C.  
10 mM dNTPs 
100 mM dATP 10 µl  
100 mM dCTP 10 µl 
100 mM dGTP 10 µl 
100 mM dTTP 10 µl 
autoclaved water 60 µl 
dNTPs were from Roche and stored at -20 °C. 
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10 x TAE 
48.4 g of Tris base 
11.4 ml glacial acetic acid 
20 ml 0.5 M EDTA (pH 8.0) 
Up to 1 L with water 
This solution was prepared and autoclaved by Cancer Research UK Cell Services and 
stored at room temperature.  
6 x DNA loading dye 
0.25 % (w/v) bromophenol blue (Sigma) 
0.25 % (w/v) xylene cyanol (Sigma) 
30 % (w/v) glycerol (Fisher) 
1 x TAE 
1% agarose gel mixture 
1 g agarose (Invitrogen) 
100 ml 1 x TAE 
5 µl of 20,000 x ethidium bromide was added to the molten agarose before pouring 
the gel 
20, 000 x Ethidium bromide 
100 mg ethidium bromide (Sigma) 
10 ml autoclaved water 
10 x BSA  
100 µl 100 x BSA (10 mg/ml, NEB) 
900 µl water   
Aliquoted and stored at - 20 °C. 
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2.1.4 PCR-based site directed mutagenesis  
PCR primers used for site-directed mutagenesis were designed to contain the intended 
mutations flanked by 15 nucleotides of wild type sequence. For each mutant, the first 
round of PCR generates two overlapping products containing the desired mutation 
(Figure 2.1). These products were gel purified and 1 µl of each PCR product was used 
as the template for a second round of PCR using a pair of outer primers (containing 
restriction sites) to amplify the template DNA containing the desired mutations. A list 
of oligos used in site directed mutagenesis is detailed in section 2.1.6. The PCR product 
was then digested, gel purified and ligated into the digested vector as described in 
Sections 2.1.2.1-3. 
 
Figure 2.1 Site directed mutagenesis overview 
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2.1.5 List of plasmids 
Plasmid Name Description 
Plasmid 
made by/ 
gift from Reference 
pSP72-XEF1α Xenopus EF1α for RNAse protection 
probe (120 nt). Linearise with HinfI 
and transcribe with SP6 polymerase. 
J. Smith (Krieg et al., 
1989) 
pGEM-FRL1α  Xenopus XCR1α coding region (573 
nt) for Northern blot probe. Linearise 
with SpeI and transcribe with T7 
polymerase. 
 
K. Dorey (Dorey and 
Hill, 2006) 
XFGF-R Xenopus FGF-receptor for RNAse 
protection probe (146 nt). Linearise 
with AseI and transcribe with T7 
polymerase.  
C. Hill (Howell et 
al., 2001) 
pGEM3Z-
XCR1α/β probe 
1-250 nt of the Xenopus XCR1α 
coding region for an RNAse 
protection probe to detect both 
XCR1α (250 nt protected fragment) 
and XCR1β (200 nt protected 
fragment) mRNA. Linearise with 
XbaI and transcribe withT7 
polymerase. 
J. Harding Unpublished 
pGEM3Z-GFP 
probe 
190 nt GFP coding region for an 
RNAse protection probe. Linearise 
with XbaI and transcribe with T7 
polymerase.  
J. Harding Unpublished 
pFTX4K-
FRL1α I-tag 
Coding region of XCR1α with an 
internal Flag-tag introduced after 
Leu37 for making sense mRNA for 
overexpression. Linearise with XbaI 
and transcribe with T7 polymerase.  
K. Dorey (Dorey and 
Hill, 2006) 
pBSK(-)XHex 
 
Xenopus Hex for in situ probe. 
Linearise with NotI and transcribe 
with T7 polymerase.  
A. Zorn  (Newman et 
al., 1997) 
pSP73-Xbra Xenopus brachyury full length cDNA 
(2210 bp) for in situ probe. Linearise 
with BglII and transcribe with T7 
polymerase. 
J. Smith (Smith et al., 
1991) 
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pBSKS-XGsc Xenopus goosecoid cDNA for in situ 
probe (440 nt). Linearise with XbaI, 
and transcribe with T3 polymerase. 
J. Smith (Cho et al., 
1991) 
pGEM4Z-
Forkhead 
Xenopus forkhead fragment for in 
situ probe. Linearise with EcoRI and 
transcribe with T7 polymerase. 
M. Howell (Howell and 
Hill, 1997) 
pBSKII-
Xantivin 
Xenopus antivin (lefty) full length 
cDNA (1.9 kB) for in situ probe. 
Linearise with BamHI and transcribe 
with T7 polymerase. 
M. Wright (Cheng et al., 
2000) 
pBSK(-) 
Xsox17α 
Xenopus sox17α full length cDNA 
(1.2 kB) for in situ probe. Linearise 
with KpnI and transcribe with T3 
polymerase. 
A. Zorn (Sinner et al., 
2004) 
ALK4 * Constitutively-active mouse ALK4 
for sense mRNA synthesis. Linearise 
with HindIII and transcribe with T7 
polymerase.  
J. Smith (Armes and 
Smith, 1997) 
pFTX4K-Xnr5 Xenopus full length Xnr5 for sense 
mRNA synthesis. Linearise with 
XbaI and transcribe with T7 
polymerase. 
K. Dorey (Dorey and 
Hill, 2006) 
pFTX4K-Xnr6 Xenopus full length Xnr6 for sense 
mRNA synthesis. Linearise with 
XbaI and transcribe with T7 
polymerase. 
K. Dorey (Dorey and 
Hill, 2006) 
pCS2+GFP GFP coding region for sense mRNA 
synthesis. Linearise with NotI and 
transcribe with SP6.  
P. Blader  
pCS2+GFP-
Dicer-MO 
X. laevis Dicer morpholino binding 
site sequence directly upstream of 
the GFP coding region to check the 
morpholino works. Linearise with 
NotI and transcribe with SP6 
polymerase for sense RNA.  
S. Gessert (Gessert et 
al., 2010) 
pCS2+N-
mCherry-H2B 
Human histone H2B (full length) 
downstream of mCherry for sense 
mRNA. Linearise with NotI and 
transcribe with SP6 polymerase. 
S. 
Woolner 
Unpublished 
pFTX4K-
eGFPC1 
GFP coding region with a stop-codon 
oligo at the 3’ end of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
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pFTX4K-
eGFPC1-
XCR1α-3’UTR 
GFP-3’UTR reporter. Full length 
XCR1α-3’UTR (1-958 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1- 
XCR1β-3’UTR  
GFP-3’UTR reporter. Full length 
XCR1β-3’UTR (1-764 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1-
XCR1β 300-
764 3’UTR 
GFP-3’UTR reporter. Partial 
XCR1β-3’UTR (1-764 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1-Xtcr1 
3’UTR 
GFP-3’UTR reporter. Full length X. 
tropicalis Cripto-1 3’UTR (1-783 nt) 
cloned downstream of GFP. For 
sense mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1-hCR1-
3’UTR 
GFP-3’UTR reporter. Full length 
human Cripto-1 3’UTR (1-1212 nt) 
cloned downstream of GFP. For 
sense mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
R. Randall Unpublished 
pFTX4K-
eGFPC1-
XCR1α 1-150 
3’UTR  
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (1-150 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1-
XCR1α 1-200 
3’UTR 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (1-200 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1-
XCR1α 1-350 
3’UTR  
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (1-350 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
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pFTX4K-
eGFPC1-
XCR1α 392-
958 3’UTR 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (392-958 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1-
XCR1α 286-
637 3’UTR 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (286-637 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (276-520 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1-
XCR1α 276-
402 3’UTR 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (276-402 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1-
XCR1α 276-
461 3’UTR 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (276-461 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1-
XCR1α 276-
579 3’UTR 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (276-579 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1- 
XCR1α 450-
520 3’UTR 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (450-520 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
pFTX4K-
eGFPC1- 
XCR1α 392-
520 3’UTR 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (392-520 nt) cloned 
downstream of GFP. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
J. Harding Unpublished 
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pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
mut-miR-107 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (276-520 nt) cloned 
downstream of GFP with 
5’TGCTGC to TCCACG mutations 
introduced beginning at 285 nt in the 
3’UTR. For sense mRNA, linearise 
with SpeI and transcribe with T7 
polymerase. 
R. Randall Unpublished 
pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
mut-miR-499 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (276-520 nt) cloned 
downstream of GFP with 
5’AGTCTTA to TCAGTAA 
mutations introduced beginning at nt 
310 in the 3’UTR. For sense mRNA, 
linearise with SpeI and transcribe 
with T7 polymerase. 
R. Randall Unpublished 
pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
mut-gga-miR-
1810 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (276-520 nt) cloned 
downstream of GFP with 
5’TATTAG to ATATAC mutations 
introduced beginning at 360 nt in the 
3’UTR. For sense mRNA, linearise 
with SpeI and transcribe with T7 
polymerase. 
R. Randall Unpublished 
pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
mut-Pub1 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (276-520 nt) cloned 
downstream of GFP with 5’ 
TTTTTTTTTAATTTTTTT to 
TATGAACTTAATCAATAC 
mutations introduced beginning at 
404 nt in the 3’UTR. For sense 
mRNA, linearise with SpeI and 
transcribe with T7 polymerase. 
R. Randall Unpublished 
pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
mut-miR-140 
GFP-3’UTR reporter. Partial 
XCR1α-3’UTR (276-520 nt) cloned 
downstream of GFP with 5’ 
TGTGGT to AGTCCA mutations 
introduced beginning at 489 nt in the 
3’UTR. For sense mRNA, linearise 
with SpeI and transcribe with T7 
polymerase. 
R. Randall Unpublished 
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pFTX4K-
eGFPC1-mut-
miR-107-full 
length XCR1α 
3’UTR 
GFP-3’UTR reporter. Full length 
XCR1α-3’UTR cloned downstream 
of GFP with 5’TGCTGC to 
TCCACG mutations introduced 
beginning at 285 nt in the 3’UTR. 
For sense mRNA, linearise with SpeI 
and transcribe with T7 polymerase. 
R. Randall Unpublished 
pFTX4K-
eGFPC1-mut-
miR-1810-full 
length XCR1α 
3’UTR 
GFP-3’UTR reporter. Full length 
XCR1α-3’UTR cloned downstream 
of GFP with 5’TATTAG to 
ATATAC mutations introduced 
beginning at 360 nt in the 3’UTR. 
For sense mRNA, linearise with SpeI 
and transcribe with T7 polymerase. 
R. Randall Unpublished 
2.1.6 List of oligos used in cloning  
Restriction sites and sequence that was removed by restriction digest is indicated in 
lower case. Red indicates the site of a mutation that was introduced into the plasmid by 
site directed mutagenesis. 
Plasmid Name Insert Primers 
pGEM3Z-
XCR1α/β probe 
F: 5’gaatctagaGGCACGAGGCGACCGTTACA 
R: 5’caaggatccTCCATGGGTGGCATTAATTG 
pGEM3Z-GFP 
probe 
F: 5’ gaatctagaGCTAGCGCTACCGGTCGCCA 
R: 5’caaggatccCACGGGCAGCTTGCCGGTGG 
pFTX4K-
eGFPC1 
Stop oligo cloned into parental vector by BglII/KpnI digest. 
5’ gatctCTAGATAACTGATggtac 
5’ cATCAGTTATCTAGa 
pFTX4K-
eGFPC1-
XCR1α-3’UTR 
F: 5’ catggatccCAGAGTAACTTGAGTCTG  
R: 5’ gcgcatcgatAGGTACAGTATTTAATGTCT 
pFTX4K-
eGFPC1- 
XCR1β-3’UTR  
F: 5’ catccatccCTGAGTAACTTGAGTCTG 
R: 5’ gcgcatcgatACTTGTTCAGTTTATATTT 
pFTX4K-
eGFPC1-
XCR1β 300-
764 3’UTR 
F: 5’ catggatccTAATCAGACACGTTGTACC 
R: 5’ggtactagtACTTGTTCAGTTTATATTT 
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pFTX4K-
eGFPC1-Xtcr1 
3’UTR 
F: 5’ gcgcggatccTGAGTAACTAGAGTCTGCTAG 
R: 5’ cgcgatcgatTACGTATTTAATGTTTCATTGC 
pFTX4K-
eGFPC1-hCR1-
3’UTR 
F: 5’ catggatccTCGACATTGACCTATTTC 
R: 5’ cgtactagtTTAGGTCAATATAGTTTCC 
pFTX4K-
eGFPC1-
XCR1α 1-150 
3’UTR  
F: 5’catggatccCAGAGTAACTTGAGTCTG 
R: 5’ gcgcatcgatATAGTTTCTGCATATTTTCA 
pFTX4K-
eGFPC1-
XCR1α 1-200 
3’UTR 
F: 5’catggatccCAGAGTAACTTGAGTCTG 
R: 5’ gcggatcgatCCTATAAAAAAAGTTATTTTATGAAAC 
pFTX4K-
eGFPC1-
XCR1α 1-350 
3’UTR  
F: 5’catggatccCAGAGTAACTTGAGTCTG 
R: 5’gcgcatcgatAATTTACATATATACAGAAT 
pFTX4K-
eGFPC1-
XCR1α 392-
958 3’UTR 
F: 5’ caggatccGCATCCTTCACAAACTTTTA 
R: 5’ gcgcatcgatAGGTACAGTATTTAATGTCT 
pFTX4K-
eGFPC1-
XCR1α 286-
637 3’UTR 
F: 5’ catggatccCTGCATGTTGAGATCAGGAA 
R: 5’ gcgcatcgatGGCTAGCACTTACATTGCT 
pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
F: 5’ catggatccCTTGCTCTTTGCTGCATGT 
R: 5’ ggtactagtGATCAGGACAAACATACAAA 
pFTX4K-
eGFPC1-
XCR1α 276-
402 3’UTR 
F: 5’ catggatccCTTGCTCTTTGCTGCATGT  
R: 5’ ggtactagtAAAAGTTTGTGAAGGATGC 
pFTX4K-
eGFPC1-
XCR1α 276-
461 3’UTR 
F: 5’ catggatccCTTGCTCTTTGCTGCATGT  
R: 5’ggtactagtAAAATGTTCCTAGATACTTTG 
pFTX4K-
eGFPC1-
XCR1α 276-
579 3’UTR 
F: 5’ catggatccCTTGCTCTTTGCTGCATGT  
R: 5’ ggtactagtGGGATGCAGTCACACACA 
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pFTX4K-
eGFPC1- 
XCR1α 450-
520 3’UTR 
F: 5’ ggtggatccTAGGAACATTTTACAAAT 
R: 5’ ggtactagtGATCAGGACAAACATACAAA 
pFTX4K-
eGFPC1- 
XCR1α 392-
520 3’UTR 
F: 5’ caggatccGCATCCTTCACAAACTTTTA 
R: 5’ ggtactagtGATCAGGACAAACATACAAA 
pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
mut-miR-107 
First round PCR primer pairs: 
F: 5’ GATCCCTTGCTCTTTCCACGATGTTGAGATCAGGA 
R: 5’ CAGGGTGGATTGAGTCCAGCC 
F: 5’ TGGACGGCGACGTAAACGGCC 
R: 5’ TCCTGATCTCAACATCGTGGAAAGAGCAAGGGATC 
Second round PCR primer pair: 
F: 5’ catggatccCTTGCTCTTTGCTGCATGT 
R: 5’ ggtactagtGATCAGGACAAACATACAAA 
pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
mut-miR-499 
First round PCR primer pairs: 
F: 5’ TGAGATCAGGAAGCTTCAGTAATACTTACCCAGTGC 
R: 5’ CAGGGTGGATTGAGTCCAGCC 
F: 5’ TGGACGGCGACGTAAACGGCC 
R: 5’ GCACTGGGTAAGTATTACTGAAGCTTCCTGATCTCA 
Second round PCR primer pair: 
F: 5’ catggatccCTTGCTCTTTGCTGCATGT 
R: 5’ ggtactagtGATCAGGACAAACATACAAA 
pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
mut-gga-miR-
1810 
First round PCR primer pairs: 
F: 5’TAAATTTTATTAACTATATACACACGTTGTACATTA 
R: 5’ CAGGGTGGATTGAGTCCAGCC 
F: 5’ TGGACGGCGACGTAAACGGCC 
R: 5’TAATGTACAACGTGTGTATATAGTTAATAAAATTTA 
Second round PCR primer pair: 
F: 5’ catggatccCTTGCTCTTTGCTGCATGT 
R: 5’ ggtactagtGATCAGGACAAACATACAAA 
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pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
mut-Pub1 
First round PCR primer pairs: 
F:x5’xCTTCACAAACTTTTATATGAACTTAATCAATACATTA
ATTGACAAAGA 
R: 5’ CAGGGTGGATTGAGTCCAGCC 
F: 5’ TGGACGGCGACGTAAACGGCC 
R:x5’xTCTTTGTCAATTAATGTATTGATTAAGTTCATATAAA
AGTTTGTGAAG 
Second round PCR primer pair: 
F: 5’ catggatccCTTGCTCTTTGCTGCATGT 
R: 5’ ggtactagtGATCAGGACAAACATACAAA 
pFTX4K-
eGFPC1-
XCR1α 276-
520 3’UTR 
mut-miR-140 
First round PCR primer pairs: 
F: 5’ TACTACATTGCATGTAGTCCATCTTGTTTGTATGTT 
R: 5’ CAGGGTGGATTGAGTCCAGCC 
F: 5’ TGGACGGCGACGTAAACGGCC 
R:x5’xAACATACAAACAAGATGGACTACATGCAATGTAGT
A 
Second round PCR primer pair: 
F: 5’ catggatccCTTGCTCTTTGCTGCATGT 
R: 5’ ggtactagtGATCAGGACAAACATACAAA 
pFTX4K-
eGFPC1-mut-
miR-107-full 
length XCR1α 
3’UTR 
First round PCR primer pairs: 
F: 5’ GGGTTCTTGCTCTTTCCACGATGTTGAGATCAGGAA 
R: 5’ CAGGGTGGATTGAGTCCAGCC 
F: 5’ TGGACGGCGACGTAAACGGCC 
R: TTCCTGATCTCAACATCGTGGAAAGAGCAAGAACCC 
Second round PCR primer pair: 
F: 5’ catggatccCAGAGTAACTTGAGTCTG  
R: 5’ gcgcatcgatAGGTACAGTATTTAATGTCT 
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pFTX4K-
eGFPC1-mut-
miR-1810-full 
length XCR1α 
3’UTR 
First round PCR primer pairs: 
F: 5’ TAAATTTTATTAACTATATACACACGTTGTACATTA 
R: 5’ CAGGGTGGATTGAGTCCAGCC 
F: 5’ TGGACGGCGACGTAAACGGCC 
R: 5’TAATGTACAACGTGTGTATATAGTTAATAAAATTTA 
Second round PCR primer pair: 
F: 5’ catggatccCAGAGTAACTTGAGTCTG  
R: 5’ gcgcatcgatAGGTACAGTATTTAATGTCT 
 
2.1.7 Linearisation of plasmids for in vitro transcription 
20 µg of plasmid DNA was digested with the appropriate restriction enzyme and 
buffer for 3 hours and then purified by phenol-chloroform extraction. 200 µl of 
phenol:chloroform:isoamyl alcohol  (Sigma) was added to the restriction digest and the 
mixture was vortexed and centrifuged at 13,000 rpm for 5 minutes. The upper aqueous 
layer was removed and transferred to an eppendorf tube containing 20 µl of sodium 
acetate pH 5.2 and 600 µl of 100% ethanol. The solution was precipitated on dry ice for 
10 minutes and centrifuged at 13,000 rpm for 15 minutes to obtain a DNA pellet. The 
pellet was washed with 80 % ethanol, dried and resuspended in 15 µl of TE. The 
concentration of the linearised DNA was adjusted to 1 µg/µl and linearisation was 
confirmed by gel electrophoresis compared to uncut plasmid DNA.  
Linearisation restriction digest 
20 µg plasmid DNA 
20 µl 10 x BSA 
20 µl NEB buffer 
3 µl restriction enzyme 
Up to 200 µl with autoclaved water 
Incubate at 37 °C for 3 hours 
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3 M sodium acetate  
24.6 g sodium acetate (anhydrous, Fisher) 
80 ml autoclaved water 
Adjust pH to 5.2 with glacial acetic acid 
Up to 100 ml with autoclaved water 
Filter sterilised by Stericup filtration (Millipore) and stored at room temperature. 
 
2.1.8 Preparation of capped mRNA for Xenopus microinjection 
40 µl of mRNA synthesis mix was added to 5 µl of linearised DNA (1 µg/µl). 5 µl of 
RNA polymerase (50,000 units/ml) was then added and the reaction mixture was 
incubated at 37 °C for 30 minutes. T7, SP6 or T3 polymerase was used as appropriate. 5 
µl of 10 mM rGTP was then added and the reaction was incubated at 37 °C for a further 
hour. 50 µl of 50-TE, 1.25 µl of DNAse I salts, 0.5 µl RNAsin (Promega) and 2 µl of 
DNAse I (2.7 units/µl, Worthington) was added and incubated for 30 minutes at 37 °C 
to remove template DNA. The mRNA was extracted by phenol-chloroform extraction. 
An equal volume of phenol:chloroform:isoamyl alcohol  (Sigma) was added and the 
mixture was vortexed and centrifuged at 13,000 rpm for 5 minutes to separate the upper 
aqueous and lower organic phases. The aqueous phase was removed and added to an 
eppendorf tube containing 300 µl of 100 % ethanol and 25 µl of 4 M ammonium acetate 
(pH 5.6). The mRNA was precipitated on dry ice for 10 minutes and centrifuged at 
13,000 rpm for 15 minutes to obtain a pellet. This was washed with 80 % ethanol, dried 
and resuspended in 80 µl of RNAse-free water (Ambion). The mRNA concentration 
was then adjusted to 1 µg/µl and stored at -80 °C.  
2.1.8.1 Assessment of RNA quality by gel electrophoresis 
The quality of the mRNA was assessed by confirming the integrity and size of the 
mRNA band by gel electrophoresis. 1 µg of RNA was added to 20 µl of formamide 
loading buffer and denatured by heating at 95 °C for 3 minutes. TAE gel electrophoresis 
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was performed as previously described, except that all gel trays and combs were washed 
with ethanol beforehand and 1 x TAE was RNAse-free.  
mRNA synthesis mix 
10 µl 10 x transcription buffer (NEB) 
6.25 µl DTT (100 mM) 
10 µl rATP (10 mM) 
10 µl rUTP (10 mM) 
10 µl rCTP (10 mM) 
5 µl rGTP (1 mM) 
5 µl CAP analogue (10 mM, NEB) 
5 µl RNAsin (Promega) 
10 µl autoclaved water 
50-TE 
50 mM Tris-HCl pH 7.5 
1 mM EDTA 
DNAse I salts 
5 µl CaCl2 (1 M) 
10 µl MgCl2 (1 M) 
10 µl DTT (100 mM) 
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4 M ammonium acetate 
30.8 g NH4OAc (BDH laboratory supplies) 
80 ml autoclaved water 
Adjust pH to 5.6 with glacial acetic acid 
Up to 100 ml with autoclaved water 
 Filter sterilised by Stericup filtration (Millipore) and stored at room temperature. 
Formamide RNA loading buffer 
0.25 % (w/v) bromophenol blue (Sigma) 
0.25 % (w/v) xylene cyanol (Sigma) 
20 mM EDTA 
Made up in deionised formamide (Fisher)  
 
2.1.9 Preparation of in situ hybridisation probes 
Linearised DNA was used as the template for in situ probe transcription. RNA probes 
were labelled with digoxygenin-11-rUTP by including DIG-UTP in the in vitro 
transcription reaction mix. The reaction was incubated at 37 °C for 2 hours and template 
DNA was then removed by the addition of 48 µl of 50-TE, 2 µl of DNAse I salts, 0.5 µl 
of RNAsin and 1 µl of DNAse I and subsequent incubation at 37 °C for 15 minutes. 
RNA was then isolated by G-50 sephadex column purification (GE Healthcare) 
according to the manufacturer’s instructions. Size exclusion on the column means that 
nucleic acids larger than 20 nucleotides are eluted and purified from unincorporated 
nucleotides. RNA concentration was estimated by Nanodrop quantification and RNA 
quality was confirmed by gel electrophoresis. Probes were diluted to a 10 x stock at a 
concentration10 ng/µl in in situ hybridisation buffer  (section 2.3.5.1) and stored at -20 
°C prior to use.  
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DIG-rNTP mix 
5 µl rCTP (100 mM) 
5 µl rGTP (100 mM) 
5 µl rATP (100 mM) 
3.25 µl rUTP (100 mM) 
17.5 µl digoxygenenin-11-rUTP (10 mM) 
164.25 µl RNAse-free water 
In situ probe transcription reaction  
5 µl 10 x transcription buffer (NEB) 
10 µl DIG-rNTP mix 
5 µl 100 mM DTT 
1 µl RNAsin  
2 µg linearised DNA  
4 µl RNA polymerase (T7, SP6 or T3 polymerase as required, 50,000 units/ml 
Up to 50 µl with RNAse-free water  
 
2.2 Xenopus laevis and Xenopus tropicalis embryo 
manipulations 
A list of general solutions used in Xenopus laevis experiments is given in Section 
2.2.6.  
2.2.1 Xenopus laevis husbandry 
Laboratory-bred adult frogs were obtained from Nasco, Fort Atkinson, WI, USA and 
the European Xenopus Resource Centre, Portsmouth, UK and housed separately 
according to sex in a Tecniplast Xenoplus housing system. The system was set to 
maintain pH at 7.5, conductivity at 1100 µS and temperature at 18 °C. Frogs were fed 1 
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ml of amphibian diet pellets per frog biweekly. The system exchanged 20 % of its 
volume every day and continuously recirculated water through a pre-filter to remove 
solid waste and a mechanical filter to trap particulate waste. Eggs were removed by 
hand as necessary. Water quality was monitored weekly by measuring levels of nitrates, 
nitrites, and ammonia using the Palintest water testing kit.  
2.2.2 Obtaining Xenopus laevis oocytes 
Female frogs were injected in the dorsal lymph sac with 50 units of PMSG (Intervet) 
3-5 days before induction of ovulation and subsequently injected with 500 units of HCG 
(Sigma) the afternoon prior to egg collection. Stimulated frogs were then massaged to 
release eggs from the cloaca into a petri dish. Excess water was removed from the 
oocytes before storage at 16 °C prior to in vitro fertilisation.  
2.2.3 In vitro fertilisation of Xenopus laevis oocytes 
An adult X. laevis male was killed according to Schedule I protocol by immersion in 
0.2 % (w/v) MS-222 for 30 minutes. Death was confirmed by severing the spinal chord. 
Testes were isolated by dissection and placed in Leibovitz’s L-15 medium (Gibco). 
Testes were crushed in 500 µl of high salt 1 x MBS using a micropestle and the solution 
was mixed by repeated pipetting and made up to 1.5 ml with high salt 1 x MBS. This 
solution was distributed evenly over the oocytes in the petri dish and allowed to 
incubate for 5 minutes. The petri dish was then flooded with 1/10 x NAM and left at 
room temperature for 30 minutes. During this time, the fertilised eggs undergo cortical 
rotation within the vitelline membrane so that the animal hemisphere faces upwards.  
2.2.4 Embryo manipulations 
2.2.4.1 De-jellying and sorting 
Embryos were prepared for subsequent manipulation by removal of the jelly coat. 
Fertilised eggs were transferred to a beaker containing 2 % (w/v) cysteine (pH 7.8) and 
gently agitated until the fertilised eggs began to pack together, which indicates de-
jellying has occurred. The fertilised eggs were washed four times in 1/10 x NAM to 
remove the cysteine solution and transferred to a clean petri dish. Eggs were sorted for 
fertilisation by selecting those resistant to deformation with a hair loop tool. 
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2.2.4.2 Microinjection  
Fertilised embryos were injected using a Narishige NM-300 microinjector in 3 % 
(w/v) Ficoll solution at various developmental stages depending upon the experiment in 
question. Morpholinos and mRNA for overexpression were injected at the 1-cell stage 
or the 4-cell stage for GFP-3’UTR reporter mRNA experiments where the spread of the 
injected mRNA was critical (see Figure 3.12). Embryos were injected in the most 
vegetal four blastomeres at the 32-cell stage for targeting of the prospective endoderm 
(Figure 3.3). An injection volume of 8 nl was used in all cases. Morpholino doses varied 
between 20 ng and 40 ng and individual mRNA doses between 200 pg and 700 pg per 
embryo. After microinjection, embryos were transferred to 1/10 x NAM and sorted for 
survival. A list of antisense oligos used for loss of function microinjection experiments 
is given in Table 2.1 and Table 2.2.  
2.2.4.3 Microdissection  
Embryos were dissected into animal and vegetal hemispheres at stage 9, or into 
animal caps, marginal zone and vegetal poles at stage 10 for subsequent Western blot 
analysis or total RNA extraction. Dissections were carried out in petri dishes coated 
with 1 % agarose and containing 1 x NAM supplemented with 0.1 % (w/v) BSA to 
avoid sticking of the embryo to the forceps during dissection. 
2.2.5 Fixation  
Embryos of the desired stage were fixed for downstream analysis by confocal 
microscopy or in situ hybridisation by removing the embryos from 1/10 x NAM and 
adding them to a Wheaton vial (Sigma) containing 4 % paraformaldehyde in RNAse-
free PBS and incubating for either 2 hours at room temperature or overnight at 4 °C. For 
in situ hybridisation, embryos were transferred from fixing solution to methanol and 
stored at -20 °C until they were processed. 
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2.2.6 General Xenopus solutions 
All solutions were prepared using MilliQ-filtered pure, deionised water.   
10 x Normal Amphibian Media (NAM) 
32.5 g NaCl 
0.75 g KCl 
1.2 g CaNO3 
1.25 g MgSO4 
1 ml 0.5 M EDTA 
Up to 500 ml with water  
10 x high salt Modified Barth’s Solution (MBS) 
51.3 g NaCl 
0.75 g KCl 
2 g MgSO4 
2 g NaHCO3 
Up to 1 L with water and adjust pH to 7.6 
1 x NAM 
100 ml 10 x NAM salts 
2 ml 1M HEPES-NaOH (pH 7.6) 
10 ml 0.1 M NaHCO3 
Up to 1 L with water 
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1 x high salt MBS 
50 ml 10 x high salt MBS 
2 ml 5 M NaCl 
350 µl 1 M CaCl2 
Up to 500 ml with water 
1/10 x NAM 
20 ml 10 x NAM salts 
4 ml 1 M HEPES-NaOH (pH 7.6)  
Up to 2 L with water 
2 % Cysteine 
6 g Cysteine (Sigma) 
300 ml 1/10 x NAM  
Adjust pH to 7.8 with NaOH 
0.2% MS-222 
4 g of Ethyl 3-aminobenzoate methanesulfonate (MS-222) 
2 L of water 
PMSG 
20 ml of the accompanying solvent was added to a vial of PMSG containing 5000 
units of hormone to make a stock of 0.25 units/ml. This was aliquoted at stored at -20 
°C. 0.2 ml of this solution was injected (50 units). 
HCG  
6 ml of autoclaved water was added to a vial of HCG containing 10,000 units of 
hormone to make a stock of 1667 units/ml. 0.3 ml of this solution was injected (500 
units). 
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2.2.7 Xenopus tropicalis in vitro fertilisation 
Wild type Xenopus tropicalis embryos were obtained in the Zimmerman laboratory at 
the National Institute for Medical Research. All animal handling was carried out by 
Zimmerman lab members and I performed the in vitro fertilisations, sorting, staging and 
microdissection of embryos. A list of Xenopus tropicalis solutions used is provided in 
Section 2.2.9. Petri dishes were coated with 1/20 x MMR with 0.1% BSA added before 
use to prevent the embryos sticking to the plastic. Female frogs were boosted the night 
before a frog experiment with 10 units of HCG and injected with 200 units of HCG four 
hours prior to squeezing. Testes were obtained from 2-3 male frogs as described in 
section 2.2.3 and were stored in 10 % calf serum (v/v) in Leibovitz’s L-15 medium at 4 
°C prior to use. Eggs were obtained from female frogs by holding the frog above a petri 
dish. A mixture of eggs from three females was collected. Testes were crushed 10 % 
calf serum/L-15 medium and spread evenly over the eggs. A few minutes were allowed 
for sperm attachment, then the petri dish was flooded with 1/20 x MMR and left at 
room temperature for 30 minutes. Unlike X. laevis, fertilised X. tropicalis embryos do 
not undergo cortical rotation.  
2.2.8 Xenopus tropicalis embryo manipulations 
2.2.8.1 De-jellying and sorting  
Embryos were de-jellied by swirling fertilised embryos in 2.2 % cysteine solution (pH 
7.8) for 7 minutes and washing four times in 1/20 x MMR with 0.1 % BSA. Sorting for 
fertilisation was done at the 2-cell stage, as unfertilised embryos do not cleave. 
Uninjected embryos were incubated at 25 °C in 1/20 x MMR plus 0.1 % BSA for 
staging, or transferred to injection dishes containing 3% Ficoll for microinjection.  
2.2.8.2 Microinjection 
Microinjection of fertilised embryos was performed at the 2-cell stage, with half the 
total morpholino dose injected into each blastomere. An injection volume of 2 nl and a 
maximum total dose of 15 ng of morpholino was used. Morpholinos were coinjected 
with fluorescein dextran as a tracer. All X. tropicalis morpholino injections were 
performed by Holly Ironfield in the Zimmerman laboratory. After injection, embryos 
were allowed to recover in Ficoll for 2 hours at 25 °C, then transferred to 1/20 x MMR 
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plus 0.1 % BSA for staging. Development of X. tropicalis embryos can be accelerated 
by incubating at 25-28 °C or slowed by incubating at 22 °C. 
2.2.8.3 Microdissection  
Microdissection of X. tropicalis embryos into animal and vegetal halves was 
performed at stage 10 exactly as described in section 2.2.4.3.  
2.2.9 Xenopus tropicalis solutions  
All solutions were made with MilliQ-filtered pure deionised water.  
1 x Marc’s Modified Ringers (MMR) 
0.1 M NaCl 
2 mM KCl 
1 mM MgSO4 
2 mM CaC12 
5 mM HEPES pH 7.8 
0.1 mM EDTA 
1/20 x MMR + gentamycin  
50 ml 1 x MMR  
1 ml gentamycin (100 mg/ml) 
Up to 1L with water 
1/20 x NAM + 0.1% (w/v) BSA 
1 L 1/20 x NAM 
1 g BSA (Sigma) 
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2.2 % Cysteine 
2.2 g Cysteine.HCl (Sigma) 
100 ml 1/20 x MMR 
pH to 7.8 with NaOH 
3% Ficoll 
3 g Ficoll (Sigma) 
100 ml 1/20 x MMR 
10 x Fluorescein dextran 
250 mg fluorescein dextran (Sigma) 
50 ml autoclaved water  
 
Morpholino Sequence Description 
MoC 5’CCTCTTACCTCAGT
TACAATTTATA 
Control morpholino against human 
β-globin 
Mo-xla-miR-427  5’ACGCCCAAAACAG
AAAGCACTTTCTCAT
CAT 
Multi-blocker microRNA 
morpholino designed to inhibit 
processing of mature xla-miR-427 
from its hairpin precursor by 
blocking Dicer site 
(Rosa et al., 2009). 
MoDicer (X. 
laevis) 
5’GAGTCATGAGCTG
AAGGCCTGCCAT 
 
Translation blocking X. laevis Dicer 
morpholino over the ATG (Gessert 
et al., 2010).  
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TP-Pumilio 5’TGTACATATATACA
GAATGCACTGG 
Antisense morpholino used as a 
target protector to block the Pumilio 
sites (PBE1-2) in the XCR1α 
3’UTR.  
Mo-miR-F (X. 
laevis and X. 
tropicalis) 
5’AGCCGAACGAGAA
GCACTTTCTCAT 
MicroRNA morpholino against 
novel Xenopus microRNA, miR-F. 
Morpholino is targeted to the guide 
strand and overlaps the Drosha site 
by 2 nt, which should prevent some 
processing of the primary miRNA 
transcript to a hairpin precursor in 
the nucleus.  
MoDicer (X. 
tropicalis) 
5’GATGTCCAGTAAT
CATACCTGATAT 
Splice-blocking X. tropicalis 
morpholino over the exon1-intron1 
boundary of Dicer prevents splicing 
out of intron1 that introduces a stop 
codon to produce a truncated 
protein.   
Table 2.1 Morpholinos used in Xenopus microinjection 
 
Antagomir Sequence Description 
Control 
antagomir 
Undisclosed 
 
Control RNA oligo 
(Ambion, catalogue number 
17010) 
α-miR-1810 
antagomir 
5’AGCUCACGUUCCCUAUUAGU Antisense RNA oligo to the 
mature gga-miR-1810 
miRNA sequence (Ambion, 
catalogue number 17010) 
Table 2.2 Antagomirs used in X. laevis microinjection 
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2.3 RNA Analysis 
All RNA procedures were carried out taking precautions to avoid RNAse 
contamination and degradation of the RNA sample, including using filter tips, RNAse-
free water, autoclaved solutions and regular changing of gloves. All RNA samples were 
centrifuged at 4 °C and kept on ice during the experiment.  
2.3.1 Total RNA extraction from Xenopus embryos 
Total RNA was extracted from embryos snap-frozen on dry ice and stored at -80 °C 
by the addition of 1ml of Trizol reagent (Invitrogen). Embryos were homogenised by 
repeated syringing through a 21G needle and light vortexing. The homogenate was then 
centrifuged at 13,000 rpm for 10 minutes at 4 °C and the resulting supernatant was 
transferred to a new eppendorf tube. 200 µl of chloroform was added and the mixture 
was vortexed and spun at 13,000 rpm for 15 minutes at 4 °C to separate the aqueous 
phase containing the RNA, and the organic phase. The aqueous layer was removed and 
transferred to an eppendorf tube containing 500 µl of isopropanol and vortexed. To 
precipitate nucleic acid, the samples were incubated on dry ice for 10 minutes and 
centrifuged at 13,000 rpm to obtain a pellet. Following removal of the supernatant, the 
pellet was washed in 80% ethanol and resuspended in 50 µl of RNAse-free water. 
 DNAse I digestion of any contaminating genomic DNA was then performed by 
addition of 95 µl of 50-TE, 0.5 µl of RNAsin (Promega) and 1 µl (2.7 units) of DNAse I 
(Worthington) and incubation at 37°C for 30 minutes. The RNA was extracted by 
addition of 150 µl of phenol:chloroform:isoamyl alcohol  (Sigma), vortexing and 
centrifugation at 13,000 rpm for 5 minutes. The aqueous layer containing the RNA was 
added to an eppendorf tube containing 300 µl 100% ethanol and 25 µl of 4 M 
ammonium acetate (pH 5.6) and incubated on dry ice for 10 minutes. An RNA pellet 
was obtained by centrifugation at 13,000 rpm for 15 minutes. After washing with 80 % 
ethanol, the RNA pellet was resuspended in 240 µl of RNAse-free water and quantified 
using the Nanodrop. The RNA quality was assessed by gel electrophoresis as described 
in Section 2.1.8.1. 250 µl of isopropanol was added to the RNA for storage as a slurry at 
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-80°C. Total RNA samples from mammalian cells were obtained from members of the 
Developmental Signalling Laboratory.  
2.3.2 Quantitative PCR  
0.5 µg of total RNA was used as the input in the reverse transcription cDNA synthesis 
reaction using the AffinityScript QPCR cDNA synthesis kit (Stratagene) according to 
the manufacturer’s instructions. The reverse transcription reaction was primed with 
random hexamers and a negative control cDNA synthesis reaction without reverse 
transcriptase enzyme was included (no RT control) to assess the level of genomic DNA 
contamination in the qPCR reaction. The 20 µl cDNA reaction was diluted by adding 80 
µl of RNAse-free water and stored on ice prior to use. 
 cDNA synthesis reaction 
10.0 µl of first strand master mix (2 x) 
3.0 µl of random primers (0.1 µg/µl) 
1.0 µl of AffinityScript reverse transcriptase 
0.5 µg of RNA 
Up to 20 µl with RNAse-free water 
 
25 °C 5 minutes 
42 °C 15 minutes 
55 °C 15 minutes 
95 °C 5 minutes 
4 °C ∞ 
 
A 15 µl mastermix containing EXPRESS SYBR GreenER qPCR Supermix 
(Invitrogen) and qPCR primers was prepared. This was pipetted into a 96 well optical 
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plate (Applied Biosystems) using an electronic pipette and 5 µl of cDNA was added. 
Triplicate repeats of samples were pipetted. The plate was sealed and centrifuged for 2 
minutes at 2000 rpm. The qPCR reaction was performed using an ABI 7500 Fast Real-
Time PCR machine. EXPRESS SYBR GreenER qPCR Supermix contains Taq 
polymerase, dNTPs and SYBR GreenER dye. SYBR GreenER binds double-stranded 
DNA and emits green light in proportion to the amount of dsDNA bound when excited 
by blue light. 40 cycles of PCR amplification were performed in the ABI 7500 Fast 
machine and fluorescence was measured at each cycle. A Ct value was recorded for 
each reaction. This is the cycle number required for the fluorescence to reach a 
threshold level, and is inversely proportional to the abundance of the PCR product. Ct 
values for each gene of interest were normalised to the Ct value of ODC, which has a 
constant mRNA level throughout Xenopus development (Paris et al., 1988). mRNA 
levels for the gene of interest were calculated relative to ODC and standard deviations 
of the triplicate repeats were plotted as error bars.  
mRNA level relative to ODC = 2 Ct(ODC)- Ct(Gene of interest) 
 
 A melt curve was also run to check the specificity of the PCR amplification. In a 
melt curve, fluorescence is measured against temperature. Heating DNA causes 
dissociation of the two strands, and a reduction in fluorescence as SYBR GreenER 
binding decreases. The temperature required to dissociate or melt the DNA varies with 
its length and so multiple peaks in melt curves can indicate the presence of multiple 
PCR products.  
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qPCR reaction mix 
10.0 µl EXPRESS SYBR GreenER qPCR Supermix (Invitrogen) 
0.4 µl Forward primer (10 µM) 
0.4 µl Reverse primer (10 µM) 
4.2 µl water  
5.0 µl diluted cDNA  
 
qPCR primer pairs 
X. tropicalis Dicer Exon1-Exon2 F: 5’ CGGAAATATCAGGTGGAACTAC 
R: 5’AGTCCCCACGGATCTGGTAT 
X. tropicalis Dicer Exon1-Intron1 F: 5’ CTGGCAACAGGAGGCTATTC 
R: 5’ CCACTGCAATGATTCTGTTCTT 
X. tropicalis ODC F: 5’ GGCCACACTGGCAACTCATGC 
R: 5’ CGGTGTGCGCTCAGTTCTGGT 
2.3.3 RNAse protection assay 
2.3.3.1 RNA probe synthesis and purification  
A radiolabelled antisense RNA probe against the mRNA target of interest was 
synthesised by in vitro transcription and gel purified. Firstly, 0.5 µg of linearised 
template DNA was incubated with probe synthesis mix, radiolabelled rUTP and either 
T7 or SP6 polymerase at 37 °C for 1 hour. Template DNA was then removed by 
DNAse I digestion. 1 µl of DNAse I (2.7 units) was added to the probe synthesis 
reaction and incubated at 37 °C for 30 minutes. 10 µl of formamide RNA loading buffer 
was added, and the sample was denatured by heating at 95 °C for 3 minutes and loaded 
onto a 6 % denaturing acrylamide gel. The gel was run with 0.5 x TBE running buffer at 
13 W until the bromophenol blue had run off. The gel was covered in saran wrap and 
the position of the probe band on the gel was determined by a 1-minute exposure of the 
gel on x-ray film. The probe band was excised and the gel slice was incubated in 350 µl 
of probe elution buffer at 50 °C for 2 hours. The probe elution solution was then 
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transferred to a new eppendorf tube and 350 µl of phenol:chloroform:isoamyl alcohol  
(Sigma) was added and the mixture was vortexed and centrifuged at 13,000 rpm for 5 
minutes. The upper, aqueous layer was transferred to an eppendorf tube containing 3 µl 
of 1 M MgCl2, 5 µl of yeast tRNA (10 µg/µl) and 900 µl of 100 % ethanol and the RNA 
was precipitated on dry ice for 10 minutes. This was followed by centrifugation at 
13,000 rpm for 20 minutes to obtain an RNA pellet which was washed in 80 % ethanol 
and dissolved in 20 µl of RNAse-free water. 1 µl of the RNA probe was counted in a 
scintillation counter and the probe concentration was adjusted to 2 x 105 cpm/µl.  
Probe synthesis reaction 
1.75 µl probe synthesis mix (see below) 
0.5 µl linearised DNA (1µg/µl) 
0.5 µl RNA polymerase (25 units) 
2.5 µ α-32P- rUTP (800 Ci/mmol, Perkin Elmer) 
Probe synthesis mix 
4 µl 10 x transcription buffer (NEB) 
2 µl rATP (10 mM) 
2 µl rGTP (10 mM) 
2 µl rCTP (10 mM) 
2 µl RNAsin (Promega) 
2 µl DTT (100 mM) 
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6 % denaturing gel mix (30 ml) 
1.5 ml 10 x TBE 
1.5 ml water 
19.8 ml Sequagel diluent (National diagnostics) 
7.2 ml Sequagel concentrate (National diagnostics) 
60 µl TEMED 
75 µl 20 % (w/v) APS 
2.3.3.2 Probe hybridisation to RNA 
Between 10 and 20 µg of Xenopus total RNA was spun out from a slurry (see section 
2.3.1). The pellet was washed in 80 % ethanol and resuspended in 30 µl of hybridisation 
buffer. 1 µl of each antisense radiolabelled probe was added and the sample was 
incubated at 85 °C for 5 minutes to allow denaturation of the RNA. Hybridisation was 
carried out overnight at 45 °C.  
2.3.3.3 RNAse digestion  
The hybridised RNA was added to 350 µl of RNAsing solution and 0.5 µl RNAse T1 
(20 units/µl, Calbiochem). The RNAse digestion reaction was incubated at 37 °C for 30 
minutes. Next, 10 µl of 20 % (w/v) SDS and 5 µl of Proteinase K (10 µg/µl) was added 
to and the samples were incubated at 37 °C for 30 minutes to remove the RNAse T1 
enzyme. The samples were then extracted by addition of 350 µl of 
phenol:chloroform:isoamyl alcohol  (Sigma), vortexed and centrifuged at 13,000 rpm 
for 5 minutes. The aqueous layer was then added to 500 µl of isopropanol with 15 µg of 
yeast tRNA added. The RNA was precipitated on dry ice for 10 minutes and centrifuged 
at 13,000 rpm at for 20 minutes to obtain an RNA pellet. The pellets were washed with 
80 % ethanol, dried and resuspended by adding 1 µl of RNAse-free water and 5 µl of 
formamide RNA loading buffer. Samples were denatured by heating at 95 °C for 3 
minutes.  
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2.3.3.4 Detection of protected mRNA fragments 
Denatured RNA samples and a radiolabelled low molecular weight ladder were 
loaded onto a 6 % denaturing gel and run for 1 hour and 15 minutes at 13 W. The gel 
was then fixed by immersion in 10 % methanol/10 % acetic acid in water for 15 minutes 
and dried on a gel dryer. The dried gel was then exposed overnight at -80 °C to obtain 
the signal for the protected mRNA fragment.  
2.3.3.5 RNAse protection assay solutions  
Probe elution buffer 
0.5 M ammonium acetate 
0.1 % (w/v) SDS 
1 mM EDTA 
Made up in RNAse-free water 
1 x Hybridisation buffer 
400 mM NaCl 
40 mM PIPES pH 6.4 
1 mM EDTA 
80 % (v/v) formamide 
RNAsing solution 
10 mM Tris pH 7.5 
5 mM EDTA 
300 mM NaCl 
Made up in RNAse-free water 
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Radioactive marker preparation 
1 µl (0.5 µg) low molecular weight marker (NEB) 
1 µl NEB buffer 2 
1 µl nucleotide mix (330 µM dATP, dTTP, dGTP) 
1 µl α-32P- dCTP (3000 Ci/mmol) 
6 µl water 
1 µl Klenow (50 units/µl NEB) 
The reaction was incubated at room temperature for 10 minutes and the radiolabelled 
marker was diluted by addition of 40 µl of TE and 50 µl of formamide dyes. 1 µl of a 
1/10 dilution of the marker was used. 
 
2.3.4 Northern blot analysis of transcripts 
20 µg to 30 µg of Xenopus embryo total RNA was analysed for transcript levels by 
Northern blot. RNA was incubated with an equal volume of denaturing solution at 50 
°C for 1 hour. 1/5 volumes of 6 x gel loading buffer was added to the denatured RNA 
and the samples were loaded onto a 1.5 % agarose gel made with sodium phosphate 
running buffer (pH 6.8). The gel was run at 4 V/cm according to the length of the gel 
until the bromophenol blue had run 10 cm. After electrophoresis, unused areas of the 
RNA gel were trimmed away and the bottom left corner was cut to orient the gel. The 
transfer apparatus was then assembled. The nylon transfer membrane (Hybond N+, 
Amersham) was prepared by cutting to the same size as the gel, pre-wetting in water 
and soaking in 20 x SSC (Gibco) for 5 minutes. In an autoclaved glass baking dish, a 
sterile tissue culture flask was used as a support and covered with a piece of Whatman 
paper. The dish was then filled with 20 x SSC and the wet Whatman paper was rolled to 
remove any air bubbles. The RNA gel was then placed face down on the wet Whatman 
paper. The gel was then surrounded with saran wrap to prevent short-circuiting of the 
transfer. The nylon membrane was placed on top of the gel and a stack of paper towels 
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were placed on top of the membrane and held in position by a glass plate and a 500 g 
weight. Transfer of the RNA onto the nylon membrane took place overnight.  
The transfer apparatus was disassembled and the nylon membrane was washed in 6 x 
SSC for 5 minutes to remove any agarose stuck to it. The membrane was dried between 
two pieces of Whatman paper and the RNA was crosslinked to the membrane using a 
UV-crosslinker (Stratagene) set to 1 minute at 120,000 µJ/cm2 and repeated on both 
sides of the membrane. Successful transfer of RNA was confirmed by staining with 
methylene blue and destaining with water to reveal ribosomal RNA bands. The 
membrane was scanned at this point to obtain a loading control. The membrane can be 
stored dry at 4 °C until use or incubated with 50 ml of hybridisation buffer at 65 °C in a 
hybridisation oven for 1-4 hours. In the meantime, a radiolabelled antisense RNA probe 
was synthesised and purified as described in Section 2.3.3.1. The RNA probe was added 
to 50 ml of fresh hybridisation buffer and hybridised to the membrane overnight by 
rotating incubation in the hybridisation oven at 65 °C. 
The membrane was then washed by exchanging the hybridisation buffer for washing 
solution. Four 5-minute room temperature washes in washing solution 1 followed by 
two washes for 10 minutes at 60 °C in washing solution 2 were carried out. The damp 
membrane was covered in saran wrap and placed in a cassette with an intensifying 
screen and exposed for 6 hours at -80 °C, then longer as necessary to develop the signal. 
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2.3.4.1 Northern blot solutions  
1 M Sodium phosphate buffer pH 6.8 
46.3 ml 1 M Na2HPO4 
53.7 ml 1 M NaH2PO4 
6 M Glyoxal (deionised)  
20 ml of glyoxal was deionised by stirring with 20 g of AG501-X8 ion-exchange 
resin (Biorad) until the resin was colourless. A further 4 g of resin was added and 
stirred for 30 minutes. This was repeated as needed until the pH reached 5.5. 
Deionised glyoxal was aliquoted and stored at -20 °C.  
Denaturing solution 
66 µl of 6 M deionised glyoxal 
1 µl 1 M sodium phosphate buffer pH 6.8 
1 µl 0.5 M EDTA 
133 µl DMSO 
6 x Loading buffer  
0.25 % (w/v) bromophenol blue 
0.25 % (w/v) xylene cyanol 
30 % (w/v) glycerol in water 
1 x Running buffer 
10 mM sodium phosphate buffer pH 6.8 
Methylene blue 
0.5 M sodium acetate pH 4.5  
0.04 % methylene blue 
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Hybridisation buffer 
50 % (v/v) deionised formamide (Fisher) 
5 x SSPE (Sigma) 
5 x Denhardt’s solution  
0.5 % (w/v) sodium pyrophosphate 
0.1 µg/ml denatured, sheared herring sperm DNA (Sigma) 
10 % (w/v) dextran sulfate 
2 % (w/v) SDS 
Made up in autoclaved water  
100 x Denhardt’s solution 
2 % (w/v) BSA 
2 % (w/v) polyvinylpyrrolidone (PVP-40, Sigma) 
2 % (w/v) Ficoll (Sigma) 
Made up in autoclaved water, aliqoted and stored at -20 °C. 
Washing solution 1 
2 x SSPE (Sigma) 
0.1 % (w/v) SDS 
Made up in autoclaved water 
Washing solution 2 
0.1 x SSPE (Sigma) 
0.1 % (w/v) SDS 
Made up in autoclaved water 
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2.3.5 Xenopus in situ hybridisation 
In situ hybridisation for mRNA of developmental markers of interest was performed 
on embryos fixed at the appropriate stage and stored in methanol. In situ hybridisations 
were carried out in Wheaton vials or homemade baskets. Washes were at room 
temperature unless otherwise stated. Embryos were rehydrated by 5 minute washes in 
75 % and 50 % ethanol in water, followed by 25 % ethanol in 75 % PBS-Tween. After 
two 5-minute washes in PBS-Tween, embryos were bleached by incubation in 
bleaching solution under bright light for 10 minutes. Bleaching solution was removed 
by two 5-minute washes in PBS-Tween. To ensure embryo integrity after bleaching, 
embryos were re-fixed for 20 minutes in 4 % paraformaldehyde in PBS-Tween. 
Embryos were then equilibrated in hybridisation buffer at 62 °C for between 2 and 3 
hours. This solution was then replaced by a 1x dilution of antisense probe in 
hybridisation buffer and incubated overnight 62 °C to allow hybridisation of the probe 
to the target mRNA.  
After recovery of the probe for later reuse, several 10-minute washing steps were 
performed at 62 °C to reduce non-specific probe binding. Embryos were washed in 
hybridisation buffer, followed by 25 % formamide, 2 x SSC and 0.1 % Tween, then 
12.5 % formamide, 2 x SSC and 0.1 % Tween, then 2 x SSC and 0.1 % Tween. A final 
30-minute wash at 62 °C in 0.2 x SSC and 0.1% Tween was performed. Embryos were 
then washed three times at room temperature in PBS-Tween for 5 minutes. Following 
equilibration in maleic acid buffer by washing twice for 5 minutes, embryos were 
incubated in blocking solution for 2 hours. Blocking solution was then replaced by anti-
DIG antibody conjugated to alkaline phosphatase (Roche) at a dilution of 1 in 2000 in 
blocking solution and incubated overnight at 4 °C. 
Post-antibody washes were performed in maleic acid buffer (MAB) with 0.1 % 
Tween for 6 hours at room temperature and subsequently overnight at 4 °C. Embryos 
were then washed twice for 10 minutes in alkaline phosphatase buffer to adjust the pH 
to 9.5 for the alkaline phosphatase reaction. The embryos were transferred to 24-well 
plates and staining was developed by addition of 1 ml of BM Purple reagent (Roche). 
Development time was varied as required at room temperature for several hours, or 
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overnight at 4 °C. Once a satisfactory staining was achieved, embryos were fixed in 4 % 
paraformaldehyde in PBS and images were acquired on a Leica dissecting microscope.  
2.3.5.1 In situ solutions 
PBS-Tween 
1 x PBS  
0.1 % (v/v) Tween-20 (Sigma) 
Bleaching solution (1ml) 
600 µl RNAse-free water 
325 µl 30 % (v/v) hydrogen peroxide (Sigma) 
50 µl deionised formamide (Fisher) 
25 µl 20 x SSC (Gibco) 
Up to 1 ml with RNAse-free water 
Hybridisation buffer  
50 % (v/v) deionised formamide 
5 x SSC  
1 mg/ml yeast RNA (torula, Sigma) 
0.1mg/ml heparin (Sigma) 
1 x Denhardt’s solution 
0.1 % Tween-20 
10 mM EDTA 
Made up in RNAse-free water 
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5 x Maleic Acid Buffer 
43.83 g NaCl  
58.03 g Maleic acid 
Adjust pH to 7.5 with sodium hydroxide 
Up to 1L with RNAse-free water 
Blocking solution 
2 g blocking reagent (Roche) 
20 ml 5 x MAB 
80 ml RNAse-free water 
Alkaline Phosphatase Buffer 
100 mM Tris pH 9.5 
50 mM MgCl2 
100 mM NaCl 
0.1 % Tween 
 
2.4 MicroRNA Analysis 
2.4.1 MicroRNA Northern blot analysis 
2.4.1.1 RNA separation and transfer 
30 µg of Xenopus embryo total RNA was spun out from an isopropanol slurry and 
resuspended in 30 µl of formamide RNA loading buffer and denatured by heating at 95 
°C for 3 minutes. The samples and a radiolabelled small RNA ladder (Decade markers, 
Ambion, prepared according to the manufacturer’s instructions) were loaded onto a 
15% denaturing gel. The gel was run using 1 x TBE running buffer at 10 W for 10 
minutes, and then 30 W for 35 minutes. To visualise the separation of the RNA and 
obtain a loading control, the gel was stained in 0.5 x TBE with 10 µl of 1 % ethidium 
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bromide solution added. The gel was then wrapped in saran and the RNA was 
transferred to a neutral (Hybond N, Amersham) or positively charged (Hybond N+, 
Amersham) nylon membrane by semi-dry blotting. The transfer was assembled by 
wetting 3 pieces of Whatman paper cut to the same size as the gel in 0.5 x TBE and 
placing them on the semi-dry transfer apparatus. Next, the nylon membrane was placed 
on top of the Whatman paper. The membrane was pre-wetted in water and equilibrated 
in 0.5 x TBE. Next the gel was placed on top of the membrane and 3 more pieces of wet 
Whatman paper were placed on top of the gel. The transfer sandwich was rolled to 
remove air bubbles and transfer was performed with a current of 2 mA/cm2 for 1.5 
hours with a maximum voltage of 25 V.  
After transfer of RNA, the membrane was dried and cross-linked either by UV cross-
linking or chemical cross-linking. For UV cross-linking, both sides of the membrane 
were cross-linked for 1 minute at 120,000 µJ/cm2 in a UV crosslinker (Stratagene). 
Chemical cross-linking improves small RNA detection compared to UV cross-linking 
by approximately 5-fold (Pall and Hamilton, 2008) and so much less RNA can be used 
(5-10 µg is sufficient for signal detection, see Figure 4.21). Chemical cross-linking 
requires transfer onto a neutral nylon membrane. For chemical cross-linking, the damp 
membrane is placed face up onto 2 Whatman papers saturated with freshly prepared 
EDC cross-linking solution. The membrane and saturated papers are wrapped in saran 
and incubated for 1 hour at 60 °C. After cross-linking, the membrane is washed in 
RNAse-free water to remove residual cross-linking solution. After cross-linking by UV 
or chemical methods, the membrane can be stored dry at 4 °C or placed directly into a 
50 ml falcon tube containing 15 ml of hybridisation buffer and equilibrated at 39 °C in a 
hybridisation oven for 1 hour.  
2.4.1.2 microRNA probe labelling 
Antisense DNA oligos for each microRNA of interest were obtained from Sigma. 
Oligos were end-labelled by the addition of a 5’ radiolabelled phosphate in an in vitro 
kinase reaction using γ-32P-ATP. The reaction was incubated at 37 °C for 1 hour. 
Labelled probe was purified from unincorporated nucleotides by applying the reaction 
to a G-25 sephadex column (GE healthcare).  
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Probe labelling by in vitro kinase reaction 
1 µl antisense DNA oligo (20 µM) 
5 µl γ- 32P-ATP (6000 Ci/mmol) 
2 µl 10 x T4 polynucleotide kinase buffer  
1 µl T4 polynucleotide kinase (20,000 units/ml, NEB) 
11 µl water 
2.4.1.3 Probe hybridisation, washing and signal detection 
The pre-hybridisation solution was poured off the membrane and replaced with 15 ml 
of hybridisation solution containing 20 µl of purified probe. The membrane was 
incubated overnight under rotation in a hybridisation oven at 39 °C. The membrane was 
then washed twice for 10 minutes with wash buffer at 39 °C. The membrane was 
covered in saran wrap and exposed overnight at -80 °C or longer as needed to obtain the 
microRNA signal. 
2.4.1.4 MicroRNA Northern blot solutions 
15 % denaturing gel mix (200 ml) 
71.2 ml 40 % acrylamide (Fisher) 
3.76 ml 2 % bis (Fisher) 
84 g urea 
50 ml 10 x TBE 
75 ml RNAse-free water 
50 µl of TEMED and 150 µl of 20 % APS (w/v) was added to 50 ml of denaturing 
gel mix and 30 minutes was allowed for the gel to polymerise. 
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Hybridisation buffer (30 ml) 
9 ml 20 x SSC 
0.6 ml 1 M Na2HPO4 pH 7 
0.75 ml 20 % (w/v) SDS 
0.3 ml 100 x Denhardt’s  
0.3 ml denatured, sheared herring sperm DNA (1 mg/ml Sigma) 
19.05 ml RNAse-free water 
Wash buffer 
60 ml 20 x SSC 
10 ml 20 % (w/v) SDS 
130 ml RNAse-free water 
EDC chemical cross-linking solution 
0.16 M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (Sigma) 
0.13 M 1-methylimidazole pH 8.0 (Sigma) 
Made up in RNAse-free water 
24 ml of EDC cross-linking solution is sufficient to saturate 320 cm2 of Whatman 
paper 
 
2.4.2 MicroRNA qPCR 
The microRNA qPCR procedure is described in Figure 4.19. 5 µg of Xenopus embryo 
or mammalian cell line RNA was polyadenylated by incubation with E. coli poly(A) 
polymerase (NEB) for 1 hour at 37 °C. The polyadenylated total RNA was extracted 
using phenol-chloroform organic extraction. 80 µl of RNAse-free water and 100 µl of 
phenol:chloroform:isoamyl alcohol (Sigma) was added to the polyadenylation reaction, 
vortexed and centrifuged at 13,000 rpm for 5 minutes. The upper aqueous layer was 
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added to an eppendorf tube containing 300 µl of 100 % ethanol and 25 µl of 4 M 
ammonium acetate (pH 5.6) and precipitated on dry ice for 10 minutes. The sample was 
then centrifuged at 13,000 rpm at 4 °C for 15 minutes to obtain an RNA pellet. The 
pellet was washed with 80 % ethanol, dried, and resuspended in 4 µl of RNAse-free 
water and the concentration of the polyadenylated RNA was adjusted to 1 µg/µl. 3 µg of 
polyadenylated RNA was used as the template for cDNA synthesis primed with a 
poly(T) adapter to reverse transcribe all polyadenylated RNA. The 20 µl cDNA reaction 
was diluted by addition of 80 µl of water. 5 µl of diluted cDNA was used in the qPCR 
reaction. The microRNA qPCR reaction was performed as described in Section 2.3.2, 
except that a universal reverse primer complementary to the poly(T) adapter sequence is 
used in all microRNA qPCR reactions. The forward primer is identical to the mature 
microRNA sequence, except that U is replaced by T. MicroRNA levels relative to ODC 
or U6 were calculated and error bars showing standard deviations of the triplicate 
repeats were plotted. 
Polyadenylation reaction 
2 µl 10 x poly(A) polymerase reaction buffer (NEB) 
2 µl dATP (10 mM) 
5 µg total RNA 
1 µl poly(A) polymerase (5 units, NEB) 
Up to 20 µl with RNAse-free water 
Chapter 2. Materials and Methods 
 104 
 cDNA synthesis reaction 
10.0 µl of first strand master mix (2 x) 
3.0 µl of poly(T) adapter (0.1 µg/µl) 
1.0 µl of AffinityScript reverse transcriptase 
3.0 µl of polyadenylated RNA (1 µg/µl) 
3 µl RNAse-free water 
 
25 °C 5 minutes 
42 °C 15 minutes 
55 °C 15 minutes 
95 °C 5 minutes 
4 °C ∞ 
 
miRNA-qPCR primers 
poly(T) adapter for cDNA 
synthesis 
5’aGCGAGCACAGAATTAATACGACTCACT
ATAGGTTTTTTTTTTTTVN 
MicroRNA qPCR reverse primer  5’ GCGAGCACAGAATTAATACGACTCAC 
MicroRNA qPCR forward primers 
miR-F 5’ GAGAAAGTGCTTCTCGTTCGGCTGA 
gga-miR-1810 5’ ACTAATAGGGAACGTGAGCT 
xtr-miR-427  5’ GAAAGTGCTTTCTGTTTTGGGCG 
PIR 32037 5’GCAGGACGGTGGCCATGGAAGTCGGAA
TC 
xtr-miR-A 5’ AGCAAATCTGTTGGTTTGTACAAAC 
xtr-miR-C 5’ TGCGCTCGGTGGATAGAAGACGTGA 
xla-miR-427 5’ AAAGTGCTTTCTGTTTTGGGCG 
xla-miR-16c 5’ TAGCAGCACGTAAATACTGGAG 
cfa-miR-30e 5’ CTTTCAGTCGGATGTTTACAGC 
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xtr-let-7c 5’ TGAGGTAGTAGGTTGTATGGTT 
xtr-let-7f 5’ TGAGGTAGTAGATTGTATAGTT 
xtr-miR-10a 5’ TACCCTGTAGATCCGAATTTGTG 
xtr-miR-16c 5’ TAGCAGCACGTAAATACTGGAG 
xtr-miR-101a 5’ TACAGTACTGTGATAACTGAAG 
xtr-miR-148a 5’ TCAGTGCACTACAGAACTTTGT  
xtr-miR-182 5’ TTTGGCAATGGTAGAACTCACA 
xtr-miR-184 5’ TGGACGGAGAACTGATAAGGCT 
xtr-miR-206 5’ TGGAATGTAAGGAAGTGTGTGG 
bta-miR-140 5’ TACCACAGGGTAGAACCACGGA 
dme-miR-184 5’ TGGACGGAGAACTGATAAGGGC 
gga-miR-30a-3p 5’ CTTTCAGTCGGATGTTTGCAGC 
hsa-let-7b 5’ TGAGGTAGTAGGTTGTGTGGTT 
hsa-miR-1825 5’ TCCAGTGCCCTCCTCTCC  
hsa-miR-423-5p 5’ TGAGGGGCAGAGAGCGAGACTTT 
Control primer pairs 
X. laevis ODC F: 5’ ACAAAGAAACCCAAACCAGA 
R: 5’ CAAACAACATCCAGTCTCCAA 
X. tropicalis ODC F: 5’ GGCCACACTGGCAACTCATGC 
R: 5’ CGGTGTGCGCTCAGTTCTGGT 
X. tropicalis U6 F: 5’ ATGGCCCCTGCGCAAGGATG 
R: miRNA qPCR reverse primer 
Human GAPDH  F: 5’ CTTCAACAGCGACACCCACT 
R: 5’ GTGGTCCAGGGGTCTTACTC 
2.4.3 MicroRNA in situ hybridisation  
2.4.3.1 DIG end-labelling of LNA probes 
LNA oligos complementary to the mature microRNA sequence were 3’ end-labelled 
with digoxigenin-ddUTP using the 3’ end labelling kit (Roche). The 20 µl DIG end-
labelling reaction was applied to a sephadex G25 microspin column (Amersham) to 
purify the probe from unincorporated DIG-ddUTP. Successful DIG end-labelling was 
confirmed by applying 1 µl spots of the reaction to a nylon membrane, UV cross-
linking and Western blotting for DIG. The membrane was blocked for 30 minutes in 
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blocking reagent and incubated overnight at 4 °C in anti-DIG antibody conjugated to 
alkaline phosphatase (Roche) diluted 1/1000 in blocking reagent (see section 2.3.5.1). 
The membrane was washed in 1 x MAB with 0.1 % (v/v) Tween (see section 2.3.5.1), 
followed by washing in alkaline phosphatase buffer. The anti-DIG blot was developed 
by applying 1 ml of CDSP reagent to the membrane (Roche) and incubation at room 
temperature for 5 minutes to allow the luminescent reaction to occur before exposing 
the blot to x-ray film to obtain the signal. If end-labelling was successful, the probe was 
diluted to a 20 x stock (200 nM) in miRNA in situ hybridisation buffer (2.4.3.2) and 
stored at -20 °C. 
DIG end-labelling reaction 
100 pmol LNA oligo (Exiqon) 
4 µl 5 x reaction buffer  
4 µl CoCl2 solution (25 mM) 
1 µl DIG-ddUTP (1 mM) 
1 µl Terminal transferase (20 units/µl) 
Up to 20 µl with RNAse-free water  
 
2.4.3.2 In situ hybridisation of LNA probes to miRNA 
Xenopus embryos for microRNA in situ hybridisation were fixed in 4% formaldehyde 
in PBSA and stored in 100% methanol at -20°C until use. All washes were at room 
temperature unless otherwise stated. Firstly, embryos were rehydrated by successive 5 
minute incubations in 75% methanol in PBST, 50% methanol in PBST, 25% methanol 
in PBST and finally three 5-minute incubations in 100% PBST. Embryos were treated 
with proteinase K (100 µl of a 10 mg/ml stock in 100 ml PBST) for 5 minutes, and then 
refixed for 20 minutes in 4% formaldehyde in PBS and washed in PBST three times for 
5 minutes. Embryos were then washed in water for 5 minutes. Endogenous alkaline 
phosphatase activity was then blocked by incubation in triethanolamine/acetic 
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anhydride solution followed by a 5-minute water wash and three 5 minute washes in 
PBST. 
The embryos were then transferred to hybridisation buffer and prehybridised for 2 
hours at 62 °C. Next, the embryos were transferred to a 10 nM solution of antisense 
DIG-labelled LNA probe in hybridisation buffer and left to hybridise overnight at 62 
°C. Post-hybridisation washed were carried out at 62 °C. Embryos were incubated for 
10 minutes in HM- buffer, then 75 % HM-/ 25 % 2 x SSCT, then 50 % HM-/ 50 % 2 x 
SSCT, then 25 % HM-/ 75 % 2 x SSCT followed by 2 x SSCT. Embryos were then 
washed twice for 30 minutes in 0.2 x SSCT and transferred to PBST by three 5-minute 
washes.  
The embryos were then blocked for 1 hour in blocking solution and incubated 
overnight at 4 °C in anti-DIG antibody conjugated to alkaline phosphatase diluted 
1/2000 in blocking solution. Post-antibody washes in TBST-levamisole were as 
follows: six 1-hour washes at room temperature followed by overnight at 4 °C. The 
embryos were then washed twice for 10 minutes in alkaline phosphatase buffer and 
staining was developed by transferring the embryos to a 24-well plate and adding 1 ml 
of BM purple reagent (Roche). Staining was developed overnight at room temperature. 
Embryos were then bleached by adding 1 ml of bleaching solution to the well and 
incubating in bright light for 10 minutes to reveal the BM purple staining. Embryos 
were washed in PBST to remove the bleach and fixed in 4 % paraformaldehyde in PBS 
overnight at 4 °C. 
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2.4.3.3 MicroRNA in situ hybridisation solutions 
PBST 
1 x PBS 
0.1 % (v/v) Tween-20 (Sigma) 
Triethanolamine/acetic anhydride solution (100 ml) 
1.49 g triethanolamine (Sigma) 
Up to 100 ml with RNAse-free water 
Then add 2.55 ml acetic anhydride (98 % w/v Sigma) 
Hybridisation buffer 
50 % (v/v) deionised formamide 
5 x SSC  
0.1 % (w/v) Tween 
9.2 mM citric acid (Fisher) 
50 µg/ml heparin (Sigma) 
500 µg/ml yeast RNA (torula, Sigma) 
Made up in RNAse-free water 
HM- buffer  
50 % (v/v) deionised formamide 
5 x SSC  
0.1 % (w/v) Tween-20 (Sigma) 
9.2 mM citric acid (Fisher) 
Made up in RNAse-free water 
Chapter 2. Materials and Methods 
 109 
2 x SSCT (100 ml) 
10 ml 20 x SSC (Gibco) 
100 µl Tween-20 (Sigma) 
Up to 100 ml with RNAse-free water 
0.2 x SSCT 
1 ml 20 x SSC (Gibco) 
100 µl Tween-20 (Sigma) 
Up to 100 ml with RNAse-free water 
Blocking solution (100 ml) 
20 ml 10 % (v/v) foetal calf serum  
0.2 g BSA (Sigma) 
Up to 100 ml in RNAse-free water 
TBST-levamisole (500 ml) 
50 ml 10 x TBS 
0.5 ml Tween-20 (Sigma) 
0.241 g levamisole (Sigma) 
Up to 500 ml with RNAse-free water 
10 x TBS 
100 mM Tris pH 7.4 
1.5 M NaCl 
Made up in water, autoclaved and stored at room temperature 
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Alkaline phosphatase buffer 
100 mM Tris-HCl pH 9.5 
50 mM MgCl2 
100 mM NaCl 
0.1 % (v/v) Tween-20 (Sigma) 
Made up in RNAse-free water 
Bleaching solution (100 ml) 
60 ml RNAse-free water 
32.5 ml hydrogen peroxide (30 % v/v Sigma) 
5 ml deionised formamide (Fisher) 
2.5 ml 20 x SSC (Gibco) 
Up to 100 ml with RNAse-free water 
2.4.4 Protein Analysis 
2.4.4.1 List of antibodies 
Antibody Species and dilution used 
α-XCR1 (homemade) Rabbit, 1/5000 
α-Phospho-Smad2 (Millipore AB3849) Rabbit, 1/1000 
α-Smad2/3 (BD transduction labs 610843) Mouse, 1/1000 
α-E-cadherin (BD transduction labs 610181) Mouse, 1/2000 
α-GFP (Cancer Research UK Cell Services) Mouse, 1/1000 
α-MCM-6 (Santa Cruz SC9843) Goat, 1/2000 
α-Tubulin (Abcam 6160) Rat, 1/2000 
2.4.4.2 Purification of α-XCR1 antibody from rabbit serum 
Serum from a rabbit immunised with an XCR1 peptide (sequence 
CKSTKTLPFLGITDGKKL) was affinity-purified using a sulfolink affinity column 
(Pierce) with the peptide coupled to the beads via the sulfhydryl group of the N-terminal 
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cysteine residue of the peptide. Following equilibration of the affinity column, the 
diluted rabbit serum was applied to the column. Fractions were collected from the 
column and those containing protein were pooled and dialysed overnight against 50 % 
glycerol/PBS. 8 ml of purified antibody was aliquoted and tested for XCR1 specificity 
by Western blot. A dilution of 1/5000 was sufficient to detect endogenous XCR1. 
2.4.4.3 Xenopus embryo protein extracts 
10 µl of lysis buffer per embryo was added to an eppendorf tube containing snap-
frozen Xenopus embryos. The embryos were lysed whilst thawing by repeated pipetting. 
The lysed embryos were centrifuged at 12,500 rpm at 4 °C to clarify the protein extract. 
10 µl of extract (equivalent to protein extract from one embryo) was added to 4 x 
loading buffer (see section 2.4.4.6) and denatured by heating at 95 °C for 5 minutes. 
Protein samples were stored at -20 °C before use. Protein samples intended for XCR1 
Western blotting were treated with 1 µl of PNGase F (500 units/µl) to remove N-linked 
sugars from proteins by incubation at 37 °C for 1 hour before protein quantification and 
denaturation.  
Xenopus embryo lysis buffer 
100 µl 1 M Tris pH 8.0 
20 µl 0.5 M EDTA pH 8.0 
250 µl 10 % (v/v) NP40 
100 µl 1.25 M sodium-β-glycerophosphate 
500 µl 1 M sodium fluoride 
5 µl 20 µM Calyculin A (Cell signalling) 
250 µl 200 mM sodium pyrophosphate 
15 µl protease inhibitor cocktail (complete mini tablet, Roche) 
Up to 5 ml with water  
Prepared immediately before use 
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2.4.4.4 Protein quantification  
Measurement of protein concentration before the addition of 4 x loading was required 
for dissected embryo protein samples to ensure even loading. Protein concentration was 
determined by preparing a standard curve of BSA (0-10 µg). 200 µl of Biorad protein 
assay reagent was added to the standards and the absorbance of the standards at 595 nm 
was measured using a Spectramax Plus spectrophotometer. The absorbance of 1 µl of 
the unknown protein sample at 595 nm after the addition of Biorad protein assay 
reagent was measured and compared to the BSA standard curve, allowing the protein 
concentration of the unknowns to be calculated.  
2.4.4.5 Western blot analysis 
 Proteins were separated according to their size and mobility by SDS-polyacrylamide 
gel electrophoresis. Resolving gel mix of the appropriate percentage (20 % gels for GFP 
and XCR1 and 10 % gels for phospho-Smad2) was poured between two sealed glass 
plates and allowed to polymerise. The resolving gel was overlaid with water to ensure a 
level gel edge formed. 6 ml of stacking gel was then poured on top of the resolving gel 
and a comb was inserted between the glass plates. After the gel had set, the comb was 
removed and the gel was placed into electrophoresis apparatus. 1 x running buffer was 
added. Denatured protein samples in 1 x loading buffer were loaded onto the gel with a 
protein molecular weight marker. The gel was run at 230 V and 65 mA for 1.5 hours 
(phospho-Smad2), 2 hours (GFP) or 2 hours 30 minutes (XCR1).  
After gel electrophoresis, the gel was opened and the stacking gel cut away. The gel 
was equilibrated in 1 x transfer buffer whilst the transfer apparatus was assembled. 3 
pieces of Whatman paper soaked with 1 x transfer buffer were placed onto a semi-dry 
transfer unit, followed by a PVDF membrane (Millipore) pre-activated in methanol and 
equilibrated in transfer buffer. Next, the gel was placed on top of the membrane and 3 
more pieces of saturated Whatman paper were placed on top of the gel. The gel 
sandwich was rolled to remove any air bubbles. The proteins were transferred to the 
membrane at 230 V, 180 mA for 1 hour. Successful transfer was confirmed by Ponceau 
S staining of the membrane and the positions of molecular weight protein markers were 
marked onto the membrane. The membrane was destained in water and washed in 
PBST for 5 minutes. The membrane was then blocked by rocking incubation in 5 % 
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milk-PBST for 30 minutes at room temperature. Next, the blocking solution was poured 
off and the primary antibody for the protein of interest diluted in 5 % milk-PBST was 
added to the membrane and incubated overnight at 4 °C on a rocker.  
The membrane was then washed four times for 15 minutes in PBST and incubated for 
1 hour with secondary antibody conjugated to horseradish peroxidase 
(DakoCytomation) diluted in 5 % (w/v) milk-PBST. The membrane was then washed 
four times for 15 minutes in PBST and finally washed in PBS for 5 minutes. The 
protein signal was then detected by applying ECL detection reagent (Amersham) to the 
membrane for 1 minute. The luminescent signal was detected by x-ray film or by a 
LAS-4000 ImageQuant machine (GE healthcare).  
2.4.4.6 Western blot buffers and reagents 
4 x loading buffer 
4 ml 20 % (w/v) SDS 
3.2 ml 1 M Tris-HCl (pH 6.8) 
4 ml glycerol (Fisher) 
0.1 ml β-mercaptoethanol 
0.025 % (w/v) bromophenol blue 
Protein molecular weight marker 
A molecular weight marker was loaded alongside Xenopus embryo extracts 
containing myosin (212 kDa), β-galactosidase (116 kDa), glycogen phosphorylase 
(98 kDa), BSA (67 kDa), catalase (58 kDa), glutamate dehydrogenase (55 kDa), 
ovalbumin (43 kDa), carbonic anhydrase (29 kDa) and RNAse A (13 kDa) at 50 
µg/ml .  
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10% resolving gel mix for Phospho-Smad2 gels 
7.3 ml water 
3.75 ml 40 % acrylamide mix  
3.8 ml 1.5 M Tris pH 8.8 
75 µl 20 % (w/v) SDS 
40 µl 20 % (w/v) APS 
30 µl TEMED 
20 % resolving gel mix 
7.5 ml 40 % (w/v) acrylamide 
0.5 ml 2% (w/v) bis acrylamide 
3.75 ml 1.5 M Tris-HCl (pH 8.8) 
3.25 ml water 
40 µl 20 % (w/v) APS 
30 µl TEMED 
Stacking gel mix 
0.625 ml 40 % (w/v) acrylamide 
0.333 ml 2% (w/v) bis acrylamide 
0.625 ml 1.0 M Tris-HCl (pH 6.8) 
3.417 ml water 
15 µl 20 % (w/v) APS 
10 µl TEMED 
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1 x Running buffer 
384 mM Glycine 
50 mM Tris-HCl 
0.1 % (w/v) SDS 
Made up in water 
10 x Transfer buffer 
1.5 M glycine 
200 mM Tris-HCl 
0.1 % (w/v) SDS 
Made up in water 
20 % (v/v) methanol is included in 1 x transfer buffer 
Ponceau S 
2 % (w/v) Ponceau S 
30 % (v/v) trichloroacetic acid 
5% Milk-PBST 
5 g powdered milk (Marvel) 
100 ml PBST 
PBST 
1 x PBS 
0.1 % (v/v) Tween-20 (Sigma) 
2.5 Microscopy 
A Leica MZFLIII dissecting scope fitted with a Leica DFC420 C camera was used to 
photograph Xenopus embryos for phenotypic analysis or record in situ hybridisation 
staining patterns. For confocal microscopy analysis, fixed stage 10 embryos were 
placed on 1 % agarose dishes and bisected through dorsal-ventral axis by cutting 
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through the dorsal lip of the blastopore. Embryos were mounted on glass slides with a 
chamber made by cutting a window in 4 layers of black electrical tape. Molwiol 
mounting medium was used (Calbiochem). Embryos were imaged using an LSM-510 
laser scanning microscope (Zeiss) fitted with a 10 x objective water immersion lens.  
2.6 Small RNA sequencing Illumina library preparation 
2.6.1 Obtaining Xenopus tropicalis embryo RNA 
Xenopus tropicalis embryos were obtained by in vitro fertilisation as described in 
section 2.2.7. Stage 8, stage 10 and stage 18 whole embryos were snap-frozen on dry 
ice and stored at -80 °C. Embryos were dissected into animal and vegetal halves at stage 
10 as described in 2.2.8.3 and snap-frozen on dry ice and stored at -80 °C. Total RNA 
was then extracted using Trizol reagent as described in section 2.3.1 and the quality of 
the RNA was confirmed by gel electrophoresis (see section 2.1.8.1). The RNA was 
stored in an isopropanol slurry at -80 °C prior to Illumina small RNA library 
preparation. I constructed the small RNA libraries at the Miska laboratory in the Gurdon 
Institute, Cambridge UK under the supervision of Javier Armisen.  
2.6.2 Purification of 18-30 nt small RNAs 
18-30 nucleotide small RNAs were purified from total RNA. The starting quantity of 
total RNA for each small RNA library was 148 µg for the stage 8, stage 10 and stage 18 
libraries, 48 µg for the stage 10 animal library and 96 µg for the stage 10 vegetal 
library. A 15 % 8 M urea gel was poured in a 1 mm Criterion cassette (Biorad) and the 
gel was pre-run using 0.5 x TBE running buffer at 200 V for 1.5 hours in a mini protein 
gel II gel apparatus (Biorad). The total RNA slurries were divided into 50 µg samples, 
precipitated on dry ice for 10 minutes and centrifuged at 13,000 rpm at 4 °C to obtain 
RNA pellets. The pellets were resuspended in 15 µl of RNAse-free water and 15 µl of 2 
x gel loading buffer II (Ambion) and denatured by heating to 80 °C for 5 minutes.  
The samples were then loaded onto the gel with an 18-26 nucleotide RNA marker 
(Sigma). An empty lane was left between the ladder and samples and between samples 
for different libraries. The gel was run at 150 V until the bromophenol blue reached the 
bottom of the gel (about 2 hours). The ladder lane was then cut out and stained with 
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ethidium bromide for 5 minutes and the gel slices corresponding to 18-30 nt for each 
RNA sample were excised and transferred to an autoclaved non-stick eppendorf tube. 
500 µl of 0.3 M sodium acetate pH 5.2 and 0.1 % (w/v) SDS solution was added and the 
RNA was eluted overnight by rotating the tube at 4 °C. The eluate was transferred to a 
new eppendorf tube and extracted using phenol-chloroform. 500 µl of 
phenol:chloroform:isoamyl alcohol (Sigma) was added and the mixture was vortexed 
and centrifuged at 13,000 rpm at 4 °C for 5 minutes. The upper aqueous layer was 
precipitated with an equal volume of isopropanol and 1 µl of glycogen (20 mg/ml, 
Roche) on dry ice for 45 minutes. The samples were then centrifuged at 13,000 rpm at 4 
°C for 30 minutes to obtain an RNA pellet. The pellet was washed with 80 % ethanol 
and dried in a vacuum centrifuge for 5 minutes on low heat. RNA samples for each 
library (stage 8, stage 10, stage 18, stage 10 animal and stage 10 vegetal) were 
recombined by resuspending sequentially in 5.7 µl of RNAse-free water. 
15 % 8 M urea gel mix 
9 ml Sequagel concentrate (National diagnostics) 
4.5 ml Sequagel diluent  
1.5 ml 10 x TBE  
120 µl 10 % (w/v) APS 
6 µl TEMED 
2.6.3 5’ adapter ligation and purification 
Next, a 26 nt RNA adapter (see section 2.6.10) was ligated onto the 5’ end of the 
purified small RNAs. Firstly, the purified small RNA was denatured by heating at 90 °C 
for 30 seconds and snap cooling on ice. The 5’ adapter ligation reaction was assembled 
and incubated at 37 °C for 2 hours. The reaction was stopped by the addition of 10 µl of 
2 x gel loading buffer (Ambion) and denatured by heating at 80 °C for 5 minutes prior 
to loading on a 15 % 8M urea gel. The gel was pre-run in 0.5 x TBE for 30 minutes at 
200 V. The ligated samples were loaded with a gap between samples from different 
libraries and 37-46 nt and 18-26 nt RNA markers (Sigma) were loaded. The gel was run 
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at 150 V until the bromophenol blue reached the end of the gel (about 2 hours). The 
marker lane was cut away and stained in ethidium bromide solution. The stained marker 
was replaced next to the gel and the gel slice corresponding to 42-56 nt was excised and 
transferred to an autoclaved non-stick eppendorf tube.  
500 µl of 0.3 M sodium acetate pH 5.2 and 0.1 % (w/v) SDS solution was added and 
the RNA was eluted overnight by rotating the tube at 4 °C. The eluate was transferred to 
a new eppendorf tube and extracted using phenol-chloroform. 500 µl of 
phenol:chloroform:isoamyl alcohol (Sigma) was added and the mixture was vortexed 
and centrifuged at 13,000 rpm at 4 °C for 5 minutes. The upper aqueous layer was 
precipitated with an equal volume of isopropanol and 1 µl of glycogen (20 mg/ml, 
Roche) on dry ice for 45 minutes. The samples were then centrifuged at 13,000 rpm at 4 
°C for 30 minutes to obtain an RNA pellet. The pellet was washed with 80 % ethanol 
and dried in a vacuum centrifuge for 5 minutes on low heat. Ligated RNA samples were 
resuspended in 6.4 µl of RNAse-free water. 
5’ adapter ligation reaction 
5.7 µl purified small RNA 
1.3 µl 5’ RNA adapter (5 µM) 
1 µl 10 x RNA ligation buffer (Promega) 
1 µl T4 RNA ligase (10 units/µl, Promega) 
1 µl RNAsin (Promega) 
  
2.6.4 3’ adapter ligation and purification 
Next, a 23 nt 3’ RNA adapter (see section 2.6.10) was ligated onto the purified small 
RNA 5’ ligation product. The purified 5’ ligation product RNA was denatured by 
heating at 90 °C for 30 seconds and snap cooling on ice. The 3’ adapter ligation reaction 
was assembled and incubated at 37 °C for 2 hours. The reaction was stopped by the 
addition of 10 µl of 2 x gel loading buffer (Ambion) and denatured by heating at 80 °C 
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for 5 minutes prior to loading on a 10 % 8M urea gel. The gel was pre-run in 0.5 x TBE 
for 30 minutes at 200 V. The ligated samples were loaded with a gap between samples 
from different libraries and 52-66 nt RNA markers (Sigma) were loaded. The gel was 
run at 150 V until the bromophenol blue reached the end of the gel (about 2 hours). The 
marker lane was cut away and stained in ethidium bromide solution. The stained marker 
was replaced next to the gel and the gel slice corresponding to 62-79 nt was excised and 
transferred to an autoclaved non-stick eppendorf tube.  
500 µl of 0.3 M sodium acetate pH 5.2 and 0.1 % (w/v) SDS solution was added and 
the RNA was eluted overnight by rotating the tube at 4 °C. The eluate was transferred to 
a new eppendorf tube and extracted using phenol-chloroform. 500 µl of 
phenol:chloroform:isoamyl alcohol (Sigma) was added and the mixture was vortexed 
and centrifuged at 13,000 rpm at 4 °C for 5 minutes. The upper aqueous layer was 
precipitated with an equal volume of isopropanol and 1 µl of glycogen (20 mg/ml, 
Roche) on dry ice for 45 minutes. The samples were then centrifuged at 13,000 rpm at 4 
°C for 30 minutes to obtain an RNA pellet. The pellet was washed with 80 % ethanol 
and dried in a vacuum centrifuge for 5 minutes on low heat. Ligated RNA samples were 
resuspended in 4.5 µl of RNAse-free water. 
10 % 8 M urea gel mix 
6 ml Sequagel concentrate (National Diagnostics) 
7.5 ml Sequagel diluent 
1.5 ml 10 x TBE 
120 µl 10 % (w/v) APS 
6 µl TEMED 
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3’ adapter ligation reaction 
6.4 µl purified 5’ ligation product 
0.6 µl 3’ RNA adapter (10 µM) 
1 µl 10 x RNA ligation buffer (Promega) 
1 µl T4 RNA ligase (10 units/µl, Promega) 
1 µl RNAsin (Promega) 
2.6.5 Reverse transcription of ligated small RNAs 
The ligated RNA was then used as the template for cDNA synthesis by reverse 
transcription using the SuperScript II reverse transcription kit (Invitrogen). The reverse 
transcription reaction was assembled and incubated as described below.  
Reverse transcription reaction 
4.5 µl purified ligated small RNA 
0.5 µl RT primer (100 µM) 
65 °C for 10 minutes 
Then add: 
2 µl 5 x first strand buffer (Invitrogen) 
0.5 µl 12.5 mM dNTP mix 
1 µl 100 mM DTT 
0.5 µl RNAsin (Promega) 
48 °C for 3 minutes 
Then add 1 µl of SuperScript II RT (200 units/µl, Invitrogen) 
Incubate at 42 °C for 1 hour 
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2.6.6 Large-scale PCR for Illumina sequencing 
The cDNA from the reverse transcription reaction was used as the template in a large-
scale PCR reaction using PCR primers 1 and 2 (see section 2.6.10). The PCR product 
was then precipitated with 20 µl of 3 M sodium acetate (pH 5.2) and 500 µl of 100 % 
ethanol on dry ice for 30 minutes. The samples were centrifuged at 13,000 rpm for 20 
minutes at 4 °C to obtain a DNA pellet. This was washed in 80 % ethanol, dried and 
resuspended in 20 µl of water and 5 µl of 5 x TBE-DNA loading buffer was added. 
Large-scale PCR reaction 
4 µl cDNA 
40 µl 5 x Phusion High Fidelity polymerase buffer (NEB) 
4 µl dNTP mix (10 mM) 
10 µl PCR primer 1 (10 µM) 
10 µl PCR primer 2 (10 µM) 
2 µl Phusion DNA polymerase (2000 units/ml) 
130 µl RNAse-free water  
PCR program 
98 °C 30 seconds 
98 °C 10 seconds 
58 °C 30 seconds 
72 °C 20 seconds 
72 °C 5 minutes 
4 °C ∞ 
2.6.7 Final gel purification for Illumina sequencing 
A 6 % native gel was poured. The PCR samples were loaded onto the gel with each 
PCR sample divided into two lanes and 5 µl of 100 bp hyperladder V (Sigma) was 
loaded. The gel was run at 100 V in 0.5 x TBE until the bromophenol blue reached the 
bottom of the gel. The gel was then stained in 0.5 x TBE with ethidium bromide 
x 20 cycles 
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solution for 5 minutes. The DNA bands were visualised on a UV trans-illuminator and 
the band at approximately 100 nt was excised, taking care to avoid the adapter-dimer 
band at around 70 nt. The 100 nt band appears smeary due to the different sizes of the 
small RNAs in the library. 400 µl of NEB buffer 2 was added to the excised gel slice 
and the DNA was eluted by rotation overnight at 4 °C. The eluate was transferred to a 
new eppendorf tube containing 1 µl of glycogen (Roche), 40 µl of 3 M sodium acetate 
pH 5.2 and 1 ml of 100 % ethanol and precipitated on dry ice for 20 minutes, then 
centrifuged at 13,000 rpm at 4 °C to obtain the DNA pellet. The pellet was washed with 
70 % ethanol, dried, and resuspended in 15 µl of sterile resuspension buffer.  
2.6.8  Quantification of small RNA PCR products 
The concentration of the resuspended PCR products was determined by Nanodrop 
quantification and adjusted to 10 nM using resuspension buffer. The libraries were then 
submitted for Illumina sequencing at the Cancer Research UK Cambridge Research 
Institute.  
6 % native gel mix 
1.5 ml 10 x TBE 
4.5 ml 40 % acrylamide Accugel (19: 1 acrylamide: bis-acrylamide, National 
diagnostics) 
24 ml water 
300 µl 10 % (w/v) APS 
10 µl TEMED 
Resuspension buffer 
10 mM Tris-HCl pH 8.5 
Autoclaved and stored at room temperature. 
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2.6.9 Illumina sequencing  
The small RNA libraries were sequenced using the small RNA sequencing primer 
(section 2.6.10) by single-end small RNA sequencing using the Illumina platform on a 
Genome Analyzer IIx. The sequencing run takes 4 days and generates FastQ sequence 
files for downstream analysis. The small RNA libraries were sequenced a second time 
approximately 1 year later for a technical repeat on an Illumina Genome Analyzer IIx at 
the Cancer Research UK London Research Institute. 
2.6.10 Illumina small RNA library oligonucleotide sequences 
5' RNA Adapter (26 nt) 
5' GUUCAGAGUUCUACAGUCCGACGAUC 
3' RNA Adapter (23 nt) 
5' P-UCGUAUGCCGUCUUCUGCUUGUidT  
RT primer  
5' CAAGCAGAAGACGGCATACGA 
PCR Primer 1  
5' CAAGCAGAAGACGGCATACGA 
PCR Primer 2  
5' AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 
Small RNA Sequencing Primer  
5' CGACAGGTTCAGAGTTCTACAGTCCGACGATC 
 
2.7 mRNA sequencing  
2.7.1 Obtaining X. tropicalis total RNA for mRNA-seq 
I obtained total RNA from stage 8, stage 10 and stage 18 X. tropicalis whole embryos 
obtained by in vitro fertilisation (section 2.2.7) and Trizol RNA extraction (section 
2.3.1).  
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2.7.2 Illumina mRNA library preparation 
 mRNA libraries were prepared from X. tropicalis total RNA by the Cancer Research 
UK Advanced sequencing facility at the Cancer Research UK London Research 
Institute. 2.5 µg of total RNA was used as the input for mRNA library preparation. 
Briefly, mRNA was purified from total RNA using magnetic beads with poly(T) oligo 
attached. The mRNA was then fragmented using positively charged ionic species (Mg2+ 
and K+) and heating to 94 °C for 5 minutes in Illumina 5 x fragmentation buffer (Tris-
acetate, magnesium acetate and potassium acetate). The fragmented mRNA was 
precipitated, resuspended in water and used as the template for first strand cDNA 
synthesis using SuperScript II reverse transcriptase (Invitrogen). Next, the mRNA 
strand was removed and a replacement cDNA strand was synthesised to generate 
double-stranded cDNA. The ends of the double-stranded cDNA were repaired using T4 
DNA polymerase and Klenow DNA polymerase. 3’ overhangs were removed by 3’ to 
5’ exonuclease activity, and 5’ overhangs were filled in by polymerase activity to 
convert overhangs into blunt ends.  
Next, a single A base was added to the 3’ end of the blunt cDNA fragments using 
Klenow. This is to allow subsequent ligation of adapters with a single T overhang at the 
5’ end. The Illumina mRNA-sequencing adapters were then ligated on to the cDNA 
fragments using T4 DNA ligase. The products of the ligation reaction were gel purified 
by electrophoresis on a 2 % agarose gel and excision of a 200 bp band. The cDNA was 
purified from the gel slice and amplified by PCR using Phusion DNA polymerase. The 
PCR products were purified using the QIAquick PCR purification kit (Qiagen) and 
eluted in 30 µl of elution buffer provided with the kit. The concentration of the mRNA 
library was measured and integrity of the 200 bp band confirmed by agarose gel 
electrophoresis. The mRNA libraries were adjusted to a suitable concentration for 
Illumina sequencing, and sequenced on Illumina Genome Analyzer IIx at the Cancer 
Research UK London Research Institute. 72 bp of single-end mRNA sequence was 
obtained and deposited in FastQ files for downstream analysis. 
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2.8 Bioinformatic analysis 
I designed the bioinformatic analysis of the small RNA sequencing and mRNA 
sequencing, which carried out by Stuart Horswell in the Cancer Research UK 
Bioinformatics and Biostatistics group. Details of bioinformatic analyses are referred to 
in the appropriate sections and figures within Chapters 4 and 5. Sequence files from the 
small RNA-seq and mRNA-seq were viewed in the Integrative Genomics Viewer 
browser (Robinson et al., 2011).  
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Chapter 3. Uncovering the mechanism of spatial 
regulation of Xenopus Cripto-1  
3.1 Introduction 
The aim of the work presented in this chapter was to determine the mechanism of 
spatial regulation of Xenopus laevis Cripto-1 protein, XCR1. XCR1 is a coreceptor for 
Nodal ligands. Therefore spatial regulation of XCR1 is critical for spatial control of 
Nodal signalling and thus patterning of the early Xenopus embryo. Firstly, I take an 
unbiased approach, by mapping the regulatory region of the XCR1 gene and then go on 
to examine the potential regulators, such as microRNAs, that mediate spatial regulation 
of XCR1.  
3.2 Results 
3.2.1 XCR1 is subject to spatial regulation in early development  
As discussed in section 1.2, XCR1 is subject to spatial regulation at the beginning of 
gastrulation, stage 10 (Dorey and Hill, 2006). XCR1 mRNA is expressed in all areas of 
the embryo at stage 10, but the protein is absent from the vegetal pole (prospective 
endoderm), indicating that XCR1 is subject to post-transcriptional spatial regulation. 
Firstly, I corroborated these results by showing that XCR1 mRNA is found in all areas 
of the embryo by RNAse protection assay with an antisense probe to the coding region 
of XCR1 (Figure 3.1). I showed that XCR1 protein is expressed in the animal cap and 
marginal zone, but not the vegetal pole of embryos at both stage 10 and stage 8 (Figure 
3.2). In addition to confirming the published result, the observation that XCR1 is 
spatially regulated at stage 8 suggests that a maternal factor may be responsible for 
spatial regulation, as stage 8 is before the onset of zygotic transcription at stage 9.  
3.2.2 Functional relevance of spatial regulation of XCR1 
In order to assess the function of spatial regulation of XCR1 protein in the Xenopus 
laevis embryo, XCR1 protein was reintroduced into the vegetal pole by targeted 
injection of 100 pg of XCR1 mRNA into the four most vegetal blastomeres at the 32-
cell stage. Effective targeting of this region was demonstrated by injection of 
fluorescein dextran (Figure 3.3A). The XCR1 construct contained only the coding 
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region and an internal Flag tag and no XCR1 3’ or 5’ UTRs. XCR1 was replaced in the 
vegetal pole at a level comparable to endogenous XCR1 in the animal cap-marginal 
zone region, as shown by Western blot for XCR1 using dissected embryo extracts 
(Figure 3.3B). 
 
Figure 3.1 XCR1 RNA is expressed in all areas of the Xenopus laevis embryo at 
stage 10  
A. Lateral view schematic of the gastrula stage embryo at stage 10 illustrating the 
animal cap (AC), marginal zone (MZ) and vegetal pole (VP) at stage 10 which can be 
dissected. B. Levels of XCR1 and EF-1α mRNA were detected by RNAse protection 
assay. EF-1α serves as a loading control. Antisense probes for XCR1 and EF-1α are 
shown prior to RNAse digestion. 20 µg of X. laevis stage 10 total RNA from the whole 
embryo (WE), animal cap (AC), marginal zone (MZ) and vegetal pole (VP) was 
analysed by RNAse protection with the XCR1 and EF-1α probes. In the tRNA lane, no 
X. laevis embryo RNA was added. The protected fragments for XCR1 and EF-1α after 
RNAse digestion are shown. 
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Figure 3.2 XCR1 protein is expressed in the animal cap and marginal zone, but not 
in the vegetal pole at stage 8 and stage 10   
A. Western blot for XCR1 protein at stage 8. Whole embryo or dissected embryo 
protein extracts were treated with PNGase F to remove N-linked sugars from XCR1 to 
improve the resolution of XCR1 bands. XCR1 overexpression (OE) serves as a positive 
control for the blot, and endogenous levels of XCR1 at stage 8 and stage 20 (no XCR1 
protein detected) are shown. Embryos were dissected into animal caps (AC), marginal 
zones (MZ) and vegetal poles (VP). XCR1 protein is absent from the vegetal pole at 
stage 8. B. Western blot for XCR1 protein at stage 10. Lanes as in A, except 
endogenous XCR1 levels at stage 10 are shown. XCR1 protein is absent from the VP at 
stage 10.  
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Figure 3.3 Spatial regulation of XCR1 can be ablated by vegetally targeted 
expression of XCR1 mRNA 
A. Schematic diagram of the 32-cell stage Xenopus embryo (lateral view) with the 
targeted blastomeres indicated in blue. The four most vegetal blastomeres are injected 
to target the prospective endoderm. In situ hybridisation for fluorescein dextran on 
bisected stage 10 embryos shows effective targeting of the prospective endoderm. The 
number of embryos out of the total analysed with the staining pattern displayed is 
shown. Animal (A), vegetal (V) and dorsal (D) regions are indicated. B. Western blot 
for XCR1 protein at stage 10. XCR1 is replaced at endogenous levels by targeted 
injection of a total dose of 100 pg of XCR1 mRNA. Uninjected and XCR1 targeted 
embryos were dissected into animal cap-marginal zone and vegetal pole regions and 
protein extracts were untreated or treated with PNGase F. Note that the exogenous band 
for XCR1 in the targeted VP lane runs with lower mobility than endogenous XCR1 due 
to an internal Flag tag. 
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Embryos with ablated spatial regulation of XCR1 were allowed to develop to stage 32 
and assessed for phenotypic changes compared to uninjected embryos. As shown in 
Figure 3.4, embryos with XCR1 vegetally targeted showed dorsalisation (11/30 
embryos), defects in head development (2/30 embryos) and partial secondary axis 
formation (1/30 embryos). However, this phenotype was not completely penetrant, as 
16/30 embryos were normal.  
To look at the effect of ablating spatial regulation on Nodal signalling, embryos were 
dissected and extracts were prepared for Western blotting for phospho-Smad2, the 
downstream transducer of Nodal signalling (Schier and Shen, 2000). Embryos were 
dissected at stage 9, when the phospho-Smad2 signal is not yet present (Faure et al., 
2000) to assess if the timing of Nodal signalling was affected by vegetal replacement of 
XCR1, and stage 11 when levels of phospho-Smad2 are high. As shown in Figure 3.5, 
vegetal replacement of XCR1 led to a detectable phospho-Smad2 signal at stage 9, in 
comparsison to no signal in uninjected embryos. At stage 11, the endogenous phospho-
Smad2 signal is strong in uninjected embryos, and vegetal replacement of XCR1 does 
not markedly enhance the intensity of the signal. Ablation of XCR1 spatial regulation 
therefore brings forward the timing of Nodal signal transduction via phospho-Smad2.  
Next, the effect of XCR1 vegetal replacement on germ layer markers was assessed by 
whole-mount in situ hybridisation at stage 10 (Figure 3.6). The molecular markers 
Forkhead, Lefty, Goosecoid and Sox17 are Nodal target genes (Bennett et al., 2007; 
Dickmeis et al., 2001). Goosecoid is a transcriptional repressor of the mesoderm-
inducing transcription factor, Xbra, which responds to activin signalling (Latinkic and 
Smith, 1999; Smith et al., 1991). Embryos with XCR1 targeted to the vegetal 
pole/prospective endoderm showed no change in the dorsal endoderm marker Hhex 
(Newman et al., 1997) or the pan-endodermal marker Sox17α (Hudson et al., 1997). 
Injected embryos showed strong downregulation of Xbrachyury, a mesodermal marker, 
and upregulation of the Nodal inhibitor Lefty (Meno et al., 1999). The mesodermal 
markers Forkhead and Goosecoid were moderately downregulated.  
The upregulation of Lefty expression could be explained by the increased levels of 
vegetal phospho-Smad2 when XCR1 is targeted to the vegetal pole, as Lefty is a Nodal 
target gene (Saijoh et al., 2000). I hypothesise that upregulation of Lefty inhibits the 
Chapter 3. Uncovering the mechanism of spatial regulation of XCR1 
 131 
activation of ALK4 (through binding of Lefty to Nodal and antagonism of EGF-CFC 
coreceptors (Chen and Shen, 2004)), resulting in less downstream phosphorylation of 
R-Smads, which in turn inhibits the activation of Nodal target genes, such as the 
mesodermal markers, Xbrachyury, Goosecoid and Forkhead.  
To determine if the phenotype of XCR1 vegetal replacement was largely due to the 
increase in phospho-Smad2 levels and premature onset of Smad2 phosphorylation, 
similar targeting experiments were performed with a constitutively-active ALK4 
receptor construct, ALK4*(Armes and Smith, 1997). Ectopic expression of ALK4* 
elevates endogenous phospho-Smad2 levels by constitutive phosphorylation of R-
Smads in the absence of ligand. Firstly, the effect of ALK4 overexpression on phospho-
Smad2 levels was confirmed by injection of 200 pg of ALK4* mRNA at the 1-cell 
stage and Western blotting for phospho-Smad2. Ectopic expression of ALK4* caused a 
strong phospho-Smad2 signal at stage 9, when the endogenous phospho-Smad2 signal 
was not yet detectable in the whole embryo (Figure 3.7A).  
25 pg of ALK4* mRNA was then targeted to the vegetal pole and embryos were 
dissected into animal and vegetal hemispheres at stage 9 and blotted for phospho-
Smad2. Endogenous levels of Smad2 in the vegetal pole at stage 10 were also analysed 
to serve as a positive control for vegetal phospho-Smad2 detection. Vegetal targeting of 
ALK4* had similar effects on Smad2 phosphorylation to vegetal targeting of XCR1: 
vegetal phospho-Smad2 was strongly increased in ALK4* targeted embryos compared 
to uninjected embryos (Figure 3.7B). Embryos with vegetally-targeted ALK4* were 
allowed to develop until stage 33 and compared to uninjected embryos for phenotypic 
changes. As shown in Figure 3.8, vegetal targeting of ALK4* largely phenocopies 
vegetal targeting of XCR1. ALK4* targeted embryos displayed dorsalisation (6/31 
embryos), head development defects (1/31 embryos) and partial axis duplication (1/31 
embryos) (Figure 3.4), reminiscent of the phenotype of XCR1 vegetal targeting. Again, 
the phenotype was not fully penetrant as 16/30 ALK4* targeted embryos were normal. 
ALK4* targeted embryos displayed an additional phenotype of left-right axis curvature 
(5/31 embryos).  
The striking similarity of the phenotypes of XCR1 and ALK4* vegetal targeting 
suggests that the functional consequences of ablating spatial regulation of XCR1 are 
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mediated through phospho-Smad2, namely increased phosphorylation of Smad2 and the 
premature onset of Nodal signal transduction at stage 9.     
    
 
Figure 3.4 Ablating spatial regulation of XCR1 leads to dorsalisation, head 
development defects and secondary axis formation  
Uninjected embryos and embryos with 100 pg of XCR1 mRNA vegetally targeted at the 
32-cell stage were allowed to develop until stage 32. The number of embryos with the 
phenotype shown out of the total number analysed is indicated. An arrowhead indicates 
a partial secondary axis on an XCR1 vegetally targeted embryo.  
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Figure 3.5 Ablation of spatial regulation of XCR1 brings forward the onset of 
Smad2 phosphorylation 
A. Western blot for phospho-Smad2 at stage 9. Embryos were uninjected (Ui) or 
injected with 100 pg of XCR1 mRNA (XCR1) in the four most vegetal blastomeres at 
the 32-cell stage to revert spatial regulation of XCR1 and then dissected into animal and 
vegetal hemispheres at stage 9. Smad2 is used as a loading control. The Smad2 isoform 
Smad2Δexon3 (Faure et al., 2000) is also detected and migrates below Smad2. B. 
Western blotting for phospho-Smad2 at stage 11. Embryos were uninjected (Ui) or 
injected with 100 pg of XCR1 mRNA targeted to the vegetal pole at the 32-cell stage 
(XCR1) and dissected into animal caps (AC), marginal zones (MZ) and vegetal poles 
(VP) at stage 11. Smad2Δexon3 is also detected.  
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Figure 3.6 XCR1 vegetal replacement affects mesendoderm markers 
Whole-mount in situ hybridisation for germ layer markers at stage 10. Embryos are 
uninjected (Control) or are subjected to targeted vegetal replacement of XCR1 at the 
32-cell stage (XCR1 targeted) as in Figure 3.3. The total number of embryos analysed 
was 5 for each marker.  
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Figure 3.7 Vegetally targeted expression of constitutively active ALK4 
recapitulates the effect of XCR1 vegetal replacement on Smad2 phosphorylation 
A. Western blot for phospho-Smad2. 200 pg of constitutively active ALK4 receptor 
mRNA was injected into Xenopus laevis embryos at the 1-cell stage and Smad2 
phosphorylation in uninjected (Ui) and injected (ALK4* OE) embryos was analysed. 
Smad2 serves as a loading control. Smad2Δexon3 has not resolved on this gel. B. 
Western blot for phospho-Smad2 as in A. A total dose of 25pg of constitutively-active 
ALK4 mRNA was targeted to the four most vegetal blastomeres at the 32-cell stage. 
Uninjected and injected embryos were then dissected into animal (A) and vegetal (V) 
hemispheres at stage 9.  Stage 10 A and V lanes serve as a control for vegetal phospho-
Smad2 detection.  
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Figure 3.8 Vegetal targeting of constitutively-active ALK4 phenocopies vegetal 
replacement of XCR1 
25 pg of constitutively-active ALK4 receptor mRNA was targeted to the four most 
vegetal cells at the 32-cell stage and embryos were allowed to develop to stage 33. 
Phenotypes of uninjected control embryos and injected embryos were scored. The 
number of embryos with the phenotype shown out of the total analysed is indicated. An 
arrowhead marks the position of a second axis on an ALK4* vegetally overexpressed 
embryo. 
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3.2.3 Spatial regulation of XCR1 is mediated by the 3’UTR of XCR1α 
Thus far, spatial regulation of XCR1 has been shown to play a role in maintaining 
correct timing and magnitude of Nodal signalling pre-gastrulation. Next, I investigated 
the mechanism of spatial regulation of XCR1 by mapping the region of the XCR1 gene 
responsible for spatial regulation. Firstly, I determined whether XCR1 was subject to 
3’UTR-mediated regulation. Xenopus laevis is pseudotetraploid, so there are two 
pseudoalleles of XCR1: XCR1α, and XCR1β. A sequence alignment of the XCR1α, 
XCR1β, Xenopus tropicalis (Xtcr1) and human Cripto-1 3’UTRs is shown in Figure 3.9. 
As described in Table 3.1, pairwise alignment scores for conservation of 3’UTR 
sequence between frog species are similar, whereas the Xtcr1 3’UTR sequence is more 
similar to the human 3’UTR than are the Xenopus laevis sequences.  
To confirm that XCR1α and XCR1β were the major XCR1 transcripts in Xenopus 
laevis and to identify any uncharacterised transcripts, Northern blot analysis on X. laevis 
and X. tropicalis total RNA with an antisense probe to the highly conserved XCR1α 
coding region was performed. As shown in Figure 3.10, there are three X. laevis XCR1 
transcripts, the most abundant of which is similar in size to the X. tropicalis transcript. 
From the known sizes of the XCR1α and XCR1β transcripts (1.7 kB and 1.4 kB 
respectively) and the similarity in size to the only X. tropicalis transcript (1.5kB), 
XCR1α is most likely the major X. laevis Cripto-1 transcript. A less abundant, longer X. 
laevis XCR1 transcript was also identified.   
Next, the expression profiles of XCR1α and XCR1β mRNA during early X. laevis 
development were compared by RNAse protection assay (Figure 3.11). XCR1α mRNA 
was more abundant than XCR1β mRNA in the oocyte, and in blastula, gastrula and 
neurula stages of early development. This suggests that XCR1α and XCR1β are subject 
to differential regulation at the mRNA level, either through transcriptional regulation, or 
post-transcriptional regulation of mRNA stability.  
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Figure 3.9 Multiple sequence alignment of Xenopus and human Cripto-1 3’UTR 
sequences coloured for percentage identity  
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3’ UTR Sequences Aligned Pairwise Alignment Score 
XCR1α: XCR1β 77 
XCR1α: Xtcr1 78 
XCR1α: human 57 
XCR1β: Xtcr1 70 
XCR1β: human 59 
Xtcr1: human 63 
 
Table 3.1 Cripto-1 3'UTR pairwise sequence alignment scores 
Cripto-1 3’UTR sequences from Xenopus laevis (XCR1α and XCR1β), Xenopus 
tropicalis (Xtcr1) and Homo sapiens (human) were aligned in Clustal W (Chenna et al., 
2003) and scored for pairwise alignment. Pairwise scores are calculated from 
percentage identities with gap positions in the alignment excluded. 
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Figure 3.10 Northern blot of Xenopus Cripto-1 transcripts 
20 µg of Xenopus total RNA was probed with an antisense RNA probe to 600 
nucleotides of the XCR1 coding region, which is highly conserved between XCR1α and 
XCR1β. There is one Cripto-1 transcript in Xenopus tropicalis, and three transcripts in 
Xenopus laevis, of which the major transcript is similar in size to the X. tropicalis 
transcript and may correspond to XCR1α. Methylene blue staining of ribosomal RNA is 
used as a loading control. 
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Figure 3.11 XCR1α  mRNA is more abundant than XCR1β  in early Xenopus 
development 
A. Schematic diagram of an antisense probe to nucleotides 1-250 of the XCR1α coding 
region. The XCR1β sequence is highly similar to the XCR1α sequence, except for a 13 
nt mismatch at 50 nt (indicated). The mismatch allows RNAse T1 digestion to occur, 
and therefore this probe yields protected fragments of 250 nt for XCR1α mRNA and 
200 nt for XCR1β mRNA. B. 20 µg of X. laevis total RNA was analysed with the probe 
described in A., to yield distinct digestion products for XCR1α and XCR1β. This allows 
for a quantitative comparison of XCR1α and XCR1β mRNA levels. In the tRNA lane, 
no X. laevis embryo RNA was added. FGF receptor mRNA levels were used as a 
loading control. 
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3.2.3.1 GFP-3’UTR reporter mRNA assay 
To determine whether spatial regulation of XCR1 was mediated through the 3’UTR 
of XCR1, GFP-3’UTR reporters were cloned for the 3’UTR sequences of XCR1α, 
XCR1β and Xenopus tropicalis Cripto-1 (Xtcr1) (section 2.1.5). To assess the 
conservation of any potential spatial regulators of XCR1 identified in Xenopus, a GFP-
3’UTR reporter for human Cripto-1 was also cloned. Reporter plasmids were linearised 
downstream of the 3’UTR and synthetic mRNA was generated by in vitro transcription. 
GFP protein levels and fluorescence provide a read-out of 3’UTR-mediated regulation 
by endogenous Xenopus laevis regulators in this assay, because endogenous factors can 
bind the 3’UTR of the reporter and regulate GFP expression. GFP-3’UTR reporter 
mRNAs were coinjected with an mRNA encoding cherry-histone-H2B into Xenopus 
laevis embryos at the 4-cell stage. This assay was optimised to obtain maximum 
spreading of injected mRNA by injection of each blastomere in the marginal zone at the 
4-cell stage. Injected embryos were allowed to develop until stage 10 (when spatial 
regulation of endogenous XCR1 occurs) and prepared for confocal microscopy analysis 
by fixation and bisection along the dorso-ventral axis (Figure 3.12). If the 3’UTR 
sequence downstream of GFP mediates spatial regulation, GFP fluorescence would be 
expected to follow the pattern of XCR1 protein localisation shown in Figure 3.2, i.e., 
GFP expression in the animal cap and marginal zone, but not in the vegetal pole. 
 Figure 3.13 shows that the 3’UTR of XCR1α confers spatial regulation of GFP 
expression, whereas the 3’UTR of XCR1β mediates repression of GFP expression, as 
fluorescence is almost undetectable. The 3’UTR of Xtcr1 also mediates spatial 
regulation of GFP expression in Xenopus laevis embryos, which suggests that the same 
regulator can bind both the X. laevis XCR1α and X. tropicalis Cripto-1 3’UTRs.  GFP 
fluorescence was observed in all areas of the embryo when the GFP-human Cripto-1 
3’UTR reporter mRNA was injected, suggesting that spatial regulators of Cripto-1 
found in Xenopus are not conserved, or are not sufficient to confer spatial regulation of 
human Cripto-1. This does not, however, preclude microRNA-dependent regulation of 
human Cripto-1 in mammalian systems. Spatial regulation mediated by the XCR1α 
3’UTR is definitely a result of translational control, as injected GFP-XCR1α 3’UTR 
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mRNA is stable and present in all areas of the embryo at stage 10, as shown in Figure 
3.14A.  
The lack of fluorescence in GFP-XCR1β 3’UTR mRNA injected embryos shown in 
Figure 3.13, and lower endogenous XCR1β mRNA levels compared to XCR1α mRNA 
(Figure 3.11), suggested that XCR1β mRNA is less stable than XCR1α mRNA. To 
assess if the lack of GFP-XCR1β 3’UTR reporter signal was due to degradation of 
injected reporter mRNA by endogenous factors in the embryo, post-injection time 
courses of GFP-XCR1α 3’UTR mRNA and GFP-XCR1β 3’UTR mRNA were analysed 
by RNAse protection against the coding region of GFP (Figure 3.14B). The level of 
GFP-XCR1α 3’UTR mRNA is relatively stable until after stage 10, when the GFP 
mRNA follows the profile of endogenous XCR1 protein, which is not expressed beyond 
stage 12. In contrast, GFP-XCR1β 3’UTR mRNA is almost entirely degraded between 
stage 9 and stage 10. The minimal level of GFP-XCR1β 3’UTR mRNA at stage 10 
accounts for the lack of GFP fluorescence seen in Figure 3.13, and suggests that the 
3’UTR of XCR1β mediates instability of the endogenous XCR1β transcript.  
In order to map the sequence in the 3’UTR of XCR1β that was responsible for mRNA 
instability, a partial GFP-3’UTR reporter clone lacking nucleotides 1-299 of the 3’UTR 
was made. As shown in Figure 3.15, this reporter mRNA showed restored GFP 
expression, indicating that nucleotides 1-299 of the XCR1β 3’UTR confer mRNA 
instability and degradation, when compared to the full length XCR1β 3’UTR. This 
result was not pursued further by finer mapping of the regulatory region within 
nucleotides 1-299.  
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Figure 3.12 A GFP-3'UTR reporter assay for spatial regulation of XCR1 
The 3’UTR of interest was cloned downstream of the coding region of GFP to construct 
a GFP-3’UTR reporter plasmid which was used as the template for in vitro transcription 
of a GFP-3’UTR reporter mRNA. A total dose of 800 pg of reporter mRNA was 
coinjected with 700 pg of mCherry-histone-H2B mRNA into the Xenopus laevis 
embryo at the 4-cell stage. Embryos were allowed to develop to stage 10, when they 
were fixed, bisected along the dorso-ventral axis and mounted for confocal microscopy 
analysis. GFP fluorescence provides a read-out of regulation mediated by the 3’UTR. If 
the 3’UTR sequence conferred spatial regulation of GFP expression, fluorescence 
would be expected in the animal cap (AC) and marginal zone (MZ), but not in the 
vegetal pole (VP), to recapitulate the localisation of endogenous XCR1 protein shown 
in Figure 3.2.  
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Figure 3.13 The 3' UTRs of XCR1α  and Xtcr1, but not XCR1β  and human Cripto-1 
confer spatial regulation of GFP expression  
Stage 10 X. laevis embryos injected with GFP-3’UTR reporter mRNAs for the XCR1α, 
XCR1β, Xtcr1 and human Cripto-1 3’UTRs are shown with mCherry-Histone-H2B 
expression as a control for spread of the injected mRNA. The total number of embryos 
with the GFP expression pattern shown out of those analysed is indicated. 
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Figure 3.14 Spatial regulation mediated by the XCR1α  3’UTR is a translational 
effect, whereas the XCR1β  3’UTR confers mRNA instability 
A. Embryos injected with GFP-XCR1α 3’UTR reporter mRNA at the 4-cell stage were 
dissected into animal caps (AC), marginal zones (MZ) and vegetal poles (VP) at stage 
10 and an RNAse protection assay was performed using a GFP probe. GFP mRNA is 
found in all areas of the embryo, in contrast to the protein, which is only expressed in 
the animal cap and marginal zone (Figure 3.13). FGF receptor (FGF-R) was used as a 
loading control and the protected fragments are indicated. B. Post-injection GFP 
mRNA time course for GFP-XCR1α 3’UTR and GFP-XCR1β 3’UTR reporter mRNAs. 
GFP-XCR1α 3’UTR mRNA is present post-injection at stage 3 (4-cell stage) and is 
stable up until stage 10 and thereafter follows the expression profile of endogenous 
XCR1 protein, which is not expressed from stage 12 onwards. In contrast, GFP-XCR1β 
3’UTR mRNA is more unstable and is degraded between stage 9 and stage 10.  
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Figure 3.15 Instability of XCR1β  mRNA is conferred by nucleotides 1-299 of the 3’ 
UTR 
Embryos were injected with GFP-XCR1β 3’UTR mRNA containing either the full 
length 3’UTR sequence, or a partial 3’UTR sequence containing nucleotides 300-764 of 
the 3’UTR and analysed for GFP fluorescence at stage 10. Excluding nucleotides 1-299 
from the GFP-XCR1β 3’UTR reporter mRNA restores mRNA stability and GFP protein 
expression. The total number of embryos with the GFP expression pattern shown out of 
the total analysed is shown. mCherry-Histone-H2B expression is a control for spread of 
the injected mRNA. 
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3.2.4 Mapping the critical region of the XCR1α 3’UTR 
The 3’UTR of XCR1-α has been shown to confer spatial regulation of GFP 
expression in a GFP-3’UTR reporter assay at stage 10 in Xenopus laevis embryos. This 
recapitulates the effect of spatial regulation of endogenous XCR1 protein at this time in 
development. Next, the GFP-3’UTR reporter assay was extended to map the critical 
region of the XCR1-α 3'UTR responsible for spatial regulation. An overlapping set of 
GFP-partial 3’UTR reporters containing nucleotides 1-150, 1-200, 1-350, 286-637 and 
392-958 of the XCR1-α 3’UTR cloned downstream of GFP was analysed (Figure 
3.16A). 
As shown in Figure 3.16B, nucleotides 1-150 of the XCR1-α 3'UTR conferred weak 
expression of GFP, whereas nucleotides 1-200 conferred strong GFP expression in all 
areas of the embryo, i.e., non-spatial expression. Nucleotides 1-350 conferred weak, 
non-spatial expression of GFP. The 5’ 350nt of the XCR1-α 3'UTR is therefore not 
sufficient to confer spatial regulation. A central region of the 3’UTR containing 
nucleotides 286-637 conferred strong, spatial regulation of GFP expression. The 3’ end 
of the 3’UTR from nucleotides 392-958 imparted strong, non-spatial expression of 
GFP. The variation in GFP protein levels between the 1-150, 1-350, and 286-637 clones 
and the spatial regulation mediated by the GFP-286-637 3’UTR reporter mRNA was 
confirmed as an effect on translation of GFP mRNA, as injected GFP mRNA levels are 
stable in all areas of the embryo (Figure 3.16C).  
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Figure 3.16 Spatial regulation of XCR1 is a translational effect mediated by 
nucleotides 286-637 of the XCR1α  3’UTR 
A. X. laevis embryos were injected with full length or GFP-partial 3’UTR reporter 
mRNAs containing nucleotides 1-150, 1-200, 1-350, 286-637 and 392-958 of the 
XCR1-α 3'UTR and analysed by cofocal microscopy at stage 10. The total number of 
embryos with the GFP expression pattern shown out of the total analysed is shown. 
mCherry-Histone-H2B expression is a control for spread of the injected mRNA. B. 
Schematic representation of GFP-XCR1-α partial 3'UTR reporter clones and summary 
of results. ‘Spatial’ indicates that the partial 3’UTR sequence conferred spatial 
regulation of GFP expression by confocal microscopy. C. RNAse protection assay. X. 
laevis embryos were injected with GFP-XCR1-α partial 3'UTR reporter mRNAs and 
dissected into animal caps (AC), marginal zones (MZ) and vegetal poles (VP) at stage 
10. Total RNA was then isolated and analysed by RNAse protection assay for GFP 
mRNA levels. EF-1α was used as a loading control. The protected fragments are 
indicated. Probes are shown prior to RNAse digestion (probes) and in the tRNA lane, no 
Xenopus embryo RNA was added. 
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The critical region for spatial regulation, nucleotides 286-637 of the XCR1-α 3'UTR, 
was next further divided into partial 3’UTR clones (Figure 3.17A) and analysed for 
spatial regulation by confocal microscopy and GFP protein levels by Western blot 
(Figure 3.17B,C). Whereas the full length XCR1-α 3'UTR and nucleotides 286-637 
confer spatial regulation of GFP expression, variable GFP levels and localisation are 
observed with partial 3’UTR sequences. It is important to note at this point that GFP 
with no 3’UTR is unstable as no fluorescence is detectable.  
Firstly, no GFP fluorescence was observed when nucleotides 276-402 were cloned 
downstream of GFP. When 60 nucleotides of downstream XCR1-α 3'UTR sequence are 
added on to this sequence in the 276-461 GFP-3’UTR clone, GFP expression is 
restored, but is not spatially regulated. The addition of another 60 nucleotides of XCR1-
α 3'UTR sequence in the 276-520 3’UTR clone now confers spatial regulation of GFP 
expression. This suggests that nucleotides 276-520 are the minimal region sufficient to 
confer spatial regulation and that there is a sequence between nucleotides 461 and 520 
that causes spatial regulation. A further 60 nucleotides of sequence reverts spatial 
regulation in the 276-579 clone, which must be counteracted by a sequence between 
nucleotides 579 and 637, as the 286-637 clone is spatially regulated. The effects 
observed with the 276-579 clone may be due to an alteration in the secondary structure 
of the GFP-3’UTR reporter mRNA. 
 In short, the minimal region for spatial regulation is 276-520, which contains a 
sequence conferring spatial regulation between 461-520 nucleotides. GFP protein levels 
in GFP-XCR1-α partial 3'UTR reporter mRNA injected embryos are averaged by 
Western blot in Figure 3.17C. This confirms the expression levels of GFP observed by 
confocal microscopy.  
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Figure 3.17 Nucleotides 276-520 of the XCR1α  3’UTR are sufficient to confer 
spatial regulation of GFP expression 
A. X. laevis embryos were injected with full length or GFP-partial 3’UTR reporter 
mRNAs containing nucleotides 286-637, 276-402, 276-461, 276-520 and 276-579 of 
the XCR1-α 3'UTR and analysed by cofocal microscopy at stage 10. The total number 
of embryos with the GFP expression pattern shown out of the total analysed is shown. 
mCherry-Histone-H2B expression is a control for spread of the injected mRNA. B. 
Schematic representation of GFP-XCR1-α partial 3'UTR reporter clones and summary 
of results. ‘Spatial’ indicates that the partial 3’UTR sequence conferred spatial 
regulation of GFP expression by confocal microscopy. C. Western blot for GFP. Protein 
extract was prepared from 20 embryos injected with GFP mRNA, uninjected (Ui) or 
injected with GFP-partial 3’UTR reporter mRNAs and blotted for GFP. GFP levels 
confirm the expression levels observed by confocal microscopy in A. GFP-partial 
3’UTR clones that conferred spatial regulation marked ‘S’. MCM-6 is used as a loading 
control. Overexpressed GFP control extracts run with lower mobility than GFP-3’UTR 
fusions because the control GFP contains extra coding sequence.   
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Figure 3.18 GFP-XCR1α  276-402 3'UTR reporter mRNA is degraded post-
injection 
20 µg of total RNA from embryos injected with full length GFP-XCR1-α 3’UTR 
reporter mRNA or a partial GFP-276-402 3’UTR reporter mRNA was analysed by 
RNAse protection assay using a GFP probe. EF-1α is used as a loading control. The 
protected fragments are indicated. Probes are shown prior to digestion. In the tRNA 
lane, no Xenopus embryo RNA was added.  
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The lack of GFP protein in the 276-402 clone was shown to be due to degradation of 
injected GFP-3’UTR mRNA, which is not suprising given that GFP with no 3’UTR is 
also unstable (Figure 3.18). This result indicates that there is an RNA-stabilising 
sequence between 402-461 to restore GFP expression. Next, the 276-520 minimal 
region of the XCR1α 3'UTR capable of conferring spatial regulation of GFP expression 
was subjected to finer mapping, shown in Figure 3.19A.  
Since nucleotides 276-402 of the XCR1α 3'UTR were unstable, nucleotides 392-520 
were cloned downstream of GFP. As shown in Figure 3.19, GFP expression was not 
spatially regulated when the 392-520 sequence was downstream of GFP. This fits with 
previous mapping data where nucleotides 392-958 conferred non-spatial expression of 
GFP (Figure 3.16) and the presence of an RNA-stabilising signal between nucleotides 
402-461. 
 A GFP-partial 3’UTR reporter mRNA for nucleotides 450-520 of the XCR1α 3’UTR 
was also cloned, in order to exclude most of the RNA-stabilising signal present within 
nucleotides 402-461. The GFP-XCR1α 450-520 3’UTR reporter mRNA conferred weak 
but spatial expression of GFP. This suggests that this 70 nucleotide sequence is 
sufficient for spatial regulation, but another input is required to maintain higher GFP 
levels seen in the full length and 276-520 GFP-3’UTR reporter mRNAs.  
In short, the minimal region sufficient for spatial regulation of the XCR1α 3’UTR at 
GFP levels comparable to the full length 3’UTR is the nucleotides 276-520. A sequence 
sufficient to confer spatial regulation of GFP expression at very low levels is located 
within nucleotides 450-520. An RNA-stabilising element is present between nucleotides 
392-450. Since 392-958 nt of the XCR1α 3’UTR is not spatial, but 276-520 nt does 
confer spatial regulation, this suggests that there is also a spatial sequence element 
between 276-392 nt. This is illustrated in Figure 3.20 and a full summary of mapping 
results and analysis for the XCR1α 3’UTR is provided in Table 3.2.   
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Figure 3.19 Fine mapping of the minimal region of the XCR1α  3’UTR shows that 
nucleotides 450-520 are sufficient for spatial regulation 
A. Confocal microscopy assay for spatial regulation. X. laevis embryos were injected 
with GFP-partial 3’UTR reporter mRNAs containing nucleotides 276-20, 392-520 and 
450-520 of the XCR1-α 3'UTR and analysed by cofocal microscopy at stage 10. The 
total number of embryos with the GFP expression pattern shown out of the total 
analysed is shown. mCherry-Histone-H2B expression is a control for spread of the 
injected mRNA. B. Schematic of partial GFP-XCR1α 3'UTR clones to map the spatial 
regulatory region within nucleotides 276-520 and summary of results. ‘Spatial’ 
indicates that the partial 3’UTR sequence conferred spatial regulation of GFP 
expression by confocal microscopy. C. Western blot showing GFP protein levels in 
stage 10 embryos injected with GFP mRNA, uninjected (Ui) or injected with GFP- 
XCR1α 3'UTR partial 3’UTR clones 276-520, 392-520 and 450-520. MCM-6 is used as 
a loading control. The result shown is an average of 20 embryos.  
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Figure 3.20 Mapping the spatial regulatory region of the XCR1α  3’UTR reveals 
three critical elements 
Schematic of the minimal spatial regulatory region of the XCR1α 3'UTR, nucleotides 
276-520. Fine mapping data indicates that there are two spatial elements and an RNA-
stabilising element within this region.   
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GFP-3’UTR clone Result Analysis 
XCR1α full length 
(1-958 nt) 
Spatially 
regulated 
The XCR1α 3'UTR confers spatial 
regulation of XCR1 
XCR1α 1-150 nt Weak and not 
spatially regulated 
 
XCR1α 1-200 nt Not spatially 
regulated 
 
XCR1α 1-350 nt Not spatially 
regulated 
1-350 nt are not required for spatial 
regulation 
XCR1α 286-637 nt Spatially 
regulated 
286-637 nt confer spatial regulation.  
Note that since 1-350 nt and 392-958 nt 
are not required for spatial regulation, this 
points to 351-392 nt containing a spatially 
regulating sequence 
XCR1α 392-958 nt Not spatially 
regulated 
392-958 nt are not required for spatial 
regulation 
XCR1α 276-402 nt RNA is unstable This sequence has no effect, as GFP 
mRNA with no 3’UTR is also unstable. 
XCR1α  276-461 nt Not spatially 
regulated 
An RNA-stabilising site exists between 
nucleotides 402-461 
XCR1α  276-520 nt Spatially 
regulated 
276-520 nt is the minimal region sufficient 
for spatial regulation. A sequence 
conferring spatial regulation is present 
between 462-520 nt in addition to another 
spatial element between 351-392 nt 
XCR1α  276-579 nt Not spatially 
regulated 
An effect on mRNA secondary structure 
when adding 60 nt on to the spatially-
regulated 276-520 nt reporter mRNA may 
explain this result 
XCR1α  392-520 nt Not spatially 
regulated 
Includes an RNA-stabilising site between 
402-461 which masks the effect of the 
450-520 spatial element and fits with 392-
958 nt as not required for spatial 
regulation 
XCR1α  450-520 nt Weak and 
spatially regulated 
This sequence is sufficient to confer 
spatial regulation, but at very low protein 
levels 
XCR1β 3’UTR 300-
764 nt 
Non-spatial GFP 
expression 
restored by 
deleting nt 1-299 
Nucleotide 300 in the XCR1β 3’UTR is 
equivalent to nt 363 in the XCR1α 3’UTR 
when aligned. This result fits with XCR1α 
392-958 nt being non-spatial.  
Table 3.2 Summary of mapping the regulatory region of the XCR1α  3’UTR 
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3.2.5 Spatial regulation of XCR1 shows some Dicer dependency  
Spatial regulation of XCR1 by the 3’UTR of XCR1α has been mapped to a critical 
region comprising nucleotides 276-520. Since the 3’UTRs of many genes are targeted 
by microRNAs, to determine whether spatial regulation mediated by the XCR1α 3’UTR 
could be a result of microRNA regulation, the microRNA-processing enzyme Dicer was 
targeted with an antisense morpholino to downregulate the production of mature 
microRNAs. If spatial regulation mediated by the XCR1α 3’UTR requires microRNAs, 
downregulation of Dicer should rescue spatial regulation of endogenous XCR1 or GFP 
expression in the vegetal pole when the GFP-XCR1α 3’UTR reporter mRNA is 
injected. Firstly, the efficacy of the translation-blocking Dicer morpholino was 
confirmed by fusing the morpholino binding site sequence upstream of the coding 
region of GFP (Gessert et al., 2010) and assessing the downregulation of GFP protein 
levels by Western blot (Figure 3.21A). Overexpression of 500 pg of morpholino binding 
site-GFP was inhibited by both 20 ng and 40 ng doses of the Dicer morpholino injected 
at the 1-cell stage. Injection of 20 ng of Dicer morpholino inhibited eye development 
and caused a loss of structures derived from neural crest cells such as cranial cartilage 
and melanocytes (Figure 3.21B). This confirms previous results obtained with this 
morpholino (Gessert et al., 2010).  
Dicer knockdown had a limited rescue effect on spatial regulation mediated by the 
full length XCR1α 3’UTR as 1/6 morphant embryos showed partial rescue of GFP 
expression in the vegetal pole (Figure 3.22).  Stronger rescue of spatial regulation was 
observed when Dicer morpholino was coinjected with a GFP-3’UTR reporter mRNA of 
the minimal 276-520 region of the 3’UTR. Embryos showed full rescue of GFP 
expression in the vegetal pole in 2/14 embryos, and partial rescue of GFP expression in 
5/14 embryos (Figure 3.22). This suggests that spatial regulation mediated by the 
minimal spatial region of the XCR1α 3’UTR (nucleotides 276-520) shows some Dicer 
dependency and implicates microRNAs as candidate regulators for spatial regulation of 
XCR1. 
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Figure 3.21 Morpholino knockdown of Dicer is effective and causes defective eye 
and neural crest development 
A. Western blot for GFP in stage 9 X. laevis embryos injected with control GFP, 
uninjected (Ui) or injected with control morpholino (MoC) or Dicer morpholino (MoD) 
with 500 pg of Dicer-morphilino binding site GFP at the 1-cell stage. The Dicer 
morpholino is translation blocking and effectively suppresses Dicer-Mo-binding site 
GFP expression at doses of 20 ng and 40 ng. Tubulin is used as a loading control. B. X. 
laevis embryos injected with 20 ng of control morpholino or Dicer morpholino were 
assessed for phenotypic changes at stage 36. A lateral and dorsal view of morphant 
embryos is shown. The number of embryos with the phenotype shown out of the total 
number analysed is indicated. Knockdown of Dicer leads to inhibition of eye 
development and loss of neural crest derivatives such as craniofacial cartilage and 
melanocytes, as previously described (Gessert et al., 2010).   
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Figure 3.22 Dicer knockdown can rescue spatial regulation mediated by the 276-
520 region of the XCR1α  3’UTR  
Confocal assay for spatial regulation. X. laevis embryos were injected with 20 ng of 
control or Dicer morpholino with the full length GFP-XCR1α 3’UTR reporter mRNA or 
the GFP-276-520 3’UTR reporter mRNA and assayed for spatial regulation of GFP 
expression at stage 10. Dicer morphant embryos show weak partial rescue of vegetal 
GFP expression with the full length XCR1α 3’UTR (1/6 embryos). Dicer morphants 
display strong rescue of vegetal GFP expression compared to control morphants (2/14 
embryos) and partial rescue in 5/14 morphants. The number of embryos with the GFP 
expression pattern shown out of the total analysed is indicated.  
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3.2.6 xla-miR-427 is a negative regulator of XCR1 
As spatial regulation of XCR1 is conferred by the 3’UTR of XCR1α and partially 
Dicer-dependent, potential Xenopus microRNA binding sites in the XCR1α 3’UTR 
were predicted using the miRanda microRNA target prediction algorithm (Enright et al., 
2003). This analysis was done in 2008, when miRbase was version 12. The known 
Xenopus laevis and Xenopus tropicalis microRNAs from miRbase (version 12) were 
scanned against the 3’UTR of XCR1α and a cut-off of a miRanda score of 120 and free 
energy of binding of -12 kcal/mol was taken. Since miRanda predicts microRNA 
binding sites using sequence-complementarity and free energy of miRNA-3’UTR 
binding to generate the miRanda score, with no bias towards complementarity of the 
microRNA seed sequence and the target 3’UTR, the miRanda results were also 
annotated for exact seed matches, defined as nucleotides 2-7 of the miRNA sequence 
matching perfectly to the XCR1α 3’UTR. 116 Xenopus microRNAs passed the miRanda 
score and free energy cut-off, of which the top ten hits sorted by miRanda score are 
presented in Table 3.3.  
Xenopus 
microRNA 
Total 
miRanda 
score 
Total miRNA: 
3’UTR binding 
energy 
(kcal/mol) 
Site 
positions 
in XCR1α  
3’UTR 
(nt) 
Exact 
seed 
match 
position 
(nt) 
xla-miR-18 571 -89.29 
850, 39, 
746, 353 
850, 39, 
746 
xla-miR-20 432 -84.5 
45, 580, 
265 
45, 580, 
265 
xla-miR-427 400 -83.63 
213, 40, 
749 40 
xla-miR-428 264 -79.26 213, 40 213, 40 
xtr-let-7a 260 -69.46 144, 463 463 
xtr-let-7b 248 -68.33 144, 455 None 
xtr-let-7c 252 -63.55 144, 463 463 
xtr-let-7e 247 -62.59 144, 460 None 
xtr-let-7f 138 -62.29 144 None 
xtr-let-7g 248 -62.21 94, 456 None 
Table 3.3 Top ten miRanda scan hits for putative microRNA binding sites in the 
XCR1α  3’UTR sorted by miRanda score 
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To determine whether the microRNAs predicted to bind the XCR1α 3’UTR most 
favourably were responsible for spatial regulation of XCR1, the top three miRanda hits, 
xla-miR-18, xla-miR-20 and xla-miR-427 were downregulated in the Xenopus laevis 
embryo by morpholino injection. Efficacy of the xla-miR-427 morpholino, which is 
designed to prevent processing of the mature miRNA from the hairpin precursor (multi-
blocker morpholino) was assessed by Northern blot for xla-miR-427 (Figure 3.23A). 
xla-miR-427 is expressed at stage 8, before mid-blastula transition and is therefore 
present maternally. Expression of mature xla-miR-427 persists until late neurula stages, 
whereas pre-miR-427 expression is curtailed post-gastrulation. Morpholino knockdown 
of xla-miR-427 is evident at stage 8, and most effective at stage 10. xla-miR-427 
morphant embryos display a highly penetrant ventralised phenotype at stage 40 as 
previously described (Rosa et al., 2009), and secondary axis development is 
occasionally observed (Figure 3.23B).   
Spatial regulation in microRNA morphants was assessed by Western blot for 
endogenous XCR1 protein in the animal cap, marginal zone and vegetal pole, and by 
GFP- XCR1α 3’UTR reporter assay. Morpholino knockdown of xla-miR-18, xla-miR-
20 and xla-miR-427 had no effect on spatial regulation of XCR1 in either assay (data 
not shown for xla-miR-18 and 20), but knockdown of xla-miR-427 increased levels of 
XCR1 protein in the animal cap at stage 10 (Figure 3.24A). An increase in XCR1 levels 
was also evident in whole embryo protein extracts (Figure 3.24B). There was no effect 
of xla-miR-427 morpholino injection on spatial regulation mediated by the XCR1α 
3’UTR when assayed by GFP-3’UTR reporter mRNA assay at stage 10 (Figure 3.25). 
These data suggest that xla-miR-427 is a negative, but not a spatial regulator of XCR1.  
Next, the mechanism of xla-miR-427-mediated repression of XCR1 was investigated 
further. xla-miR-427-mediated repression is not mediated via the XCR1α 3’UTR, as 
GFP levels were comparable at stage 10 between control and xla-miR-427 morphant 
embryos which were coinjected with the GFP- XCR1α 3’UTR reporter mRNA (Figure 
3.26A). xla-miR-427 does not affect XCR1 transcript stability, as shown by RNAse 
protection assay in control and xla-miR-427 morphant embryos at stage 10 with a probe 
against the coding region of XCR1 (Figure 3.26B). The Nodal ligands Xnr5 and Xnr6, 
which specifically signal through XCR1, are known xla-miR-427 targets (Rosa et al., 
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2009). To test the possibility that XCR1 may be indirectly regulated by xla-miR-427 via 
Xnr5 and Xnr6 ligand levels, Xnr5 and Xnr6 were overexpressed at doses of 500 pg and 
XCR1 levels analysed by Western Blot (Figure 3.26C). If XCR1 levels were regulated 
by ligand availability, ectopic expression of Xnr5 and Xnr6 should have the same effect 
as the xla-miR-427 morpholino: increased XCR1 protein. As shown in Figure 3.26, 
XCR1 this was not the case, instead, overexpression of Xnr5 and Xnr6 appeared to 
decrease XCR1 expression.  
In summary, xla-miR-427 is a negative regulator of XCR1 that does not target the 
XCR1 3’UTR or play a role in sensing XCR1-specific ligand levels in the Nodal 
pathway. However, it is still possible that xla-miR-427 directly targets the XCR1 gene, 
as there is a perfect seed match site for xla-miR-427 in the coding region of XCR1.  
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Figure 3.23 Morpholino knockdown of xla-miR-427 is effective at stages 8 and 10 
and leads to a highly ventralised phenotype 
A. Northern blot for xla-miR-427 in control (MoC) and xla-miR-427 morpholino (Mo-
427) injected embryos. Ethidium bromide staining of tRNA is used as a loading control. 
B. xla-miR-427 morphants display a highly penetrant, ventralised phenotype compared 
to control morphants at stage 40. A secondary axis developed in 2/74 embryos. The 
number of embryos with the phenotype shown out of the total analysed is indicated.  
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Figure 3.24 xla-miR-427 is a negative, but not a spatial regulator of XCR1 
A. Western blot for XCR1. 20 ng of control (MoC) or xla-miR-427 morpholino (Mo-
xla-miR-427) was injected at the 1-cell stage and X. laevis embryos were allowed to 
develop to stage 10. Whole embryo extracts were treated or not with PNGase F. E-
cadherin is used a loading control because it is a membrane protein, as is XCR1. XCR1 
levels are increased in xla-miR-427 morphant embryos compared to control morphants. 
B. Western blot for XCR1. Control and xla-miR-427 morphant embryos were dissected 
into animal caps (AC), marginal zones (MZ) and vegetal poles (VP) at stage 10 and 
protein extracts were blotted for XCR1. xla-miR-427 morphant embryos do not show 
any rescue of XCR1 expression in the vegetal pole, but XCR1 levels in the animal cap 
are increased.  
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Figure 3.25 xla-miR-427 does not affect spatial regulation mediated by the XCR1α  
3’UTR  
Confocal microscopy assay for spatial regulation. X. laevis embryos were injected with 
GFP-XCR1-α 3'UTR reporter mRNA and either control morpholino (MoC) or xla-miR-
427 morpholino and analysed by confocal microscopy at stage 10. The strong GFP 
expression in the xla-miR-427 morphant is at the back of the blastocoel. The total 
number of embryos with the GFP expression pattern shown out of the total analysed is 
indicated. mCherry-Histone-H2B mRNA was coinjected and is a control for spread of 
the injected mRNA. 
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Figure 3.26 xla-miR-427 is an indirect negative regulator of XCR1 
A. Western blot for GFP expression in stage 10 embryos injected with GFP-XCR1α 
3'UTR reporter mRNA and 20 ng of control or xla-miR-427 morpholino. GFP 
overexpression is used as a control and MCM-6 serves as a loading control. B. 20 µg of 
total RNA from control or xla-miR-427 morphants at stage 10 was analysed by RNAse 
protection assay for XCR1 mRNA levels with a probe against the XCR1 coding region. 
EF-1α mRNA levels are used as a loading control. C. Western blots for phospho-
Smad2 and XCR1 at stages 8, 9 and 10 in X. laevis embryos. Smad2 is used as a loading 
control. Embryos were uninjected or injected with 500 pg of Xnr5 or Xnr6 mRNA for 
overexpression (OE).  
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3.2.7 A mutagenesis approach to find spatial regulators 
The critical region of the XCR1α 3’UTR for mediating spatial regulation of XCR1 
was shown in section 3.2.4 to be nucleotides 276-520. Drawbacks of the miRanda 
microRNA target prediction approach described in section 3.2.6 include a lack of bias 
to exact seed matches in the target 3’UTR and simply taking all known Xenopus 
microRNAs in miRbase version 12 without the insight from expression data as to 
whether the microRNA is expressed in early development, and at the correct stages to 
potentially regulate XCR1: stage 8 and stage 10.  Since limited numbers of Xenopus 
microRNAs have been identified and most have been found in adult tissues (Tang and 
Maxwell, 2008), very little was known about microRNA expression in early 
development. One study had identified 26 mature Xenopus laevis miRNA sequences 
expressed at stages from oocyte to tadpole (Watanabe et al., 2005).  
In order to obtain an exhaustive list of microRNAs that were present in early 
development, and therefore could potentially regulate XCR1, I carried out Illumina 
genome-wide sequencing of small RNAs in Xenopus tropicalis at stages 8, 10 and 18. 
Xenopus tropicalis rather than Xenopus laevis small RNAs libraries were prepared 
because a complete reference genome has been sequenced for Xenopus tropicalis 
(Hellsten et al., 2010). The characterisation and analysis of the complete small RNA 
dataset is discussed extensively in Chapters 4 and 5. For the purposes of this chapter, 
the small RNA libraries of stages 8 and 10 were subjected to microRNA profiling. 
Small RNA sequences were compared to all microRNA sequences deposited in 
miRbase version 14, and microRNAs that were present at both stage 8 and stage 10 with 
a perfect seed match within the 276-520 nucleotide region of the XCR1α 3’UTR 
responsible for spatial regulation of XCR1 were retained as candidates. RNA-binding 
proteins with putative binding sites from a literature search within the 276-520 region 
were also noted. Figure 3.27 shows the predicted microRNA and RNA binding protein 
sites.  
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Figure 3.27 Candidate microRNA and RNA binding protein sites within the 
minimal region of the XCR1α  3’UTR 
Xenopus XCR1 3’UTR sequences were aligned in Clustal W (Chenna et al., 2003). 
XCR1α, XCR1β and Xtcr1 3’UTR alignments to nucleotides 276-520 of the XCR1α 
3’UTR are shown and coloured for percentage identity. Exact seed match sites for 
microRNAs that were sequenced in Xenopus tropicalis at both stage 8 and stage 10 in 
the 276-520 minimal spatial region of the XCR1α 3’UTR are shown in orange. Where 
an X. tropicalis microRNA was found in multiple species, only the xtr-miR label has 
been used for clarity. The name of the microRNA retains the name of the sequence used 
in miRbase version 14. Candidate RNA-binding protein sites are marked in red. Note 
that the microRNAs listed in this figure were obtained by allowing one mismatch 
between the small RNA sequencing read and the miRbase microRNA sequence.  
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The 276-520 region of the XCR1α 3’UTR contains predicted seed match sites for the 
following microRNAs sequenced in Xenopus tropicalis:  bta-miR-107 and xtr-miR-107, 
overlapping sites for cel-miR-44, dme-miR-279, hsa-miR-499-5p and xtr-miR-499, 
gga-miR-1810 and a site for bta-miR-140 and hsa-miR-140-3p. The Pumilio family of 
RNA binding proteins recognise the motif TGTANA in the 3’UTR of target genes and 
are negative post-transcriptional regulators (Wharton and Aggarwal, 2006). There are 
two Pumilio sites in the 276-520 region. There are also overlapping sites for the yeast 
RNA binding protein poly(U) binding protein 1 (Pub1), which stabilises transcripts 
(Ruiz-Echevarria and Peltz, 2000) and the RNA-stabilising protein Hur (Lopez de 
Silanes et al., 2004). To determine whether these putative microRNA and RNA binding 
protein sites played a role in spatial regulation, GFP-mutant-276-520 nt- XCR1α 3’UTR 
reporters were cloned with multiple mutations in the predicted binding sites introduced 
by site-directed mutagenesis. The mutations are described in Table 3.4. Pumilio sites 
were analysed by antagonising the binding of Pumilio protein with a target protector 
oligo (Choi et al., 2007). 
GFP-Mut-276-520-3’UTR reporter mRNAs for Mut-499, Mut-140, Mut-1810, Mut-
Pub1/Hur and Mut-107 were analysed for their ability to confer spatial regulation of 
XCR1 by confocal microscopy and Western blot (Figure 3.28). In comparison to the 
wild-type 276-520 3’UTR, Mut-499, Mut-140 and Mut-Pub1/Hur had no effect on 
spatial regulation or GFP levels (Figure 3.28). Mut-1810, however, did revert spatial 
regulation as GFP was strongly expressed in the vegetal pole of stage 10 embryos, and 
total GFP levels were increased in the whole embryo. Mut-107 had no effect on spatial 
regulation, but strongly down-regulated GFP expression, as no GFP fluorescence was 
detectable by confocal microscopy, and only a trace of protein was detectable by 
Western blot.  
Next, the effect of blocking the predicted Pumilio sites on spatial regulation was 
assessed (Figure 3.29). No effect of blocking Pumilio binding with 30 ng of target 
protecting oligo was seen on spatial regulation or GFP levels when coinjected with 
partial GFP-XCR1α 3’UTR reporter mRNAs (276-520, 286-637 and 276-402 to allow 
for concentration-dependent effects) or with the full length GFP-XCR1β 3’UTR where 
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the Pumilio sites are conserved. Spatial regulation is therefore independent of Pumilio 
proteins binding the XCR1α 3’UTR.  
Candidate 
regulator 
MicroRNA 
seed sequence 
Predicted 
binding site in 
3’UTR 
Mutated binding site 
 
bta-miR-107 
xtr-miR-107 
 
5’GCAGCA 
 
5’ TGCTGC  
Mut-107 
5’TCCACG      
 
cel-miR-44 
dme-miR-279 
 
5’ GACUAG 
 
5’CTAGTC 
Mut-499 
5’CTTCAG      
 
hsa-miR-499-
5p  
xtr-miR-499 
 
5’UAAGACU 
 
5’AGTCTTA 
Mut-499 
5’TCAGTAA   
 
gga-miR-1810 
 
5’CUAAUA 
 
5’TATTAG 
Mut-1810 
5’ATATAC    
 
bta-miR-140  
hsa-miR-140-
3p 
 
5’ ACCACA 
 
5’TGTGGT 
Mut-140 
5’AGTCCA      
 
Pub1 
  
5’[TTTTTTTTT]-
A[ATTTTTTT] 
Mut-Pub1/Hur 
5’[TATGAACTT]A[A
TCAATAC]  
              
 
Hur 
  
5’[TTTTATTTT-
TTTTTAATTTT] 
 
Mut-Pub1/Hur 
5’[TTTTATATGAAC
TTAATCAAT]AC 
 
Pumilio 
  
5’[TGTATA]TA[
-TGTAAA] 
 
 
Target protector over 
binding site  
Table 3.4 MicroRNA and RNA-binding protein binding site manipulations in the 
XCR1α  3’UTR 276-520 3’UTR sequence 
Nucleotides mutated by site directed mutagenesis are coloured red. Square brackets 
define the limits of RNA binding protein binding sites. Mut-499 disrupts the predicted 
binding sites for cel-miR-44, dme-miR-279, hsa-miR-499-5p and xtr-miR-499 shown 
by yellow shading. Mut-Pub1/Hur1 disrupts the predicted binding for both Pub1 and 
Hur.  
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Figure 3.28 GFP-Mut-276-520 3'UTR reporter mRNA analysis shows that Mut-
1810 reverts spatial regulation at stage 10 
A. Confocal microscopy assay for spatial regulation. X. laevis embryos were injected 
with wildtype or GFP-Mut-276-520 3’UTR reporter mRNAs and mCherry-Histone-
H2B mRNA and analysed by confocal microscopy at stage 10. The total number of 
embryos with the GFP expression pattern shown out of the total analysed is indicated.  
B. Western blot for GFP. Whole embryo extracts were prepared from stage 10 embryos 
injected with control GFP, uninjected (Ui) or injected with wildtype (Wt) or mutant 
(Mut) GFP-276-520 3’UTR reporter mRNAs as described in Table 3.4. Tubulin serves 
as a loading control.  
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Figure 3.29 Spatial regulation is not dependent on Pumilio proteins  
A. Confocal microscopy assay for spatial regulation. X. laevis embryos were injected 
with the miminal spatial region GFP-3’276-520 3’UTR reporter mRNA and 30 ng of 
control morpholino (MoC) or 30 ng of a target protector against Pumilio binding sites 
(TP-Pumilio) and mCherry-Histone-H2B mRNA and analysed by confocal microscopy 
at stage 10. The total number of embryos with the GFP expression pattern shown out of 
the total analysed is indicated. B. Western blot for GFP. Whole embryo extracts were 
prepared from stage 10 embryos injected with control GFP, uninjected (Ui) or injected 
with GFP-3’UTR reporter mRNAs and control morpholino or target protector against 
Pumilio sites (TP-Pum). MCM-6 serves as a loading control.  
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In order to determine if the Mut-1810 and Mut-107 binding site mutations had the 
same effect on spatial regulation or GFP levels in the context of the full length XCR1α 
3’UTR sequence as the 276-520 nt region, these mutations were introduced into the full 
length 3’UTR. GFP-Mut-1810- XCR1α 3’UTR and GFP-Mut-107 XCR1α 3’UTR 
reporter mRNAs were analysed for spatial regulation (Figure 3.30). Mut-1810 reverted 
spatial regulation in the context of the full length 3’UTR, shown by rescue of GFP 
expression in the vegetal pole, accompanied by an large increase in GFP levels shown 
by Western blot. Mut-107 did not have the effect of decreasing GFP expression to 
undetectable levels in the context of the full length sequence, but instead increased GFP 
expression, although no striking effect on spatial regulation (as in Mut-1810) was 
evident. In short, spatial regulation mediated by the XCR1α 3’UTR can be abolished by 
mutating 5’ TATTAG to 5’ ATATAC beginning at nucleotide 360 in the 3’UTR. This 
sequence is an exact seed match for gga-miR-1810.  
The microRNA gga-miR-1810 was identified in the stage 8 and stage 10 Xenopus 
tropicalis small RNA libraries at very low read numbers: 1 read at stage 8, 3 reads in 
the stage 10 whole embryo library, 14 reads in the stage 10 animal pole library and 15 
reads in the stage 10 vegetal pole library. To validate the expression of gga-miR-1810 
in both frog species, I performed microRNA-qPCR and Northern blot analysis. gga-
miR-1810 was detectable by qPCR in both Xenopus tropicalis and Xenopus laevis at 
stages 8, 10 and 18 ( Figure 3.31). The qPCR profile of gga-miR-1810 in X. tropicalis 
was similar to the small RNA-seq read number profile, whilst gga-miR-1810 expression 
decreases specifically at stage 10 in X. laevis. Mature gga-miR-1810 was not detectable 
by Northern blot analysis (expected size 20 nt) (Figure 3.32), however, a pre-miRNA 
band of 70 nt was observed. The lack of a mature miRNA band could be due to the low 
abundance of gga-miR-1810 indicated by the low small RNA-seq read numbers and the 
lower sensitivity of Northern blotting in comparison to qPCR (see Chapter 4). Next, 
gga-miR-1810 was inhibited by antagomir antisense oligo (Ambion) injection in X. 
laevis and spatial regulation of the GFP-XCR1α 3’UTR reporter was analysed. 
Antagomirs are cholesterol-conjugated small RNAs with a modified phosphodiester 
backbone and a 2’-O-methyl modifcation on ribose (Krützfeldt et al., 2006). Antagomir 
doses of 0.2 pmol, 0.5 pmol, 1 pmol, 2 pmol and 4 pmol were tested. Embryos injected 
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with 1-4 pmol of negative control antagomir did not develop normally in comparison to 
uninjected embryos, suggesting that this dose is toxic. No effect on spatial regulation 
was observed at lower doses of gga-miR-1810 antagomir (Figure 3.33). The mature 
sequence of gga-miR-1810 aligns to Xenopus tropicalis 28S ribosomal RNA, and gga-
miR-1810 has been re-annotated as a ribosomal RNA fragment in the latest version of 
miRbase (version 17). Moreover, when the mature gga-miR-1810 sequence is aligned to 
the Xenopus tropicalis genome (14 alignment sites) and the surrounding sequence 
extracted and folded, no hairpin structures pass basic criteria for a microRNA pre-
miRNA structure, such as the mature sequence located in one arm of the hairpin. This 
suggests that although this small RNA sequence does exist in both frog species, it is 
probably not a microRNA and clearly does not affect spatial regulation of XCR1 
mediated by the XCR1α 3’UTR, as shown by antagomir inhibition. Nevertheless, the 
region of the XCR1α 3’UTR necessary for spatial regulation has been mapped to four 
nucleotides and potential regulators binding this site will be discussed in section 3.3.  
3.2.7.1 Integration of 3’UTR mapping and mutagenesis data 
The data presented have shown that the 5’ TATTAG sequence beginning at 
nucleotide 360 in the XCR1α 3’UTR is necessary for spatial regulation, as when it is 
mutated to 5’ ATATAC, spatial regulation is reverted in the context of nucleotides 276-
520 and the full length 3’UTR. The minimal region of the 3’UTR sufficient to 
recapitulate spatial regulation at GFP levels similar to the full length 3’UTR is 
nucleotides 276-520. When this minimal region is further dissected, a GFP-3’UTR 
mRNA containing nucleotides 276-402 is unstable, as is GFP with no 3’UTR, and is 
stabilised by the addition of nucleotides 403-461. The 276-461nt GFP-reporter mRNA 
does not confer spatial regulation of GFP expression. This is an apparent contradiction, 
as this sequence includes the 5’TATTAG sequence at 360 nt, and therefore should 
confer spatial regulation if this sequence was both necessary and sufficient. However, a 
sequence downstream of 461 nt (i.e. within 462-520 nt) is also required. Further 
mapping revealed that nucleotides 450-520 alone conferred very weak spatial regulation 
of GFP expression and thus contain the second sequence necessary for spatial 
regulation. This sequence combined with the RNA-stabilising sequence in the 392-520 
nt GFP-3’UTR reporter does not confer spatial regulation, therefore all three sequences 
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are required: the 5’ TATTAG at 360 nt, the RNA stabilising sequence at 403-450 nt and 
the 450-520 nt sequence. This model will be presented in the section 3.3. 
 
Figure 3.30 Mut-1810 reverts spatial regulation in the context of the full length 
XCR1α  3’UTR 
A. Confocal microscopy assay for spatial regulation. X. laevis embryos were injected 
with wildtype or mutated (Mut-1810, Mut-107) full length GFP-XCR1α 3’UTR reporter 
mRNA and mCherry-Histone-H2B mRNA and analysed by confocal microscopy at 
stage 10. The total number of embryos with the GFP expression pattern shown out of 
the total analysed is indicated. B. Western blot for GFP. Whole embryo extracts were 
prepared from stage 10 embryos injected with control GFP, uninjected (Ui) or injected 
with wildtype or mutated (Mut-1810, Mut-107) full length GFP-XCR1α 3’UTR reporter 
mRNA. Tubulin serves as a loading control.  
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Figure 3.31 Ratification of gga-miR-1810 in Xenopus tropicalis and Xenopus laevis 
A. Small RNA-seq reads profile for gga-miR-1810 in X. tropicalis small RNA libraries 
at stages 8, 10, 18 and stage 10 animal and vegetal libraries. B. gga-miR-1810 qPCR 
profile in X. tropicalis. Total RNA was isolated from stage 8, stage 10 and stage 18 
embryos and prepared for microRNA-qPCR (see Figure 4.19). gga-miR-1810 levels 
were normalised to ODC mRNA levels and error bars are standard deviations of 
triplicate repeats C. gga-miR-1810 qPCR profile in X. laevis at stages 8, 10 and 18. 
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Figure 3.32 gga-miR-1810 Northern blot shows a pre-miRNA precursor 
X. tropicalis and X. laevis total RNA from whole embryos or stage 10 animal (A) and 
vegetal (V) halves was probed for gga-miR-1810. Mature gga-miR-1810 is 20 
nucleotides long from the small RNA-seq data and the pre-miRNA hairpin is predicted 
to be 77nt according to miRbase. A band of the correct size is evident for the gga-miR-
1810 pre-miRNA, but not the mature miRNA.  
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Figure 3.33 Knockdown of gga-miR-1810 does not affect spatial regulation of GFP- 
XCR1α  3’UTR 
Confocal assay for spatial regulation. X. laevis embryos were injected with full length 
GFP-XCR1α 3’UTR reporter mRNA, control or α-gga-miR-1810 antagomir at 0.2 pmol 
or 0.5 pmol doses and mCherry-Histone-H2B mRNA.  Embryos were analysed by 
confocal microscopy at stage 10. The total number of embryos with the GFP expression 
pattern shown out of the total analysed is indicated. 
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3.3 Discussion 
3.3.1 Summary of results 
• Spatial regulation of XCR1 is required to maintain the correct timing and 
magnitude of Nodal signalling during mesoderm induction via phospho-Smad2 
• xla-miR-427 is an indirect negative regulator of XCR1 
• Spatial regulation of XCR1 shows some Dicer-dependency and is mediated 
through the 3’UTR of XCR1α 
• Nucleotides 276-520 define the minimal region of the XCR1α 3’UTR sufficient 
for spatial regulation 
• There are three sequence elements required for spatial regulation: a necessary 
spatial site at nt 360, an RNA stabilising site at 402-461 and a spatial site at 450-
520 nt 
3.3.2 Spatial regulation of Nodal signalling by XCR1 
The biological role of spatial regulation of XCR1 can be illuminated by replacing 
XCR1 protein in the vegetal pole. Embryos with vegetal XCR1 showed premature onset 
of Smad2 phosphorylation at stage 9, reduced mesodermal markers and upregulation of 
the Nodal inhibitor Lefty at stage 10 and dorsalisation and defects in head development 
at stage 32. Nodal signalling in the vegetal pole originates from induction of Xnr 
expression by the transcription factor VegT, which is maternally deposited in the 
vegetal pole (Zhang and King, 1996). Individual Nodal ligands require different XCR 
coreceptors to signal (Dorey and Hill, 2006). Xnr5 specifically requires XCR1, whereas 
Xnr1, Xnr2, Xnr4 and Xnr5 require both XCR1 and XCR3 to signal. When XCR1 is 
overexpressed vegetally, signalling by Xnr5 is introduced to the vegetal pole as XCR1 
protein is normally absent from the vegetal pole. Signalling through Xnr1, Xnr2, Xnr4 
and Xnr6 is potentiated, as these ligands require both XCR1 and XCR3 to signal (Dorey 
and Hill, 2006). This results in increased levels of phospho-Smad2 and consequent 
induction of Lefty, a Nodal target gene (Saijoh et al., 2000) (Figure 3.34). Since the 
effect of XCR1 replacement is on mesodermal markers, rather than in the prospective 
endoderm where XCR1 is added, a cell-non-autonomous factor must be responsible. 
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Lefty is a diffusible inhibitor of Nodal signalling that competes with Nodal for binding 
to XCR1 (and other EGF-CFCs) to form a negative feedback loop (Meno et al., 1999). 
Lefty mRNA is specifically upregulated in the prospective mesoderm/marginal zone as 
detected by in situ hybridisation in embryos with XCR1 vegetally overexpressed and 
could thus explain the downregulation of mesodermal markers Xbra, Forkhead and 
Goosecoid at stage 10. Later phenotypes of XCR1 vegetally replaced embryos are 
consistent with a lack of trunk and head mesoderm. One study has shown that Lefty 
overexpression inhibits mesoderm formation (shown by Xbra downregulation) but also 
causes gastrulation defects (Tanegashima et al., 2000). It could be that the endoderm is 
less sensitive to levels of Lefty than mesoderm, thus explaining the lack of an effect on 
endoderm markers. In short, spatial regulation of XCR1 is critical to maintain the 
timing and spatial control of Nodal signalling during mesoderm specification in 
gastrulation.  
 
Figure 3.34 XCR1 replacement in the vegetal pole restricts mesoderm formation 
via increased levels of the Nodal pathway inhibitor, Lefty  
Targeted overexpression of XCR1 to the vegetal pole potentiates Nodal signalling 
through Xnr1, Xnr2, Xnr4 and Xnr5 to increase phosphorylation of Smad2. The Nodal 
target gene Lefty is upregulated by high phospho-Smad2 levels and acts cell non-
autonomously to inhibit Nodal signalling in the prospective mesoderm, thus 
downregulating mesodermal markers Xbra, Xforkhead and Goosecoid.  
 
I have shown that XCR1 is negatively regulated by the microRNA xla-miR-427. The 
mechanism of xla-miR-427 regulation of XCR1 is unclear, but is independent of the 
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3’UTR and levels of Xnr5 and Xnr6. There is however, a perfect xla-miR-427 seed 
match site in the XCR1 coding region that could be investigated as a potential regulatory 
site by a mutagenesis approach. It has been previously shown that xla-miR-427 also 
modulates Nodal signalling by 3’UTR-mediated repression of Lefty, Xnr5 and Xnr6b 
(Rosa et al., 2009). Loss of function analysis shows that xla-miR-427 is required for 
proper mesoderm induction and organiser formation (Rosa et al., 2009). xla-miR-427 
therefore modulates Nodal signalling at multiple levels in the pathway: by inhibition of 
ligand and inhibitor expression and indirect downregulation of XCR1 coreceptor 
expression. The inputs to phospho-Smad2 levels in Nodal signalling through XCR1 are 
summarised in Figure 3.35. The zebrafish homologue of xla-miR-427, miR-430 was 
also shown to inhibit Lefty and the Nodal ligand Squint (Choi et al., 2007). The human 
homologue, miR-302, also inhibits Lefty in human embryonic stem cells (Barroso-
Deljesus et al., 2011; Rosa et al., 2009). Further conservation of xla-miR-427/miR-430 
function has also been demonstrated as miR-427/miR-430 initiate degradation of 
maternal mRNAs after zygotic transcription begins by deadenylation of target mRNAs 
in both Xenopus (Lund et al., 2009) and zebrafish (Giraldez et al., 2006). The Nodal 
pathway is also subjected to microRNA regulation in Xenopus by xla-miR-15a and xla-
miR-16 targeting of the ActRIIA Nodal Type II receptor (Martello et al., 2007).  
 
Figure 3.35 xla-miR-427 regulation of Nodal signalling via controlling inputs to 
phospho-Smad2 levels 
xla-miR-427 represses both Xnr ligands and the Nodal inhibitor Lefty, which competes 
with Xnrs for XCR1 binding to antagonise Nodal signalling. xla-miR-427 also 
decreases XCR1 protein levels via a 3’ UTR-independent mechanism. Phospho-Smad2 
levels integrate these signal inputs to activate Nodal target genes.  
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3.3.3 Spatial regulation of XCR1 requires a minimal region of the 3’UTR 
containing 3 key elements and is partially Dicer-dependent 
As a possible additional level of microRNA modulation of Nodal signalling, spatial 
regulation of XCR1 shows some Dicer dependency and is dependent on the 3’UTR, 
suggesting that microRNAs may directly regulate spatial control of Nodal signalling 
through XCR1. A model of the regulation within the minimal 276-520 region sufficient 
for spatial regulation in the XCR1α 3’UTR is presented in Figure 3.36. I have shown 
that three key factors are necessary for spatial regulation: a spatial regulator binding 
TATTAC at position 360 in the 3’UTR, an RNA-stabilising factor and an additional 
spatial regulator between nucleotides 450-520. These results are in some aspects 
complementary to another model of XCR1α 3’UTR regulation published whilst this 
work was in progress (Figure 3.37) (Zhang et al., 2009).   
 
Figure 3.36 Spatial regulatory sites within the minimal 276-520 nt region of the 
XCR1α  3’UTR sufficient for spatial regulation  
The mutated nucleotides necessary for spatial regulation beginning at nucleotide 
position 360 are shown in red. An RNA-stabilising factor binds between nt 402-450, 
possibly an RNA-binding protein. A further sequence located between nucleotides 450-
520 is necessary for spatial regulation, shown in red brackets. 
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Figure 3.37 Zhang et al. show that Pumilio core sequences and CUG-BP1 sites are 
necessary but not sufficient for spatial regulation 
Pumilio binding elements (PBE) with a core sequence of TGTA (shown in blue) are 
located near the TATTAC spatial site I identified but do not overlap. The target 
protector oligo I used (TP-Pumilio shown by a blue bracket) which had no effect on 
spatial regulation was located over the PBE1/2 core TGTA sequences. The RNA-
binding protein CUG-BP1 was also shown to be necessary but not sufficient by Zhang 
et al., and is located in the spatial sequence I identified (450-520).  
 
Zhang et al. show that the same region of the XCR1α 3’UTR is sufficient for spatial 
regulation, nucleotides 286-637, which I have refined to 276-520 nt. Zhang et al. show 
that mutating the core TGTA region of three Pumilio binding elements (PBEs) and the 
binding site for the negative translational regulator CUG-BP1 protein in the context of 
286-637 nt partially relieves repression of vegetal translation of XCR1 mRNA (Zhang et 
al., 2009). They conclude that the Pumilio and CUG-BP1 sites are necessary but not 
sufficient for spatial regulation. The four nucleotides I identified as necessary for spatial 
regulation (TATTAC, Figure 3.36) do not overlap with the core TGTA Pumilio regions 
mutated by Zhang et al. Moreover, blocking Pumilio binding with a target protector 
over the PBE1/2 site has no effect on spatial regulation (Figure 3.29). Since TP-Pumilio 
has no effect and mutating the TATTAC site at 360 nt completely reverts spatial 
regulation in a GFP-3’UTR reporter mRNA assay, which is a visual readout of spatial 
regulation, rather than an indirect luciferase-3’UTR assay requiring dissection of the 
embryo used by Zhang et al., I conclude that an unknown factor binding the TATTAC 
site at 360nt is necessary for spatial regulation. Mutating Pumilio core elements near 
this site may alter the secondary structure of the mRNA, contributing to the partial 
reversion of spatial regulation indirectly observed by Zhang et al. 
Interestingly, Zhang et al. also show that a CUG-BP1 RNA binding protein site is 
also necessary for spatial regulation. The CUG-BP1 site is within the 450-520 nt region 
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I identified as the second sequence necessary for spatial regulation and could therefore 
be a necessary factor for spatial regulation. This could be studied by knocking down 
CUG-BP1 and assaying for loss of spatial regulation. Although Zhang et al. do identify 
the CUG-BP1 site as necessary for spatial regulation, no evidence is presented that the 
protein itself plays any role in spatial regulation. Similarly, Pumilio knockdown data 
would strengthen the model presented by Zhang et al. In short, the mapping data from 
both studies is complementary, although the regulator binding the TATTAC site at 360 
nt has yet to be conclusively identified.  
3.3.4 Potential spatial regulators of XCR1 
Potential regulators for binding the RNA-stabilising sequence between 402-450nt in 
the XCR1α 3’UTR included the poly(U) binding protein (Pub1) and the RNA-binding 
protein Hur. The mutational analysis in Figure 3.28 showed that mutating the 
overlapping predicted binding sites from a T/U rich sequence to 
5’TTTTATATGAACTTAATCAATAC had no effect on spatial regulation or RNA 
stability assessed by GFP levels. Since both Pub1 and Hur bind AU-rich elements 
(AREs), mutating bases from T to A may not have been the optimal strategy to test the 
effect of Pub1, Hur or any ARE-binding protein on spatial regulation and/or RNA 
stability. Mutations from T to G/C should be tested before the role of ARE binding 
proteins, which recruit the exosome to degrade target RNA (Chen and Shyu, 1995), on 
RNA stability in the context of the XCR1α 3’UTR is ruled out.  
A scan of the full length XCR1α 3’UTR sequence against the database of RNA 
protein binding specificities, (RBPDB) (Cook et al., 2010) yielded 112 hits with a score 
greater than 80 % of the maximum possible score for the protein. RNA binding protein 
hits within the 276-520 nt region are presented in Table 3.5. There are 7 Hur/ELAV 
motif sites within 402-461 RNA-stabilising sequence and a site for Poly(A) binding 
protein at 461nt which are strong candidates for stabilising mRNA. Notably, the Mut-
107 site at 285-290 nt disrupts a motif for the pre-mRNA splicing regulator MBNL1, 
which may explain why Mut-107 caused a decrease in GFP expression to undetectable 
levels in the context of the 276-520 3’UTR. Intriguingly, the RNA-binding protein QKI, 
which can regulate translation as well as RNA stability and localisation (Biedermann et 
al., 2010), has a motif at 352-361 nt which overlaps the necessary spatial four 
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nucleotides at 360 nt and may therefore play a role in spatial regulation. An RNA pull-
down experiment in the context of wild-type and Mut-1810 full length XCR1α 3’UTR 
and subsequent mass spectrometry or bandshift analysis would reveal whether this site 
was a critical RNA-binding protein sequence for spatial regulation.  
There are both Xenopus laevis and Xenopus tropicalis homologues of QKI, qki-a, qki-
b and qki respectively (Bowes et al., 2010). Mice mutant for QKI display defective 
myelination of neurons and ‘quaking’ tremors (Larocque et al., 2002). Further analysis 
revealed that in QKI mutant mice, myelin basic protein (MBP) mRNA is retained in the 
nucleus instead of exported to the cytoplasm (Larocque et al., 2002). As well as 
regulating mRNA localisation, QKI is also known to stabilise p27(Kip1) mRNA to 
increase levels of the protein (Larocque et al., 2005). The most relevant reported 
function of QKI proteins for the mechanism of XCR1 spatial regulation is probably that 
of the C. elegans QKI protein, GLD-1, which acts as a translational repressor for cyclin 
E (Biedermann et al., 2009), p53 (Schumacher et al., 2005) and multiple early 
development mRNA targets including one target where spatial repression of translation 
is observed (RME-2) (Lee and Schedl, 2001). Intriguingly, in mice, QKI-6 has been 
found to interact with Ago-2, which suggests that QKI proteins may interact with the 
microRNA-targeting pathway (Wang et al., 2010b). In short, the possibility that 
Xenopus laevis QKI proteins are responsible for spatial regulation of XCR1 could be 
tested by loss of function studies with morpholinos and assaying for spatial regulation. 
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Relative 
Score RBP Name Start End Matching sequence Comment 
100% ELAVL2 399 407 UUUUAUUUU Also known as Hur 
100% ELAVL2 399 407 UUUUAUUUU  
80% ELAVL2 400 413 
UUUAUUUUUUU
UUA 
 
88% ELAVL2 409 417 UUUUAAUUU  
100% A2BP1 482 487 UGCAUG 
Regulates 
alternative splicing 
100% A2BP1 288 293 UGCAUG  
100% a2bp1 483 487 GCAUG 
Zebrafish ATBP1 
homologue 
100% a2bp1 289 293 GCAUG  
94% PABPC1 461 467 ACAAAUA 
Poly(A)binding 
protein involved in 
translation initiation 
regulation via 
PAIP1/2 
88% RBMY1A1 392 396 CACAA  
100% Pum2 502 505 UGUA  
100% Pum2 343 346 UGUA  
100% Pum2 372 375 UGUA  
100% Pum2 335 338 UGUA  
100% MBNL1 278 281 UGCU  
100% MBNL1 285 288 UGCU pre-mRNA splicing 
100% EIF4B 303 306 GGAA  
100% EIF4B 451 454 GGAA  
100% KHSRP 470 473 GUCC Splicing regulation 
100% KHSRP 511 514 GUCC  
100% RBMX 324 327 CCAG  
81% QKI 352 361 UAUUAACUUA 
pre-mRNA splicing, 
mRNA export, 
mRNA stability and 
protein translation 
83% YTHDC1 384 389 GCAUCC  
80% YTHDC1 474 479 UACUAC Splice site selection 
100% SFRS1 302 305 AGGA  
100% SFRS1 450 453 AGGA Alternative splicing 
88% SFRS13A 434 440 AGAGAAC 
Repressor of pre-
mRNA splicing 
88% SFRS13A 432 438 AAAGAGA  
94% KHDRBS3 422 427 AUUAAU 
Alternative splicing 
regulator 
100% ELAVL1 507 510 GUUU  
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100% ELAVL1 499 502 GUUU  
93% KHDRBS3 410 415 UUUAAU  
86% ELAVL1 403 406 AUUU  
86% ELAVL1 414 417 AUUU  
86% ELAVL1 456 459 AUUU  
86% ELAVL1 348 351 AUUU  
82% KHDRBS3 343 348 UGUAAA  
81% KHDRBS3 377 382 AUUAAC  
81% KHDRBS3 353 358 AUUAAC  
Table 3.5 RNA binding protein motif matches in the 276-520 region of the XCR1α  
3’UTR as predicted by the RBPDB database with an 80 % relative score threshold.  
Proteins referred to in the text are highlighted in yellow and functions as described in 
the Uniprot database are annotated.  
 
In order to expand the list of possible spatial microRNA regulators from those tested 
so far, 10 nucelotides of 3’UTR sequence was added either side of the four nucleotide 
spatial sequence at 360 nt and scanned for seed matches in all miRbase microRNAs. 
This was to include microRNAs which were not present in the X. tropicalis small RNA-
seq libraries and microRNAs where the Mut-1810 mutations would disrupt microRNA 
binding, but not necessarily in the entire seed sequence. As shown in Table 3.6, miR-
187 was the microRNA with the most number of seed matches across species including 
X. tropicalis, humans and other mammalian species that could be disrupted by mutating 
the 5’TATTAG spatial site in the XCR1α 3’UTR. Mouse miR-187 was sequenced with 
12 reads in the X. tropicalis stage 10 small RNA library. Other microRNAs were 
isolated examples with unique seeds (e.g. osa-miR-440) or microRNA families in a 
single plant species such as the ptc-miR-478 family example. miR-187 is therefore a 
candidate spatial regulator because its binding to the XCR1α 3’UTR is predicted to be 
disrupted by the Mut-1810 manipulation and could be tested by miR-187 loss of 
function experiments.  
Other candidate microRNAs regulating the XCR1α 3’UTR can be added by taking 
microRNAs that are expressed at stage 10 in the small RNA-seq (relaxing the criteria of 
presence in both the stage 8 and stage 10 libraries) and looking for exact seed matches 
to the full length 3’UTR sequence (Table 3.7). There are 12 microRNAs with exact seed 
matches in the 276-520 minimal region of the XCR1α 3’UTR that have not yet been 
tested, including mmu-miR-187. These candidate spatial regulators could be tested by 
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mutating the predicted miRNA seed binding site and loss of function studies with 
microRNA morpholinos.  
In summary, there are multiple candidates including RNA binding proteins and 
microRNAs that could mediate spatial regulation of XCR1 through the XCR1α 3’UTR 
that remain to be experimentally investigated. I have shown that spatial regulation of 
XCR1 is a result of repression of translation in the vegetal pole at stage 10, partly 
requiring Dicer, and two spatial regulatory sequence elements and an RNA stabilising 
element in the XCR1α 3’UTR are necessary. Uncovering the mechanism of spatial 
regulation of XCR1 highlighted the lack of knowledge about microRNA expression in 
early development, which led me to perform genome-wide small RNA sequencing of 
early development small RNA libraries, as discussed in Chapter 4.   
miRNA 
seed 
sequence 
Seed match proximity to 5’tattag 
spatial site in 3’UTR 
Number 
of 
miRNAs 
with that 
seed miRNA 
5’CGTGTC 
 
5’TTTATTAACTtatta[gACACG]TTGTA 20 miR-187 in 
many species 
including: 
xtr-miR-187, 
hsa-miR-187 
and  
smo-miR-536 
5’GTGTCT 
 
5’TTTATTAACTtatt[agACAC]GTTGTA 1 osa-miR-440 
5’AACGTG 
 
5’TTTATTAACTtattagA[CACGTT]GTA 13 ptc-miR-478 
family  
Table 3.6  miR-187 is the best candidate for a microRNA a seed match proximate 
to the spatial four nucleotides sequence at 360nt 
The spatial site ‘tattag’ is shown in lower case and the square brackets indicate the 
position of the microRNA seed match in the XCR1α 3’ UTR sequence.
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X. tropicalis st 10 
miRNA sequence Read number 
Start of seed 
alignment in 
XCR1α  3’UTR (nt) 
cel-miR-72 113 717 
cel-miR-73 52 717 
cel-miR-74 8 717 
hsa-miR-26a 28 13 
hsa-miR-101 49 884, 936 
mmu-miR-101a 12 884, 936 
mmu-miR-124 12 160 
mmu-miR-125a-5p 12 843 
mmu-miR-125b-5p 12 843 
mmu-miR-126-5p 12 849 
mmu-miR-130a 12 61 
mmu-miR-135a 12 542 
mmu-miR-136 12 695 
mmu-miR-144 12 884, 936 
mmu-miR-152 12 248 
mmu-miR-153 12 142, 595 
mmu-miR-154 12 707 
mmu-miR-10b 12 898 
mmu-miR-181a 12 658, 798 
mmu-miR-186 12 775 
mmu-miR-187 12 370 
mmu-miR-193 12 23 
mmu-miR-199a-5p 12 249 
mmu-miR-199a-3p 12 271 
cel-miR-237 33 843 
dme-miR-263a 15 381, 929 
dme-miR-279 15 313 
dme-miR-124 233 160 
mmu-miR-106a 12 63, 603 
mmu-miR-106b 12 63, 603 
mmu-miR-130b 12 61 
dme-miR-125 233 843 
dme-miR-31a 41 717 
dme-miR-312 76 918 
mmu-miR-148a 12 248 
mmu-miR-103 12 290 
mmu-miR-148b 12 248 
mmu-miR-135b 12 542 
mmu-miR-101b 12 884, 936 
mmu-miR-107 12 290 
mmu-miR-10a 12 898 
mmu-miR-17 12 63, 603 
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mmu-miR-199b 12 271 
mmu-miR-181b 12 658, 798 
mmu-miR-181c 12 658, 798 
cel-miR-35 31 329 
hsa-miR-363 8 918 
gga-miR-30a-3p 428 135 
gga-miR-101 65 885, 937 
dre-miR-10a 445 898 
xla-miR-427 92 62 
dre-miR-10c 1 898 
bta-miR-29a 30 633 
xtr-miR-10a 521 898 
xtr-miR-10b 342 898 
xtr-miR-17-5p 1 63, 603 
xtr-miR-26 22 13 
xtr-miR-30a-3p 3 135 
xtr-miR-30b 13 231 
xtr-miR-107 11 290 
xtr-miR-130a 14 61 
xtr-miR-130b 12 61 
xtr-miR-202 2 719 
xtr-miR-181a 1 658, 798 
xtr-miR-101a 189 884, 936 
xtr-miR-148a 189 248 
xtr-miR-25 12 918 
xtr-miR-31 3 717 
xtr-miR-20b 1 63, 603 
bta-miR-107 19 290 
bta-miR-140 99 494, 642 
sme-miR-31b 20 717 
mmu-miR-181d 12 658, 798 
mmu-miR-193b 12 23 
dme-miR-193 233 23 
dme-miR-1002 233 322 
dme-miR-137 233 623 
dme-miR-1001 233 325 
dme-miR-1003 233 558 
dme-miR-1004 233 558 
dme-miR-1005 233 809 
dme-miR-1013 233 403, 777 
xtr-miR-31 3 280, 716 
mmu-miR-466i 35 210 
mmu-miR-1-2-as 12 508, 888 
mmu-miR-1186 12 247 
mmu-miR-1197 12 474, 515 
oan-miR-31 5 717 
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cfa-miR-31 55 717 
cfa-miR-101 12 884, 936 
cfa-miR-30e 1038 135 
cfa-miR-140 51 641 
cfa-miR-363 32 918 
hsa-miR-182 12 249 
mmu-miR-1905_ 12 761 
mmu-miR-1906 12 290 
mmu-miR-1904 12 145 
mmu-miR-1930 12 696 
mmu-miR-1933-3p 12 516 
mmu-miR-1935 12 20 
mmu-miR-1944 12 823 
mmu-miR-1950 12 143 
mmu-miR-1959 12 578 
mmu-miR-1960 12 248 
mmu-miR-1971 12 723 
mmu-miR-1981 11 723 
mmu-miR-1982.2 12 899 
spu-miR-10 6 898 
bfl-miR-2076 40 918 
dpu-miR-31 10 717 
 
Table 3.7 110 stage 10 microRNAs that bind the full length XCR1α  3’UTR with an 
exact seed match 
12 miRNAs with seed matches in the spatial 276-520 spatial region of the 3’UTR not 
yet studied are highlighted in yellow. MicroRNAs are those passing the filters of 22-
23nt in length, with zero mismatches to a miRbase version 14 microRNA sequenced at 
stage 10 with an exact seed match in the XCR1α 3’UTR.  
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Chapter 4. Genome-wide small RNA sequencing of 
the early Xenopus embryo reveals dynamic and 
localised expression of small RNAs 
4.1 Introduction 
The aim of the work described in this chapter was to sequence all small RNAs in the 
Xenopus tropicalis embryo at three stages in early development: blastula (stage 8), 
gastrula (stage 10), neurula (stage 18) and in animal and vegetal hemispheres of the 
gastrula stage embryo. This project emerged from working on the mechanism of spatial 
regulation of Xenopus Cripto-1 in early development. Very few Xenopus microRNAs 
were known in early development, as most microRNAs had been cloned in adult tissues 
(Watanabe et al., 2005). To fill this void, I sequenced all small RNAs present at three 
stages of X. tropicalis early development to characterise new Xenopus microRNAs and 
obtain dynamic and spatial information on microRNA expression and expression of 
other small RNAs during early development.  
 I prepared small RNA libraries size selected for 18-30 nucleotides in length as 
described in Chapter 2 and Figure 4.1 which were sequenced using the Illumina next-
generation sequencing platform. The small RNA libraries were designed to contain 
microRNAs (~22 nt), endogenous siRNAs (21-24 nt) and any Piwi-interacting RNAs 
(piRNAs, 25-30 nt) plus any other unknown small RNA species. Xenopus tropicalis 
rather than Xenopus laevis libraries were prepared due to the availability of the X. 
tropicalis reference genome (Hellsten et al., 2010). Characterisation and experimental 
validation of the small RNA-seq dataset is presented in this chapter. Bioinformatic 
analysis of the raw dataset was performed by Stuart Horswell in the Cancer Research 
UK Bioinformatics and Biostatistics Group and I designed the downstream analysis of 
the dataset.    
4.2 Results 
4.2.1 Quality of the small RNA libraries 
Firstly, the quality of the small RNA libraries was assessed. Following ligation of 
Illumina adapter sequences onto the small RNAs and reverse-transcription PCR 
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amplification (Figure 4.1), the final stage of small RNA library preparation showed 
strong bands at ~100 nt in each of the libraries (Figure 4.2). Adapter dimer bands were 
avoided, and the small RNA cDNA libraries were gel purified and quantified for 
Illumina sequencing. Libraries were submitted at a 10 nM concentration for single-end 
small RNA sequencing using the Illumina platform on a Genome Analyzer IIx at the 
Cancer Research UK Cambridge Research Institute. A technical repeat of the Illumina 
sequencing using the same libraries was performed approximately one year later on a 
Genome Analyzer IIx at the Cancer Research UK London Research Institute. All 
analysis presented in this chapter refers to the results from the first sequencing run, 
except where the datasets are directly compared. 
 The FastQ files from the initial sequencing run were analysed. Over 14 million small 
RNA raw reads were obtained per library. These were filtered to retain reads that 
contained at least six contiguous nucleotides of Illumina adapter sequence and had at 
least 15 nucleotides of sequence remaining when the adapter sequence was removed. 
Approximately 70 % of raw reads were retained after adapter trimming in each library 
(Table 4.1). Trimmed reads were then aligned to version 4.1 of the X. tropicalis genome 
with zero mismatches permitted. Between 48.8 % and 59.3 % of the raw reads passed 
this strict alignment criteria (Table 4.2). Less than 0.1 % of untrimmed reads in each 
library aligned with no mismatches to the genome. This is an estimate of the false 
detection rate, as untrimmed reads contain fragments of the unique Illumina adapter 
sequences at the 3’ end that do not align anywhere in the genome.  
Small RNA reads can be compressed into tags, which are unique sequences. For 
example, a small RNA library could be comprised of millions of reads which are many 
copies of the same sequence and would therefore collapse into one tag. In the early 
Xenopus tropicalis embryo, the number of tags that align perfectly to the genome ranges 
between 387,173 at stage 10 to 718,228 in the stage 10 vegetal pole library. Another 
feature of the dataset obvious at this stage in the analysis is high multiplicity: when a 
read aligns to more than one place in the genome. For example, as shown in Table 4.2, 
at stage 8, over 670,000 tags align to more than 26 million places in the genome. This 
could be due to alignment to repetitive regions in the genome or multiple loci for small 
RNA genes.  
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The quality of the data set was enhanced by biological replicates within the libraries, 
as there are a total of three stage 10 samples (stage 10 whole embryo, stage 10 animal 
pole and stage 10 vegetal pole), which should overlap in small RNA content (see 
section 4.2.2.1). A technical repeat of the small RNA sequencing performed one year 
later at the Cancer Research UK London Research Institute yielded greater sequencing 
depth, indicated by the increase in raw read numbers from around 14 million to over 20 
million per library (Table 4.3). The percentage of raw reads aligning perfectly to the 
genome was similar to the first run at 45-57 % and the number of aligned tags followed 
the same pattern of tags decreasing between stage 8 and 10, then increasing at stage 18 
with more vegetal than animal tags at stage 10. An increase in tags resulted from the re-
sequencing for the stage 8, stage 18 and stage 10 vegetal libraries. The additional 
microRNAs tags identified by re-sequencing the libraries are presented in Table 4.7.  
Finally, an immediate picture of the quality of the libraries is given by the length 
distribution of small RNA species sequenced, shown for trimmed, aligned reads and 
tags in the first sequencing run at the CRI, and for the technical repeat performed at the 
LRI (Figure 4.3). Firstly, the accuracy of the size selection of small RNAs of length 18-
30 nt can be assessed. The reads are trimmed of adapter sequence so some of the 
sequences in the length distribution fall between 13-18 nt. Secondly, an impression of 
heterogeneity within the library is revealed. Peaks in the length distribution can suggest 
the presence of different classes of small RNAs in the libraries. Thirdly, the libraries 
can be compared to one another. Figure 4.3 shows that the raw read and tag length 
distributions are similar for all the libraries, with the stage 10 library containing the 
fewest tags.  
The length distribution of reads in the first sequencing run (CRI reads) shows a major 
peak at 28 nucleotides in all libraries, and a lesser peak at 23 nt in all except the stage 
10 animal library. These sizes correspond to piRNAs and microRNAs respectively 
(Armisen et al., 2009). The 28 nt peak does not collapse when raw reads are compressed 
into tags, indicating a complex population of small RNAs characteristic of piRNAs. The 
23 nt peak does collapse, which is a feature of microRNA reads, as many identical 
microRNA sequences compress into far fewer tags (Armisen et al., 2009). When the 
initial sequencing run and technical repeat length distributions are compared, it is 
obvious that the read length profiles share very similar features, except that the 23 nt 
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peak is not apparent in the technical repeat. The tag profiles for both sequencing runs 
are similar, with the technical repeat showing lower abundance of 28 nt tags compared 
to the initial sequencing run. In short, the length distributions from both runs of small 
RNA sequencing are highly reproducible.  
In summary, the high quality of the small RNA libraries was established by alignment 
of the small RNA-seq reads to the X. tropicalis genome and by the length distribution of 
small RNAs within the library. Re-sequencing of the libraries in a technical repeat 
reiterated and added to the findings of the initial study.  
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Figure 4.1 Overview of Illumina small RNA library construction 
Schematic diagram of Illumina small RNA library construction. The protocol and 
primer sequences are described in section 2.6. Briefly, small RNAs of 18-30 nt length 
are purified and ligated onto 5’ and 3’ Illumina RNA adapters by an RNA ligation 
reaction. The adapter sequence is needed to stick the template DNA to the flow cell in 
the Illumina Genome Analyser IIx sequencing machine. The 3’ RNA adapter contains a 
modified base, idT. The ligated small RNAs are then reverse transcribed and the 
resulting cDNA is used as the template for a large scale PCR reaction using Illumina 
PCR primers 1 and 2. The final PCR product is about 100 bp (see Figure 4.2). The 
dsDNA PCR library of small RNAs is purified and sent for Illumina sequencing.   
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Figure 4.2 Final quality control stage of small RNA library preparation 
After both Illumina adapters were ligated on and cDNA libraries were PCR-amplified 
as described in Figure 4.1, dsDNA PCR small RNA libraries were gel purified. The 
PCR products are run on a 6 % native polyacrylamide gel and stained with ethidium 
bromide. The ~100 bp band (red box) is excised, avoiding the adapter dimers at ~ 70 bp.  
The integrity and successful preparation of the library was confirmed at this stage 
before final quantification and Illumina sequencing. 
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Small RNA 
library 
 
Number of 
Raw Reads 
Number of 
Reads after 
Adapter 
Trimming 
Trimmed 
Reads as % of 
Raw Reads 
Stage 8 15,824,233 11,553,093 73.0 
Stage 10 15,338,864 11,634,636 75.9 
Stage 18 14,739,870 10,463,257 71.0 
Stage 10 animal 14,297,841 10,277,485 71.9 
Stage 10 vegetal 15,171,802 10,350,900 68.2 
Table 4.1 Approximately 70 % of raw reads are retained after adapter trimming  
Raw reads were filtered by retaining reads with at least six contiguous nucleotides of 
Illumina adapter sequence at the 3’ end with no less than 15 nt of sequence remaining. 
Adapter sequences were removed from raw reads to give trimmed reads.  
 
Small RNA 
library 
 
Number of 
Reads aligning 
to the genome 
(0 mismatches) 
Aligned 
Reads as % 
of Raw 
Reads 
Number of 
Aligned Tags 
Multiple 
Alignments 
Stage 8 9,125,752 57.7 672,032 26,419,988 
Stage 10 9,092,783 59.3 387,173 16,331,788 
Stage 18 8,067,818 54.7 566,646 26,770,113 
Stage 10 animal 8,182,367 57.2 551,798 25,413,967 
Stage 10 vegetal 7,399,178 48.8 718,228 33,261,573 
Table 4.2 Alignment of trimmed reads to the Xenopus tropicalis genome 
Trimmed reads were aligned to the X. tropicalis genome with zero mismatches. 
Approximately 50-60 % of the raw reads aligned to at least one place in the genome 
with no mismatches after adapter trimming. Tags often align to multiple places in the 
genome. The multiple alignments column indicates the total number of alignments for 
all tags. 
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Small RNA 
library 
 
Number of 
Raw Reads 
Trimmed 
Reads as % 
of Raw 
Reads 
Aligned Reads 
as % of Raw 
Reads 
 
 
 
Number of 
Aligned Tags 
Stage 8 23,119,446 67.1 54.7 696,569 
Stage 10 21,565,804 71.5 57.1 358,909 
Stage 18 27,893,758 61.5 48.9 599,334 
Stage 10 animal 20,704,206 68.3 56.0 528,987 
Stage 10 vegetal 26,455,794 60.4 44.8 834,281 
Table 4.3 A technical repeat of library sequencing shows improved sequencing 
depth 
Raw read numbers improved from approximately15 million to over 20 million raw 
reads on re-sequencing of the small RNA libraries. The alignment percentages and are 
comparable to the initial sequencing run (Table 4.2). The number of aligned tags 
increases in the stage 8, stage 18, and stage 10 animal libraries and decreases in the 
stage 10 and stage 10 animal libraries on re-sequencing, although the number of tags is 
broadly similar to the initial run.  
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Figure 4.3 Length distributions of trimmed, aligned Reads and Tags in the small 
RNA libraries  
Reads can be compressed into unique sequences known as ‘tags’. Read and tag number 
is plotted against read length for the stage 8, stage 10, stage 18, stage 10 animal and 
stage 10 vegetal libraries for the first sequencing run (CRI) and the technical repeat 
sequencing run (LRI). The reads and tags are trimmed to remove adapter sequences and 
align to the genome with zero mismatches. The read profiles for all small RNA libraries 
in the LRI dataset contain peaks at ~23 nt and 28 nt, whereas the tag profile shows one 
major peak at 28 nt.  
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4.2.2 Overview of the X. tropicalis early development small RNAome  
In order to annotate the small RNAs sequenced in the five libraries, trimmed reads 
that aligned to the X. tropicalis genome with zero mismatches were aligned to non-
coding RNA databases. Firstly, the mature miRNA sequences contained in the miRbase 
miRNA database for all species (Griffiths-Jones et al., 2006) were compressed into 
unique sequences, retaining a Xenopus tag when a microRNA was also conserved in 
other species. This left 5,213 miRbase miRNA tags of which 156 were Xenopus 
tropicalis miRNAs. Trimmed reads were then aligned to these miRbase tags and 
normalised to allow comparison across the small RNA libraries by dividing the number 
of aligned reads by the total number of reads which aligned to the genome in each 
library and multiplying by 1x107. The number of reads aligning to a miRbase 
microRNA in each library and the number of microRNA tags in each library is shown 
in Figure 4.4A.  
Both microRNA reads and tags were highest in the stage 18 library, suggesting that 
microRNAs increase in abundance and sequence diversity between gastrulation and late 
neurula stage in X. tropicalis. A maximum of 851 microRNA tags was obtained in the 
stage 18 library in this initial filtering, of which 75 were already known in X. tropicalis. 
Therefore, 48 % of the known X. tropicalis miRNAs were sequenced and are present in 
early development. More microRNA reads and tags were present in the stage 10 animal 
pole library than in the stage 10 vegetal pole library, which will be explored further in 
Section 4.2.2.1. MicroRNA-star and hairpin sequences were also downloaded from 
miRbase as were microRNAs in the RNAdb database (Pang et al., 2005) and aligned to 
trimmed reads. In total, all microRNA-related sequences comprised less than 1-2 % of 
the small RNAome in all the libraries. MicroRNAs were maximally 1.56 % of the 
trimmed reads at stage 18 (Table 4.4).  
Next, the reads annotated as mature microRNAs, miRNA-star or hairpin sequences 
were removed and the unannotated trimmed reads left were compared to the RNA 
family database, Rfam, a repository of non-coding RNAs (Griffiths-Jones et al., 2003). 
Reads aligning to Rfam RNA sequences were the most abundant of the annotated 
sequences in the X. tropicalis small RNAome, seen by the high normalised read 
Chapter 4. Genome-wide small RNA sequencing of the early Xenopus embryo  
 206 
numbers in the libraries (Figure 4.4C), and the percentage of trimmed reads aligning 
which ranged from 1.1 % at stage 8 to 2.2 % in the stage 10 animal pole library (Table 
4.4). When the categories of non-coding RNAs hit by the trimmed reads were analysed 
(Figure 4.5), the profiles were consistent across the five small RNA libraries and the 
most frequently hit Rfam tags were ribosomal RNAs (38-43 %), tRNA (10-14 %) and 
small nucleolar RNA (snRNA, 10-13 %). Since the small RNAs cloned were 18-30 nt, 
these are alignments to part of the Rfam tag sequence.  
The remaining unannotated reads were then aligned to Piwi-interacting RNAs in 
RNAdb.  piRNA reads were highest in the stage 10 animal pole library, and increased 
from stage 10 to stage 18 (Figure 4.4B). Interestingly, piRNA tags decreased between 
stage 8 and stage 10, and the number of piRNA unique sequences was higher in the 
stage 10 vegetal pole library compared to the animal pole, despite the lower piRNA 
read numbers. This suggests that some piRNAs show stage-specific expression and the 
vegetal pole contains a more complex population of piRNAs at lower abundances than 
the animal pole. Piwi-interacting RNAs were a maximum of 0.88 % of the small 
RNAome in the stage 10 animal library.  
Tags from the other non-coding RNA datasets in RNAdb were sequentially extracted 
from the Hinv, Fantom3, Evofold, antisense non-coding RNA pipeline and literature-
curated datasets (Pang et al., 2005). Fantom3 tags were hit by up to 0.49 % of trimmed 
reads, whereas the sum of the other database tag hits was minimal, at less than 1.1 x10-3 
%. Significantly, between 95 % and 98 % of small RNA trimmed reads, which align to 
the genome, remained unannotated following comparison to known non-coding RNA 
databases. This result was confirmed by analysis of the technical repeat sequencing run, 
where between 91% and 96 % of the reads that aligned to the genome were unannotated 
(Table 4.5). The percentage of microRNAs and piRNA reads was very similar in the 
technical repeat, but more reads aligned to Rfam and Fantom3 than in the first 
sequencing run, reducing the number of unannotated reads. 
In summary, most of the X. tropicalis small RNAome in early development is as yet 
uncharacterised, and the question of what these small RNAs are, and their role in early 
development will be addressed in Chapter 5. 
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Figure 4.4 Read and Tag profiles across the libraries for microRNAs, piRNAs and 
Rfam small RNAs.  
A. Trimmed reads were aligned to microRNAs in miRbase version 14 (5,213 unique 
sequences) and normalised to allow comparison across the libraries by dividing the 
number of miRNA reads by the total number of reads aligning perfectly to the genome 
and multiplying by 1x107. The absolute number of miRbase miRNA tags sequenced is 
shown, with known X. tropicalis miRNA tags in grey (156 possible sequences). B. 
Reads were aligned to the piRNAs in RNAdb. C. Reads were aligned to non-coding 
RNAs in the RNA families (Rfam) database.
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Figure 4.5 Percentage breakdown of Tags aligning to Rfam database small RNAs 
Tags matching to Rfam RNA sequences in the stage 8, stage 10, stage 18 and stage 10 
animal and vegetal libraries were analysed for which Rfam category they corresponded 
to. The ‘cis-regulatory element’ Rfam category contains RNA sequences with a known 
cis-regulatory function, such as stem-loops in 3’ UTRs that interact with proteins. The 
‘gene’ category contains non-coding RNA genes and the alignment to tags is broken 
down into a ‘sense’ and ‘antisense’ alignment. MicroRNAs present in the Rfam 
database do not overlap with miRbase sequences as the latter were extracted prior to 
Rfam alignments. The ‘ribozyme’ category contains RNA enzyme sequences. The 
‘rRNA’ category contains ribosomal RNA sequences. ‘snoRNA’ refers to small 
nucleolar RNA sequences, whereas the ‘snRNA’ category contains small nuclear RNA 
sequences. The ‘tRNA’ category contains transfer RNA sequences. The ‘intron’ Rfam 
category contains RNA sequences originating from introns such as self-splicing 
catalytic introns. The ‘unannotated’ Rfam category contains sequences that have not 
been assigned to any RNA family.   
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Small 
RNA 
Library 
% 
miRNA 
reads 
total 
% 
piRNA 
reads 
% 
Rfam 
reads 
% 
Fantom3 
reads 
% Hinv, 
Evofold, 
Antisense 
ncRNA 
pipeline and 
literature data 
set reads 
% Un-
annotated 
genomic 
reads 
Stage 8 0.17 0.37 1.10 0.21 3.8 x10-4 98.1 
Stage 10 0.32 0.31 1.19 0.15 5.0 x10-4 98.0 
Stage 18 1.56 0.56 1.17 0.26 3.3 x10-4 96.5 
Animal 0.67 0.88 2.20 0.49 1.1 x10-3 95.8 
Vegetal 0.33 0.68 1.41 0.32 8.2 x10-4 97.3 
Table 4.4 X. tropicalis early development small RNAome annotation  
Summary of the percentage of trimmed reads that align with zero mismatches to 
miRNA sequences (mature miRNAs, miRNA* and hairpin sequences from miRbase 
and miRNAs from RNAdb), piRNA sequences (from RNAdb), Rfam sequences, 
Fantom3 sequences (mouse non-coding RNAs) and other non-coding RNA databases in 
the small RNA libraries from the first sequencing run (Cambridge Research Institute 
run). The percentage of unannotated reads that align to the genome is shown.  
 
Small 
RNA 
Library 
% 
miRNA 
reads 
total 
% 
piRNA 
reads 
% 
Rfam 
reads 
% 
Fantom3 
reads 
% Hinv, 
Evofold, 
Antisense 
ncRNA 
pipeline and 
literature data 
set reads 
% Un-
annotated 
genomic 
reads 
Stage 8 0.15 0.35 1.45 2.47 0.35 95.2 
Stage 10 0.27 0.33 1.79 1.27 0.21 96.1 
Stage 18 1.21 0.56 1.94 2.25 0.29 93.8 
Animal 0.49 1.04 3.13 4.91 0.21 93.2 
Vegetal 0.25 0.70 2.94 4.91 0.29 90.9 
Table 4.5 Technical repeat of small RNAome annotation (LRI sequencing run) 
Annotation of the small RNAome as described in Table 4.4 for the technical repeat 
sequencing run performed at the Cancer Research UK London Research Institute about 
one year after the first sequencing run at the Cambridge Research Institute. 
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4.2.2.1 MicroRNA characterisation  
In order to gain an accurate profile of microRNA expression in the five small RNA 
libraries, trimmed reads of length 22-23 nt with a perfect match to a miRbase 
microRNA tag which was sequenced a minimum of 10 times (i.e. 10 reads) in at least 
one of the libraries were retained. A read length of 22-23 nt was selected to eliminate 
noise from shorter reads aligning to part of a miRNA sequence, or multiple miRNA 
sequences. 169 miRbase microRNA sequences passed this filter including 51 known X. 
tropicalis and two X. laevis miRNAs, xla-miR-427 and xla-miR-449. The filter vastly 
cuts down the number of microRNA tags from a maximum of 851 microRNA tags 
shown in Figure 4.3.  
The five most frequently sequenced microRNAs in each library are presented in 
Table 4.6. Small RNA sequencing is semi-quantitative, therefore sequencing frequency 
correlates with miRNA abundance (Creighton et al., 2009). Notably, xtr-miR-206 and 
cfa-miR-30e dominate the stage 18 microRNA profile. xtr-miR-206 reads are 33 % and 
cfa-miR-30e reads are 19 % of all miRNA reads at stage 18. hsa-miR-1825 is the most 
abundant stage 8, stage 10 animal and stage 10 vegetal miRNA, strikingly accounting 
for 50 % of miRNA reads in the vegetal pole. hsa-miR-1825 is the 7th most abundant 
miRNA in the stage 10 whole embryo, accounting for 5.3 % of miRNA reads. 
Comparing the microRNAs sequenced in the stage 10, stage 10 animal and stage 10 
vegetal libraries can estimate the reproducibility of the microRNA profiles. As shown in 
Figure 4.6, 97 microRNAs out of a total of 154 were sequenced in the stage 10 whole 
embryo, stage 10 animal and stage 10 vegetal libraries. A further 18 microRNAs were 
sequenced in either the stage 10 animal or vegetal libraries and the stage 10 library, 
giving a total overlap of microRNAs sequenced in the stage 10 whole embryo and 
dissected libraries of 115/154 microRNAs, or 75 %. The five microRNAs found in the 
stage 10 library, but not in the animal or vegetal libraries, were present at read numbers 
less than 26 in the stage 10 whole embryo, and were detected at low read numbers at 
stage 8 and/or 18. This implies that the limit of sequencing sensitivity was approached. 
MicroRNAs sequenced in animal or vegetal libraries but not the stage 10 whole embryo 
libraries were generally present in the stage 18 libraries. This could be explained by the 
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extra time required to dissect the animal and vegetal poles at stage 10, which was 
performed after freezing the whole embryo samples. 
Heat maps of microRNA expression in the five small RNA libraries were generated 
by multiple sequence alignment of all microRNA tags that passed a read length filter of 
22-23 nt and zero mismatches in sequence to a miRbase microRNA to create a 
dendrogram. The dendrogram divides into four branches based on microRNA sequence 
similarity (Figure 4.7). MicroRNA expression was illustrated using a colour scale of log 
(base 10) of normalised read number in each library, where green corresponds to low 
normalised read numbers and red to high normalised read numbers. The most abundant, 
dynamically expressed and spatially localised microRNAs in the dataset can be selected 
from the heat maps.  
In Branch 1 (Figure 4.8), xtr-miR-101a is expressed at comparatively high levels in 
all the libraries (~200 reads at stage 8 and stage 10, and over 800 reads at stage 18), 
whereas xtr-miR-130b is the most abundant and dynamic miRNA, increasing almost 
200-fold in abundance between stage 10 and stage 18. xtr-miR-183, xtr-miR-130c and 
xtr-miR-130b are the most dynamically expressed miRNAs, increasing in expression 
between stage 10 and stage 18. dme-miR-312 is the most localised miRNA, showing 
25-fold higher abundance in the animal pole than the vegetal pole at stage 10.  
In Branch 2 (Figure 4.9), cfa-miR-363 and hsa-miR-363 are the most abundant 
microRNAs, and are dynamic in expression, increasing over 14-fold and 45-fold 
respectively from stage 10 to stage 18. xtr-miR-367 is highly abundant at stage 18, and 
is the most dynamically expressed microRNA increasing from zero reads at stage 10 to 
124 reads at stage 18. xtr-miR-107 is the most spatially localised miRNA with ~8-fold 
higher abundance in the animal pole compared to the vegetal pole at stage 10.  
dme-miR-184 is the most abundant miRNA in branch 3 of the heatmap (Figure 4.10), 
and is the most spatially localised with ~13-fold higher abundance in the animal pole 
than the vegetal pole at stage 10. In contrast, dme-miR-263a and xtr-miR-24a are more 
abundant in the vegetal pole. gga-miR-146c is the most dynamically expressed miRNA 
in Branch 3, again increasing in abundance between stage 10 and stage 18.  
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Branch 4 of the heat map (Figure 4.11) reveals that hsa-miR-1825 is the most stably 
expressed abundant miRNA, whereas the most abundant miRNA sequenced in the 
dataset, xtr-miR-206 shows dynamic expression by increasing over 300-fold between 
stages 10 and 18. cfa-miR-30e is a highly abundant miRNA that increases 12-fold 
between stage 10 and stage 18. The let-7 family of miRNAs is also highly abundant at 
stages 10 and 18. xtr-miR-16c, mmu-miR-466i, rno-miR-10b-3p, mmu-miR-10b, xtr-
miR-10b and cfa-miR-200b follow a trend of increasing abundance at stage 18 
compared to stages 8 and 10. Spatially, bmo-miR-184 is the most localised miRNA, 
with 10-fold higher normalised reads in the animal compared to the vegetal pole at stage 
10. The spatial and dynamic expression profiles of miRNAs will be experimentally 
validated in section 4.2.4.2. 
As previously stated, small RNA libraries were re-sequenced to obtain a technical 
repeat. For this dataset, the same filter was applied to microRNA tags that matched a 
miRbase miRNA. On re-sequencing, 179 microRNAs passed the filter, compared to 169 
with the first sequencing run. 23 new microRNAs were present in the re-sequenced 
dataset (Table 4.7), however, 13 microRNAs present in the original dataset were not re-
sequenced meaning that the technical repeat was 87 % identical to the original dataset in 
terms of microRNA tags. The new microRNAs sequenced in the technical repeat were 
all relatively low read numbers; the most abundant microRNA, xtr-miR-148b was 
sequenced 29 times at stage 18. 
Since miRbase has been updated to include new microRNAs since this work began, 
the microRNA sequences in miRbase 17 were filtered to remove identical entries from 
different species and compared to the trimmed, aligned, small RNA sequencing reads. 
miRbase 17 contains 12,187 miRNA tags compared to the 5,213 tags in miRbase 14 
after filtering. When compared to miRbase 17, a total of 414 additional microRNAs 
were found in the small RNA libraries that were not listed in miRbase 14, bringing the 
total number of Xenopus microRNAs I identified to 606. New miRbase 17 microRNAs 
found in the libraries are listed in the Appendix (Table 6.1).  
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Small RNA 
library MicroRNA 
Normalised 
Read Number % of total miRNA reads 
hsa-miR-1825 991 18.2 
hsa-miR-423-5p 423 7.8 
xtr-let-7c 267 4.9 
xtr-let-7f 255 4.7 
Stage 8 
xtr-miR-148a 234 4.3 
hsa-miR-423-5p 1482 10.1 
cfa-miR-30e 1042 7.1 
dme-miR-184 1018 7.0 
bmo-miR-184 996 6.8 
Stage 10 
xtr-let-7f 785 5.4 
xtr-miR-206 21374 33.4 
cfa-miR-30e 12401 19.4 
mmu-miR-10b 2857 4.5 
rno-miR-10a-3p 2856 4.5 
Stage 18 
xtr-miR-130b 2387 3.7 
hsa-miR-1825 2624 12.0 
dme-miR-184 2374 10.9 
bmo-miR-184 2351 10.8 
cfa-miR-30e 1379 6.3 
Stage 10 animal 
hsa-miR-423-5p 1347 6.2 
hsa-miR-1825 4952 49.7 
cfa-miR-30e 818 8.2 
hsa-miR-423-5p 417 4.2 
xtr-let-7f 257 2.6 
Stage 10 vegetal 
bmo-miR-184 231 2.3 
Table 4.6 The most frequently sequenced X. tropicalis miRNAs in early 
development 
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Figure 4.6 Venn diagram showing overlap of miRNA sequencing at stage 10 
MicroRNAs that were sequenced in any of the stage 10 small RNA libraries (whole 
embryo, animal or vegetal pole) are plotted to show the number of microRNAs that are 
present in more than one stage 10 library.  
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Figure 4.7 Dendrogram of miRNAs for heat map expression profiles 
MicroRNA tags in all five libraries passing a filter of 22-23 nt read length and zero 
mismatches to a miRbase microRNA were aligned and grouped by sequence similarity 
to form a dendrogram with four major branches. There are 169 microRNAs in total.  
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Figure 4.8 MicroRNA heat map for dendrogram branch 1 showing dynamic and 
localised miRNA expression 
Heat maps were calculated using a colour key based on log base 10 of values of 
normalised read numbers. Green corresponds to low and red to high miRNA read 
numbers respectively. MicroRNA tags of 22-23 nt length with a perfect match to a 
miRbase microRNA sequence were analysed.  
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Figure 4.9 MicroRNA heat map for dendrogram branch 2 showing dynamic and 
localised miRNA expression 
Heat maps were calculated using a colour key based on log base 10 of values of 
normalised read numbers. Green corresponds to low and red to high miRNA read 
numbers respectively.  
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Figure 4.10 MicroRNA heat map for dendrogram branch 3 showing dynamic and 
localised miRNA expression 
Heat maps were calculated using a colour key based on log base 10 of values of 
normalised read numbers. Green corresponds to low and red to high miRNA read 
numbers respectively.  
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Figure 4.11 MicroRNA heat map for dendrogram branch 4 
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MicroRNA 
 
Stage 8 Stage 10 Stage 18 Stage 10 animal Stage 10 vegetal 
xtr-miR-148b 17 0 29 16 7 
dme-miR-306 0 0 19 0 0 
mmu-miR-29c 0 13 18 9 6 
mml-miR-96 0 0 16 0 0 
hsa-miR-224 0 0 15 0 0 
dre-miR-456 0 17 13 0 9 
cfa-miR-181a 0 1 13 0 0 
dmo-miR-317 0 0 13 22 2 
xtr-miR-34a 0 0 13 9 0 
xtr-miR-7 2 1 12 0 2 
rno-miR-143 4 10 11 1 5 
xtr-miR-15a 8 13 9 6 2 
oan-miR-30d 2 0 8 19 8 
bta-miR-30a-5p 2 13 5 7 3 
mmu-miR-744 13 0 5 0 10 
oan-miR-30a 6 13 4 13 1 
hsa-miR-21 16 20 0 0 1 
rno-miR-350 0 18 0 0 0 
hsa-miR-26b 0 17 0 0 0 
mmu-miR-15b 0 12 0 0 5 
dme-miR-9c 0 0 0 14 1 
hsa-miR-28-3p 0 0 0 14 0 
hsa-miR-532-5p 0 0 0 20 0 
mmu-let-7i 0 0 0 14 0 
Table 4.7 New microRNAs obtained by re-sequencing the libraries  
Normalised read numbers for miRNAs that were obtained by re-sequencing the small 
RNA libraries are shown (LRI technical repeat sequencing run). 
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4.2.2.2  Piwi-interacting RNA characterisation  
To obtain profiles of piRNA expression and localisation in the small RNA libraries, 
trimmed reads of length 25-30 nt that perfectly matched a piRNA tag from RNAdb with 
at least 10 reads in one small RNA library were retained. 64 piRNA sequences passed 
this filter and are listed in Figure 4.13-4.16. Table 4.8 shows the five most frequently 
sequenced piRNAs in each small RNA library and the percentage of piRNA reads they 
represent. Strikingly, PIR32037 is the most abundant piRNA in all five small RNA 
libraries, and dominates the piRNA expression profile of the whole embryo libraries, 
comprising 71.6 % to 87.8 % of all the piRNA reads. Interestingly, the PIR32037 read 
percentage is lower (44.3 %) in the stage 10 vegetal pole library because read numbers 
of other piRNAs such as PIR75449, PIR72436, PIR75451 and PIR63462 are higher in 
the vegetal pole. This suggests that the vegetal pole has a more diverse piRNA 
population than the animal pole and whole embryo at stages 8 to 18.  
A dendrogram shows the sequence similarity when all piRNA tags passing filtering 
criteria are aligned and the four major branches shown (Figure 4.12) are analysed by 
heatmap expression profiling. In Branch 1 of the heat map (Figure 4.13), PIR32037 
stands out as the most abundant piRNA and is stably expressed from stages 8 to 18 and 
is not localised to the animal or vegetal pole at stage 10. Most piRNAs are relatively 
low read number (green on the colour scale) with the exception of PIR63462, PIR63461 
and PIR63463 which are all present at over 300 reads in more than one small RNA 
library.  
In Branch 2 of the piRNA heatmap (Figure 4.14), PIR31623 and PIR64428 are highly 
abundant and stably expressed, whereas PIR57010 increases 18-fold between stage 10 
and stage 18. PIR 5416 is 9.7-fold enriched in the vegetal pole compared to the animal 
pole at stage 10.  
PIR63554 is the most abundant piRNA in Branch 3 of the heatmap (Figure 4.15) and 
is vegetally enriched 7.7-fold compared to the animal pole at stage 10. PIR59215 
appears to be dynamically expressed with expression peaking at stage 10, whereas most 
piRNAs on this branch are stably expressed at read numbers of 10 or less. Interestingly, 
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PIR32354 is enriched 8.4-fold in the animal pole and PIR37983 is enriched 8-fold in the 
vegetal pole at stage 10.  
PIR75451, PIR75449 and PIR72436 are the most abundant piRNAs in Branch 4 
(Figure 4.16) and show strong vegetal pole enrichment with over 1000 reads in the 
vegetal pole library. PIR75451 and PIR64874 expression peaks at stage 10, whereas 
PIR75449, PIR75450, and PIR32103 peak at stage 18. Experimental validation of 
dynamic and spatial piRNA expression is detailed in section 4.2.4.3. 
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Small RNA 
library piRNA 
Normalised 
Read Number % of total piRNA reads 
PIR32037 9101 87.8 
PIR63461 323 3.1 
PIR63463 139 1.3 
PIR63462 105 1.0 
Stage 8 
PIR64428 104 1.0 
PIR32037 8396 83.4 
PIR63461 348 3.5 
PIR75451 159 1.6 
PIR63463 117 1.2 
Stage 10 
PIR64874 112 1.1 
PIR32037 7102 71.6 
PIR63462 359 3.6 
PIR32103 236 2.4 
PIR63463 235 2.4 
Stage 18 
PIR75200 139 1.4 
PIR32037 9579 74.8 
PIR63462 752 5.9 
PIR64428 520 4.1 
PIR63463 192 1.5 
Stage 10 animal 
PIR72436 163 1.3 
PIR32037 7198 44.3 
PIR75449 1536 9.5 
PIR72436 1362 8.4 
PIR75451 1263 7.8 
Stage 10 vegetal 
PIR63462 866 5.3 
Table 4.8 The most frequently sequenced piRNAs in early development 
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Figure 4.12 Dendrogram of piRNAs for heat map expression profiling 
piRNA tags in all five libraries passing a filter of 25-30 nt read length and zero 
mismatches to an RNAdb piRNA were aligned and grouped by sequence similarity to 
form a dendrogram with four major branches. There are 64 piRNAs in total.  
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Figure 4.13 piRNA heat map for dendrogram branch 1 showing dynamics and 
localisation of piRNA expression 
Heat maps were calculated using a colour key based on log base 10 of values of 
normalised read numbers. Green corresponds to low and red to high piRNA read 
numbers respectively. piRNA tags of length 25-30 nt match a piRNA sequence in 
RNAdb with no mismatches.  
Chapter 4. Genome-wide small RNA sequencing of the early Xenopus embryo  
 226 
 
Figure 4.14 piRNA heat map for dendrogram branch 2 showing dynamics and 
localisation of piRNA expression 
Heat maps were calculated using a colour key based on log base 10 of values of 
normalised read numbers. Green corresponds to low and red to high piRNA read 
numbers respectively.  
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Figure 4.15 piRNA heat map for dendrogram branch 3 showing dynamics and 
localisation of piRNA expression 
Heat maps were calculated using a colour key based on log base 10 of values of 
normalised read numbers. Green corresponds to low and red to high piRNA read 
numbers respectively.  
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Figure 4.16 piRNA heat map for dendrogram branch 4 showing dynamics and 
localisation of piRNA expression 
Heat maps were calculated using a colour key based on log base 10 of values of 
normalised read numbers. Green corresponds to low and red to high piRNA read 
numbers respectively.  
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4.2.3 MicroRNA and Piwi-interacting RNA expression show contrasting 
dynamics and localisation in the early embryo 
MicroRNA and piRNA tags that passed the read length and perfect match criteria 
were next analysed for their expression profiles from blastula stage (stage 8) to late 
neurula stage (stage 18) and in the animal and vegetal pole at the onset of gastrulation 
(stage 10) to investigate the dynamics and localisation of microRNA and piRNA 
expression in early X. tropicalis development.  
MicroRNA and piRNA read numbers at stage 8, stage 10 and stage 18 are shown 
relative to stage 8 in Figure 4.17. MicroRNAs increase in abundance 3.7-fold on 
average between stage 8 and stage 10 and 75-fold between stage 8 and stage 18. 
MicroRNA expression is therefore characterised by a dramatic increase at stage 18, 
although individual microRNAs in the dataset do decrease in abundance at stages 10 
and 18 (Figure 4.17). There are 13 microRNAs which increase over 100-fold between 
stage 8 and stage 18, including the most frequently sequenced stage 18 microRNAs, xtr-
miR-206 and cfa-miR-30e (Table 4.6). This agrees with the previous conclusion that a 
small number of highly abundant miRNAs dominate the stage 18 microRNA profile. In 
contrast, piRNA expression is less dynamic in early development, increasing 6.8-fold at 
stage 10 relative to stage 8 on average, and 15-fold at stage 18 relative to stage 10.  
MicroRNA and piRNA normalised read numbers in the animal and vegetal pole are 
shown in Figure 4.18. MicroRNAs are distributed towards the animal pole (Figure 
4.18A), indicating that in general, microRNAs are more abundant in the animal pole 
compared to the vegetal pole. piRNA localisation is more variable in the embryo, with 
no bias towards expression in either the animal or vegetal pole. This result is not 
skewed by the higher cell number in the animal compared to the vegetal pole, as the 
libraries are normalised to the total number of reads aligning to the genome (i.e. total 
number of small RNAs cloned) in each library, and contrasting results were obtained for 
microRNA and piRNA localisation.  
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Figure 4.17 MicroRNA and piRNA dynamics from the blastula to late neurula 
stages of X. tropicalis development  
A. Normalised read numbers for individual microRNAs at stages 10 and 18 are shown 
relative to stage 8 values for the stage 8, stage 10 and stage 18 libraries. Essentially, all 
stage 8 reads are set to a value of 1. The mean is indicated by a red line. Note that the 
axes are continuous, i.e., values greater than 1 and less than or equal to 100 are plotted 
on the middle section of the graph and the upper section contains values greater than 
100 and less than or equal to 8000. B. Piwi-interacting RNA read numbers are displayed 
as above.  
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Figure 4.18 Spatial distribution of microRNAs and piRNAs at gastrulation shows 
that microRNAs are more localised to the animal pole at stage 10.  
A. Normalised microRNA reads in the stage 10 animal and stage 10 vegetal libraries are 
plotted on a logarithmic scale with y = x superimposed to show the animal-vegetal 
distribution. B. Normalised piRNA reads are plotted as above.  
Chapter 4. Genome-wide small RNA sequencing of the early Xenopus embryo  
 232 
4.2.4 Experimental validation of small RNA-seq data 
4.2.4.1 Optimisation of small RNA detection   
In order to experimentally validate the expression profiles of small RNAs in the 
libraries, sensitive detection techniques were required. I optimised microRNA qPCR 
and small RNA Northern blot protocols. For detection of miRNAs by qPCR as shown 
in Figure 4.19A, total RNA is polyadenylated and reverse transcription is performed 
using the NVT-adapter primer that hybridises to the 5’ poly-adenosines (Shi and 
Chiang, 2005). The resulting cDNA is used as the template for miRNA qPCR 
amplification, with a forward primer identical to the mature miRNA sequence and a 
reverse primer in the adapter sequence. The predicted sizes of PCR products according 
to the miRNA-qPCR protocol for two X. tropicalis small RNAs, xtr-miR-427 and U6 
were 69 bp and 98 bp respectively. This was confirmed by native gel electrophoresis of 
the miRNA RT-PCR products (Figure 4.19B).  
MicroRNA qPCR profiles for two known Xenopus laevis microRNAs that are present 
in early development, xla-miR-427 and xla-miR-16c (Watanabe et al., 2005) were 
consistent with those previously described (Figure 4.20A), and the qPCR profile of xla-
miR-427 mirrored the expression shown by Northern blot in Figure 4.20B. Relative 
miRNA levels to ornithine decarboxylase (ODC) or the spliceosomal small RNA U6 
were calculated. ODC was selected because its expression levels are constant 
throughout Xenopus development (Paris et al., 1988). U6 was also chosen because it is 
uniformly expressed during Xenopus development (data not shown) and is an internal 
control for polyadenylation efficiency of small RNAs. There was no difference in 
results when normalisation to ODC or U6 was compared.  
Northern blotting with UV cross-linking such as that shown in Figure 4.20B requires 
large quantities of total RNA for effective detection of small RNAs (30 µg), which is 
impractical for large-scale validation of multiple small RNA species in X. tropicalis. An 
alternative chemical cross-linking method using 1-ethyl-3-3-dimethylaminopropyl 
carbodiimide, (EDC), a chemical that cross-links the 5’ phosphate of small RNAs to the 
nylon membrane (Pall and Hamilton, 2008) was compared to UV cross-linking. As 
shown in Figure 4.21, EDC cross-linking strongly increases the mature xla-miR-427 
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signal so that a signal can be detected with as little as 5 µg of RNA, but has no 
significant effect on the pre-miRNA signal.   
4.2.4.2 MicroRNA validation 
I used microRNA qPCR to confirm the existence of the sequenced microRNAs and 
validate their dynamic and spatial expression patterns. Only microRNAs with qPCR 
dissociation curves indicating a single PCR product were retained for analysis and 
miRNA forward primers were screened for cross-reactivity with other similar 
microRNAs. Experimental validation of dynamically expressed microRNAs selected 
from Figure 4.8-4.11 is presented in Figure 4.23 and 4.33. The small RNA seq read 
number profiles closely matched the qPCR profile at stages 8, 10 and 18 for the 
following miRNAs: cfa-miR-30e, xtr-miR-16c, xla-miR-427, xtr-miR-101a, xtr-miR-
182, xtr-miR-206 and xtr-miR-148a (Figure 4.22). The qPCR profiles for xtr-let-7c, xtr-
let-7f and xtr-miR-10a showed lower miRNA abundance at stage 10 than expected from 
the small RNA seq read profile (Figure 4.23). This is not due to a quality issue with the 
stage 10 small RNA library or qPCR input RNA, as strong miRNA expression at stage 
10 is validated by qPCR for xla-miR-427. The stage 8 miRNA level for xtr-miR-184 is 
lower than expected in the qPCR compared to the small RNA sequencing. In short, 7 
out of 11 microRNAs experimentally validate at all stages and there is a discrepancy 
between the small RNA seq and experimental validation at one stage for 4 out of 11 
miRNAs assessed. The validation rate for dynamic microRNAs is therefore 64 %.  
Next, spatially localised microRNAs were experimentally validated (Figure 4.24). 
xla-miR-427 was selected as a control microRNA that is abundant at similar levels in 
the animal and vegetal pole by small RNA sequencing. The microRNA qPCR for xla-
miR-427 was similar to the small RNA sequencing read profile. MicroRNAs with 
qPCR profiles where the animal and vegetal abundances validated the small RNA 
sequencing results included bta-miR-140, gga-miR-30a-5p and hsa-mir-1825. Animal 
and vegetal miRNA levels were within the error bars for miRNA qPCR on hsa-let7b 
and hsa-miR-423-5p targets, which could indicate equal or weakly localised miRNA 
levels in the animal or vegetal pole at stage 10. Opposite animal and vegetal miRNA 
levels compared to the small RNA sequencing were found for dme-miR-184 and xtr-
miR-148a by qPCR. In summary, 4/8 spatial miRNAs were successfully validated, a 
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spatial validation rate of 50 %. The experimental validation of the microRNA 
expression profiles could be less than 100 % due to bias in the PCR amplification of the 
small RNA cDNA libraries (see Figure 4.1), which reproducibly over-amplifies certain 
small RNA sequences (Linsen et al., 2009). 
I then investigated the spatial localisation of the most abundant microRNA 
sequenced, xtr-miR-206. Homologues of miR-206 in other vertebrate species play a role 
in myogenesis; for example miR-206 regulates skeletal muscle development in the 
mouse (Anderson et al., 2006), and is induced during muscle development in humans 
(Rao et al., 2006). Zebrafish miR-206 is expressed in muscle by WISH (Wienholds et 
al., 2005), therefore a muscle-specific expression pattern was also expected for xtr-miR-
206 in Xenopus. MicroRNAs can be detected by WISH with DIG end-labelled locked 
nucleic acid (LNA) probes (Kloosterman et al., 2006). Successful end-labelling of 
probes was confirmed by blotting for DIG as described in section 2.4.3.1. Figure 4.25 
shows that xtr-miR-206 is expressed in presomitic mesoderm at stage 18 in Xenopus 
tropicalis and in somites at stage 24 in Xenopus laevis. No specific expression pattern 
above background staining was observed by WISH for cfa-miR-30e, xtr-miR-130a, xtr-
miR-182 and xtr-miR-10b (data not shown). This could be because the protocol was not 
sufficiently optimised for sensitive microRNA detection, as only the most abundant 
microRNA (miR-206) was detected.  
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Figure 4.19 microRNA qPCR overview 
A. Schematic of miRNA detection by qPCR. Total RNA is polyadenylated and reverse 
transcribed with the NVT-adapter primer. qPCR is performed with the cDNA template, 
a forward primer identical in sequence to the microRNA (except Ts substituted for Us) 
and a reverse primer complementary the adapter sequence. B. Native gel electrophoresis 
of RT-PCR products for xtr-miR-427 and U6 at stages 8, 10 and 18 in X. tropicalis (32 
cycles). A 6 % native acrylamide gel was run and stained with ethidium bromide. 
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Figure 4.20 MicroRNA qPCR detection of the known Xenopus laevis microRNAs 
xla-miR-427 and xla-miR-16c  
A. Total RNA was extracted from whole X. laevis embryos at stages 8, 10 and 18 and 
prepared for miRNA qPCR as described in Figure 4.19. X. laevis miRNAs xla-miR-427 
and xla-miR-16c were detected by qPCR and relative RNA levels to Ornithine 
decarboxylase (ODC) were calculated. Error bars are standard deviations of triplicate 
repeats. B. Northern blot for xla-miR-427. 30 µg of X. laevis total RNA from whole 
embryos at stages 8, 10 and 18 was probed for xla-miR-427. An antisense probe to the 
mature miRNA also hybridises to the pre-miRNA. Sizes of molecular weight markers 
(nt) are indicated.  
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Figure 4.21 Chemical cross-linking improves sensitivity of small RNA detection by 
Northern Blot 
Northern blots for xla-miR-427 in Xenopus laevis at stage 10 were cross-linked by 
ultra-violet light or 1-ethyl-3-3-dimethylaminopropyl carbodiimide (EDC) chemical 
cross-linking. 30, 20, 10 and 5 µg of X. laevis total RNA was probed. Ethidium bromide 
staining of tRNA serves as a loading control. RNA sizes (nt) were determined by 
comparison to radiolabelled decade markers (Ambion). 
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Figure 4.22 Successful qPCR validation of dynamically expressed microRNAs 
MicroRNAs with qPCR profiles closely matching small RNA-seq data. See Figure 4.23 
for a full legend. 
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Figure 4.23 MicroRNA qPCR profiles of dynamic microRNAs with a mismatch in 
miRNA levels compared to small RNA-seq   
X. tropicalis total RNA from whole embryos at stages 8, 10 and 18 was prepared for 
qPCR as in Figure 4.19 and microRNAs exhibiting dynamic expression patterns by 
Illumina small RNA sequencing were detected by qPCR and relative RNA levels to 
ODC or U6 were calculated. Error bars are standard deviations from triplicate repeats. 
qPCR profiles (blue) were compared to the normalised microRNA read number 
(orange) obtained by small RNA sequencing in each library. Whereas the microRNA 
qPCR profiles shown in Figure 4.22 closely match the small RNA-seq read profiles, the 
qPCR profiles in this figure show lower microRNA levels at one stage than obtained in 
the small RNA-seq data. Note that in Figure 4.22, the xtr-miR-427 primer detects what 
is annotated as xla-miR-427 and xtr-miR-427 in miRbase. 
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Figure 4.24 miRNA qPCR validation of spatially localised miRNAs 
qPCR profiles of spatially localised miRNAs normalised to ODC or U6 (blue) were 
compared to the miRNA normalised read number obtained by small RNA sequencing 
(orange) in the stage 10 animal pole (A), stage 10 vegetal pole (V) and stage 10 whole 
embryo (st10) small RNA libraries. Error bars are standard deviations from triplicate 
repeats.  
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Figure 4.25 Xenopus miR-206 shows tissue-specific expression in muscle 
Stage 18 Xenopus tropicalis and stage 24 Xenopus laevis embryos (shown here in dorsal 
view) were subjected to WISH using an xtr-miR-206 antisense LNA probe which was 
end-labelled with DIG. Probe hybridisation was detected with an anti-DIG antibody 
followed by staining in BM Purple. The number of embryos out of the total analysed 
with the staining pattern shown is indicated.  
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4.2.4.3 Piwi-interacting RNA validation 
Experimental validation of piRNA expression by qPCR was only possible for the 
most abundant piRNA sequenced, PIR-32037. The small RNA read profile for PIR-
32037 was consistent with the qPCR profile (Figure 4.26). All other piRNA qPCR 
primers tested gave rise to non-specific detection when qPCR dissociation curves were 
inspected. This is probably due to inefficient polyadenylation of the 3’ end of piRNAs 
due to the presence of a methyl group on the 2’ hydroxyl group of ribose (Kirino and 
Mourelatos, 2007). Northern blot detection of piRNAs in X. tropicalis was used to 
validate dynamic and spatially localised piRNAs. PIR-75450 was selected for 
experimental validation due to its stage-specific expression at stage 18 in the small 
RNA sequencing. Northern blot analysis with an antisense probe for PIR-75450 
detected bands of approximately 30-32 and 70 nt (Figure 4.26). This could correspond 
to PIR-75450, which is 28 nt in the rat, and a biogenesis intermediate at 70 nt, as the 
mechanism of piRNA biogenesis is largely uncharacterised (Brennecke et al., 2007). By 
Northern blot, PIR-75450 is not expressed at stage 8 (fitting with zero reads in the small 
RNA seq at stage 8) and is weakly expressed at stage 10, increasing to a strong signal at 
stage 18. Overall, this expression profile fits with the small RNA seq results, except that 
low-level expression of PIR-75450 was not detected by small RNA seq at stage 10.  
PIR-63460 shows stage-specific expression at stages 8 and 18 by small RNA seq, 
whereas Northern blot analysis showed bands of approximately 30 and 70 nt at all 
stages (Figure 4.26). The expected size of PIR-63460 is 32 nt and fewer than 100 small 
RNA seq reads were obtained, which may account for the weak signal on the Northern 
blot. PIR-75449 and PIR-72436 were highly abundant and vegetally localised according 
to the small RNA seq data with over 1000 vegetal reads at stage 10. Northern blot 
analysis in Figure 4.27 ratified the vegetal localisation and detected both piRNAs at 
stage 10, despite the lack of reads at stage 10 in small RNA-seq.   
In short, the dynamic and spatial expression of the piRNA tags sequenced matched 
the experimental validation in terms of predicted abundance by small RNA seq, 
however the piRNA tags seemed to be slightly longer in X. tropicalis than the 
mammalian homologues used to annotate the piRNA tags. Importantly, the existence of 
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piRNAs later in development than the oocyte stage (see section 1.5.3) was 
experimentally confirmed. A 70 nt RNA species was detected in all piRNA Northern 
blots, which may be a biogenesis intermediate. 
 
Figure 4.26 Dynamic piRNA validation 
The number of normalised piRNA reads obtained by small RNA sequencing in X. 
tropicalis at stages 8, 10 and 18 (orange bars) is compared to qPCR (blue bars) or 
Northern blot expression at the same stages in X. tropicalis whole embryos for the 
piRNAs PIR 32037, PIR 75450 and PIR 63460. For the qPCR, piRNA levels were 
normalised to ODC and the error bars are standard deviations of triplicate repeats.  
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Figure 4.27 Spatial piRNA validation 
The number of normalised piRNA reads obtained by small RNA sequencing in X. 
tropicalis in the stage 10 whole embryo (st10), stage 10 animal (A) and stage 10 vegetal 
(V) libraries (orange bars) is compared to Northern blot expression in X. tropicalis for 
the piRNAs PIR 75449 and PIR 72436 which are vegetally localised in the small RNA 
seq libraries at stage 10. Sizes of small RNAs were determined by comparison to 
decade markers (Ambion). 
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4.3 Discussion 
4.3.1 Summary of results 
• Over 14 million small RNAs are present in the early Xenopus tropicalis embryo. 
• MicroRNAs are less than 1.6 % of the small RNAome in early development, 
and piRNAs are less than 0.9 %. 
• Over 95 % of the small RNAs in early development are as yet uncharacterised. 
• 169 microRNAs and 64 piRNAs were identified in X. tropicalis early 
development by stringent comparison to known databases, of which 56 
microRNAs were already known in Xenopus. A further 23 miRNAs were 
identified by re-sequencing the libraries, including 3 known Xenopus miRNAs. 
• MicroRNAs present at stage 8 and stage 10 by small RNA-seq were analysed 
for seed matches in the minimal 276-520 nt region of XCR1α 3’UTR 
responsible for spatial regulation (see Figure 3.27). 
• MicroRNAs increase in abundance and diversity between blastula and late 
neurula stages of X. tropicalis development and are more abundant in the animal 
than the vegetal pole at gastrulation.  
• Piwi-interacting RNAs are present in the developing embryo and with stable 
expression from blastula to gastrulation and no general trend for localisation to 
the animal or vegetal pole at gastrulation. 
• Specific microRNAs and piRNAs are dynamically and spatially localised in 
early development. 
• Thorough experimental validation, a technical sequencing repeat and stage 10 
small RNA library biological repeats confirm the quality of the small RNA 
sequencing dataset.  
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This study is the first to characterise the small RNAome of early X. tropicalis 
development, and one of the first studies comparing stages of early vertebrate 
development. Previously, very little was known about microRNA expression in early 
vertebrate development. Most Xenopus tropicalis microRNAs listed in miRbase had 
been identified in adult tissues (Tang and Maxwell, 2008) and 26 mature Xenopus laevis 
miRNA sequences were identified at stages from oocyte to tadpole (Watanabe et al., 
2005). The small RNA profile of the X. tropicalis oocyte and adult liver and skin tissues 
had been characterised by small RNA sequencing (Armisen et al., 2009). In total, I have 
identified 192 microRNAs (169 from the first CRI sequencing run and and additional 
23 from the technical repeat) that are present in at least one stage of blastula to late 
neurula development of X. tropicalis. Of these miRNAs, 133 were identified by 
comparison to microRNAs identified in other (non-Xenopus) species. This is strong 
evidence for conservation of microRNAs across species. In total, I sequenced 59 known 
Xenopus microRNAs in the early development small RNA libraries, out of a possible 
182 known Xenopus microRNAs listed in miRbase. Therefore about 32 % of the known 
Xenopus microRNAs are present in early development. This fits with the result that 
microRNA expression is highly dynamic between stages 10 and 18, with microRNA 
abundance and sequence diversity increasing dramatically with time in development. 
This agrees with a previous microarray study of microRNA expression in early 
zebrafish development that showed a general trend of increasing microRNA abundance 
with hours post-fertilisation (Wienholds et al., 2005). 
Moreover, microRNAs were less than 1.6 % of the small RNAome in early 
development. This fits with previous work comparing the microRNA profile of the X. 
tropicalis oocyte and adult tissues, where 34 and 114 known X. tropicalis microRNAs 
were sequenced at read numbers greater than 10 respectively (Armisen et al., 2009). 
Interestingly, xtr-miR-10b, xtr-miR-101 and xtr-miR-148a were the most frequently 
sequenced microRNAs in the oocyte, which correlates with their expression at stage 8 
in the small RNA libraries I sequenced (Figure 4.23). Notably, both xtr-miR-101a and 
xtr-miR-148a decrease at stage 10 compared to stage 8, and increase again at stage 18. 
This suggests that maternally abundant miRNAs do undergo some regulation at the 
mid-blastula transition when maternal RNAs are degraded with the onset of zygotic 
transcription.  
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MicroRNA expression increasing between stages 10 and 18 could be due to the 
increase in the number of tissues from three at gastrulation (endoderm, mesoderm and 
ectoderm) to the onset of multiple tissue specification at stage 18, for example neural 
crest and somites are specified post-gastrulation. MicroRNAs are thought to fine-tune 
gene expression; for example, muscle specific miRNAs including miR-206 are 
upregulated at the onset of skeletal muscle development in human cell lines by 
myogenic transcription factors Myogenin and MyoD (Rao et al., 2006). Tissue-specific 
expression of microRNAs has been documented at later developmental stages in X. 
tropicalis in organs such as the eye, and brain and in the nervous system (Walker and 
Harland, 2008).  
The five most frequently sequenced microRNAs at stage 18, xtr-miR-206, cfa-miR-
30e, mmu-miR-10b, rno-miR-10a-3p and xtr-miR-130b comprise 66 % of total 
microRNA reads. This suggests that the stage 18 microRNA profile is dominated by a 
small number of highly abundant microRNAs, and it would be exciting to further 
explore the functional role of these microRNAs later in development with loss of 
function studies. Moreover, I found that microRNAs were generally more abundant in 
the animal than the vegetal pole at stage 10 and validated the animally localised 
microRNAs bta-miR-140 and gga-miR-30a-5p. MicroRNAs may play a role in fine-
tuning the expression of genes expressed in the prospective ectoderm, such as genes 
involved in specification of tissues derived from ectoderm such as the epidermis and 
nervous system. This would explain why tissue-specific expression of microRNAs is 
often observed in the nervous system of X. tropicalis (Walker and Harland, 2008) and 
zebrafish (Kapsimali et al., 2007).  
Many microRNAs sequenced in this study matched to microRNA homologues in 
multiple species; for example, the mouse, X. tropicalis, human and horse homologues of 
miR-182 were all sequenced (see Figure 4.8). By definition, the sequences of these 
microRNA homologues are distinct, as they correspond to different tags. Their 
sequences are shown in Table 4.9. The presence of miR-182 homologues from multiple 
species in the X. tropicalis small RNA libraries could be due to several reasons. The 
miR-182 sequences differ by one nucleotide at the 5’ end (mmu-miR-182) or 2-3 
nucleotides at the 3’ end. This could be an artefact of trimming the raw reads to remove 
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adapter sequences in the case of shortening eca-miR-182 by one G base to give the hsa-
miR-182 sequence, or genuine editing of the end nucleotides of the mature miRNAs 
(Kawahara et al., 2007b; Seitz et al., 2008). Adenosine deaminase-dependent 
microRNA editing is more often observed in the primary miRNA transcript (Kim et al., 
2010) (Kawahara et al., 2007a) and is limited to conversion of adenosine to inosine, 
which base-pairs with cytosine instead of uracil. This means that this type of miRNA 
editing can only account for U to C alterations in miRNA sequence. However, 
microRNAs have been shown to display genuine sequence variability by addition or 
deletion of 1-2 nt at the 3’ end in Drosophila, C. elegans and mouse (Seitz et al., 2008). 
Therefore the similarity of the X. tropicalis, human and horse miR-182 sequences 
sequenced in X. tropicalis could be explained by inherent 3’ variability from 
Drosha/Dicer processing, which yields several microRNA tags that are identical in 
sequence to a miR-182 homologue from another species. Another possibility is the 
existence of a miR-182 microRNA family in X. tropicalis, which is plausible given that 
the mmu-miR-182 sequence cannot be formed by addition/deletion of 1 or 2 nucleotides 
from the X. tropicalis, human and horse sequences (see Table 4.9).   
MicroRNA 
homologue sequenced 
in X. tropicalis miRNA sequence 
mmu-miR-182 (mouse) 5’ UUGGCAAUGGUAGAACUCACACCG 
xtr-miR-182 (X. 
tropicalis) 5’ UUUGGCAAUGGUAGAACUCACA 
hsa-miR-182 (human) 5’ UUUGGCAAUGGUAGAACUCACACU 
eca-miR-182 (horse) 5’ UUUGGCAAUGGUAGAACUCACACUG 
Table 4.9 miR-182 homologues sequenced in X. tropicalis 
 
11 let-7 family microRNAs sharing the seed sequence 5’ GAGGUA were sequenced 
in the X. tropicalis small RNA libraries (Figure 4.11), including four known X. 
tropicalis let-7 miRNAs, human, Drosophila, bull, opossum and mouse let-7 
homologues. Their sequences are listed in Table 4.10 and show that single nucleotide 
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differences in the middle of the miRNA sequence and differences in the end nucleotides 
are present in a microRNA family.  
let-7 family microRNA 
homologue sequenced in 
X. tropicalis miRNA sequence 
xtr-let-7a (X. tropicalis) 5’ UGAGGUAGUAGGUUGUAUAGUU 
xtr-let-7c (X. tropicalis) 5’ UGAGGUAGUAGGUUGUAUGGUU 
xtr-let-7f (X. tropicalis) 5’ UGAGGUAGUAGAUUGUAUAGUU 
hsa-let-7b (human) 5’ UGAGGUAGUAGGUUGUGUGGUU 
hsa-let-7d (human) 5’ AGAGGUAGUAGGUUGCAUAGUU 
hsa-let-7e (human) 5’ UGAGGUAGGAGGUUGUAUAGUU 
hsa-let-7f (human) 5’ UGAGGUAGUAGAUUGUAUAGUU 
dme-let-7 (Drosophila) 5’ UGAGGUAGUAGGUUGUAUAGU 
bta-let-7e (bull) 5’ UGAGGUAGGAGGUUGUAUAGU 
mdo-let-7d (opossum) 5’ AGAGGUAGUAGGUUGCAUAGU 
mmu-let-7g (mouse) 5’ UGAGGUAGUAGUUUGUACAGUU 
Table 4.10 let-7 family microRNAs sequenced in X. tropicalis 
 
The biological roles of miRNAs in early Xenopus development have only been 
characterised for a handful of miRNAs. miR-427 modulates Nodal signalling by 
repressing the expression of Nodal ligands (Xnr 5 and Xnr6) and the Nodal inhibitor 
Lefty (Rosa et al., 2009) and I have shown that miR-427 negatively regulates XCR1 
expression in the animal cap, as discussed in section 3.3.2. Modulation of Nodal 
signalling at the receptor level by Xenopus miR-15 and miR-16 has also been 
documented (Martello et al., 2007). To determine whether any of the microRNAs I 
sequenced in X. tropicalis modulated Nodal signalling by targeting XCR1, I screened 
the list of microRNAs I sequenced at stages 8 and 10 for exact seed matches to the 
region of the XCR1α 3’UTR I had shown was responsible for spatial regulation (276-
520 nt). xtr-miR-107, cel-miR-44, dme-miR-279, gga-miR-1810, bta-miR-140 and hsa-
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miR-140-3p passed this criteria, however it is worth noting that one mismatch was 
allowed when comparing small RNA-seq reads to the miRbase miRNA sequence and so 
cel-miR-44, gga-miR-1810 and hsa-miR-140-3p are not listed in the heatmaps in 
Figures 4.8-4.11 which use a zero mismatch filter. Other biological roles of miRNAs in 
early Xenopus development involve clearance of maternal mRNA by miR-427 (Lund et 
al., 2009). X. tropicalis miR-206 probably functions in muscle development given its 
role in human muscle development (Rao et al., 2006), expression in somites in X. 
tropicalis and X. laevis (Figure 4.25) and identical mature sequence to human miR-206. 
As very few microRNAs have been assigned a function in early development, the 
function of the 133 microRNAs I sequenced that are new to Xenopus could be explored 
further by knockdown studies, as well as using the small RNA-seq data to investigate 
the mechanism of XCR1 spatial regulation.  
Previous studies of piwi-interacting RNAs have focussed on their role preserving 
genome integrity in the germline against transposon integration during germline 
development in Drosophila, zebrafish and C. elegans (Brennecke et al., 2007; Houwing 
et al., 2007; Ruby et al., 2006). In Xenopus, Piwi family proteins have been found in the 
oocyte, but not in somatic cells (Wilczynska et al., 2009). Similarly, piRNAs were 
exclusively expressed in X. tropicalis oocytes and not in adult tissues in a previous 
small RNA sequencing study (Armisen et al., 2009).  
In this small RNA sequencing study, I found 64 piRNAs in the developing X. 
tropicalis embryo. The lack of piRNAs in adult tissues in the previous X. tropicalis 
small RNA sequencing study may be due to relatively poor sequencing depth: 
approximately 6 million small RNA reads were obtained per library, in contrast to over 
14 million reads per library in my study. However, the piRNAs analysed by Armisen et 
al. had been more rigorously experimentally validated than in my work by confirming 
an interaction of the piRNA with PIWI and the presence of a 2’O-methyl modification 
at the 3’ end of the piRNA (Armisen et al., 2009). piRNAs have also been found in 
somatic tissues of C. elegans (21U-RNAs), Drosophila, mouse and the Rhesus macaque 
(Kato et al., 2009; Yan et al., 2011), which fits with my observation of piRNA 
sequences in X. tropicalis early development and suggests that piRNAs may be 
important outside of germline development. This will be discussed further in Chapter 6. 
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Previous small RNA-seq studies have focused largely on microRNA profiling of 
human disease, for example, leukemia development in a mouse model (Kuchenbauer et 
al., 2008), or comparing microRNA profiles of normal tissue and tumour samples 
(Farazi et al., 2011), comparing microRNA expression during tumour progression to 
identify biomarkers (Martens-Uzunova et al., 2011) and miRNA profiling of stem cells 
(Morin et al., 2008). MicroRNA profiling by small RNA-seq has been used for novel 
microRNA discovery in organisms ranging from unicellular algae to silkworms to the 
ancient vertebrate amphioxus (Chen et al., 2009; Liu et al., 2010; Molnar et al., 2007). 
However, the only other study of small RNAs in early vertebrate development apart 
from this thesis to date is in the chicken embryo (Glazov et al., 2008). Small RNA-
sequencing of days 5, 7 and 9 of chicken embryo development revealed a statistically 
significant increase in the expression of 7 miRNAs and a decrease in the expression of 
22 miRNAs, which the authors speculate could be due to a restriction in microRNA 
expression domains as development progresses, which is contrary to my observations 
and could be due to the relatively late time points in chicken development sequenced.  
Small RNA-seq analysis of stages in C. elegans development ranging from embryo to 
young adult showed that the proportion of microRNA reads was 33 % in the C. elegans 
embryo, increasing to 61 % the first larval stage (L1), 69 % in the fourth larval stage 
(L4) and was 65 % in the young adult worm (Kato et al., 2009). This agrees with my 
conclusion that microRNA expression increases with time in development (Table 4.4 
and Figure 4.17A). However, it is striking that a much larger proportion of the small 
RNA reads were identified as microRNAs in C. elegans, compared to less than 1.6 % of 
the early X. tropicalis embryo in my study. MicroRNA expression in C. elegans was 
also found to be dynamic: 16 % of the sequenced miRNAs changed in expression at 
least 10-fold between embryo and young adult stage. This agrees with the dynamic 
expression of miRNAs I observed in Figures 4.8 to 4.11. Interestingly, C. elegans 
piRNAs, known as 21U-RNAs, increased from 0.7 % of reads in the third larval stage 
(L3) to a maximum of 6.8 % of small RNA reads in the young adult stage (Kato et al., 
2009). This suggests that piRNAs are more abundant and dynamic in C. elegans 
development compared to early X. tropicalis development where piRNAs are less than 
0.9 % of small RNA reads, and supports the conclusion from my work and other studies 
that piRNAs are present in somatic tissues. 
Chapter 4. Genome-wide small RNA sequencing of the early Xenopus embryo  
 252 
Although I sequenced many dynamic and spatially localised X. tropicalis microRNAs 
and piRNAs in this study, microRNAs were less than 1.6 % and piRNAs less than 0.9 
% of the small RNA reads sequenced. In total, less than 5 % of reads were annotated by 
comparison to known databases.  The remaining 95 % of unannotated reads align to the 
genome and are genuine small RNAs rather than mRNA degradation products, as 
mRNA degradation products lack the necessary 5’ phosphate and 3’ hydroxyl groups 
required for small RNA library construction (Hafner et al., 2008). This raises the 
exciting possibility that these unannotated reads may represent a new class of small 
RNAs that mediate a novel mode of gene regulation. The annotation and function of the 
unknown reads will be explored in Chapter 5.  
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5.1 Introduction 
The aim of the work presented in this chapter was to characterise the 95 % to 98 % of 
the X. tropicalis small RNAome that could not be annotated by comparison to databases 
of known small RNAs, but aligns perfectly to the genome. These uncharacterised small 
RNAs potentially represent novel regulatory small RNAs. Firstly, the unannotated reads 
are fed into a novel microRNA prediction pipeline to yield candidate microRNAs. One 
candidate microRNA, provisionally named miR-F, is characterised in detail. Secondly, I 
analyse the results of a genome-wide annotation of the small RNAs based on where 
they align in the genome and proximity to other small RNAs in clusters. A possible 
regulatory role for an exciting class of novel small RNAs that cluster in introns is 
discussed.  
5.2 Results 
5.2.1 Novel microRNA discovery 
In order to reveal novel microRNAs within the unannotated small RNAs, I designed a 
de novo microRNA prediction pipeline, which was constructed and operated by Stuart 
Horswell in the Cancer Research UK Bioinformatics and Biostatistics group. All 
unannotated tags from all five small RNA libraries of read number greater than 10 reads 
and a length of between 22 and 23 nt were selected for novel microRNA analysis. This 
eliminated noise from low abundance tags and reads outside the size range for miRNA. 
The reads were aligned to the X. tropicalis genome with up to two mismatches 
permitted and contigs of overlapping reads (tag-contigs) were assembled (Figure 5.1) 
(Jung et al., 2010). Bases are assigned a weighted depth by calculating the number of 
overlapping reads per base. The genomic sequence of tag-contigs with a contiguous 
depth greater than 1 and length greater than 22 nt was retained and all other sequences 
were discarded. The genomic sequence of the tag-contig was extended by 10 
nucleotides 5’ and 60 nucleotides 3’ or vice versa to form a candidate miRNA precursor 
sequence (pre-miRNA). The putative pre-miRNA sequence was folded into a secondary 
structure by minimising the free energy of folding using Mfold (Zuker, 2003). Resulting 
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secondary structures were screened against the criteria for miRNA precursors, such as a 
hairpin secondary structure without large bulges, the mature miRNA sequence 
contained within one arm of the hairpin and at least 16 bp of the mature miRNA 
sequence base pairing with the candidate microRNA-star sequence (Ambros et al., 
2003a). Six candidate microRNAs passed these criteria provisionally named miR-A, B, 
C, D, E and F (Figure 5.2). 
 I then attempted to experimentally confirm the expression of the novel candidate 
microRNAs at stages 8, 10 and 18 in X. tropicalis development by miRNA-qPCR. miR-
A, miR-C and miR-F were experimentally validated (Figure 5.3). However, non-
specific amplification was observed for miR-B, miR-D and miR-E as multiple non-
symmetrical peaks were observed in the qPCR dissociation curves. This is a successful 
prediction rate for the novel microRNA prediction pipeline of 50 %. Interestingly, miR-
F was predicted to exist in the stage 18 library and this was experimentally ratified by 
qPCR. miR-A and miR-C were predicted to exist in the stage 8 and stage 10 animal 
libraries respectively, but were found to be expressed at stage 8, 10 and 18 by qPCR. 
Sequences and genomic locations for experimentally validated miRNAs are presented 
in Table 5.1. MicroRNAs are officially named according to sequence homology with 
other miRNAs by the miRbase miRNA naming service only after a manuscript is 
accepted for publication; hence provisional miRNA names are used throughout this 
chapter. In short, three completely novel microRNAs in early X. tropicalis development 
were confidently identified from the unannotated reads obtained in small RNA 
sequencing; xtr-miR-A, xtr-miR-C and xtr-miR-F. 
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Figure 5.1 Tag-contig assembly from overlapping small RNA reads 
Tags with read numbers greater than 10 and length of 22-23 nt were aligned to the 
genome with 2 mismatches from all five small RNA libraries. Overlapping small RNA 
reads form tag-contigs. Bases in the tag-contig are assigned a weighted depth by 
calculating the number of overlapping reads per base. Only tag-contigs of a maximum 
depth greater than 1 and length greater than 22 bases were retained for the next step of 
novel microRNA prediction. 
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Figure 5.2 Six candidate miRNAs passed hairpin folding criteria 
The genomic sequence of tag-contigs was extracted, extended and folded into secondary 
structures based on minimising the free energy of folding using Mfold. Six candidate 
microRNAs formed secondary structures obeying the rules for potential microRNA 
precursors (pre-miRNAs), provisionally named miR-A-F. Note that miR-E and miR-F 
are predicted to be a miRNA* and mature miRNA pair respectively. A yellow line 
indicates mature miRNA sequences within the hairpin precursor. 
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Figure 5.3 Experimental validation of novel microRNAs 
X. tropicalis total RNA from whole embryos at stages 8, 10 and 18 was prepared for 
qPCR as in Figure 4.8 and the candidate novel microRNAs xtr-miR-A, xtr-miR-C and 
xtr-miR-F were detectable as a single PCR product by qPCR and relative RNA levels to 
ODC were calculated. Error bars are standard deviations from triplicate repeats. xtr-
miR-B, xtr-miR-C and xtr-miR-E were not detectable by qPCR.  
 
 
Provisional 
miRNA 
name Sequence of mature miRNA 
Genomic 
location 
Small RNA 
library 
predicted in 
xtr-miR-A 5’agcaaatctgttggtttgtacaaac 3’ scaffold 1337 stage 8 
xtr-miR-C 5’tgcgctcggtggatagaagacgtga 3’ scaffold 212 stage 10 animal 
xtr-miR-F 5’gagaaagtgcttctcgttcggctga 3’ scaffold 1310 stage 18 
Table 5.1 Experimentally validated novel microRNAs  
The sequences of the mature novel microRNAs that were confidently identified are 
shown with their approximate genomic locations and the small RNA library that they 
were predicted to exist in for comparison with the experimentally determined 
expression in Figure 5.3.  
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5.2.2 Novel microRNA function and conservation 
xtr-miR-F was also experimentally validated in X. tropicalis by Northern blot (Figure 
5.4), whereas no signal was detectable for xtr-miR-A and xtr-miR-C, possibly due to 
their low abundance. xtr-miR-F was therefore studied in more detail. Mature xtr-miR-F 
is expressed in X. tropicalis from stage 18 to stage 40 (Figure 5.4), however the 
precursor miRNA (pre-xtr-miR-F) is present at stages 8 and 10, which indicates that the 
processing of mature miR-F is developmentally regulated. xtr-miR-F is also conserved 
in Xenopus laevis, as both pre-miRNA and mature miRNA bands are present when total 
X. laevis RNA was probed with an antisense probe to the xtr-miR-F sequence (Figure 
5.5A). The expression profile of xla-miR-F was very similar to that of xtr-miR-F, with 
mature miRNA expression beginning at stage 18 and persisting until tadpole stage. The 
onset of mature xla-miR-F expression was refined by probing X. laevis RNA from 
stages 10 through to 20 for xla-miR-F. Mature xla-miR-F is processed out from the 
hairpin precursor at stage 12, the beginning of neurulation, and reaches maximal levels 
at stage 15 (Figure 5.5B). This stage-specific expression suggests that miR-F may play 
a role in regulation of gene expression during neurulation, as mature miR-F levels 
decline post stage 18 in X. tropicalis and after stage 26 in X. laevis.  
In order to assess whether miR-F was dependent on the microRNA-processing 
enzyme Dicer for its expression, Dicer was knocked down by morpholino injection in 
X. tropicalis and in X. laevis. Knockdown of Dicer would be expected to decrease the 
level of Dicer-dependent mature miRNAs and increase the pre-miRNA levels. Figure 
5.6A shows that a splice-blocking morpholino designed to inhibit splicing out of intron 
1 from between exons 1 and 2 of X. tropicalis Dicer mRNA is effective at stage 18. 
Insertion of intron 1 introduces a premature stop codon in the mRNA sequence to 
produce a functionally inactive truncated protein. When xtr-miR-F levels are assessed in 
a dicer morphant background, there is a modest decrease in mature miR-F levels and 
increase in pre-miR-F (Figure 5.6B). When the ratio of pre-miRNA to mature miRNA 
is quantified, there is a 10.2 % increase in the pre-miRNA: mature miRNA ratio when 
Dicer morpholino is injected compared to control morpholino. Intriguingly, when the 
expression profile of Dicer mRNA in X. tropicalis development is assessed by qPCR, 
developmental regulation of Dicer expression is observed. Dicer mRNA increases 
dramatically from stage 10 to stage 18, in a similar manner to global microRNA 
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expression (Figure 4.6A). Previously, Dicer mRNA expression had been assessed by 
EST profiles from cDNA libraries (Bowes et al., 2010). According to this approximate 
gene expression profile of Dicer, mRNA is present from the neurula to adult stages but 
had not been identified in ESTs from libraries at egg or gastrula stage.  
A translation blocking X. laevis Dicer morpholino was shown to be highly effective in 
Figure 3.21A. A small decrease in mature xla-miR-F expression at stage 38 was 
observed in X. laevis dicer morphant embryos compared to control embryos (Figure 
5.7A). Dicer-dependency of xla-miR-427 was also analysed by Northern blot (Figure 
5.7B). A decrease in mature xla-miR-427 was observed in Dicer morphants at stages 26 
and 36 when no pre-miRNA is detectable. This suggests that Dicer knockdown may 
only affect mature miRNA levels at later stages, perhaps because some mature miRNAs 
are relatively stable; for example miR-223 in mammalian cells decays slowly over days 
when its biogenesis is terminated (Baccarini et al., 2011). In short, miR-F appears to be 
partially Dicer-dependent, as a modest increase in pre-miRNA and a reduction in 
mature xtr-miR-F is observed in X. tropicalis Dicer morphants at stage 18, and xla-miR-
F expression is decreased at later stages in X. laevis Dicer morphants. It is also possible 
that miR-F could be processed by another enzyme (see section 5.3 for further 
discussion).  
To explore the functional role of xtr-miR-F and xla-miR-F, I knocked down miR-F in 
both frog species using the same morpholino. Morpholino inhibition of xtr-miR-F in X. 
tropicalis led to defective axis elongation and posterior development (7/22 embryos), 
however this phenotype was not fully penetrant as 8/22 embryos were relatively normal 
albeit slightly delayed in development compared to control embryos (Figure 5.8). A 
small proportion of embryos were normal but curved (2/22 embryos, data not shown) 
and 5/22 embryos died between stage 18 and stage 38. Inhibition of xla-miR-F in 
Xenopus laevis led to a less penetrant axial/posterior development phenotype (2/44 
embryos). Morphant embryos also displayed reduced eye size and fewer melanocytes 
(10/44 embryos). Neither of these phenotypes was fully penetrant, hence 29/44 
morphant embryos were normal compared to control morpholino-injected embryos. In 
summary, miR-F leads to defective axial and posterior development to some extent in 
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both frog species, with an additional role in eye development and pigmentation in 
Xenopus laevis.  
Since miR-F was conserved between frog species, I explored whether miR-F was also 
conserved in mammalian species. miR-F was found to be present in human keratinocyte 
cells (HaCats (Boukamp et al., 1988)), human lymphoblastoid cells (Levy et al., 1968), 
human breast carcinoma cells (MDA-MB-231 (Cailleau et al., 1974)) and human 
embryonic kidney cells (293Ts (Graham et al., 1977)) when these cell lines were tested 
for miR-F expression by qPCR (Figure 5.10). Excitingly, miR-F levels were higher in 
the normal cell line models (HaCat and lymphoblastoids) compared to the breast cancer 
cell line MDA-MB-231 and 293T cells which are transformed, which raises the 
possibility of human miR-F downregulation in cancer and a role as a tumour suppressor.  
5.2.3 Novel microRNA target prediction 
I initiated an unbiased approach to find miR-F target genes by preparing total RNA 
from control and xtr-miR-F morpholino-injected stage 18 X. tropicalis embryos for 
transcriptome profiling by genome-wide mRNA sequencing. Since microRNAs are 
thought to lead to degradation of their target mRNAs (Baek et al., 2008), miR-F target 
genes would be expected to be upregulated in stage 18 xtr-miR-F morphant embryos. A 
similar approach to find the targets of the let-7 microRNA in C. elegans was successful 
using a similar approach: let-7 was overexpressed and microarray analysis revealed 
downregulated candidate target genes (Johnson et al., 2007). Unfortunately, the 
coverage of the genome was very poor for the miR-F knockdown library. Of over 23 
million raw mRNA-seq reads, only 0.88 % aligned to the X. tropicalis genome with 
zero mismatches. The quality of the mRNA seq data was too low to merit analysis and 
the mRNA libraries needing remaking in this case. However, the observation that miR-
F is conserved in mammalian cells means that knockdown of miR-F and mRNA-seq 
can be performed in cell culture, thereby avoiding the possible indirect effects of 
miRNA knockdown caused by multiple tissue interactions in the embryo. Another 
approach could be to look for exact miR-F seed matches in the 3’UTRs of X. tropicalis 
or human genes; however, this is likely to yield an unworkably high number of 
candidate target genes.
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Figure 5.4 xtr-miR-F is expressed from late neurula stage onwards in X. tropicalis 
Total RNA from uninjected X. tropicalis embryos from stage 8 to 40 was extracted and 
probed for xtr-miR-F with an antisense LNA probe. RNA sizes (nt) were determined by 
comparison to radiolabelled decade markers (Ambion).  
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Figure 5.5 miR-F is conserved in X. laevis and expressed from the onset of 
neurulation 
A. Northern blot analysis of total RNA from uninjected X. laevis embryos at stages 8 to 
40 probed for xla-miR-F using an antisense LNA probe. RNA sizes (nt) were 
determined by comparison to radiolabelled decade markers (Ambion). B. Northern blot 
analysis of total RNA from uninjected X. laevis embryos at stages 10 to 20. An 
antisense DNA oligo was used to probe for xla-miR-F and sizes of small RNAs were 
determined by comparison to decade markers as in A.  
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Figure 5.6 xtr-miR-F Dicer-dependency at stage 18 in X. tropicalis 
A. Total RNA from stage 8, stage 10 and stage 18 X. tropicalis embryos either 
uninjected or injected with 15 ng of a splice-blocking morpholino targeting Dicer (Mo 
Dicer) was prepared for qPCR. The splice-blocking morpholino is designed to inhibit 
splicing out of intron 1 from between exons 1 and 2, which will introduce a premature 
stop codon in Dicer mRNA. Primers complementary to exon 1 and intron 1 of X. 
tropicalis Dicer were used in qPCR amplification. Relative RNA levels to ODC are 
shown and error bars are standard deviations of triplicate repeats. B. Northern blot 
analysis of total RNA prepared from stage 18 X. tropicalis embryos injected with 15 ng 
of control morpholino (MoC) or Dicer morpholino (Mo Dicer) for xtr-miR-F. Ethidium 
bromide staining of tRNA serves as a loading control. Pre-miRNA: mature miRNA 
ratios were quantified in ImageJ. Sizes of small RNAs were determined by comparison 
to decade markers (Ambion). C. Total RNA from uninjected X. tropicalis embryos was 
prepared for qPCR. Primers complementary to exon 2 and exon 3 of X. tropicalis Dicer 
were used in qPCR amplification.  
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Figure 5.7 Dicer-dependency of xla-miR-F and xla-miR-427 in X. laevis 
A. Total RNA was prepared from X. laevis embryos injected with 20 ng of control 
morpholino (MoC) or translation-blocking Dicer morpholino (MoDicer) at stages 8 to 
38. Northern blot analysis for xla-miR-F using an antisense DNA probe was performed. 
Ethidium bromide staining of tRNA serves as a loading control. Sizes of small RNAs 
were determined by comparison to decade markers (Ambion). B. Total RNA was 
prepared from X. laevis embryos injected with 20 ng of control morpholino (MoC) or 
translation-blocking Dicer morpholino (MoDicer) at stages 8 to 36. Northern blot 
analysis for xla-miR-427 was performed. Ethidium bromide staining of rRNA serves as 
a loading control.
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Figure 5.8 Phenotype of xtr-miR-F knockdown in X. tropicalis 
X. tropicalis embryos were either uninjected or injected with 15 ng of morpholino 
against xtr-miR-F (Mo xtr-miR-F) and analysed for phenotypic differences at stage 38. 
The number of embryos with the phenotype presented out of the total analysed is 
indicated.  
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Figure 5.9 Phenotype of xla-miR-F knockdown in X. laevis 
X. laevis embryos were injected with 15 ng of control morpholino (MoC) or morpholino 
against xla-miR-F (Mo xla-miR-F) and analysed for phenotypic differences at stage 38. 
The number of embryos with the phenotype presented out of the total analysed is 
indicated. White arrowheads indicate reduced eye size in xla-miR-F morphant embryos.  
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Figure 5.10 miR-F is conserved in human cell lines and down-regulated in a cancer 
cell line 
Total RNA was prepared for miRNA qPCR from the indicated human cell lines. miR-F 
was amplified and relative RNA levels to GAPDH were calculated. Error bars are 
standard deviations of triplicate repeats.  
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5.2.4 Characterisation of unannotated reads 
As well as being fed into the novel microRNA prediction pipeline, the unannotated 
reads that comprise 95 % to 98 % of the X. tropicalis early development small RNAome 
were characterised by a genome-wide annotation of where they align in the genome and 
their proximity to other small RNAs. For example, unannotated small RNAs could align 
to a cluster of small RNAs in the genome or be isolated from other small RNAs in the 
genome. The annotation parameters are defined in the following sections.  
5.2.4.1 Definition of Unique, Multi and Intermediate tags 
Due to the high multiplicity observed within the small RNA libraries (Table 4.2), 
unannotated reads were compressed into tags and classified depending on the number of 
loci in the genome the tag aligned to. All tags aligned to the genome with zero 
mismatches and were represented by at least 10 identical reads to eliminate noise. 
Unique tags aligned to a single locus in the genome. Multi tags aligned to ten or more 
different loci in the genome. Intermediate tags aligned to between two and nine loci in 
the genome. As shown in Table 5.2, approximately 42 % of tags in all small RNA 
libraries were classed as unique tags, 25 % were multi tags and 33 % were intermediate 
tags.  
Small RNA library % Unique tags % Multi tags % Intermediate tags 
Stage 8 42.9 24.0 33.2 
Stage 10 42.1 25.0 33.0 
Stage 18 42.7 24.5 32.8 
Stage 10 animal 41.0 25.9 33.1 
Stage 10 vegetal 43.1 24.5 32.4 
Table 5.2 Percentage of tags that are classed as unique, intermediate or multi tags 
5.2.4.2 Definition of Low, High and Mixed blocks 
The regions of the genome where tags aligned were defined as blocks depending upon 
the type of tag aligning and how close the aligned tags were to each other (Figure 5.11) 
(Armisen et al., 2009). Low blocks are a contigous region of the genome containing at 
least two unique tags that are no more than 200 bases apart, but can contain other tags. 
High blocks contain at least two multi tags that are no more than 200 bases apart, but 
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can contain other tags. Mixed blocks contain at least two tags of any type (unique, multi 
or intermediate) that are less than 200 bases apart. Isolated tags are tags of any type that 
do not fall into a block. It is worth noting that all high and low blocks will be contained 
within a mixed block. Mixed blocks are therefore analysed separately to avoid double 
counting of tags.  
Figure 5.12 shows the results of genome-wide small RNA block analysis for tags 
falling into high, low and mixed blocks or isolated tags. Firstly, very few tags did not 
fall into any block, as isolated tags were less than 0.08 % of tags in high/low block and 
mixed block annotations. Isolated tags in the high/low block annotation were 
exclusively unique tags, as no multi tags fell outside blocks. In other words, very few 
tags were more than 200 nucleotides from another tag in the genome, and those that 
were corresponded to small RNAs that only align to one place in the genome (unique 
tags). Secondly, the percentage of high and low block tags was consistent across the 
five small RNA libraries. Between 35-37 % of small RNA tags fell into high blocks and 
between 59-63 % of small RNA tags fell into low blocks. 
 In the mixed block annotation, intermediate tags are counted in addition to unique 
and multi tags. The definition of a mixed block is much less stringent than a high or low 
block, as two tags of any type (multi/unique/intermediate) must be within 200 
nucleotides of each other. Mixed blocks therefore overlap some low and high blocks 
(for example the mixed block in Figure 5.11) and all high and low blocks are contained 
within a mixed block, therefore mixed block annotation is presented separately in 
Figure 5.12. Approximately 98 % of tags fall into mixed blocks in all five small RNA 
libraries.  
To fully annotate the unknown 95-98 % of the X. tropicalis early development 
RNAome according to the small RNA block criteria, small RNA tags counted in Figure 
5.12 were expanded back into reads and the percentage of reads in each library falling 
into high, low and mixed blocks was calculated (Figure 5.13). When tags are expanded 
back into reads, the small RNA block profile is similar in all the libraries and more 
reads fall into high blocks (56-60 %) than low blocks (35-39 %). This is in contrast to 
tags, which fell into low blocks more than high blocks (Figure 5.12). This suggests that 
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multi tags correspond to high numbers of reads as well as aligning to multiple sites in 
the genome. 
When the length distribution of tags falling into low, high, or mixed blocks and 
isolated tags in each library is analysed (Figure 5.14), similar length distributions for 
tags are observed in all five small RNA libraries. A 28 nt length peak is seen in all 
libraries for tags falling into low, high and mixed blocks.  
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Figure 5.11 Genome-wide small RNA block annotation 
Schematic of small RNA block annotation. Multi, unique and intermediate tags align to 
the X. tropicalis genome (plus and minus strand indicated). The minimum criteria for a 
low or high block are two unique or two multi tags less than 200 nt apart respectively. A 
minimal high block is shown, containing two multi tags 200 nucleotides apart.  
Although the length of the low or high block is determined by the distance between the 
unique or multi tags, other types of tag may be contained in the blocks. For example, a 
low block defined by two low tags but also containing a multi tag and an intermediate 
tag is shown. A mixed block contains two tags of any type that are less than 200 nt 
apart. For example, a mixed block spans the high and low blocks illustrated as the gap 
between the high block and the low block is less than 200 nt.  
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Figure 5.12 Small RNA block annotation of tags 
All tags were aligned to the genome and low, high and mixed blocks of tags were 
defined depending on the type of tag contained within the block (Figure 5.11). Isolated 
tags did not fall into any block and were less than 0.08 % of tags, hence are not visible 
on the pie charts. Only multi or unique tags falling into a high or low block, isolated 
tags and the known small RNA tags identified in Chapter 4 are counted in the high/low 
block annotation. For the mixed block annotation, all tags that align to the genome and 
fall into a mixed block, are isolated, or correspond to known small RNA tags are 
counted. The percentage of annotated tags in each small RNA library is shown.  
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Figure 5.13 Small RNA block annotation of reads 
Small RNA block annotation was performed as in Figure 5.12 with all tags expanded 
back into read numbers. The percentage of annotated reads in each small RNA library is 
shown. Again, isolated reads are not visible as they were less than 0.09 % of reads. 
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Figure 5.14 Length distributions of tags in small RNA blocks  
The length and abundance of small RNA tags that are annotated as falling into a mixed 
block, high block, low block or as isolated tags is plotted for each small RNA library.  
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5.2.5 Multi-tags align to introns 
The genome-wide small RNA block annotation of the previously unknown small 
RNA reads characterises the abundance, length, multiplicity and clustering of the 
unknown reads. Next, I investigated the extent to which the previously unannotated 
small RNAs align to genes to explore a possible role of the unknown small RNAs in 
gene regulation.  
Firstly, the unannotated tags were analysed for whether or not they aligned to the 
coding region of a gene as defined by the RefSeq annotation database (Pruitt et al., 
2009) (Figure 5.15). Approximately 46 % of tags aligned to a RefSeq coding region 
(CDS) that includes 5’ and 3’ UTRs, exons and introns, whereas the remaining 54 % of 
tags aligned to intergenic regions in all five small RNA libraries. When the tags 
aligning to coding regions were classified as multi, unique or intermediate according to 
the definitions in Section 5.2.4.1, it was clear that intermediate and multi tags align to 
genes more often than unique tags. Intermediate and multi tags aligning to a CDS were 
about 26 % and 17 % of the unannotated tags, whereas unique tags aligning to a CDS 
were approximately 3 % of unannotated tags across the small RNA libraries.  
Next, tags were analysed for their alignment to introns and exons (Table 5.3). 
Strikingly, the unannotated tags were found to align much more often to introns than 
exons, and multi and intermediate tags showed a strong bias towards intron alignment. 
Multi tags were enriched in introns by at least 40-fold (animal library) compared to 
exons, and intermediate tags were enriched in introns by at least 20-fold (vegetal 
library) compared to exons. Both sense and antisense alignments to introns and exons 
were permitted. 51 % of multi tags aligned to introns in the sense orientation and 49 % 
in the antisense orientation. 54 % of intermediate tags aligned in the sense orientation 
and 46 % in the antisense orientation. This result is exciting because it suggests that the 
unannotated small RNAs cluster in introns, and may therefore be a new class of 
regulatory small RNAs. Since the small RNAs align in both the sense and antisense 
orientations in similar proportions and are intermediate and multi tags, this is a strong 
argument that they are not simply cellular mRNA degradation products, as these would 
by definition be unique tags that align in the sense orientation.  
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Figure 5.16 shows previously unannotated small RNAs clustering in the introns of 
trim37, a predicted E3 ubiquitin ligase in X. tropicalis (Bowes et al., 2010) in the 
Integrative Genomics Viewer (IGV) (Robinson et al., 2011). Two large clusters and 
several minor small RNA clusters align to introns in both the sense and antisense 
orientations. Strikingly, the clusters are entirely reproducible in all five small RNA 
libraries and none of the small RNAs align to exons. Further examples of X. tropicalis 
genes with intronic small RNA clusters are illustrated in Figure 5.17. Multiple introns 
are hit by a small RNA cluster in many of the genes analysed. Figure 5.18 shows an 
example of an intergenic small RNA cluster upstream of the top2A gene, which also 
contains intronic small RNA clusters. Intergenic small RNA clusters upstream of genic 
regions were observed for multiple genes, including igfbp4 and stat1.  
 
Figure 5.15 Unannotated tags align to coding regions of genes and intergenic 
regions 
All unannotated tags that aligned to the genome with zero mismatches were analysed 
for alignment to a RefSeq coding region sequence (CDS), which includes 5’ and 
3’UTRs, exons and introns. Tags that aligned to a CDS were annotated as unique, 
intermediate or multi tags according to the definitions in Section 5.2.4.2. Tags that did 
not align to a CDS were classed as intergenic. Tags were allowed to align to a CDS in 
both the sense and antisense orientations.  
For example, if a tag aligned to 10 loci in the genome (a multi tag), and one of those 
loci was in a CDS, then the tag would be counted as a CDS multi tag. If a tag only 
aligned to loci in intergenic regions, then it was counted as an intergenic tag.  
Chapter 5. Analysis of unannotated small RNAs 
 277 
 
 
Small 
RNA 
library 
% 
Multi 
exon 
tags 
%    
Multi 
intron 
tags 
% 
Unique 
exon 
tags 
%          
Unique 
intron tags 
% 
Intermediate 
exon tags 
% 
Intermediate 
intron tags 
Stage 8 0.73 32.2 0.67 3.66 1.54 45.3 
Stage 10 0.82 33.2 0.77 3.60 1.74 46.4 
Stage 18 0.84 33.1 0.86 3.91 1.85 46.5 
Animal 0.86 34.6 0.78 3.43 1.80 47.4 
Vegetal 0.80 32.7 1.27 3.68 2.25 45.4 
Table 5.3 Percentage of unannotated tags that align to exons and introns  
The number of multi, unique and intermediate tag hits aligning to exons and introns is 
displayed as a percentage of the total number of unannotated tags. Both sense and 
antisense tag alignments to exons and introns are permitted. Note that these categories 
are not mutually exclusive as one tag can align to an exon and an intron at different loci 
and contribute to the percentage for both categories. Exons are defined by RefSeq, and 
introns are defined as sequences between two flanking RefSeq exons.  
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Figure 5.16 Small RNA intron clusters in trim37 
Unannotated small RNA tags in the stage 8, stage 10, stage 18, stage 10 animal and 
stage 10 vegetal libraries are displayed aligning to the X. tropicalis genome in the 
Integrative Genomics Viewer (IGV). The gene trim37 is used as an example of a gene 
where the unannotated small RNAs cluster in introns. Tags are coloured red for sense 
alignments and blue for antisense alignments. The entire trim37 gene is displayed with 
exons as blue boxes (highlighted with arrowheads) and introns as blue lines. The 
orientation of the gene is indicated by the arrows on the introns. A 10 kb scale bar is 
shown. A zoomed in picture of tags in part of a small RNA intron cluster is shown at a 
sequence level view.
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Figure 5.17 Examples of small RNA intron clusters 
Small RNA intron clusters in the selected genes are displayed in the IGV browser as in 
Figure 5.16. A partial or complete gene sequence is displayed for clarity. Only the stage 
10 vegetal library track for each gene is shown, but the small RNA intron clusters were 
conserved in all five small RNA libraries.
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Figure 5.18 Intergenic and intronic small RNA clusters in top2A 
Small RNA clusters in top2A are displayed in the IGV browser as in Figure 5.16. The 
small RNAs cluster in intergenic regions upstream of the top2A gene and in introns. 
The small RNA clusters are conserved in the X. tropicalis stage 8, 10, 18 and stage 10 
animal and vegetal small RNA libraries. A 10 kb scale bar is shown. 
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5.2.6 Correlation of small RNA intron clusters with gene expression by 
mRNA sequencing  
Small RNAs such as siRNAs, microRNAs and piRNAs negatively regulate gene 
expression post-transcription (see section 1.4). Moreover, small RNAs can silence gene 
expression by remodelling chromatin to a transcriptionally inactive state in Arabidopsis, 
yeast, Drosophila and mammalian systems (Gonzalez et al., 2008; Pal-Bhadra et al., 
2004; Swiezewski et al., 2007; Verdel et al., 2004). In order to investigate whether there 
was a correlation between the presence of an intronic small RNA cluster in a gene and 
its expression level, Illumina sequencing of mRNA libraries from the same stages in X. 
tropicalis development as the small RNA libraries was performed.  
mRNA sequencing gives a readout of transcript levels which is superior in sensitivity 
for differential gene expression in comparison to microarrays (Marioni et al., 2008). As 
described in section 2.7, I extracted total RNA from X. tropicalis embryos obtained by 
in vitro fertilisation at stages 8, 10 and 18 and mRNA libraries were prepared by the 
Advanced Sequencing Facility at the Cancer Research UK London Research Institute. 
The quality of the mRNA sequencing was confirmed by alignment of the mRNA-seq 
reads to the X. tropicalis genome (Table 5.4) and assessing read coverage of exons of 
developmental genes that are known to be expressed at stages 8, 10 and 18.  
The quality of the alignment of mRNA-seq reads back to the genome was not as high 
as the small RNA-seq alignment: between 25-28 % of mRNA-seq reads aligned to the 
genome with two mismatches, in contrast to 49-59 % of small RNA-seq reads with zero 
mismatches. However, this does not take into account mRNA-seq reads that align over 
an exon-exon boundary. Including these spliced mRNA reads increased the mRNA-seq 
alignment to between 35-39 %. The mRNA seq reads aligned to exons as expected, and 
the expression of ODC, Gsc and MyoD by mRNA-seq matched their known expression 
profiles (Figure 5.19). ODC is expressed at the same level as stages 8, 10 and 18 in X. 
tropicalis, (Paris et al., 1988) and this is observed by the high numbers of mRNA-seq 
reads aligning in the sense orientation to exons of ODC in all the mRNA-seq libraries. 
Goosecoid is highly expressed at stage 10 and declines in expression post-stage 16 (Cho 
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et al., 1991), and this is mirrored in the mRNA-seq read alignments. MyoD1 is 
expressed from stage 14 onwards in Xenopus (Hopwood et al., 1989), and this is 
reflected by no mRNA seq reads aligning in the stage 8 and 10 mRNA libraries and 
many reads aligning in the stage 18 library. The overall percentage of genes undergoing 
at least a 5-fold or 10-fold change in gene expression by mRNA-seq between stages 8, 
10 and 18 was analysed to gain an impression of the proportion of genes undergoing 
developmental regulation in the early X. tropicalis embryo (Table 5.5). 31 % of genes 
increased or decreased in transcript levels by at least 5-fold, and 19.6 % by at least 10-
fold, indicating that 31 % of genes undergo substantial developmental regulation. 
mRNA 
library 
Number of raw 
mRNA-seq 
reads 
% of raw reads that 
align to the genome   
(2 mismatches) 
% of raw reads 
aligning to the genome 
including spliced reads 
Stage 8 26,595,676 25.4 39.3 
Stage 10 25,522,643 25.4 35.3 
Stage 18 26,716,900 28.1 38.2 
Table 5.4 Overview of mRNA sequencing quality 
mRNA sequencing reads from stage 8, stage 10 and stage 18 X. tropicalis whole 
embryos were aligned to version 4.1 of the X. tropicalis genome. The number of raw 
reads obtained in each library and the percentage of raw reads aligning to the genome is 
shown. Note these are unspliced alignments that do not include mRNA-seq reads over 
an exon-exon boundary.   
 
 
mRNA expression % of genes 
At least 5-fold change  31.0 
At least 10-fold change 19.6 
Table 5.5 Developmentally-regulated gene expression measured by mRNA 
sequencing 
mRNA sequencing reads from stage 8, stage 10 and stage 18 mRNA libraries were 
normalised to allow comparison of gene expression across the libraries and analysed for 
fold changes in mRNA-seq read numbers. The percentage of genes undergoing at least a 
5-fold or a 10-fold change (increase or decrease) in gene expression between stages 8, 
10 and 18 is shown. To account for genes where one stage had zero mRNA-seq reads, 
zero reads was set at 1 read for calculation of fold changes.  
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Figure 5.19 mRNA-seq read alignments to odc1, goosecoid and myod1 are exonic 
and match their known expression profiles  
mRNA seq read alignment to the exons of odc1, goosecoid (Gsc) and myod1 in the 
stage 8, stage 10 and stage 18 mRNA libraries. IGV browser annotation is the same as 
Figure 5.16. A 2 kb scale bar for all genes is shown. Spliced mRNA-seq reads are 
indicated by a blue line connecting reads that span exon-exon boundaries. 
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Since multi tag small RNAs were the most enriched in introns compared to unique 
and intermediate tags, for subsequent analysis I focused on multi-tag small RNA intron 
clusters. In total, 6991 X. tropicalis genes were hit by a multi-tag in an intron at stage 8, 
6860 genes were hit at stage 10 and 7165 genes were hit at stage 18 (Table 5.6). Multi 
tags were allowed to align in either the sense or antisense orientation. When the overlap 
of all genes hit by intronic small RNAs was compared between stages 8, 10 and 18, 
strikingly, 88 % of the genes were common to all three libraries (Figure 5.20).  
To determine whether a gene was ‘on’ or ‘off’ by mRNA-seq, I defined ‘on’ as at 
least 50 % of exons contained at least one mRNA seq read alignment in the sense 
orientation and ‘off’ if the criteria for ‘on’ were not met (i.e. less than 50 % of exons 
were hit by an mRNA-seq read). As described in Table 5.6, approximately 63 % of all 
genes were ‘on’ at stages 8, 10 and 18. When genes containing an intronic multi tag hit 
were analysed, a very similar percentage of genes were ‘on’ and ‘off’ compared to all 
genes (~ 63 % and 37 % respectively), suggesting that gene expression is not affected 
by the presence of an intronic small RNA hit and that many intronic small RNAs are 
located in genes that are actively transcribed. Intronic small RNAs aligned to ‘on’ and 
‘off’ genes in the sense and antisense orientations in approximately equal proportions 
(Table 5.7).  
Genes with intronic small RNA hits were then sorted by the mean number of small 
RNA hits per intron for further analysis (Table 5.8). Although there appears to be no 
global correlation between the presence of intronic small RNAs and gene expression 
(Table 5.6), when the genes hit by intronic small RNAs are sorted by highest intronic 
small RNA density, 70 % of the top 20 genes are ‘off’ and 66 % of the top 50 genes are 
‘off’, indicating that genes with the most intronic small RNAs may be silenced. This is 
compared to 37 % of all genes containing an intronic small RNA hit being ‘off’. The 
gene categories hit by small RNAs in Table 5.8 include histones, chromatin-associated 
proteins, RING-domain containing proteins, membrane proteins (transporters and 
receptors) and metabolism and signalling proteins. This suggests that intronic small 
RNAs may silence the expression of these genes. 7 of the top 50 genes changed from 
‘off’ to ‘on’ or vice versa between stages 8 and 18, indicating that the expression of 
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most genes with high intronic small RNA density is not developmentally regulated 
between late-blastula and neurula stage.  
 
Figure 5.20 Overlap of genes hit by intronic small RNAs 
Venn diagram of genes hit by intronic small RNAs at stage 8, stage 10 and stage 18 in 
X. tropicalis.  
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mRNA 
library 
% all genes 
ON 
% all 
genes 
OFF 
Number of 
genes hit by 
intronic 
small RNAs 
% intronic 
hit genes 
ON 
% intronic 
hit genes 
OFF 
Stage 8 62.8 37.2 6991 63.3 36.7 
Stage 10 63.8 36.2 6860 63.9 36.1 
Stage 18 62.5 37.5 7165 61.9 38.1 
Table 5.6 Correlation of small RNA intron clusters and gene expression 
Genes were classed as ‘on’ if at least 50 % of exons contained at least one mRNA seq 
read alignment in the sense orientation and ‘off’ if the criteria for ‘on’ were not met. 
The ‘on’ or ‘off’ status of all genes is compared to genes with at least one multi tag 
intronic small RNA (intronic hit genes).  
 
mRNA library 
% of ON 
genes with 
sense intronic 
small RNAs 
% of ON 
genes with 
antisense 
intronic small 
RNAs 
% of OFF 
genes with 
sense intronic 
small RNAs 
% of ON 
genes with 
antisense 
intronic small 
RNAs 
Stage 8 50.6 49.4 52.2 49.4 
Stage 10 51.0 49.0 52.2 49.0 
Stage 18 50.7 49.3 52.1 49.3 
Table 5.7 Percentage of sense and antisense intronic small RNAs in ON and OFF 
genes 
Genes that were classified as ‘on’ or ‘off’ were analysed for whether the intronic small 
RNAs reads were aligning in the sense or antisense orientation. Note that in this table, 
‘on’ is defined as at least one mRNA seq read aligning to an exon and ‘off’ is defined as 
zero mRNA seq reads aligning to exons.   
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Mean small RNA hits per 
intron 
Gene ‘on’ or ‘off’ 
by mRNA-seq 
Gene st 8 st 10 st 18 st 8 st 10 st 18 
histone cluster 2 H2ab 440,429 322,159 311,823 ON ON ON 
zinc binding alcohol 
dehydrogenase domain 292,776 297,161 233,488 OFF OFF OFF 
bromodomain and PHD finger 
containing 3 252,899 228,102 201,725 OFF OFF OFF 
SH2B adaptor protein 3 249,408 209,543 202,728 ON OFF OFF 
myosin 15A_isoform1 226,892 184,136 174,395 OFF OFF OFF 
interferon-induced protein 
with tetratricopeptide repeats 5 154,045 201,024 131,011 OFF OFF OFF 
transmembrane protein 11 146,025 92,939 101,487 ON ON ON 
solute carrier family 47  142,675 154,358 107,829 OFF OFF OFF 
myosin 15A_isoform5 131,859 137,462 102,097 OFF OFF OFF 
c16orf57 129,686 158,498 119,128 OFF OFF OFF 
copper metabolism (Murr1) 
domain containing 1 108,629 89,929 82,036 ON ON ON 
butyrophilin subfamily 2 
member A1 99,908 74,720 76,182 ON ON OFF 
C1q and tumor necrosis factor 
related protein 4 91,375 99,362 76,198 OFF OFF OFF 
solute carrier family 39 (zinc 
transporter), member 3 90,311 91,575 75,337 OFF OFF OFF 
phosphoribosylformylglycina
midine synthase  85,971 62,323 66,045 OFF OFF OFF 
ring finger protein 5  85,625 71,398 63,881 ON ON ON 
hypothetical protein 
LOC100145503 82,294 94,414 68,400 OFF OFF OFF 
Cdk5 and Abl enzyme 
substrate 2  81,805 94,102 67,726 OFF OFF OFF 
KIAA0895 protein 80,850 78,774 63,053 OFF OFF OFF 
histone cluster 1, H4a 78,096 44,922 53,412 OFF OFF OFF 
LY6/PLAUR domain 
containing 6 73,118 108,350 72,031 OFF OFF ON 
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opioid binding protein/cell 
adhesion molecule-like 68,940 82,189 71,997 OFF OFF OFF 
brain abundant membrane 
attached signal protein 68,210 83,176 49,073 OFF OFF ON 
chromodomain helicase DNA 
binding protein 9 65,253 81,976 65,657 OFF OFF OFF 
sirtuin 4 64,148 88,764 57,847 OFF OFF OFF 
DNA-directed DNA 
polymerase kappa 63,440 74,628 46,308 ON ON OFF 
hypothetical protein 
LOC100170434 58,576 35,705 38,469 OFF OFF OFF 
yippee-like 2 58,213 65,725 46,950 OFF OFF OFF 
small G protein signaling 
modulator 1 57,450 68,699 42,758 OFF OFF OFF 
microphthalmia-associated 
transcription factor 54,893 38,810 40,095 OFF OFF OFF 
ornithine decarboxylase 
antizyme 2 53,943 44,475 40,039 ON ON ON 
novel C3HC4 type (RING 
finger) and B-box zinc finger 
protein with SPRY domain 53,482 42,491 36,430 OFF OFF OFF 
U3 small nucleolar 
ribonucleoprotein homolog 50,650 40,562 37,754 ON ON ON 
guanylate binding protein 2 50,551 41,749 37,775 OFF ON OFF 
chromobox homolog 6 49,334 44,218 37,897 ON ON OFF 
t-SNARE domain containing 1 48,279 54,001 36,018 OFF OFF OFF 
interferon-induced protein 
with tetratricopeptide repeats 5 43,356 42,465 40,060 OFF OFF OFF 
cell adhesion molecule 2 
precursor 42,396 27,970 31,093 OFF OFF OFF 
solute carrier family 7, 
member 6 opposite strand 41,838 26,768 29,529 ON ON ON 
arylsulfatase D 39,807 51,362 36,997 OFF OFF OFF 
deleted in malignant brain 
tumors 1_isoform1 38,899 54,236 35,062 ON OFF OFF 
deleted in malignant brain 
tumors 1 _isoform2 38,899 54,236 35,062 OFF OFF OFF 
cytochrome P450 family 2  37,226 20,440 24,742 OFF OFF OFF 
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ring finger protein 126 36,894 30,931 27,714 ON OFF OFF 
interferon gamma receptor 1 36,732 27,298 28,467 ON ON ON 
c17orf103 36,458 23,194 25,321 ON ON OFF 
synapse differentiation- 
inducing 1 36,093 37,787 26,533 OFF OFF OFF 
der-like domain containing 2 34,492 28,879 25,725 ON ON ON 
beta-transducin repeat- 
containing 34,192 28,703 25,620 ON ON ON 
crystallin, lambda 1 32,370 26,973 24,439 ON ON OFF 
Table 5.8 Gene expression status of the top 50 genes hit by intronic small RNAs 
X. tropicalis genes containing intronic small RNA hits were sorted by the mean number 
of small RNA hits per intron and 50 genes with the highest intronic small RNA density 
are displayed. The mean number of small RNA intron hits at stage 8, 10 and 18 are 
listed, with the corresponding expression status of the gene at stages 8, 10 and 18 as 
determined by mRNA-seq transcriptome profiling. ‘On’ and ‘off’ are defined as in 
Table 5.6. 
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5.3 Discussion 
5.3.1 Summary of results 
• The 95 % of small RNA reads that were previously unannotated were fed 
into a novel microRNA prediction pipeline, with a 50 % experimental 
validation rate to yield three novel microRNAs, xtr-miR-A, xtr-miR-C and 
xtr-miR-F.  
• xtr-miR-F is expressed from neurula stage to tadpole stage and is conserved 
in X. laevis, where it is expressed from stage 12 onwards.  
• Morpholino inhibition of xtr-miR-F causes defects in posterior and axis 
development, whereas in X. laevis, an additional effect on eye development 
and fewer melanocytes are observed when xla-miR-F is inhibited. 
•  Dicer mRNA expression increases between stages 10 and 18, similar to 
global microRNA expression. 
• Xenopus miR-F is conserved in four human cell lines, and miR-F levels are 
lower in the breast cancer cell line, MDA-MB-231 compared to 
untransformed cell lines. 
• The unannotated reads were subject to annotation according to their 
multiplicity in the genome and were classified as multi, unique and 
intermediate tags. 
• Genome-wide clustering of unannotated small RNAs into high and low 
blocks revealed that more unannotated small RNA reads fell into high 
blocks, whereas more tags fell into low blocks. 
• The majority of unannotated small RNAs that aligned to genes aligned to 
introns, not exons. 
• Clusters of intronic small RNAs were observed in many genes. 
• mRNA-seq transcriptional profiling of the stage 8, 10 and 18 X. tropicalis 
embryo allowed a comparison between the presence of small RNA intron 
clusters and gene expression levels. 
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• There is no global correlation between gene expression level and the 
presence of an intronic small RNA. 
• Genes with the highest density of small RNA intronic hits are mainly ‘off’ 
(66 % of the top 50 genes with intronic hits compared to 37 % of all genes). 
• Genes with high intronic small RNA densities are chromatin-associated 
proteins, RING domain proteins and membrane proteins (receptors and 
transporters). 
 
The aim of the work presented in this chapter was to characterise and investigate a 
function for the 95-98 % of the X. tropicalis early development small RNAome that 
could not be annotated by comparison to databases of known small RNAs. I found three 
novel microRNAs within the unannotated reads, which validates the prediction of 
microRNAs from small RNA-seq reads based on hairpin-folding criteria. Importantly, I 
showed that one novel microRNA, xtr-miR-F was conserved in Xenopus laevis and in 
all human cell lines tested. Human miR-F levels are lower in the breast cancer cell line 
MDA-MB-231 compared to the more normal lymphoblastoid cells and keratinocytes 
(HaCats), which suggests that it may be worth investigating if miR-F is downregulated 
in cancer. Global down-regulation of microRNAs is thought to be a feature of cancer 
(Kumar et al., 2007; Lu et al., 2005) and therefore studying the effect of loss and gain of 
function of miR-F in human cell lines would potentially reveal whether miR-F plays a 
role in cancer development, for example as a tumour suppressor. Previous work has 
shown that microRNAs can act as oncogenes (e.g. the miR-17-92 cluster) (Mendell, 
2008), tumour suppressors (e.g. let-7) (Johnson et al., 2005) and initiate metastasis in 
cancer (miR-10b)(Ma et al., 2007). Moreover, inhibition of the microRNA-processing 
enzyme Dicer by miR-103/107 has been shown to promote EMT in mammalian systems 
(Martello et al., 2010b).  
X. tropicalis Dicer morphant embryos showed a stabilisation of pre-miR-F and a 
reduction in mature miR-F at stage 18 (an increase of 10.2 % in the pre-miRNA: mature 
miRNA ratio, Figure 5.6), suggesting that miR-F is partially Dicer-dependent in X. 
tropicalis. miR-F and xla-miR-427 showed some Dicer-dependency in later stages of X. 
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laevis development (tadpole and tailbud stage respectively), as a reduction in mature 
miRNA levels was observed at these stages when Dicer was inhibited with a 
morpholino. This suggests that miR-F and xla-miR-427 are stable, which agrees with 
previous work showing that mature microRNAs have a half-life of days (Baccarini et 
al., 2011). miR-F is conserved in humans where there is only one Dicer gene 
(DICER1(Flicek et al., 2011)), therefore siRNA knockdown of DICER1 in mammalian 
cells and Northern blot analysis for miR-F would reveal whether miR-F is Dicer-
dependent and eliminate the possibility that there are multiple Dicer genes in Xenopus.  
 However, not all microRNAs require Dicer for their processing; miR-451 has been 
reported as an Argonaute-2-dependent microRNA in mouse and zebrafish (Cheloufi et 
al., 2010b; Cifuentes et al., 2010). The stability of microRNAs and the existence of 
more Dicer-independent microRNAs may explain the late phenotypes of Dicer 
knockdown (reduced eye and neural crest development) shown in Figure 3.21. I found 
that Dicer mRNA levels in X. tropicalis vastly increase between stages 10 and 18, 
reminiscent of global microRNA expansion in diversity and abundance between stages 
10 and 18. This suggests that Dicer is developmentally regulated to facilitate increased 
microRNA processing as development progresses. 
As well as uncovering novel microRNAs contained within the unannotated reads, a 
genome-wide annotation of the unknown reads revealed that most of the reads cluster 
together in contiguous regions of the genome that are hit by multi tags (high blocks). 
When the reads are compressed into tags, low blocks are favoured, which suggests that 
multi tags are high copy number as well as aligning to multiple loci in the genome. The 
most abundant unknown reads had a tag length of 28 nt. When the unannotated reads 
were aligned to genes, they showed a strong bias towards intronic alignment in both the 
sense and antisense orientations. Small RNA intron clusters are present in many genes, 
and small RNAs often hit multiple introns in a gene. Determining the extent to which 
the intronic small RNAs align to repetitive sequences and the level of duplication of 
intronic small RNA binding sites in the genome will be important for investigating the 
potential function of the intronic small RNAs. Many repetitive elements in the genome 
such as transposon integration sites direct the formation of regulatory small RNAs such 
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as piRNAs (Brennecke et al., 2007), and therefore a bias towards repetitive sequence 
elements would not exclude a functional role for intronic small RNAs. 
 Previous studies addressing unknown reads obtained in small RNA-seq have also 
revealed novel small RNAs with a non-random clustering in the genome. For example, 
‘tiny’ RNAs of sizes around 18 nt were found to associate with transcriptional start sites 
when small RNA-seq data from mammalian cells, chicken embryo and Drosophila was 
analysed (Taft et al., 2009). ‘Tiny’ RNAs generally correlated with active transcription 
and the activatory H3K4 mark. ‘Tiny’ RNAs were suggested to arise from RNA 
polymerase stalling or backtracking on the promoter, as tiny RNAs originate from the 
same strand as the promoter. Another study revealed the existence of 19 nt small RNAs 
in Hela cells that were derived from Dicer-dependent cleavage of tRNA (Cole et al., 
2009). Examination of small RNA-seq data from humans, monkeys and rats led to the 
discovery of ‘miRtrons’ in mammals (Berezikov et al., 2007). miRtrons are microRNAs 
that are generated by splicing excision of introns from mRNA instead of Drosha 
cleavage in the nucleus (Okamura et al., 2007). Potentially, some of the intronic small 
RNAs I identified could be miRtrons, although the 20-30 nt size range of intronic small 
RNAs peaks at 28 nt, in contrast to the 22-23 nt size of microRNAs. In short, a wealth 
of novel small RNAs with roles in gene regulation have been found by further 
investigation of unannotated small RNA-seq reads.  
In order to determine whether the intronic small RNAs I found by small RNA-seq 
correlated with active gene expression or silencing, transcriptome profiling by mRNA-
sequencing was carried out at the same developmental stages in X. tropicalis as the 
small RNA libraries. Small interfering RNAs (siRNAs) can silence gene expression 
post-transcription in most organisms (notable exceptions are Xenopus and zebrafish) 
and was initially demonstrated in animals in C. elegans (Fire et al., 1998). In C. 
elegans, an RNA-dependent RNA polymerase (Ego-1) synthesises antisense 22 nt 
siRNAs that bind to the target mRNA to trigger post-transcriptional gene silencing 
(Maniar and Fire, 2011). In contrast to the small RNAs I sequenced, which were a range 
of sizes from 20-30 nt and aligned in both the sense and antisense orientation to introns, 
the C. elegans siRNAs aligned in the antisense orientation to exons.  
Chapter 5. Analysis of unannotated small RNAs 
 294 
An RNA-dependent RNA polymerase is also required for siRNA amplification and 
siRNA-mediated post-transcriptional gene silencing in plants (but not in 
vertebrates)(Baulcombe, 2004). Whereas shorter plant siRNAs (21- 22 nt) correlate 
with target mRNA degradation, long plant siRNAs (24-25 nt) can also mediate gene 
silencing by directing heterochromatin formation via histone H3K9 methylation and 
DNA methylation (Hamilton et al., 2002; Zilberman et al., 2003). Small RNA-seq data 
in Arabidopsis showed that ‘heterochromatic’ plant siRNAs align to repetitive 
sequences (e.g. transposons) and are absent from known protein-coding genes 
(Kasschau et al., 2007). This contrasts with the intronic location of the small RNA 
clusters I sequenced, although how repetitive the intronic small RNA loci are has not 
yet been analysed.   
Intriguingly, previous Arabidopsis small RNA-seq studies have interpreted clusters of 
siRNAs as possible sites of biogenesis (Zhang et al., 2007). siRNA clusters that align to 
one strand of the genome are thought to originate from single-stranded mRNA folded 
into hairpins and processed by Dicer-like enzymes. siRNA clusters that align to both 
strands of the genome are suggested to originate from dsRNA synthesised by an RNA-
dependent RNA polymerase or from overlapping sense and antisense transcripts 
(overlapping transcription) (Zhang et al., 2007). Furthermore, antisense transcription of 
the Arabidopsis Flowering Locus C 3’UTR (a protein repressor of flowering) produces 
two siRNAs of length 24 nt and 30 nt that match one strand at the 3’ end of the gene 
and mediate chromatin silencing via H3K9 methylation (Swiezewski et al., 2007). 
When the genomic region corresponding to the siRNAs is mutated, the Flowering locus 
C gene is de-repressed and flowering is delayed (Swiezewski et al., 2007).  
Since the intronic small RNAs I sequenced align to the genome in the sense and 
antisense orientations in approximately equal proportions (Table 5.7), and are located in 
a coding region, it is plausible that the intronic small RNAs originate from overlapping 
transcription and subsequent cleavage. As overlapping transcription can produce 
siRNAs of different lengths in Arabidopsis, this would fit with the intronic small RNA 
length distribution of 21-30 nt, (peaking at 28 nt) I observe (Figure 5.14). A further 
example of overlapping transcription contributing to small RNA-mediated epigenetic 
silencing is miRNA-directed chromatin remodelling of the INK4/ARF locus in 
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mammalian cells, which requires an antisense transcript overlapping the promoter 
(Gonzalez et al., 2008). The long, antisense non-coding RNAs ANRIL and Xist are also 
synthesised by transcription in the opposite direction to their target genes and are 
known to mediate gene repression of their complementary loci by recruitment of the 
PRC2 complex and remodelling of chromatin to a transcriptionally silent conformation 
via H3K9 methylation (Kotake et al., 2011) (Chow and Heard, 2009).  
Other examples of small RNAs negatively regulating gene expression at the level of 
chromatin include siRNA-directed chromatin remodelling in yeast (Verdel et al., 2004). 
Heterochromatin formation in yeast is directed by the RNAi-Induced Transcriptional 
Silencing (RITS) complex that contains siRNA bound to Ago2 and a chromodomain 
chromatin-binding protein (Chp1) and is mediated by methylation of histone H3K9, 
which recruits the yeast homologue of heterochromatin protein 1(HP1). piRNA 
silencing of transposons is also thought to have an epigenetic component, as mutating 
piRNA biogenesis components relieves silencing of genes normally found in 
heterochromatin (Pal-Bhadra et al., 2004).  
With these observations in mind, intronic small RNAs in X. tropicalis genes may 
negatively regulate gene expression, at either the posttranscriptional level (siRNA-like 
mechanism) or by transcriptional silencing via chromatin remodelling. When the 
expression of all X. tropicalis genes was compared to those with intronic small RNA 
hits, there was no difference in global gene expression. However, genes with the highest 
number of small RNA hits per intron were mainly ‘off’ (70 % of the top 20) and the 
genes were in non-random categories such as chromatin-related proteins and membrane 
proteins (transporters or receptors), suggesting that intronic small RNAs may silence 
these genes.  To investigate epigenetic silencing of genes with high numbers of intronic 
small RNA hits, histone modifications on the genes could be assessed by analysing an 
X. tropicalis genome-wide Chip-Seq dataset where the activatory and repressive 
chromatin marks (trimethylated lysine 4 on histone H3, and H3K27 respectively) and 
RNA polymerase II binding were correlated with gene expression by mRNA-seq 
(Akkers et al., 2009), or by comparing to H3K9 methylation (another activatory histone 
modification). This would reveal if genes with intronic small RNAs were associated 
with distinct activatory or repressive chromatin modifications that correlate with their 
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level of gene expression. Peaks of RNA polymerase II binding near small RNA clusters 
may indicate a possible mechanism of small RNA biogenesis. The existence of 
intergenic small RNA clusters upstream of genic regions suggests that the same analysis 
of mRNA-seq gene expression correlation with the presence of intergenic small RNA 
clusters could be performed to investigate whether intergenic small RNAs target 
promoter or enhancer regions to regulate gene expression. In summary, the intronic 
small RNA clusters in the previously uncharacterised 95-98 % of the X. tropicalis early 
development RNAome merit further investigation as they may be a new class of novel 
regulatory small RNAs and will be discussed further in Chapter 6.   
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Chapter 6. Concluding Discussion 
The aims of this thesis were to characterise the role of small RNAs as regulators in 
early vertebrate development, firstly by investigating the mechanism of spatial 
regulation of Xenopus Cripto-1, a coreceptor for the Nodal signalling pathway, and 
secondly, by genome-wide sequencing of the small RNAome of the early X. tropicalis 
embryo.  
6.1 Summary of Results 
• Spatial regulation of Xenopus Cripto-1 translation in the gastrula-stage embryo 
is required for control of Nodal signalling timing and magnitude during germ 
layer specification and is critical for normal embryonic development. 
• MicroRNA regulation of Nodal signalling occurs at the level of coreceptor via 
xla-miR-427 targeting of XCR1. 
• Spatial regulation of XCR1 via its 3’ UTR is partially Dicer-dependent and is 
mediated by three sequence elements in the 3’ UTR of XCR1α: 2 necessary 
spatial elements and an RNA-stabilising element. 
• Genome-wide sequencing of the early X. tropicalis embryo revealed that there 
were between ~370,000 and 740,000 unique small RNAs present (Table 4.2), of 
which more than 95 % were previously uncharacterised in any species. 192 
microRNAs were identified in the early X. tropicalis embryo, of which 163 were 
new to Xenopus but had been identified in other species. 64 piRNA sequences 
were also identified.  
• MicroRNA expression increases between late-blastula and late-neurula stages, 
with microRNAs expanding in both diversity and abundance, which correlates 
with increased Dicer mRNA expression. MicroRNAs showed a bias towards 
expression in the animal pole (prospective ectoderm) in gastrula-stage embryos. 
• In contrast, stable piRNA expression is observed between blastula and neurula 
stages with no bias towards animal or vegetal pole localisation in gastrula-stage 
embryos. 
• Characterisation of a novel microRNA, miR-F, uncovered a role in posterior, 
axial, eye and melanocyte development in Xenopus, and conservation in human 
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cell lines with lower miR-F levels detected in a breast cancer cell line compared 
with untransformed cell lines.  
• Characterisation of the unannotated small RNA reads led to the identification of 
novel intronic small RNA clusters, which may silence expression of genes with 
the highest intronic small RNA density as revealed by transcriptome profiling of 
the early embryo. These genes include chromatin-associated proteins, RING-
domain proteins and membrane proteins.   
6.2 Implications of the results and future work 
6.2.1 Regulation of Cripto-1 and Nodal signalling in development and 
cancer 
An unbiased mapping approach led me to identify 3 critical elements in the XCR1 3’ 
UTR required for spatial regulation. Utilising the list of X. tropicalis microRNAs 
expressed at the same stages of development as XCR1 spatial regulation from my 
genome-wide small RNA sequencing led to the identification of a critical 5’ TATTAG 
sequence beginning at nucleotide 360 in the 3’ UTR that reverts spatial regulation when 
mutated. However, the microRNA or RNA-binding protein regulators that interact with 
this site, or the RNA-stabilising and second spatial elements remain uncharacterised. 
Spatial regulation occurred at the level of translation, showed 3’ UTR-dependency and 
partial Dicer-dependency, indicating a role for microRNA regulation. As discussed in 
section 3.3.4, potential spatial regulators interacting with the 5’ TATTAG sequence 
include the RNA-binding protein QKI (of which there are two pseudoalleles in X. 
laevis, qki-a and qki-b) and xtr-miR-187 (mmu-miR-187 was sequenced at stage 10). 
Moreover, the RNA-binding protein Hur/ELAV has multiple predicted sites in the 
minimal 3’ UTR sequence. QKI and Hur/ELAV can promote RNA stability and QKI 
can also act as a translational repressor, which could explain repression of XCR1 
translation in the vegetal pole.  
In order to test whether these proteins or miRNAs spatially regulate XCR1, loss of 
function studies by morpholino coinjection with GFP-3’ UTR reporter mRNAs to assay 
spatial regulation should be carried out. Determining the expression profiles of these 
candidate regulators, and their localisation in the embryo at stages 8 and 10 may reveal 
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whether spatial localisation of an RNA-binding protein or mature microRNA 
contributes to the mechanism of XCR1 spatial regulation. Interplay between RNA-
binding proteins and microRNAs may also be important, as several studies have 
indicated the proximity of Hur, Pumilio and DND1 sites to microRNA binding sites and 
the influence of RNA-binding proteins on RNA secondary structure alterations or 
miRNA binding site occlusion (Mukherjee et al., 2011) (Kedde et al., 2007; Kedde et 
al., 2010). RNAi in Xenopus and microRNA overexpression by injection of double-
stranded precursors and Ago mRNA should now be possible due recent work showing 
that limiting Ago protein prevents RNAi in Xenopus (Lund et al., 2011). The effect of 
Ago protein loss and gain of function on spatial regulation would also be illuminating, 
as loss of Ago function should rescue spatial regulation if microRNAs are responsible. 
Ago gain of function should enhance any miRNA-mediated repression. Interestingly, 
the interaction of Ago with GW182 proteins (Eulalio et al., 2008) suggests another 
mechanism of miRNA-mediated translational repression of XCR1 in the vegetal pole, 
as GW182 proteins can inhibit translation initiation via Ago recruitment to the 3’ UTR.  
I showed that XCR1 in the animal cap was negatively regulated by xla-miR-427, a 
critical regulator of embryogenesis in zebrafish and Xenopus and of cell fate in human 
embryonic stem cells. MicroRNAs therefore regulate Nodal signalling in early 
vertebrate development at the level of Nodal coreceptor expression, as well as targeting 
ligands, receptors and inhibitors in zebrafish and frogs. xla-miR-427 activity did not 
affect spatial regulation or target the 3’ UTR of XCR1. However a seed match site in the 
coding region remains to be tested, which could be done by injection of a xla-miR-427 
target protector complementary to the coding region miR-427 site. The human miR-427 
homologue, miR-302 only targets the Nodal inhibitor Lefty in human ES cells, thereby 
upregulating Nodal signalling. Since Nodal is secreted by melanomas and signalling is 
reactivated in prostate cancer, it would be interesting to profile the expression of miR-
302 in melanoma and prostate cancer cells, to explore whether miR-302 function is 
involved in aberrant Nodal signalling in these cancers. A search for Lefty expression in 
cancer in the Oncomine database (Rhodes et al., 2007) reveals downregulation of Lefty 
mRNA in B-cell lymphoma and upregulation of Lefty mRNA in oesophageal cancer and 
testicular carcinoma and seminoma.  
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Cripto-1 is overexpressed in many cancers and is a stem cell marker, consistent with 
its expression in early development when embryonic cells are pluripotent. Since Cripto-
1 is repressed by xla-miR-427 and xla-miR-427 promotes differentiation into 
mesodermal cell fates, it would be intriguing to analyse whether loss of miR-427/302 
promotes Cripto-1 expression in cancer and inhibits differentiation, a feature of tumour 
cells (Hanahan and Weinberg, 2000). The potential for 3’ UTR mediated microRNA 
regulation of human Cripto-1 has not yet been fully explored, as I tested whether 
regulators present in the Xenopus embryo could confer spatial regulation of the human 
3’ UTR (Figure 3.13). MicroRNA regulation of human Cripto-1 could be investigated 
in human ES cells (where Cripto-1 is expressed) using luciferase-3’UTR reporters with 
mutated microRNA binding sites. A survey of predicted Cripto-1 microRNA binding 
sites in TargetScan (www.targetscan.org) reveals three highly conserved 8 nt exact 
microRNA seed matches in the 3’ UTR; hsa-miR-516a-3p, hsa-miR-299-5p and hsa-
miR-338-5p.  
6.2.2 Small RNA regulation in early vertebrate development  
I performed a genome-wide small RNA sequencing study of the early X. tropicalis 
embryo when it became clear from working on the mechanism of spatial regulation of 
XCR1 that very few microRNAs had been identified in early Xenopus laevis 
development, as most of the known miRNAs had been cloned in adult X. tropicalis 
tissues. I showed that microRNAs increase in abundance and diversity from late-
blastula to neurula stage, agreeing with previous studies of global microRNA 
expression in early zebrafish development. This result is also consistent with the role of 
microRNAs as regulators of differentiation, as the embryo becomes less pluripotent 
with the specification of more tissue types between gastrulation and neurulation, and 
with global microRNA downregulation in cancer leading to inhibition of tumour cell 
differentiation. Moreover, microRNAs were enriched in the animal pole compared to 
the vegetal pole at gastrulation, which may contribute to the differentiation of neural 
tissue in the prospective ectoderm, as neural-specific expression of microRNAs has 
been widely reported (Walker and Harland, 2008; Wienholds et al., 2005).  
MicroRNAs have been sequenced in unicellular organisms such as C. reinhardtii 
(Molnar et al., 2007), suggesting that they existed before complex organisms evolved, 
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however, a comparative microRNA profiling study reveals that microRNAs are more 
diverse in complex animals compared to simpler animals such as Nematostella 
(anemone), suggesting that microRNA expansion is linked to evolutionary progression 
(Grimson et al., 2008). Moreover, the lesser severity of miRNA knockouts in animals 
such as C. elegans compared to the mouse (Smibert and Lai, 2008) suggests that 
microRNA control of gene expression is essential in vertebrates.  
I also showed that 64 piRNA sequences were present in the early X. tropicalis embryo 
and that piRNAs were less abundant and dynamic than microRNAs. The main function 
of piRNAs is thought to be suppression of transposons in the germline to preserve 
genomic integrity for subsequent gamete production (Lin and Spradling, 1997). 
Recently, other studies have sequenced piRNAs in somatic tissues (e.g. mouse 
pancreas) (Yan et al., 2011), suggesting that piRNAs exist and may have a function 
outside of germline development. Since piRNAs were not sequenced in adult X. 
tropicalis tissues in a previous study (Armisen et al., 2009), it is possible that piRNA 
transcription is not maintained into adulthood as the embryo develops. The function of 
piRNAs in somatic cells could also be to silence non-transposon repeats and maintain 
heterochromatin repression of repetitive elements in the genome.  
In order to take the small RNA sequencing dataset forward to further explore the role 
of small RNAs in early vertebrate development, the function of the most abundant and 
spatially localised microRNAs and piRNAs could be studied in more detail. For 
example, morpholino loss of function or dsRNA overexpression (gain of function) 
experiments could be performed for microRNAs where the mammalian homologues are 
not well-characterised, for example, cfa-miR-30e, the second most abundant microRNA 
I sequenced or hsa-miR-1825, which strikingly accounts for 50 % of miRNAs reads in 
the vegetal pole at stage 10. Full experimental validation of the piRNA sequences 
should be performed, firstly to confirm a biochemical interaction with Piwi proteins and 
the presence of the 3’ 2-O-methyl modification, a distinguishing feature of piRNAs. 
The presence of endo-siRNAs in X. tropicalis was suggested by the presence of 21- 24 
nt small RNA species in the small RNA-seq dataset, but this was not characterised 
further. A comparison of X. tropicalis 21-24 nt small RNA sequences to the recently 
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identified endo-siRNAs in mouse ES cells could be used to profile endo-siRNA 
expression in early X. tropicalis development (Babiarz et al., 2008).  
By examination of the previously unannotated small RNA reads, I identified 3 novel 
microRNAs and characterised one, miR-F, in detail. This microRNA will be named by 
sequence similarity on submission to the miRbase microRNA database. The expression 
profile and phenotype of miR-F depletion in Xenopus morphants suggested roles in 
axial, posterior, eye and melanocyte development. In situ hybridisations for molecular 
markers of neural development (e.g. N-tubulin) and neural crest development (Slug and 
Snail) may give more insight on the mechanism of miR-F activity in early development. 
Since miR-F is conserved in mammalian cells, miR-F knockdown or overexpression in 
cell culture followed by mRNA-seq would identify direct mRNA targets without the 
complications of multiple tissue interactions in the Xenopus embryo. More extensive 
profiling of miR-F in normal and cancer cell lines should be carried out to determine 
whether the lower levels of miR-F observed in the breast cancer cell line MDA-MB-231 
compared to untransformed cell lines is a more general occurrence, and if so, the 
question of the role of miR-F in tumourigenesis could be investigated.   
I also identified a novel class of intronic small RNAs by examining where the 
unannotated reads aligned in the X. tropicalis genome. Firstly, the genomic sequence 
that the small RNAs align to could be compared to the Repbase database of eukaryotic 
transposon, LINE, SINE and LTR and other genomic repeats (Jurka et al., 2005) to 
assess if some of the small RNA target sequences are derived from transposon 
integration or other repeats. This could illuminate the function of this novel class of 
small RNAs, as repeat-associated RNAs can be involved in transposon silencing, or 
heterochromatic silencing of repetitive regions (see sections 1.5.1 and 1.5.3). Since the 
small RNAs are 21-28 nt in length, map to introns in the sense and antisense orientation 
and align to genic regions, it is possible that the small RNAs are derived from 
overlapping sense and antisense transcription and subsequent cleavage into small 
RNAs, in a mechanism similar to endo-siRNA biogenesis. This could be tested by RT-
PCR amplification of antisense transcripts and analysing the Dicer and Ago2 
dependency of the small RNAs. Also, to further investigate the question of where and 
how the intronic small RNAs are made, RNA polymerase II binding near or overlapping 
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an intronic small RNA cluster could be analysed by comparing my small RNA-seq data 
with a genome-wide Chip-seq dataset including RNA polymerase II binding in X. 
tropicalis (Akkers et al., 2009). Moreover, the abundance and expression profiles of 
intronic small RNAs could be analysed by small RNA-qPCR.  
 Although there was no global correlation of gene expression with the presence of an 
intronic small RNA cluster by mRNA-seq, 66 % of the 50 genes with the highest 
number of intronic small RNA hits were ‘off’ compared to 37 % of all genes with 
intronic hits being ‘off’, suggesting that intronic small RNAs could negatively regulate 
the genes they align to. This could be via a mechanism involving chromatin-mediated 
epigenetic silencing. This could be tested by looking for repressive chromatin 
modifications on genes hit by intronic small RNAs. For example, chromatin 
modifications could be analysed by comparison to a genome-wide Chip-seq dataset for 
activatory H3K4 trimethylation and repressive H3K27 trimethylation deposition in X. 
tropicalis (Akkers et al., 2009), or by Chip-Seq for repressive marks such as 
trimethylated H3K9 or HP-1 binding. This analysis could be extended to include the 
intergenic small RNA clusters I observed (Figure 5.18) to investigate a possible role in 
gene regulation. In short, the unanswered questions regarding the novel intronic small 
RNAs are where are they synthesised from in the genome, what regulates their 
biogenesis and most importantly, what effect, if any, do they have on gene regulation? 
The presence of histones, chromatin-associated proteins and RING-finger containing 
proteins in the genes with the highest density of intronic small RNAs is suggestive of a 
role in chromatin remodelling, which remains to be explored. Other genes were 
membrane proteins and ‘housekeeping’ genes, suggesting that intronic small RNAs 
target non-random categories of genes. This may indicate a role for intronic small 
RNAs in regulating timing of replication or spatial control of gene expression in the 
nucleus (Sexton et al., 2007).  
6.2.3 Implications of the genome-wide sequencing approach 
The genome-wide small RNA sequencing and mRNA sequencing datasets provide an 
important resource cataloguing the small RNAome and gene expression profile of early 
X. tropicalis development that will be available to the research community on 
publication of this work. 95 % of the X. tropicalis early development small RNAome 
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could not be identified by comparison to known small RNAs, suggesting that there are 
many small RNAs and possible regulatory mechanisms in the early embryo that we do 
not yet understand. However, in this study, I characterised the unannotated reads by 
their abundance and clustering in the genome and experimentally validated a novel 
microRNA prediction pipeline starting from unannotated reads with a success rate of 50 
%, i.e., 50 % of the predicted novel miRNAs were experimentally validated. Also, by 
analysing the genomic alignment of unannotated small RNAs, I noticed that most small 
RNAs that align to genes are intronic, and by integration of the small RNA-sequencing 
with genome-wide mRNA sequencing, the expression of the targeted genes was 
assessed to explore a possible function of intronic small RNAs in gene regulation. This 
illustrates the power of combining genome-wide sequencing technologies such as small 
RNA-seq and mRNA-seq, or Chip-seq and mRNA-seq to correlate histone 
modifications with gene expression to assess if global mechanisms of gene regulation 
exist. For example, to investigate whether microRNA or siRNA play a global role in 
regulation of the chromatin landscape as some studies have suggested, genome-wide 
Chip-sequencing for histone modifications in Dicer and Ago2 mutant zebrafish 
compared to wild type animals could be compared.  
Small RNA-sequencing in this thesis has raised the questions of what roles do 
piRNAs, novel microRNAs and intronic small RNAs play in early development. 
Previous work has shown that pursuing unannotated reads that appear to be distributed 
non-randomly in the genome can lead to the identification of new classes of small 
RNAs that give insight onto mechanisms of gene regulation. For example ‘tiny’ RNAs 
are associated with the promoter of actively transcribed genes in human, chicken and 
Drosophila, where they are suggested to be products of RNA polymerase stalling or 
backtracking (Taft et al., 2009).  
The microRNAs I identified in the early X. tropicalis embryo can be used as a list of 
candidate regulators of any developmental process occurring between late-blastula and 
late-neurula stage, such as dorso-ventral patterning, EMT in germ layer specification 
and neural crest migration, or neural patterning. For example, the microRNAs present at 
stages 8 and 10 in X. tropicalis were screened for perfect seed matches to the critical 
regulatory region of the Xenopus Cripto-1 3’ UTR which led me to identify the 
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necessary element for spatial regulation of XCR1, which is essential for the spatial 
control, timing and magnitude of Nodal signalling. Another example of how the dataset 
could be developed is screening for novel microRNA regulators of EMT within the 
newly identified X. tropicalis miRNAs to investigate how microRNAs outside the miR-
200 family might regulate EMT in development and in cancer. I have obtained a list of 
new microRNAs with exact seed matches to the 3’UTRs of the key EMT genes Snail1, 
Snail2, Sox9, Sox10, Twist1 and Twist2, all of which are expressed in the neurula stage 
embryo. To begin with, GFP-3’UTR wild-type and microRNA-binding site mutant 
reporters could be analysed for miRNA-mediated repression in the Xenopus embryo and 
the role of microRNA regulation of EMT genes could then be explored in mammalian 
systems. In summary, this thesis has generated a wealth of data that is the starting point 
for understanding how small RNAs regulate signalling and patterning embryonic tissues 
in early vertebrate development.  
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Table 6.1 List of miRbase version 17 microRNAs sequenced in the X. tropicalis 
small RNA libraries 
hsa-miR-4753-3p rno-miR-3557-5p dme-miR-994-5p mcmv-miR-m01-3* 
ppt-miR1023e-3p hsa-miR-30a* gga-miR-140* osa-miR166e 
gma-miR4395 rno-miR-3596c cte-miR-184b sme-miR-2a-2* 
aly-miR4239 pma-miR-1b dme-miR-9c-5p cin-miR-4001d-5p 
rno-miR-465* ssc-miR-320 dme-miR-995-3p oar-miR-543-3p 
cte-miR-31 bmo-miR-1b* dsi-miR-1012 gma-miR1520p 
pma-miR-25b hsa-miR-378c dme-miR-317-3p oan-miR-454* 
bfl-miR-34b-5p rno-miR-455* oan-miR-7-1* sko-miR-4818b* 
hsa-miR-452* mmu-miR-322* dme-miR-313-5p tgu-miR-146b* 
pab-miR947 mmu-miR-1b-5p pma-miR-30b mmu-miR-3084 
oan-miR-187* cel-miR-44-3p hsa-miR-92a-2* bdi-miR5199 
ppy-miR-576-5p cte-miR-1 rno-miR-322* hsa-miR-4768-5p 
oan-miR-1421y-2* dme-miR-279-3p ssc-miR-1306-5p dps-miR-2572* 
ame-miR-3794 dme-miR-312-3p dme-miR-1011-3p vvi-miR3627 
rno-miR-3553 hsa-miR-103b mmu-miR-23b* mmu-miR-92a-2* 
dre-miR-140* oar-miR-379-5p crm-lin-4 csi-miR3946 
bfl-miR-182c pma-miR-128 mmu-miR-350 gga-miR-1553* 
hsa-miR-4443 pma-miR-1c ppc-miR-63b hsa-miR-4645-3p 
mmu-miR-669a-5p dme-miR-34-5p gga-miR-126 oan-miR-146a 
cel-miR-2953-3p dme-miR-31a-5p hsa-miR-4692 dme-miR-4-3p 
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tca-miR-29-3p rno-miR-291b hsa-miR-4530 tae-miR5086 
hsa-miR-3925-5p dre-miR-202* mmu-miR-149* mmu-miR-674* 
mmu-miR-3096-5p xtr-miR-199a* zma-miR164d* mmu-miR-106b* 
hsa-miR-4451 dme-miR-311-5p hsa-miR-4454 mmu-miR-28* 
tca-miR-3791-3p dme-miR-14-5p oan-miR-92c tca-miR-100-5p 
bmo-miR-3259 mmu-miR-1a bfl-miR-4896 api-miR-263b 
cel-miR-4816 dme-miR-10-5p sme-bantam-c* dme-miR-8-5p 
ppy-miR-920 hsa-miR-3591-3p cte-miR-317 rno-miR-3554 
dps-miR-2567c* api-miR-184b hsa-miR-3196 mmu-miR-3963 
pma-miR-16 cel-miR-54-5p cin-miR-4154-3p oan-miR-15b 
rgl-miR5142 mmu-miR-466i-3p bhv1-miR-B10 aae-miR-124 
tca-miR-2944c-5p hsa-miR-23b* bfl-miR-71* hsa-miR-3074-5p 
oar-miR-370-5p bta-miR-26c aly-miR4236 ssc-miR-151-3p 
hsa-miR-3127-5p rno-miR-3543 dme-miR-999-3p ppy-miR-199b-5p 
bmo-miR-2779 mmu-miR-3095-3p mmu-miR-3098-3p mmu-miR-3074-5p 
oar-miR-1185-3p rno-miR-582* bta-miR-2889 hsa-miR-202* 
cin-miR-4034-5p bta-miR-3604 tgu-miR-460a* dme-miR-124-3p 
bta-miR-2898 rno-miR-3556b rno-miR-351* rno-miR-202 
pma-miR-4571-3p bfl-let-7a* bta-miR-2890 gga-miR-202* 
gma-miR156g tca-miR-7-5p bfl-miR-4857 ssc-miR-146b 
dps-miR-2574a rno-miR-92b* osa-miR2866 hsa-miR-4485 
sme-miR-13 mmu-miR-92b* cin-miR-1-3p cel-miR-239a* 
oan-miR-196a* pma-miR-194 xtr-miR-181a-2* aly-miR847* 
rno-miR-3573-3p ssc-miR-365-5p hsv1-miR-H7 rlcv-miR-rL1-34-3p 
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aly-miR838 dme-miR-7-5p gga-miR-449b* hsa-miR-3907 
dme-miR-2501-3p lgi-miR-96b mmu-miR-5109 ptr-miR-922 
bmo-miR-3242 mmu-miR-669b* rno-miR-3571 hsa-miR-4497 
hsa-miR-33a* crm-miR-87* bta-miR-2897 hsa-miR-4459 
mmu-miR-140* dps-miR-2574b pta-miR783 ppt-miR390c 
mmu-miR-1963 crm-miR-35e nvi-miR-281 bmo-miR-2818 
bmo-miR-2840 ath-miR5021 zma-miR482 zma-miR171k* 
xtr-miR-181a-1* hsa-miR-3545-5p pma-miR-1a dme-miR-975-5p 
dps-miR-2555* rno-miR-3590-5p hsa-miR-3656 ssc-miR-2476 
pma-miR-143 bta-miR-2957 mmu-miR-5119 
mmu-miR-3102-
3p.2 
zma-miR395a* cbr-miR-71 api-miR-275 hsa-miR-4762-5p 
api-miR-29 rno-miR-3586-3p aae-miR-275 rno-miR-3542 
pma-miR-203a hsa-miR-499a-5p dme-miR-275-3p cbr-miR-2226 
hsa-miR-4486 mmu-miR-101c cqu-miR-8 bmo-miR-3404 
aly-miR822* tgu-miR-456 dme-miR-92a-5p cte-miR-29b 
tca-miR-989-3p crm-miR-48 pma-miR-192 pma-miR-130a 
sko-miR-4819* mmu-miR-365-1* aae-miR-92a tca-miR-3872-5p 
ppy-miR-16 pma-miR-29a tca-miR-9b-3p ppy-miR-1233 
pma-miR-152a rno-miR-3545-5p 
mmu-miR-3102-
5p.2 
rno-miR-3597-5p 
hsa-miR-30c-2* pma-miR-22b mmu-miR-5107 hsa-miR-3607-3p 
mmu-miR-5110 cte-miR-34 rno-miR-194* tca-miR-92b-3p 
hsa-miR-4732-5p cte-miR-29a hsa-miR-378f dre-miR-1788* 
bta-miR-2399* pma-miR-22a hsa-miR-194* tgu-miR-200a* 
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crm-miR-40 rno-miR-17-1-3p hsa-miR-19a* mdo-miR-200a* 
rno-miR-208 crm-miR-1 oan-miR-205* oan-miR-19a* 
dps-miR-989 oan-miR-92a-1* mmu-miR-19a* rno-miR-203* 
mmu-miR-30e* dme-miR-31b-5p ssc-miR-199a* mmu-miR-130b* 
cte-miR-2695 bfl-miR-4885a oan-miR-200b* ssc-miR-133b 
bmo-miR-3312 mmu-miR-3057-3p cel-miR-77-5p tgu-miR-200b* 
bta-miR-2904 crm-miR-75 rno-miR-3596b tgu-miR-489 
pma-miR-203a* osa-miR5075 hsa-miR-92b* rno-miR-133a* 
hsa-miR-1224-3p iltv-miR-I1* mmu-miR-1934* hsa-miR-3153 
rno-miR-221* tca-miR-263a-5p dme-miR-310-3p rno-miR-34a* 
pma-let-7d cte-miR-1987 dme-miR-311-3p mmu-miR-301a* 
dps-miR-2513b aae-miR-263a mmu-miR-18a* dme-miR-219-5p 
hsa-miR-221* rno-miR-146a* dme-miR-276a-3p mmu-miR-3102 
dme-miR-989-3p mtr-miR2634 mmu-miR-363-5p rno-miR-3552 
tca-let-7-5p cel-miR-55* dme-miR-304-5p tgu-miR-34c 
far-miR1134 oar-miR-487b-5p aae-miR-14 aae-miR-13 
dme-miR-306-5p ame-miR-989 dme-miR-278-5p tgu-miR-1329 
bfl-miR-125b mtr-miR2595 dme-miR-8-3p dps-miR-2517b 
tca-miR-3858-3p cte-miR-10c bta-miR-3602 ssc-miR-335 
bfl-let-7b ssc-miR-206 aae-miR-31 rno-miR-3556a 
oan-miR-221* mtr-miR2673a hsa-miR-3120-5p xtr-miR-9a* 
bta-miR-3600 gga-miR-146b dps-miR-137* mmu-miR-205* 
csi-miR3949 dme-miR-988-3p tgu-miR-124* dre-miR-19a* 
rno-miR-3596d hsa-miR-4286 hsa-miR-4252 dme-miR-210-3p 
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pma-let-7c bta-miR-146a aae-miR-276 hsa-miR-130b* 
rno-miR-423* crm-miR-63* dme-miR-14-3p rno-miR-3582 
tgu-miR-30b-3p ppc-miR-63a dme-miR-79-3p rno-miR-205 
bta-miR-193a cel-miR-54-3p hsa-miR-18a* hsa-miR-34a* 
mmu-miR-30c-1* mmu-miR-378b aae-miR-317 egr-miR-124b 
mmu-miR-25* hsa-miR-378d cte-miR-7 xtr-miR-9a 
cte-miR-71 mmu-miR-5128 cqu-miR-210 cte-miR-92c 
mmu-miR-221* mmu-miR-1306-5p dme-miR-263a-5p oan-miR-205 
dme-miR-184-3p crm-miR-80 hsa-miR-877* pma-miR-200b 
dme-miR-1-3p dme-miR-970-3p dre-miR-3906 pma-miR-9a* 
dme-let-7-5p crm-miR-249 tca-miR-31-5p dme-miR-92a-3p 
hsa-miR-25* mmu-miR-17* oan-miR-1349  
bta-miR-3596 dme-miR-305-3p ssc-miR-199b  
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